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Summary 
 
Biological systems are made up of very large numbers of different components 
interacting at various scales. Most genes, proteins and other cell components carry 
out their functions within a complex network of interactions and a single component 
can affect a wide range of other components. Interactions involved in biological 
processes have been previously characterized individually, but this „„reductionist‟‟ 
approach suffers from a lack of information about time, space, and context in which 
the interactions occur in vivo. A global, integrative, approach has been developed for 
several years, focusing on the building of protein-protein interaction maps 
(interactomes). These interaction networks are complex systems, where new 
properties arise. This is part of an emergent field, called systems biology which is 
„„the study of an organism, viewed as an integrated and interacting network of genes, 
proteins and biochemical reactions which give rise to life‟‟ 
(http://www.systemsbiology.org/). This interdisciplinary approach, involving 
techniques from the mathematical, computational, physical and engineering sciences 
is required to understand complex networks. Detailed knowledge of protein 
interactions and protein complex structures is therefore fundamental to understand 
how individual proteins function within a complex and how the complex functions as a 
whole.  
This PhD thesis targeted the characterization by structural and functional proteomics 
approaches of selected protein complexes involved in relevant molecular processes 
and can have an impact on their industrial applications. The following systems of 
biotechnological interest have been analysed in this study: 1) Phenol Hydroxylase 
(PH) from Pseudomonas sp. OX1. It is a bacterium endowed with the ability to grow 
on a wide spectrum of hydroxylated and non-hydroxylated aromatic compounds for 
this reason it can be use in bioremediation of contaminated environments. In this 
context the research has been aimed at characterizing the endogenously expressed 
Phenol Hydroxylase (PH) complex from Pseudomonas sp. OX1, using biochemical 
approaches integrated to mass spectrometry analysis. Moreover, in order to define 
the protein-protein interaction networks of this complex a functional proteomic 
approach was carried out. 2) Characterization of the complex between pLG72 
and human D-amino acid oxidase (hDAAO), linked to the onset of 
schizophrenia. The molecular basis of schizophrenia is still elusive and current 
treatments focus on eliminating the symptoms of the disease. The clarification of the 
role of this specific complex and the identification of other physiological or conditional 
partners in this biochemical process will be useful in developing molecules that can 
be effective in the disease treatment. 
Moreover, as a parallel goal, and strictly connected with the former issue, I worked at 
3) the development of an innovative structural analysis approach based on the 
use of a femtosecond UV laser as a novel zero length protein-protein cross-
linker. Such photo-physical approach could obviate many of the problems 
associated with standard chemical cross-linking reagents, and put cross-linking in a 
proteome-wide position for the characterizations of protein-protein interactions in vivo 
in intact cells, the study of the transient interactions among proteins, mapping 
molecular interfaces in protein complexes, providing information on the dynamics of 
the contacts within a multi-protein complex.  
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Riassunto 
  
I sistemi biologici sono costituiti da un elevato numero di diverse componenti 
che interagiscono tra loro su vari livelli e che svolgono la propria funzione all‟interno 
di una complessa rete di interazioni. La disciplina volta a studiare gli organismi 
biologici nella loro interezza è la systems biology che, focalizzandosi sull‟intero 
sistema di geni e prodotti genici, ha l‟obiettivo di comprendere gli effetti delle 
interazioni tra le componenti di un dato sistema e come quest‟ultimo interagisca con 
il suo ambiente [1]. Affinché ciò sia possibile è necessario conoscere i meccanismi 
molecolari che sono alla base di tali interazioni. 
Tra le diverse macromolecole, presenti nella cellula, le proteine sono le più versatili e 
sono coinvolte nella maggior parte dei processi cellulari. Le proteine svolgono il loro 
ruolo biologico grazie alla particolare conformazione che assumono. La possibilità di 
subire cambiamenti conformazionali, modifiche post-traduzionali e di modulare le 
interazioni proteina-proteina, conferisce a queste macromolecole la capacità di 
adattarsi rapidamente ai bisogni cellulari. La capacità delle proteine di assemblarsi in 
diversi complessi proteici all‟interno dell‟ambiente cellulare, consente inoltre a queste 
macromolecole di svolgere ruoli funzionali diversi. 
Negli ultimi anni è cresciuto l‟interesse da parte della comunità scientifica per lo 
studio della funzione biologica delle proteine e la comprensione, a livello molecolare, 
dei meccanismi cellulari in cui sono coinvolte. Le proteine, infatti, non agiscono da 
sole ma si è stimato che oltre l‟80% di esse è organizzato in complessi. Infatti, la 
maggior parte dei meccanismi molecolari richiede l‟azione coordinata di un elevato 
numero di proteine che si assemblano in complessi multiproteici. Inoltre, la quasi 
totalità dei processi biologici è diretta e regolata da una cascata dinamica di segnali 
che comporta interazioni transienti proteina-proteina.  
Siccome il ruolo di una proteina riflette la fitta rete di interazioni che è in grado di 
formare, è possibile inoltre ottenere informazioni sulla  funzione di una molecola 
proteica anche attraverso la caratterizzazione dei suoi interattori molecolari. 
Studiare l‟eterogeneità delle proteine, sia da un punto di vista delle interazioni che 
esse instaurano all‟interno della cellula, che della loro funzione, sta ricoprendo un 
ruolo sempre più importante. Ciò è fondamentale non solo per comprendere come 
sia evoluta la loro funzione nel tempo, o quale sia il loro riconoscimento cellulare, ma 
anche per lo sviluppo delle biotecnologie. In questo settore, infatti, la natura versatile 
delle proteine può essere utilizzata per la progettazione di nuovi farmaci (settore 
biomedico) e per ottimizzare le applicazioni dell‟ingegneria proteica (settore 
industriale), al fine di utilizzare le proteine in modo innovativo [2].  
L‟identificazione e la caratterizzazione strutturale dei complessi multiproteici è, 
quindi, di fondamentale importanza per lo studio della loro funzione biologica e della 
conoscenza dei più importanti meccanismi molecolari cellulari [3].  Lo studio della 
rete di interazioni che presiedono al funzionamento dei complessi proteici può essere 
importante, infatti, non solo dal punto di vista della conoscenza stessa, ma anche dal 
punto di vista applicativo, immaginando di poter intervenire nei processi di interesse 
biologico, bloccando o immettendo specifici segnali che intervengano sulle 
interazioni proteina-proteina, o anche modulando la composizione di tali complessi 
[4]. Sono state sviluppate numerose metodologie, come ad esempio il sistema del 
doppio ibrido, o tecniche di coimmunoprecipitazione, per identificare i partner proteici 
all‟interno di un complesso e determinare se due o più proteine interagiscono in vivo. 
Tuttavia l‟organizzazione strutturale delle subunità che costituiscono un complesso 
non è sempre accessibile con questi approcci e, al tempo stesso, l‟identificazione di 
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interazioni transienti o caratterizzate da costanti di dissociazione alte, risulta 
estremamente difficile.  
E‟ necessario, quindi, sviluppare tecniche o strategie di analisi che permettano lo 
studio di interazioni proteina-proteina su scala proteomica, e che abbiano cinetiche 
che consentano la caratterizzazione di interazioni transienti in contesti cellulari. 
L‟integrazione di metodologie quali la proteolisi complementare, il cross-link, già 
patrimonio della più classica chimica delle proteine, con le tecniche avanzate di 
spettrometria di massa può offrire un valido apporto in campi quali: i) la validazione di 
modelli di struttura, ii) l‟analisi strutturale e delle variazioni conformazionali in sistemi 
dinamici, iii) lo studio delle interazioni proteina-proteina.  
La finalità del presente progetto di dottorato è stata l‟applicazione di metodiche di 
biochimica classica integrata a tecniche di spettrometria di massa e lo sviluppo di 
metodologie e strategie atte a caratterizzare e identificare complessi proteici in vitro e 
in vivo, in sistemi molecolari di interesse biotecnologico che non si prestavano ad 
analisi ad alta risoluzione. In particolare la mia attività di ricerca è stata incentrata su 
i) lo studio strutturale del complesso enzimatico della fenolo ossidrilasi da 
Pseudomonas sp. OX1, ii) la caratterizzazione del complesso hDAAO-pLG72 
coinvolto nella patologia schizofrenica. iii) Parallelamente, la mia attività di ricerca è 
stata volta alla messa a punto di una metodologia innovativa che utilizza un laser 
pulsato a luce ultravioletta per indurre cross-link proteina-proteina. 
 
Sistema della fenolo ossidrilasi da Pseudomonas sp. OX1. 
Il complesso enzimatico della fenolo ossidrilasi da Pseudomonas sp. OX1 
appartiene alla famiglia delle monoossigenasi batteriche ed è in grado di 
metabolizzare diversi composti aromatici ad elevato impatto ambientale; riveste 
pertanto un particolare interesse nel biorisanamento e nelle applicazioni di sintesi 
industriale [5,6]. Tale ceppo batterico è stato isolato da fanghi attivi di scarichi 
industriali ed è capace di crescere utilizzando come unica fonte di carbonio e di 
energia diverse molecole aromatiche tra cui benzene, fenolo, toluene, o-xilene, 2,3 e 
3,4-dimetilfenolo e i cresoli. Nel genoma di P. sp. OX1 è presente una regione ph 
(phenol hydroxylase) che codifica per un‟attività fenolo ossidrilasica, che catalizza 
reazioni di monossigenazione dell‟anello aromatico. Nel locus genico ph, sono state 
inizialmente identificate cinque ORFs (open reading frames) codificanti per le cinque 
subunità costituenti il complesso, denominate PHL, PHM, PHN, PHO, PHP. La 
subunità PHP, un‟ossidoreduttasi contenente FAD e un cofattore ferredossinico del 
tipo [2Fe-2S], rappresenta il primo accettore di elettroni nella catena di trasporto. Da 
tale subunità gli elettroni sono trasferiti al subcomplesso dimerico PH(LNO)2 che 
rappresenta la componente ossidrilasica del sistema. La subunità PHM ha attività 
regolatoria e, nonostante non sia ancora completa una dettagliata caratterizzazione 
del suo ruolo, la sua presenza è indispensabile per l‟attività catalitica dell‟intero 
complesso PH. Recentemente, a monte del gene codificante per la subunità PHL, è 
stata identificata una sesta orf, denominata phK omologa alla proteina DmpK della 
fenolo ossidrilasi espressa dal batterio Pseudomonas CF600. E‟ importante 
sottolineare che la delezione del gene phk non consente ai ceppi di CF600 di 
crescere utilizzando il fenolo come unica fonte di carbonio e di energia, indicando il 
ruolo fondamentale che la subunità riveste nell‟ambito del complesso, sebbene 
DmpK non sia indispensabile ai fini dell‟attività catalitica [7]. È stata dunque avanzata 
l‟ipotesi che DmpK, pur non partecipando direttamente agli eventi catalitici che 
portano alla ossidrilazione del substrato, rivesta un ruolo fondamentale durante 
l‟assemblaggio del sito attivo della componente ossidrilasica.  
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Con il mio lavoro, in collaborazione con il gruppo del Prof. Di Donato del dipartimento 
di Biologia Strutturale e Funzionale dell‟Università di Napoli “Federico II”, ho 
contribuito a caratterizzare il ruolo funzionale di PHK. 
Esprimendo il cluster genico della fenolo ossidrilasi in E. coli in presenza dell‟orf 
codificante per PHK, si è osservato un aumento dell‟attività ossidrilasica, suggerendo 
quindi un effetto positivo da parte della proteina accessoria sull‟attività enzimatica 
della fenolo ossidrilasi. 
Sono stati condotti diversi esperimenti incubando il complesso della fenolo ossidrilasi 
PH(LNO)2 in presenza delle singole componenti purificate PHK e PHM, ed in 
presenza o in assenza di ferro, analizzando i prodotti mediante cromatografia ad 
esclusione molecolare integrata a tecniche di spettrometria di massa. 
I dati ottenuti, parallelamente alla caratterizzazione enzimatica condotta presso il 
gruppo del Prof. Di Donato, hanno contribuito a formulare un modello caratterizzato 
da eventi molecolari in cui è evidenziato il possibile ruolo di PHK. Il modello prevede 
che PHK si lega inizialmente, in modo transiente, al complesso apo-PH(LNO)2 
favorendo l‟inserimento di ferro intracellulare all‟interno del sito attivo e portando alla 
formazione della specie holo-PH(LNO)2. In seguito alla dissociazione di PHK si ha il 
legame della componente regolativa PHM che sembra proteggere il ferro all‟interno 
del sito attivo, evitandone il rilascio, come è anche possibile osservare dalla struttura 
cristallografica. Una volta completato il ciclo di ossidrilazione, PHM si dissocia in 
modo da permettere alla reduttasi PHP di legarsi all‟esamero e iniziare un nuovo un 
ciclo catalitico. La dissociazione di PHM permetterebbe il legame di PHK con la 
conseguente formazione del complesso inattivo PHK-PH(LNO), che si 
riorganizzerebbe a formare la specie apo-PH(LNO)2. 
A conferma che PHK possa formare in vivo un complesso con la fenolo ossidrilasi, è 
stato condotto un esperimento di pull down incubando un estratto cellulare di 
Pseudomonas sp. OX1 con PHK, precedentemente biotinilata, immobilizzata su 
resina di avidina. L‟analisi degli interattori molecolari effettuata mediante 
spettrometria di massa ha mostrato che PHK interagisce in modo specifico con il 
complesso ossidrilasico PH(LNO)2. 
I dati ottenuti sono stati recemente pubblicati: Izzo V, et al (2010) Archives of 
Biochemistry and Biophysics. 
 
Caratterizzazione del complesso hDAAO-pLG72 coinvolto nella patologia 
schizofrenica.  
Altro oggetto di studio della mia tesi di dottorato è stata l‟analisi strutturale e 
funzionale del complesso costituito dalle proteine hDAAO e pLG72, coinvolto nella 
patologia schizofrenica. Il ruolo fisiologico della DAAO nel cervello è di controllare i 
livelli di D-serina, un attivatore allosterico del recettore N-metil-D-aspartato (NMDA) 
[8]. La degradazione della D-serina, causata dalla DAAO, impedisce il suo legame al 
recettore NMDA, necessario per la trasmissione dell‟impulso nervoso [9]. Si ipotizza 
che un‟ipofunzionalità dei recettori NMDA potrebbe essere l‟origine molecolare di 
alcuni sintomi della schizofrenia [10]. L‟associazione tra alterazione del metabolismo 
della D-serina e la schizofrenia è stata dimostrata in studi che hanno evidenziato la 
diminuzione dei livelli di D-serina nel liquido cerebrospinale e nel siero di pazienti 
schizofrenici [11]. Studi recenti [12] hanno inoltre collegato l‟insorgenza della 
patologia schizofrenica alla formazione di un complesso di DAAO con pLG72, 
proteina di cui non è nota la struttura e la funzione. 
Recenti studi in vitro condotti dal gruppo del Prof. Pollegioni, dell‟università 
dell‟Insubria di Varese, con cui questo progetto è condotto in collaborazione, hanno 
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evidenziato la formazione di un complesso di circa 200 kDa costituito da due 
omodimeri di hDAAO (80kDa x 2) e due molecole di pLG72 (20kDa x 2), con una KD 
di formazione del complesso di circa 8 x 10-6M [13]. Inoltre esperimenti in vivo di co-
immunoprecipitazione e immunofluorescenza hanno dimostrato che entrambe le 
proteine sono espresse nello stesso tipo cellulare, gli astrociti della corteccia 
cerebrale umana, e presentano una parziale colocalizzazione subcellulare. 
La caratterizzazione di questo complesso, oltre a fornire dettagli molecolari 
sull‟insorgenza della malattia, è fondamentale per la progettazione di farmaci mirati 
alla cura della patologia, piuttosto che al trattamento dei soli sintomi. 
La caratterizzazione strutturale del complesso è stata, dapprima, condotta con 
esperimenti di proteolisi limitata e complementare. Gli esperimenti sono stati condotti 
seguendo nel tempo la cinetica di rilascio dei vari peptidi e sono stati impiegati 
enzimi proteolitici a diversa specificità di substrato. 
Inoltre, l‟indagine è stata condotta sulle proteine hDAAO e pLG72 isolate e sul 
complesso in modo da poter successivamente confrontare la topologia dei siti di 
idrolisi preferenziali e quindi definire le regioni delle proteine coinvolte in variazioni 
conformazionali indotte dalla formazione del complesso. 
Dal confronto della topologia della proteina hDAAO in assenza e in presenza della 
proteina pLG72 è risultato evidente che la formazione del complesso provoca 
profonde modifiche conformazionali. La prima osservazione generale è che hDAAO 
quando è in complesso con pLG72 è molto più accessibile all‟azione delle proteasi, 
infatti, sono state utilizzate condizioni d‟idrolisi molto più stringenti che per hDAAO 
isolata. Quest‟osservazione è peculiare del complesso in questione, in quanto, 
solitamente si osserva una riduzione della flessibilità ed accessibilità globale delle 
singole molecole proteiche quando si associano a formare un complesso. La 
seconda osservazione è la sostanziale diversificazione dei siti d‟idrolisi nei due casi. 
La regione C-terminale della proteina, estremamente accessibile in hDAAO isolata, 
risulta decisamente meno esposta nel complesso hDAAO-pLG72. La formazione del 
complesso induce cambiamenti strutturali radicali in altre regioni della proteina: i siti 
L189, R191, L194 e i siti E249, L250 localizzati in due diversi loop della molecola non 
sono più accessibili in presenza di pLG72. Questa variazione è accompagnata dalla 
concomitante esposizione di diversi residui, Y34, Y55, F167, N180, L296 e R297, 
distribuiti lungo la sequenza e non accessibili in assenza di pLG72. 
E‟ possibile inoltre ipotizzare che la formazione del complesso renda la struttura di 
pLG72 meno esposta all‟azione delle proteasi, poiché da un‟analisi qualitativa 
preliminare delle cinetiche d‟idrolisi, si può osservare una minore accessibilità in 
presenza di hDAAO.  
Esperimenti di cross-linking chimico con un reattivo omobifunzionale, integrati ad 
analisi di spettrometria di massa, hanno fornito informazioni complementari 
individuando zone di contatto in hDAAO in corrispondenza di quelle regioni che 
risultavano protette all‟azione delle proteasi negli esperimenti di proteolisi limitata 
descritti in precedenza. 
Sulla base della struttura tridimensionale della hDAAO si può dunque concludere che 
i) i siti idrolizzati negli esperimenti si trovano tutti in prossimità del sito di legame del 
cofattore flavinico, ii) i siti di idrolisi nella proteina isolata sono tutti localizzati 
spazialmente in una ristretta regione della struttura, iii) si può ipotizzare che il legame 
con pLG72 determini la protezione dei precedenti siti e l‟esposizione di nuove regioni 
della macromolecola, comunque tutte localizzate nelle immediate vicinanze spaziali 
della zona protetta. 
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Al fine di delucidare i meccanismi molecolari alla base della patologia schizofrenica, 
sono stati condotti esperimenti di proteomica funzionale per individuare nuovi 
interattori delle proteine in questione. A tale scopo hDAAO è stata espressa in cellule 
umane come proteina di fusione con uno specifico peptide (c-Myc), in modo da 
poterla purificare mediante cromatografia di affinità insieme alle proteine a lei 
complessate.  
È in fase di stesura un manoscritto che riporta i risultati ottenuti per la 
caratterizzazione strutturale del complesso hDAAO-pLG72. 
 
Utilizzo di un laser ad impulsi ultrabrevi nella regione dell’UV per lo studio delle 
interazioni proteina-proteina. 
La terza parte del mio progetto di dottorato è consistita nella messa a punto di 
una metodologia innovativa, che prevede l‟utilizzo di un laser UV ultracorto per 
indurre cross-link proteina-proteina. L'uso di un laser pulsato con una durata di 
alcune decine di femtosecondi (fs), unitamente ad un dispositivo che modella 
l'impulso in modo specifico, può fornire numerosi vantaggi rispetto alle strategie 
convenzionali di cross-link delle proteine. Infatti, la scala temporale degli impulsi 
laser ultrabrevi, (intervalli nell‟ordine dei nano- pico o anche femto- secondi) che è 
paragonabile e compatibile con il tempo di emivita delle interazioni transienti 
proteina-proteina, consente di investigare i contatti transienti, la dinamica molecolare 
delle proteine, la flessibilità conformazionale e la cinetica delle interazioni. Ulteriore e 
non minore vantaggio è la prospettiva di utilizzare questa metodologia per ottenere 
informazioni sulla dinamica dei network di complessi proteici in vivo, all‟interno della 
cellula, senza bisogno di ingegnerizzazioni della cellula in esame. Questa parte del 
progetto è stata condotta in collaborazione con il gruppo del Prof. Velotta ed il Dr. 
Altucci del Dipartimento di Fisica, il gruppo della Prof.ssa Piccoli del Dipartimento di 
Biologia Strutturale e Funzionale e il gruppo della Prof.ssa Costello della Boston 
University. 
In letteratura sono presenti studi di questo tipo rivolti soltanto al sistema acidi 
nucleici-proteine [14], in cui è evidenziato che questo tipo di meccanismo coinvolge 
gruppi in grado di assorbire la radiazione emessa dal laser. Inoltre la 
caratterizzazione del processo è incentrata esclusivamente sulle basi azotate e non 
sulle proteine.  
Il punto di partenza di questo studio sono stati i peptidi, un sistema più semplice 
rispetto alle proteine. Sono stati condotti esperimenti utilizzando uno spettro di 
peptidi (xenopsina, angiotensina, interleuchina) che si differenziava per il contenuto 
in aminoacidi. Il sistema modello è stato irraggiato per tempi molto brevi (da 1 sec a 
1 min) utilizzando un‟energia del laser di 110 µJ, ad una frequenza di 2 kHz e ad una 
lunghezza d‟onda di 267 nm. Mediante analisi di massa MALDI-TOF è stato possibile 
osservare in prima analisi che, a seguito dell‟irraggiamento, solo quei peptidi 
contenenti aminoacidi aromatici davano come prodotto specie dimeriche costituite da 
due peptidi covalentemente legati, dimostrando dunque che è possibile indurre la 
formazione di cross-link per irraggiamento con laser UV ultracorto. Al fine di 
localizzare gli aminoacidi coinvolti nel legame, la specie d‟interesse è stata 
sottoposta ad analisi di spettrometria di massa tandem, ed è stato possibile 
individuare quali aminoacidi coinvolti nel legame indotto dal laser, il Trp della 
xenopsina e la Tyr dell‟angiotensina, per l‟etero dimero xenopsina-angiotensina. 
Analogamente il Trp è anche risultato coinvolto nel cross-link dell‟omodimero 
xenopsina-xenopsina.  
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Il passo successivo è stato studiare il meccanismo molecolare alla base di un 
processo di questo tipo. Partendo dall‟ipotesi che il tipo di reazione comporta la 
formazione di specie radicaliche, abbiamo effettuato l‟irraggiamento dei singoli 
peptidi in presenza di molecole quali 2-metile-2-nitrosopropano (MNP) e 5,5-dimetil-
1-pirrolidin N-ossido (DMPO), dette spin trap, specie reattive verso i radicali [15]. 
Anche in questo caso per la xenopsina e per l‟angiotensina era presente l‟addotto 
con lo spin trap, assente invece per l‟interleuchina (che non presenta aminoacidi 
aromatici), dimostrando dunque che a seguito dell‟irraggiamento si generano radicali, 
verosimilmente sulla catena laterale di aminoacidi aromatici. I dati di spettrometria di 
massa tandem hanno confermato tali ipotesi, ovvero il legame dello spin trap è stato 
individuato sul Trp per la xenopsina e sulla Tyr per l‟angiotensina. 
Messo a punto la metodologia, abbiamo aumentato la complessità del sistema 
utilizzando come proteina modello l‟alcool deidrogenasi (ADH) da Saccaromyces 
cerevisiae, proteina omo-tetramerica e contenente diversi aminoacidi aromatici. 
Variando differenti parametri, quali energia del laser, tempo di irraggiamento e 
concentrazione proteica, è stato possibile osservare, mediante elettroforesi 
denaturante, la formazione di aggregati ad alto peso molecolare assenti nella 
rifermento non irraggiato. Considerando la natura radicalica del meccanismo di 
reazione, abbiamo aggiunto alla nostra miscela di analisi un antiossidante, l‟acido 
ascorbico, in concentrazione variabile, con lo scopo di ottenere bande discrete e una 
minore eterogeneità del campione. Le migliori condizioni utilizzate sono risultate, 
energia del laser 220 μJ e aggiunta di acido ascorbico ad una concentrazione finale 
di 5 mM dopo 1 min di esposizione. Mediante elettroforesi denaturante è stato, infatti, 
possibile osservare per i campioni irraggiati la comparsa di specie ad un peso 
molecolare corrispondente al dimero di ADH. La banda di interesse è stata escissa 
dal gel, idrolizzata in situ con tripsina ed analizzata mediante spettrometria di massa 
MALDI-TOF. Nello spettro di massa della miscela peptidica della specie irraggiata è 
stato possibile osservare dei segnali assenti nel riferimento ed imputabili a peptidi 
coinvolti in legami covalenti indotti dal laser.  
Recentemente sono stati ottenuti risultati preliminari su cellule intatte. Abbiamo, 
infatti, esteso la metodologia a cellule umane esprimenti la proteina ricombinante 
ApoA-I, con l‟obiettivo di isolare gli interattori della proteina di interesse. Le cellule 
risospese in un tampone a pH fisiologico sono state irraggiate e in seguito lisate. 
L‟estratto cellulare è stato analizzato mediante western blotting utilizzando l‟anticorpo 
specifico per ApoA-I ed è stato possibile rivelare, ottimizzate le condizioni di 
reazione, oltre alla proteina ricombinante, delle specie ad elevato peso molecolare, 
imputabili alla proteina complessata ai suoi interattori.  
Obiettivo futuro sarà quello di purificare mediante cromatografia di immunoaffinità gli 
interattori della proteina di interesse, dall‟estratto cellulare di cellule irraggiate. Sarà 
così possibile identificare quei partner proteici che in vivo interagiscono in modo 
transiente, avendo congelato mediante UV cross-link anche le interazioni più labili.   
Gli spettri di frammentazione ad alta risoluzione sono stati ottenuti durante la 
permanenza presso il gruppo della Prof.ssa Costello della Boston University, School 
of Medicine, Mass Spectrometry Resource An NIH-Supported Resource Center. 
Si ringrazia il Programma di scambi internazionali promosso dall‟Università di Napoli 
“Federico II”, perché fonte di finanziamento durante la permanenza presso il gruppo 
della Prof.ssa Costello. 
È in corso di stesura un manoscritto che riporta i risultati ottenuti sui peptidi. 
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I. Introduction  
 
  
I.1 Systems biotechnology for strain improvement 
 
The indispensable role of biotechnology is increasing in nearly every industry, 
including the healthcare, pharmaceutical, chemical, food and agricultural industries, 
exponentially with the identification of organisms, isolation of novel compounds and 
their pathways, and the molecular characterization of cellular components. 
Production of large-volume low-value bioproducts requires the development of lower-
cost and higher-yield processes. Towards this goal, improved microorganisms have 
traditionally been developed through random mutagenesis followed by screening 
processes [1]. Rational metabolic and cellular engineering approaches have also 
been successful in improving strain performance in several cases. However, such 
attempts were limited to the manipulation of only a handful of genes encoding 
enzymes and regulatory proteins selected using available information and research 
experience. 
Recent advances in high-throughput experimental techniques supported by 
bioinformatics have resulted in rapid accumulation of a wide range of omics data at 
various levels, thus providing a foundation for in-depth understanding of biological 
processes. As DNA sequencing has become faster and cheaper the genome 
sequences of many microorganisms have been completed and many more are in 
progress. With the complete genome sequence, post-genomic research (the „omics‟ 
fields) is increasing rapidly. New technologies have recently become available, which 
allow a thoroughly high-throughput assessment of changes at gene (genomics) and 
protein (proteomics) levels involved in determining productivity in different 
environmental conditions, and establish functional relationships between cellular 
organization and productivity. Considering that most cellular metabolic activities are 
directly or indirectly mediated by proteins, proteome profiling takes us one step 
further towards understanding cellular metabolic status and for deciphering the 
functions and characteristics of biological systems [2,3]. The central task of systems 
biotechnology is to comprehensively collect global cellular information, such as omics 
data, and to combine these data through metabolic, signalling and regulatory 
networks to generate predictive computational models of the biological systems. 
 
 
I.2 Proteins as molecular machinery 
 
The past decade has experienced a huge leap in the amount of data 
generated from different areas of life sciences and has seen the complete 
sequencing of several eukaryotic genomes. One of these advancements was the 
completion of the Human Genome project in 2003 [4,5]. The new challenge is to 
understand the function of all the genes identified by the human genome project 
shifting the focus from the DNA to proteins.  
Biological systems are made up of very large numbers of different components 
interacting at various scales. Most genes, proteins and other cell components carry 
out their functions within a complex network of interactions and a single component 
can affect a wide range of other components. Vital cellular functions such as DNA 
replication, transcription and mRNA translation require the coordinated action of a 
large number of proteins that are assembled into an array of multiprotein complexes 
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of distinct composition and structure. Similarly, biological processes are orchestrated 
and regulated by dynamic signalling networks of interacting proteins that link 
chemical or physical stimuli to specific effector molecules.  
Since proteins compose most of the functional units in the cell, the complete 
understanding of their role in the cell is very critical in understanding how the cell 
functions. Proteomics focuses on understanding the many aspects of proteins that 
can involve their structures, modifications, localization and their protein-protein 
interactions [6]. 
The analysis of protein complexes and protein-protein interaction networks - and the 
dynamic behaviour of these networks as a function of time and cell state - is 
therefore of central importance in biological research. Interactions involved in 
biological processes have been first characterized individually, but this „„reductionist‟‟ 
approach suffers from a lack of information about time, space, and context in which 
the interactions occur in vivo.  
A global, integrative, approach has been developed for several years, focusing on 
the building of protein-protein interaction maps (interactomes). These interaction 
networks are complex systems, where new properties arise. An interactome is the 
whole set of molecular physical interactions between biological entities in cells and 
organisms and it is essential to understand how gene functions and regulations are 
integrated at the level of an organism. Indeed, many proteins mediate their biological 
function through protein interactions, which are involved in supramolecular 
assemblies (collagens, elastic fibers, actin filaments), in the building of molecular 
machines (molecular motors, ribosomes, proteasome) and in major biological 
processes such as immunity (antigen-antibody interaction), metabolism (enzyme-
substrate interaction), signalling (interaction of messenger molecules, hormones, 
neurotransmitters with their cognate receptors), and gene expression (DNA-protein 
interactions). This is part of an emergent field, called systems biology which is „„the 
study of an organism, viewed as an integrated and interacting network of genes, 
proteins and biochemical reactions which give rise to life‟‟ 
(http://www.systemsbiology.org/) (Fig.I.1). This interdisciplinary approach, involving 
techniques from the mathematical, computational, physical and engineering sciences 
is required to understand complex networks [7].  
Furthermore, the sequencing of the genome and advances in proteomics lead to the 
identification of proteins of unknown functions [8]. Interaction networks might give 
clues on the functions of these newly discovered proteins or on new functions of 
already identified proteins. 
Proteins interact with each other to form distinct stable and transient assemblies. 
Such non-covalent interactions are mediated by van der Waals, electrostatic and 
hydrophobic forces and hydrogen bonding. Stable protein-protein interactions are 
strong and irreversible, whereas a complex qualifies as transient if it readily 
undergoes changes in the oligomeric state.Transient complexes can be subdivided 
into weak and strong. Weak transient complexes show a dynamic mixture of different 
oligomeric states in vivo, whereas strong transient complexes change their 
quaternary state only when triggered by, for example, ligand binding. Weak transient 
interactions are characterized by a dissociation constant (KD) in the micromolar range 
and lifetimes of seconds. Strong transient interactions, stabilized by binding of an 
effector molecule, may last longer and have a lower KD in the nanomolar range [9].  
The connectivity between several different proteins may give the protein complex a 
new functional role. Proteins inside the cell do not interact randomly. Protein 
associations need precise regulation. The spatial and temporal regulation of enzyme 
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activities through extensive interactions bears remarkable functional relevance. In 
human, mutations or environmental factors that interfere with protein-protein 
interaction lead to pathology. This is the case in the Immunodeficiency, Centromeric 
instability, Facial anomalies (ICF) syndrome, caused by defects in DNMT3B, a DNA 
methyltransferase [10].  
A wide variety of modular and specialized binding domains have been mapped that 
mediate protein-protein recognition [11]. Even though the distinction is not always 
very strict, interaction domains are thought to generally operate through two 
mechanisms. Domains sometimes bind other domains. Typically, this type of 
interactions involves large binding interfaces provided by the rigid globular domains. 
This is illustrated by the interaction taking place between Ras and its GTPase 
activating protein Ras-GAP, which play a crucial role in regulating cellular signal 
transduction processes [12]. Domain-domain interactions are thus generally 
characterized by relatively high stabilities and affinities in the low nM to pM range 
[13,14]. In other cases, interactions are mediated by short sequences, typically 
between 3 and 10 amino acids, present in disordered parts of proteins. These short 
linear motifs are critical to many biological processes. They often show low affinities 
(0.5-10 µM) [15,16]. They tend to be mediators in transient interactions, such as the 
ones seen in cell signalling [17]. 
 
 
 
Fig.I.1. Biological systems hierarchy. Within the hierarchy, every constituent part is embedded in a 
more complex system that provides its context. Design of new behaviour occurs with the top of the 
hierarchy in mind but is implemented bottom-up. At the bottom of the hierarchy are DNA, RNA, 
proteins, and metabolites. The next layer, comprises biochemical reactions that regulate the flow of 
information and manipulate physical processes. At the module layer, the complex pathways that 
function like integrated circuits. The connection of these modules to each other and their integration 
into host cells allows the scientist to extend or modify the behaviour of cells in a programmatic fashion. 
 
Various large-scale efforts have thus attempted to define protein interactomes in 
several organisms, including Saccharomyces cerevisiae [18], Drosophila 
melanogaster [19], Caenorhabditis elegans [20] and Homo sapiens [21,22].  
Recent experimental evidence suggests that promiscuity, not only in interactions but 
also in the actual function of proteins, is not as rare as was previously thought. This 
has implications not only for our fundamental understanding of molecular recognition 
and how protein function has evolved over time but also in the realm of biotechnology 
(Fig.I.2). Understanding protein promiscuity is becoming increasingly important not 
only to optimize protein engineering applications in areas as diverse as synthetic 
biology and metagenomics but also to lower attrition rates in drug discovery 
I. Introduction 
 
12  
 
programs, identify drug interaction surfaces less susceptible to escape mutations and 
potentiate the power of polypharmacology [23]. 
Enhanced understanding of promiscuity can facilitate progress in protein engineering 
and drug design for industrial applications. The action of drugs relies on the 
promiscuous character of their protein targets, and their side effects relate to the 
promiscuity of unintended targets. 
 
 
 
Fig.I.2. Schematic representation of protein promiscuity: levels, triggering conditions, 
molecular mechanisms and overall effects.  
 
Thus, to design drugs less likely to have deleterious side effects and more likely to 
withstand resistance mutations, we need to understand how to exploit and manage a 
protein‟s tendency for binding promiscuity. In biotechnology, the promiscuous nature 
of proteins could also be exploited to evolve enzymes with different 
reaction/substrate specificities [24] or to use proteins in innovative ways (e.g., in the 
context of synthetic biology projects) [25], and the industrial exploitation of such and 
similar systems will greatly benefit from the knowledge and the molecular 
characterization of biotechnological relevant systems. 
 
 
I.3 Biochemical approaches to map protein-protein interactions 
 
The ultimate goal of functional proteomics is to decipher the molecular function 
of an entire cell by generating a construction master plan describing all molecular 
machines, their functions, their reactions to external stimuli and their 
interconnectivities. An interdisciplinary and community-wide effort will be required to 
realize this vision, even when limited to the characterization of a few cellular states.  
Different approaches have been used to characterize protein complexes and protein-
protein interaction networks.  
The first interactome maps were obtained using the yeast two-hybrid system. More 
recently, a combination of affinity purification techniques and mass spectrometry (AP-
MS) has been used to greatly advance our understanding of protein complex 
composition [26]. Alternative strategies are also emerging, like protein chips and 
luminescence-based mammalian interactome mapping (LUMIER). Fluorescence-
based interaction assays such as fluorescence resonance energy transfer (FRET), 
hold great promise as they allow the monitoring of protein-protein interaction inside a 
living cell and computational prediction methods, some of which are based on known 
three-dimensional structures and binding motifs. 
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The yeast two-hybrid system is a genetic, ex vivo assay that allows the discovery of 
binary protein-protein interactions. Its principle relies on the modular nature of many 
transcription factors that contain both a site-specific DNA binding domain (DBD) and 
a transcriptional activation domain (AD) that recruits the transcriptional machinery to 
the promoters. The interaction between a „bait‟ fusion protein (hybrid protein X-DBD) 
and a „prey‟ fusion protein (hybrid protein Y-AD) reconstitutes a functional 
transcription factor which turns on the expression of a reporter gene or selectable 
marker [27]. 
The key advantage of the two-hybrid system, besides scalability and flexibility, is its 
capacity to detect transient interactions and those that are very weak. This includes 
interactions with dissociation constants down to 10−7 M, which correspond to the 
weakest interactions that occur within the cell. The system, however, has drawbacks 
due to its ex vivo nature and for this reason this does not necessarily reflect 
physiological events. Expressed fusion proteins are forced to the nucleus, which may 
not be where they are usually localised. Membrane proteins, for example, are usually 
not compatible with such a nuclear-based assay. The bait or prey proteins may not 
undergo appropriate post-translational modification. Similarly, interactions that 
involve co-operative, allosteric events or chaperone-assisted assembly may not 
occur correctly in the nucleus. Finally, transcription factors, as well as other proteins 
(about 5-10% of gene products), can auto activate the transcription of reporter genes. 
Such proteins are thus unsuitable to the approach. 
In contrast to yeast two hybrid and related methods, AP-MS can be performed under 
near physiological conditions. AP-MS does not typically perturb relevant post-
translational modifications, which are often crucial for the organization and/or activity 
of complexes (Fig.I.3).  
 
 
 
Fig.I.3. Main routes of protein-complex purification. (a) In immunochemical purification, the 
endogenous protein complex is precipitated using an antibody to the target protein, allowing protein-
complex characterization without expression of a tagged protein. (b) In one-step affinity purification, 
the purified protein complex is obtained by expression of the tagged construct in the cell, followed by 
specific binding and elution from an affinity column. (c) In two-step affinity purification, two rounds of 
specific binding and specific elution assure a highly purified protein complex with little contaminating 
proteins at the cost of losing transient interactions. 
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Another advantage of AP-MS is that it can be used to probe dynamic changes in the 
composition of protein complexes, especially when used in combination with 
quantitative proteomics techniques [28,29]. 
In immunochemical methods, protein complexes are precipitated from a cell lysate by 
using an immobilized antibody to a known component of a complex. The protein 
complex is then purified by washing away nonspecific interactors. A fundamental 
advantage of this approach is that protein complexes can be isolated with a specific 
and efficient antibody from all types of biological sources, including tissue samples 
from patients, circumventing the need to express the target protein. 
Affinity purification techniques exploit the biochemical properties of a tag attached to 
the bait protein to purify the other components of a protein complex. Using standard 
cloning techniques, target protein and peptide-tag coding sequences are fused, and 
the resulting construct is expressed in target cells. A variety of epitope tags have 
been developed in the past such as His tags, glutathione S-transferase (GST) tags, 
Flag tags, Myc tags, HA tags, the calmodulin-binding peptide, the streptavidin binding 
peptide or the in vivo biotinylation of the target tagged protein. Corresponding 
antibodies or affinity resins (e.g. anti-Myc, anti-HA, anti-Flag, anti-KT3, glutathione) 
are commercially available [30]. 
One of the most successful tags developed to date is the tandem affinity purification 
(TAP) tag [31,32], which uses two sequential enrichment steps. Developed for yeast, 
the original TAP tag is composed of a protein A tag, followed by a tobacco etch virus 
(TEV) protease cleavage site and a calmodulin binding peptide. In the first 
purification step, the protein complex is purified from the cell lysate on an 
immunoglobulin gamma (IgG) affinity resin. The target protein complex is cleaved 
from the protein A tag with TEV protease. The eluate is then selectively enriched by 
increased [Ca2+] in a second affinity purification step on an immobilized calmodulin 
column. The TAP-tag significantly reduce background noise, but probably result in 
the loss of some of the more transient and weak binding partners during the 
purification procedure, as the second affinity step essentially causes infinite sample 
dilution. Indentification of the single protein components is then achieved by means 
of mass spectrometry. 
 
 
I.4 Biochemical approach to map three-dimensional structure of proteins and 
protein complexes 
 
A comprehensive study of the structural details of protein-protein interactions 
is an important step to understand how the information contained in a genome is put 
into action. Methods such as two-hybrid assays, functional genetics, FRET and, 
recently, large-scale chip-based proteomics have uncovered a vast number of 
protein-protein interactions; in yeast alone it is estimated that one protein molecule 
has on average about nine different interaction protein partners [33]. However, 
although a number of experimental techniques can report on the existence of a 
protein- protein interaction, very few can provide detailed structural information.  
Since its inception in the 1950s of the 20th century, structural biology provided critical 
observations in biology, and it continues to contribute greatly to the understanding of 
many biological processes. Structures helped to decipher basic principles of protein 
assembly, mechanisms of biochemical reactions, and details of macromolecular 
interactions, and contributed to developing new pharmaceuticals.  
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I.4.1 High resolution structural characterization 
 
Structural proteomics is the large scale structural analysis of proteins and 
complexes present in a given cell. It holds special significance since cellular 
mechanisms are functions of the structures and interactions between 
macromolecular complexes involved in cellular biological transactions. Important 
questions in structural proteomics involve elucidating the structure of these 
multicomponent assemblies, including their subcomponents and their assembly, and 
relating their structure to function. At present, the majority of proteins associated with 
many key cellular processes have structural representatives known. High-quality 
structural models are available for the majority of important protein families. 
Moreover, the structures of numerous complexes and multi-component assemblies 
have been also determined. At the same time it is worth noticing that some very large 
and important protein families are still poorly structurally studied.  
Structural genomics researchers‟ intention was to fill this major gap by developing 
high-throughput methods, improving quality of structures and reducing the cost of 
structure determination. According to PDB records, the number of solved structures 
increased more than fourfold since 1993.  
A detailed knowledge of three-dimensional protein structure and the elucidation of 
interacting amino acid sequences in protein complexes are of outstanding 
importance for the understanding of protein functions in a cell. A number of well-
established analytical techniques are available to address the questions of spatial 
and topological organizations of proteins and protein complexes, currently primarily 
x-ray crystallography and NMR spectroscopy. Both techniques yield detailed 
information on the three dimensional structure of proteins at atomic resolution.  
In principle x-ray crystallography is not limited to the size of the macromolecule, but 
the protein has to be crystallized and it is not easy to obtain well-structured crystals 
with good diffraction pattern for high-resolution reconstruction.  
NMR is an appropriate technique to study weak and strong interactions of protein 
complexes in solution. It also allows studies of conformational changes in time 
courses. However most NMR structures can be solved of proteins with a molecular 
weight distribution in the range of 20 kDa and limited to 50 kDa and NMR 
spectroscopy requires large quantities of pure protein in a specific solvent. 
Neither of these methods affords high throughput, which is an important 
consideration of the fast-evolving modern scientific regime. In this regard, MS is an 
attractive alternative to provide important low-resolution structural information. 
 
I.4.2 Low resolution structural characterization 
 
Mass spectrometry is an invaluable tool to provide low-resolution structural 
information on the interface of proteins and protein complexes. Although X-ray 
crystallography and NMR methods remain the gold standard in terms of resolution, 
MS possesses distinct advantages such as relative speed, sensitivity, and 
adaptability to different types of protein that account for its popularity to analyze 
protein complexes.  
MS can monitor conformational alternations in flexible loop regions that are often not 
resolved by traditional methods. Another advantage of MS is that the targeted 
proteins can interact with their ligands in solution under native conditions, and can be 
monitored under a more physiological-like concentration. 
I. Introduction 
 
16  
 
Among the mass spectrometric techniques used for structural studies of proteins are 
hydrogen-deuterium exchange, limited proteolysis, gel filtration, analysis of the intact 
non-covalent complexes in the gas phase and chemical cross-linking followed by 
enzymatic digestion and mass spectrometric identification of the cross-linked 
peptides. 
Limited proteolysis is based on the evidence that the three-dimensional structure of a 
protein constitutes a barrier against the enzymatic hydrolysis, which occurs only on 
exposed and flexible region of the backbone [34]. Controlled experimental conditions 
(pH, T, time, Ionic strength, E/S ratio), in order to ensure the stability of the target 
protein, will produce a single hydrolysis on the exposed/flexible region of the protein, 
and the mass of the resulting two complementary peptides is easily determined by 
MS, even if in trace amounts. By using a wide range of proteases is then possible to 
get a detailed picture of the exposed protein backbone. The use of identical 
proteolysis conditions for different states of the protein allows to compare different 
conformations occurring on formation of complexes with molecular effector, either of 
low or high molecular weight. It is applicable to analytes at low concentrations, it 
does not require specific solvent provided that the protease is active.  
In recent years, chemical cross-linking coupled with mass spectrometry (MS) has 
become a powerful method for studying protein interactions [35,36]. Chemical cross-
linking stabilizes protein interactions through the formation of covalent bonds and 
allows the detection of stable and weak protein-protein interactions in native cells or 
tissues. In addition to capturing protein interacting partners, many studies have 
shown that chemical cross-linking can yield low-resolution structural information 
about the constraints within a molecule or protein complex. Identification of cross-
linked peptides provides distance constraints that aid in constructing the structural 
topology of proteins and/or protein complexes. Moreover, it is applicable to analytes 
at low concentrations, it does not require protein crystals or proteins in a specific 
solvent and it is a fast method provided that data analysis can be automated [37-39].  
A cross-linker is simply a chemical reagent with two or more reactive groups 
connected by a spacer or linker region. The selection of the reactive groups depends 
on the target molecules to be cross-linked. For the purposes of labelling proteins, the 
reactive ends can be amine-, sulfhydryl-, or photo-reactive. The length of the spacer 
chain is often used as a „„ruler‟‟ for estimating the distance of the two linked residues, 
providing approximate topological information on proteins or protein complexes. 
Many structural variants of the basic, conventional cross-linker (two reactive groups 
and a simple spacer chain) are commercially available. 
However, protein-protein cross-linking techniques present multiple experimental and 
analytical challenges. The choice of cross-linker is crucial, as cross-linkers vary in 
cell-permeability, reactivity and spacer arm length. Cross-linker concentrations, 
reaction times, and buffer pH must be optimized to achieve a high yield of cross-
linked product, while not disrupting the three-dimensional protein structures by 
introducing too many cross-links per molecule.  
To conduct chemical cross-linking experiments of proteins, two alternative strategies 
exist in principle, which is commonly referred to as bottom-up and top-down 
approaches. In the bottom-up approach, the protein reaction mixture is enzymatically 
digested after the cross-linking reaction, and mass spectrometric identification of the 
cross-linked products is performed, based on the resulting proteolytic peptides.  
One of the most direct techniques to analyze cross-linked products is the top-down 
approach, in which the cross-linked proteins are analyzed intact rather than being 
digested before the mass spectrometric analysis. Within the mass spectrometer, the 
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cross-linked protein is isolated and directly fragmented, without the introduction of the 
fractionation step before the mass spectrometric analysis. Because this approach 
starts from MS detection of the intact protein, it has the potential for full protein 
characterization. 
 
 
I.5 The mass spectrometry role in the analysis of protein complexes 
 
The trend toward mass spectrometry as the technique of choice for identifying 
and probing the covalent structure of proteins was accelerated by the genome 
project. Genomics demonstrated the power of high-throughput, comprehensive 
analyses of biological systems. Genomics also provides complete genomic 
sequences, which are a critical resource for identifying proteins quickly and robustly 
by the correlation of mass spectrometric measurements of peptides with sequence 
databases. The systematic analysis of all the proteins in a tissue or cell was 
popularized under the name proteomics, with mass spectrometry central to most 
proteomic strategies. 
Mass spectrometry is currently the method of choice for peptide sequencing because 
it is sensitive and it routinely allows for the identification of peptides that are present 
at femtomole levels. MS is also rapid; sequencing of individual peptides can be 
achieved within hundreds of milliseconds, and thousands of peptides can therefore 
be identified in a single MS run. Last, MS is compatible with high-throughput 
strategies and is easily automated. It also allows for the characterization of peptide 
modifications (including naturally occurring post-translational modifications, such as 
phosphorylation, and exogenously added modifications, such as chemical cross-
linkers). MS can also be adapted to quantitatively measure peptide abundance and 
does not require pre-existing knowledge of the proteins to be analysed [40,41]. 
Advances in sample processing and instrumentation have gone hand-in-hand with 
the development of software tools that automatically retrieve sequence information 
from acquired mass spectra and provide statistical validation of the accuracy of the 
determined sequences [42].  
Mass spectrometry was restricted for a long time to small and thermostable 
compounds because of the lack of effective techniques to softly ionize and transfer 
the ionized molecules from the condensed phase into the gas phase without 
excessive fragmentation. The development in the late 1980s of two soft ionization 
techniques for the routine and general formation of molecular ions of intact 
biomolecules, electrospray ionization (ESI) [43] and matrix assisted laser 
desorption/ionization (MALDI) [44], dramatically changed this situation and made 
polypeptides accessible to mass spectrometric analysis [45]. 
Mass spectrometric measurements are carried out in the gas phase on ionized 
analytes. By definition, a mass spectrometer consists of an ion source, a mass 
analyser that measures the mass-to-charge ratio (m/z) of the ionized analytes, and a 
detector that registers the number of ions at each m/z value.  
Matrix-assisted laser desorption ionization (MALDI) was developed by Karas & 
Hillenkamp in the late 1980s. To generate gas phase, protonated molecules, a large 
excess of matrix material is cocristallized with analyte molecules. The resulting solid 
is then irradiated by nanosecond laser pulses, usually from small nitrogen lasers with 
a wavelength of 337 nm. The matrix is typically a small organic molecule with 
absorbance at the wavelength of the laser employed and the matrices differ from 
each other in the amount of energy they impart to the biomolecules during desorption 
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and ionization and hence the degree of fragmentation (unimolecular decay) that they 
cause. Typically, only singly charged ions are observed in MALDI.  
The precise nature of the ionization process in MALDI is still largely unknown and the 
signal intensities depend on incorporation of the peptides into crystals, their likelihood 
of capturing and/or retaining a proton during the desorption process, and a number of 
other factors including suppression effects in peptide mixtures [46].  
Electrospray mass spectrometry (ESMS) has been developed for use in biological 
mass spectrometry by Fenn et al. Liquid containing the analyte is pumped at low 
microliter-per-minute flow rates through a fine needle at high voltage to 
electrostatically disperse, or electrospray, small, micrometer-sized droplets, which 
rapidly evaporate and which impart their charge onto the analyte molecules. ESI 
typically induces a range of charge states; because most mass spectrometers 
actually detect mass/charge or m/z, the resulting spectra may have many ions for 
each analysis. This includes proteins, oligonucleotides, sugars and polar lipids [47]. 
After ionization, the analytes enter in the mass analyser. It is, literally and figuratively, 
central to the technology. In the context of proteomics, its key parameters are 
sensitivity, resolution, mass accuracy and the ability to generate information-rich ion 
mass spectra from peptide fragments (tandem mass or MS/MS spectra) [48,49]. 
There are four basic types of mass analyser currently used in proteomics research 
(Fig.I.4). These are the quadrupole (Q), ion trap (IT), time-of-flight (TOF), and Fourier 
transform ion cyclotron resonance (FT-ICR) analysers [50]. They are very different in 
design and performance, each with its own strength and weakness. These analysers 
can be stand alone or, in some cases, put together in tandem to take advantage of 
the strengths of each.  
 
 
 
Fig.I.4. Mass spectrometers used in proteome research.  
 
The quadrupole mass filter consists of a linear array of four symmetrically arranged 
rods to which radio frequency (RF) and DC voltages are supplied. Forces are exerted 
in a plane normal to the direction (z-direction) in which the ions drift. The RF potential 
gives rise to a field which alternatively reinforces and then dominates the DC field. 
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Ions oscillate in the x,y-plane with frequencies which depend on their m/z values. If 
the oscillations of an ion in this plane are stable, the ion will continue to drift down the 
rod assembly and reach the detector. Stable oscillations are only achieved by ions of 
given m/z value for a given rod assembly, oscillation frequency, RF voltages and DC 
voltages. Commercially available instruments usually have mass/charge limits 
ranging from 0 to 4000 m/z and at best are normally set to resolve the various 13C 
isotope peaks for a singly charged ion, although the resolution may be intentionally 
degraded to improve sensitivity. In ESI, multiple charging enables quadrupole mass 
measurement of molecules >100,000 Da, if the molecule can be charged sufficiently.  
The ion trap consists of three electrodes, the central ring electrode and two end-cap 
electrodes of hyperbolic cross-section. In this device too, ions are subjected to forces 
applied by an RF field but the forces occur in all three, instead of just two, 
dimensions. In ion-trap analysers, ions are resonantly activated and ejected by 
electronic manipulation of this field. Ion traps are robust, sensitive and relatively 
inexpensive, and so have produced much of the proteomics data reported in the 
literature. A disadvantage of ion traps is their relatively low mass accuracy, due in 
part to the limited number of ions that can be accumulated at their point-like centre 
before space-charging distorts their distribution and thus the accuracy of the mass 
measurement. The „linear‟ or „two dimensional ion trap‟ [51,52] is an exciting recent 
improvement in quadrupole ion traps, with higher scan ranges, larger electronic trap 
fields, increased sensitivity, higher resolution and mass accuracy.  
In the Time-of flight (TOF) analyzers the ions are accelerated through a fixed 
potential into a drift tube. As all the ions with same charge obtain the same kinetic 
energy after acceleration, the lower m/z ions achieve higher velocities than higher 
m/z ions. Moreover, ion velocities are inversely related to the square root of the m/z. 
Thus, by measuring the time it takes to reach the detector, the m/z of the ion can be 
determined. Ion manipulations are used to increase resolution (delayed extraction of 
ions from the source, two stage sources with complex voltage gradients, and 
reflectron technology) and a commercial TOF instrument can typically achieve 
resolution of 10,000 or greater.  
A Fourier-transform ion-cyclotron resonance (FT-ICR) mass spectrometer (also 
referred to as a Fourier-transform mass spectrometer, or FTMS) uses a magnetic 
field to determine the m/z of an ion. In an FT-ICR ions have kinetic energies, at most, 
of a few tens of electron volts (eV). At low kinetic energies, ions are actually trapped 
under high vacuum in the magnetic field. For a constant magnetic field, ions oscillate 
around the magnetic field with a cyclotron frequency that is inversely related to the 
m/z. In a very simplified view of FT-ICR, the cyclotron frequencies of the ions trapped 
in the FT-ICR are measured and then converted into m/z. State-of-the-art electronic 
equipment is capable of measuring frequencies with extremely high precision. This 
translates to a very high mass resolution, which is the property FT-ICR is most widely 
known for. Mass resolutions in the hundreds of thousands are fairly easy to obtain on 
instruments with large magnetic field strengths (that is, > 7 Tesla), and resolutions in 
the millions have been demonstrated. Very high mass accuracies, down to the ppm 
level, can also be obtained (resolution >1,000,000) [53,54].  
Very recently, a new type of mass analyzer called orbitrap has emerged. It was 
invented by A. Makarov [55-57]. As its name suggests, orbitrap is an ion trap. But it is 
not a conventional ion trap; there is neither RF nor a magnet to hold ions inside. 
Instead, moving ions are trapped in an electrostatic field. The electrostatic attraction 
towards the central electrode is compensated by a centrifugal force that arises from 
the initial tangential velocity of ions. The electrostatic field which ions experience 
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inside the orbitrap forces them to move in complex spiral patterns. The axial 
component of these oscillations is independent of initial energy, angles and positions, 
and can be detected as an image current on the two halves of an electrode 
encapsulating the orbitrap. A Fourier transform is employed to obtain oscillation 
frequencies for ions with different masses, resulting in an accurate reading of their 
m/z. Such measurements achieve very high resolution rivalling that of FT-ICR 
instruments, and surpassing, by an order of magnitude, the resolution presently 
obtainable with orthogonal time-of-flight analyzers. The instrument is capable of 
routinely achieving high sensitivity (attomole to femtomole range), high mass 
accuracy (low ppm), and isotope resolution of small proteins. This instrument 
presents characteristics similar to an FT-ICR spectrometer in terms of resolution and 
mass accuracy but without the burden of an expensive superconducting magnet.  
 
I.5.1 Tandem mass spectrometry  
 
The power of mass spectrometry can be dramatically increased by employing 
methods of tandem mass spectroscopy [58,59]. In the tandem MS (MS/MS) and MSn 
experiments, the first mass analyzer is used to selectively pass an ion into another 
reaction region where excitation and dissociation take place. The second mass 
analyzer is used to record the m/z values of the dissociation products. Low-energy 
collision-induced (activated) dissociation (CID or CAD) tandem mass spectrometry 
has been, by far, the most common method used to dissociate peptide ions for 
subsequent sequence analysis. Upon collisional activation with a nonreactive gas, 
such as argon or helium, the amide bond of the peptide backbone will fragment to 
produce, ideally, a homologous series of b and y-type fragment ions. The observed 
fragmentation pattern depends on various parameters including the amino acid 
composition and size of the peptide, excitation method, time scale of the instrument, 
the charge state of the ion, etc. Peptide precursor ions dissociated under the most 
usual low-energy collision conditions fragment along the backbone at the amide 
bonds forming structurally informative sequence ions and less useful non-sequence 
ions by losing small neutrals like water, ammonia, etc.  
An alternative method for peptide dissociation (electron capture dissociation, ECD) 
was introduced by McLafferty and co-workers [60]. Low energy electrons were 
reacted with peptide cations in the magnetic field of a Fourier transform ion cyclotron 
resonance mass spectrometer (FT-ICR-MS). The reaction resulted in the attachment 
of electrons to the protonated peptides producing peptide cations containing an 
additional electron. The odd-electron peptide then undergoes rearrangement with 
subsequent dissociation. Peptide backbone cleavage by ECD is relatively indifferent 
to either peptide sequence or length. Unlike CID, ECD does not cleave chemical 
modifications from the peptide, but rather induces random breakage of the peptide 
backbone. With ECD, labile modifications such as phosphorylation, N- and O-
glycosylation, sulfonation, as well as other labile PTMs remain intact. However, ECD 
requires an FT-ICR mass spectrometer, instruments that are not readily available to 
many in the proteomics field.  
Electron transfer dissociation (ETD) is another method to fragment peptides that 
utilizes ion/ion chemistry. ETD fragments peptides by transferring an electron from a 
radical anion to a protonated peptide. This induces fragmentation of the peptide 
backbone, causing cleavage of the Cα–N bond just as ECD does. This creates 
complementary c and z-type ions instead of the typical b and y-type ions observed in 
CID. ETD also preserves PTMs that are labile by CID and sequence information on 
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the peptide can be obtained. ETD uses a RF quadrupole ion trapping device instead 
of an FT-ICRMS for ion trapping and detection. RF ion trap mass spectrometers are 
low-cost, low-maintenance, and widely accessible as compared to the FT-ICR-MS 
[61].  
A peptide contains three different bonds in its backbone: NH-CH, CH-CO and CO-
NH. According to the nomenclature for peptide fragmentation each breakage at any 
of the bonds gives rise to a different ion depending on which fragment retains the 
charge. Peptide fragment ions are termed a-, b-, c-ions if the charge is retained on 
the N-terminus and x-, y- and z-ions if the charge is kept on the C-terminus (Fig.I.5). 
The peptide can be manually sequenced by systematically calculating the mass 
difference between two adjacent ions of one series that correspond to one amino 
acid at the position of cleavage. Nowadays computer programs (such as Mascot) 
facilitate this task.  
 
 
 
Fig.I.5. Roepstorff Nomenclature Scheme. Illustration of fragment ions formed from the backbone 
cleavage of protonated peptides.  
 
I.5.2 Non-covalent protein complexes - Native mass spectrometry 
 
Soon after the introduction of electrospray ionization (ESI), researchers 
realized that it could be used to monitor intact proteins and even protein complexes 
by MS [62], because ESI is an extremely soft ionization technique and non covalent 
interactions between molecules can be preserved [63]. Recent application of native 
MS have highlighted its ability to define stoichiometry, topology and dynamics of 
many protein complexes, ranging from recombinant expressed large oligomeric 
complexes, such as viruses and chaperones complexes, to endogenously expressed 
structurally less well characterized protein complexes. A major breakthrough was 
implemented with the development of nano-ESI that facilitates the ionization 
efficiency due to a decreased flow. The successful analysis of non covalent 
assemblies by MS requires the preservation of the native state of the complex in 
solution. In addition, to ensure efficient ES, it is crucial to use aqueous solutions 
containing only volatile buffers. Owing to their neutral pH and high volatility, the two 
most commonly used buffers are ammonium acetate and ammonium carbonate. 
Millimolar quantities (ranging from 5 mM to 1 M) of volatile buffer at physiological pH 
are typically employed so that complexes are introduced from solution conditions in 
which the native state is preserved.  
Native mass spectrometry does not yield detailed molecular (and atomic) structure 
information, but it has some major advantages over traditional structural biology 
methods, such as its sensitivity, speed, selectivity and ability to simultaneously 
measure several species present in a mixture. 
 
 
 
I. Introduction 
 
22  
 
I.6 Aim of the PhD thesis 
 
Proteins form stable and dynamic multi-subunit complexes under different 
physiological conditions to maintain cell viability and normal cell homeostasis. 
Detailed knowledge of protein interactions and protein complex structures is 
fundamental to understand how individual proteins function within a complex and 
how the complex functions as a whole.  
This PhD thesis targets the characterization by structural and functional proteomics 
approach of selected protein complexes involved in relevant molecular processes 
and that can have an impact on their industrial applications.  
Moreover, as a parallel goal, and strictly connected with the former issue, I worked at 
the development of an innovative structural analysis approach based on the use of a 
femtosecond UV laser in order to capture transient protein-protein interactions.  
 
Chapter 2 describes the analysis of the endogenously expressed Phenol 
Hydroxylase (PH) complex from Pseudomonas sp. OX1, using biochemical 
approaches integrated to mass spectrometry analysis. Moreover, in order to define 
the protein-protein interaction networks of this complex a functional proteomic 
approach was carried out.  
Pseudomonas sp. OX1 is a bacterium endowed with the ability to grow on a wide 
spectrum of hydroxylated and non-hydroxylated aromatic compounds. Aromatic 
hydrocarbons released in the biosphere by human activities are today a major threat 
not only to environment but also to human health due to their potential 
carcinogenicity [64]. By expressing various catabolic pathways, microorganisms can 
use a wide array of aromatic compounds as the sole carbon and energy source, thus 
providing a set of diversified tools that can be used in bioremediation of contaminated 
environments. Bacterial Multicomponent Monooxygenases (BMMs) are actually key 
enzymes that catalyze the hydroxylation of the aromatic ring at different positions and 
for this reason they can be use in bioremediation of contaminated environments.  
This part of my thesis has been carried out in collaboration with the Prof. Di Donato‟s 
group of the Department of Structural Biology at the University of Naples “Federico 
II”. 
 
The work in chapter 3 is aimed on the characterization of the complex between 
pLG72 and human D-amino acid oxidase (hDAAO), which has recently been linked 
to the onset of schizophrenia. Schizophrenia affects almost 1% of the world‟s 
population and accounts for ~2.5% of the healthcare costs of the European 
Community. It is a psychiatric disorder that develops as a result of neurobiological 
and genetic predispositions interacting with environmental factors. In the past years, 
yeast two-hybrid experiments with the pLG72 protein identified the enzyme D-amino 
acid oxidase (DAAO) as an interacting partner [65]. 
Because the causes of schizophrenia are still unknown, current treatments focus on 
eliminating the symptoms of the disease. The clarification of the key role of this 
protein-protein interaction and the structural effects of drugs on this interaction, as 
well as the identification of other physiological or conditional partners in this 
biochemical pathway, will be extremely useful in developing molecules effective in 
the disease treatment. 
In this perspective the structural features of the pLG72-hDAAO complex was defined 
by low resolution strategies (limited proteolysis and chemical cross-linking) coupled 
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with mass spectrometric techniques. Moreover functional proteomics experiments 
using hDAAO as bait have been carried out with the aim of identifying other 
interactors of this protein.  
This part of my thesis has been carried out in collaboration with the Prof. Pollegioni of 
the University of Insubria.  
 
Chapter 4 introduces the development of an innovative methodology to induce 
cross-linking in proteins, based on the use of an UV ultra shorts pulsed laser with 
duration of few tens of femtoseconds as a novel zero length protein-protein cross-
linker. This work has been in collaboration with Proff. R. Velotta and C. Altucci‟s 
group of the Physic Department at the University of Naples “Federico II”.  
Although the combination of chemical cross-linking and mass spectrometry has been 
successful, effective detection and accurate identification of cross-linked peptides as 
well as unambiguous assignment of cross-linked sites remain extremely challenging 
due to their low abundance and complicated fragmentation behaviour in MS analysis. 
Therefore, new reagents and methods are urgently needed to allow unambiguous 
identification of cross-linked products and to improve the speed and accuracy of data 
analysis to facilitate its application in structural elucidation of large protein 
complexes. It is expected that UV-laser cross-linking will offer a powerful tool to 
investigate protein-protein interactions, especially transient interactions and binding 
kinetics, because the number of photons required for covalent complex formation can 
be delivered very rapidly thus resulting in efficient cross-linking. Such photo-physical 
approach could obviate many of the problems associated with standard chemical 
cross-linking reagents, and put cross-linking in a proteome-wide position for the 
characterizations of protein-protein interactions in vivo in intact cells, since no 
chemical reagent has to enter the cell, and thus false-positive interactions such as 
those resulting from the loss of spatial organization during cell lyses are also 
avoided. 
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II. Structural e functional characterization of Phenol Hydroxylase 
(PH) complex from Pseudomonas sp. OX1: key enzyme involved 
in bioremediation of contaminated environments 
 
 
II.1 The bioremediation 
 
Aromatic hydrocarbons released in the biosphere by human activities are 
today a major threat not only to environment but also to human health due to their 
potential carcinogenicity [1]. As an example, cyanides, phenols, polycyclic aromatic 
compounds or long chain aliphatics may be hazardous and, particularly if accidentally 
or deliberately released by the processing industry, they exhibit acute or chronic 
toxicity. Therefore, a major goal of environmental biotechnology is to establish highly 
efficient biological processes that use the naturally existing catabolic potential for the 
elimination and detoxification of these chemicals.  
The advent of the post-genome era has fostered research on bacterial 
biodegradation at the level of the genome, enabling environmental microbiologists to 
better understand the process of biodegradation. This development in the study of 
biodegrading bacteria has resulted in the impetus to develop a suitable strategy for 
bioremediation. Therefore, the extensive and intensive characterization of the 
catabolic genes, proteins, and metabolites in microorganisms associated with 
pollutant degradation is absolutely necessary in order to devise the most effective 
strategy for bioremediation [2]. 
Microorganisms can use a wide array of aromatic compounds as the sole carbon and 
energy source, thus providing a set of diversified tools that can be used in 
bioremediation of contaminated environments [3,4]. In bacteria, aerobic catabolic 
pathways for aromatic hydrocarbon degradation can schematically be divided into 
two major biochemical steps. First, early reactions, the so-called upper pathways 
leads to the formation of partially oxidized aromatic intermediates. Then, in the lower 
pathways, dihydroxylated aromatic molecules that can undergo the cleavage of the 
ring are produced and further processed to give compounds that can enter the 
tricarboxylic acid cycle and eventually mineralized to carbon dioxide and water 
(Fig.II.1) [5].  
 
 
II.2 Bacterial multicomponent monooxygenases (BMMs) 
 
Bacterial multicomponent monooxygenases (BMMs) are key enzymes of the 
upper pathway that hydroxylate and epoxidize an array of hydrocarbon substrates, 
including alkanes, alkenes, and aromatics in a regio- and enantioselective fashion 
[6,7]. The substrate transformations performed by this family of enzymes are 
responsible, in part, for removing atmospheric methane, a greenhouse gas, and 
carcinogenic halogenated solvents like Trichloroethylene (TCE) from the 
environment.  
Recently, it has been recognized that bacterial multicomponent monooxygenases 
(BMMs) constitute a family of enzymes which can be divided into six distinct groups, 
each with a characteristic subunit composition. BMMs are transcribed from single 
operons that code for four to six polypeptides.  
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Fig.II.1. Catabolic pathways in microorganisms for benzene, phenol and toluene. In bacteria, 
aerobic catabolic pathways for aromatic hydrocarbon degradation can schematically be divided into 
two major biochemical steps, the upper and lower pathways. MO indicates monooxygenase, while DO 
dioxygenase.  
 
Analysis of the sequences from nucleotide and protein databases indicates that most 
bacterial strains possess only one BMM, but a few cases (3 out of 31) of bacterial 
genomes coding for more than one monooxygenase have been found [8]. 
BMMs usually consist of a 200-250 kDa dimeric hydroxylase of the form (αβγ)2, a 10-
16 kDa regulatory protein, devoid of any cofactor, that enhances catalytic turnover by 
30-150-fold and a FAD- and [2Fe-2S]- containing 38-40 kDa reductase that mediates 
the electron transfer from NADH to the active site of the hydroxylase [7-9]. An 
additional Rieske protein may be present to assist the electron transfer between the 
reductase and hydroxylase components. The hydroxylation chemistry takes place at 
non-heme carboxylate-bridged diiron(III) center coordinated by four glutamate and 
two histidine ligands from a four-helix bundle. Solvent-derived water and hydroxide 
ions complete the octahedral coordination spheres [10].  
Pseudomonas stutzeri OX1 is able to grow on a wide spectrum of aromatics, 
including phenol, cresols, and dimethylphenols, but also on nonhydroxylated 
molecules such as toluene, o-xylene and benzene. Two different monooxygenases 
have been found in the genome of P. stutzeri OX1, phenol hydroxylase (PH) [6] and 
toluene o-xylene monooxygenase (ToMO) [11,12]. 
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II.3 Phenol Hydroxylase from Pseudomonas stutzeri OX1 
 
Phenol Hydroxylase is a multicomponent monooxygenases enzyme 
composed by five polypeptides - PHL, PHM, PHN, PHO, PHP - organized as three 
components [6]. PHP is the NADH-oxidoreductase responsible for supplying 
electrons to the diiron cluster housed in the active site of the hydroxylase component. 
This latter component comprises three polypeptides (L, N, O) organized in a 
quaternary structure of the type (LNO)2 (from here named PHH). Finally, PHM has 
been shown to be a regulatory protein, devoid of any cofactor or metal, which is 
essential for efficient catalysis of phenol hydroxylation (Fig.II.2).  
 
 
 
Fig.II.2. Mechanism of electron transfer from NADH to the PHH complex. 
 
A comparative analysis of the polypeptide sequences of PH proteins showed a 
significant degree of identity with the components of the multicomponent phenol 
hydroxylase encoded by the dmp genes in Pseudomonas sp. CF600. Sequencing of 
5‟ region of ph locus coding for the multicomponent phenol hydroxylase of P. sp.OX1 
revealed the presence of a putative orf whose deduced amino acid sequence shared 
62.6% identity (74% similarity) to DmpK [13-18]. In the Pseudomonas sp. strain 
CF600 PH, DmpK was suggested to play a role in the expression of active 
recombinant hydroxylase [18]. Auxiliary proteins that are required for correct metal 
center assembly are not a unique feature of BMMs since proteins with a similar role 
have been identified in a number of metalloenzymes including Fe/S proteins, 
nitrogenase, urease, CO-dehydrogenase, and hydrogenase [19-21]. These 
components share several common features: they are small proteins with a 
molecular mass of about 10 kDa, devoid of cofactors, expressed at low levels in their 
respective native organisms, and inhibiting enzyme activity in vitro when present in 
stoichiometric amounts. 
Despite these common aspects the role of accessory proteins in BMMs has been 
elusive so far, although they have been hypothesized to be involved in the assembly 
of the active form of the hydroxylase component, as for example in the case of the 
protein MMOD, isolated from the methanotrophic bacterium Methylococcus 
capsulatus (Bath) [9,19]. Even when devoid of any significant indication of homology, 
these genes have been identified across all the different groups of BMMs [7,8,22-24], 
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suggesting that proteins someway involved in the assembly of the active diiron center 
might be more widespread than it is currently assumed.  
Different molecular mechanisms employed to facilitate the insertion of metal sites into 
target proteins have been reported in literature [25]. However, none of the 
mechanisms described so far has been unambiguously assigned to proteins such as 
DmpK and MMOD. 
 
II.4 Aim of the project 
 
This part of the work was focused to gain further insight into the role of PHK, 
the accessory protein of phenol hydroxylase from P. sp. OX1, by a structural 
proteomics approach, including classical biochemical experiment (gel filtration) 
integrated with mass spectrometry analysis. Moreover, in order to gain further insight 
in this molecular process, to provide evidence for the specificity of the binding 
between PHK and the LNO subunits of the PH hydroxylase moiety, and to verify the 
possibility of other proteins interacting with PHK, we carried out an affinity purification 
strategy using an avidin pull-down assay on two different celluar extracts of 
Pseudomonas sp. OX1.  
The start up of this project was the observation of an improved efficiency of the PHH 
complex when coexpressed with the accessory subunit PHK, that is not part of the 
functional complex, but can be found as a genetic element in most (if not all) of the 
phenol hydroxylase operons sequenced so far. General chaperone? Metal delivery 
factor? Metallochaperone? Several hypotheses can be outlined for this component, 
but none of these had been proved so far. The only evidences being, as stated 
above, that it is not essential to the enzymatic activity, but, when present during the 
recombinant production process, the efficiency of the active enzyme is improved. 
The phenol hydroxylase gene cluster was cloned and expressed in E. coli in the 
absence or in the presence of the orf coding for PHK. In the latter case, recombinant 
cells showed an increased phenol hydroxylase activity compared to cells not 
expressing PHK, thus suggesting a positive effect of the accessory protein on the 
enzymatic activity of phenol hydroxylase. Interestingly, it has been isolated from the 
soluble extract of cells expressing the complete ph gene cluster, including phk, active 
PH(LNO)2 and PH(LNO)2/PHM complexes. It has been also isolated a stable 
complex formed by PHK bound to a PH(LNO) trimer, devoid of either iron or activity, 
which could not be reactivated, at least under our experimental conditions. To 
elucidate the role of PHK, this component was subcloned and overexpressed in E. 
coli and characterized its interaction with the active hydroxylase moiety, PH(LNO)2, 
showing that the protein, like MMOD and DmpK, is not directly involved in the 
catalytic activity of the phenol hydroxylase complex. However, PHK does not appear 
to be required for the production of active recombinant hydroxylase as previously 
observed for DmpK [26]. PHK seems instead to be involved in increasing the 
apparent affinity of apo-PH(LNO)2 for iron, thus possibly stimulating the incorporation 
of the transition metal into the active site of the protein.  
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II.5 Material and Methods 
 
II.5.1 Analytical gel filtration 
 
Analytical gel filtration experiments were carried out as follows: 200 l of 
sample were loaded on a Superdex 200 HR 10/30 or on Superdex 75 HR 10/30 
column previously equilibrated in 25 mM Tris-HCl, 5% glycerol, 0.2 M NaCl and 2 mM 
L-cysteine, pH 7.0 installed on an AKTA™fplc™ (GE Healthcare Life Science), and 
isocratically eluted at room temperature at a flow rate of 0.5 mL min-1, and monitored 
at 280 nm. The column had been previously calibrated in the same buffer with the 
following proteins of known molecular mass: apotransferrin (400 kDa), alcohol 
dehydrogenase (150 kDa) bovine serum albumin (66 kDa), carbonic anhydrase (29 
kDa), cytochrome c (12 kDa). When necessary, the area of each peak was estimated 
by nonlinear curve-fitting of the elution profile using PeakFit software (Systat 
Software). 
 
II.5.2 Preparation of iron-reconstituted PHH 
 
The way of reconstituting phenol hydroxylase activity of apoproteins was 
carried out by adding a diluted solution of Fe(NH4)2(SO4)2·6H2O directly in eppendorf 
along with the other purified components in the in vitro reconstitution of the PH 
complex and immediately after having added apo-PHH to the mixture.  
 
II.5.3 Biotinylation of PHK 
 
PHK (3.0 mg, in MOPS 25 mM pH 7.0, 5% glycerol, 0.2 M NaCl) was 
incubated with 1.37 mg of Sulfo-NHS-Biotin (sulfosuccinimidobiotin) (Pierce) (molar 
ratio 20:1), dissolved in the same buffer, on ice in the dark for 2 hours. The reaction 
was stopped with 0.1 M Tris pH 7.0 and the excess of non-reacted biotin reagent was 
removed by size exclusion chromatography on PD-10 columns (GE-Healthcare) in 
sodium phosphate 0.1 M pH 7.2, NaCl 0.15 M. , following absorbance at 220 nm and 
280 nm to single out K-containing fractions. These fractions were pooled and added 
to the Avidin Agarose Resin (settled gel, Pierce) in order to immobilize the 
biotinylated protein.  
 
II.5.4 Immobilization of biotinylated PHK on avidin and “Pull down” assay 
 
450 µl of resin were equilibrated with five volumes of Binding Buffer (Sodium 
Phosphate 0.1 M pH 7.2, NaCl 0.15 M) and incubated with biotinylated PHK (3 mg 
biotinylated PHK per mL of settled avidin agarose resin) at 4°C for 1 hour. The resin 
was washed with 10 volumes of Binding Buffer.  
Pseudomonas sp. OX1 cells grown on M9 minimal medium containing 5 mM phenol 
or 5 mM malat as unique carbon and energy source were disrupted by sonication in 
MOPS 25 mM pH 7.0, NaCl 0.15 M, 5% glycerol, 1 mM PMSF and protease 
inhibitors cocktail (Sigma Aldrich). The extracts were centrifuged at 12,000 rpm for 1 
hour and filtered with 0.45 µm PVDF filter. Total protein cell extracts, quantified with 
the BioRad protein assay, were incubated with 125 µl of mouse anti-IgG agarose 
conjugated beads (Sigma) overnight at 4ºC (preclining step). Cell extracts were then 
incubated with 450 µl of biotinylated-PHK immobilized on avidin resin and incubated 
at 4ºC for 2 hours. The resin was washed with 10 volumes of Binding Buffer and the 
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protein samples were eluted with 70 µl of Laemmli sample buffer. Samples were 
analyzed by SDS-PAGE (12.5 %), and proteins were stained with Coomassie Brilliant 
Blue G-Colloidal (Pierce, Rockford, USA). 
 
II.5.5 Mass spectrometric analysis 
 
Identification of complex subunits was carried out on trypsin digested samples 
either in solution or by in situ digestion after fractionation on polyacrilamide gel 
elecrophoresis. Proteins were detected on the gel using colloidal Coomassie (Pierce, 
Rockford, USA). Excised bands were destained, reduced with 10 mM DTT, 
carbamidomethylated with 55 mM iodoacetamide in 0.1 M NH4HCO3 buffer, pH 7.5, 
and subjected to tryptic in-gel digestion for 16 h at 37°C, by adding 100 ng of trypsin. 
Peak top fractions from analytical gel filtration experiments (1 mL) were lyophilized, 
resuspended in 100 μl of H2O, and digested at 37°C for 16 h with 100 ng of trypsin. 
The reaction was stopped by lowering pH to about 1 with formic acid and the peptide 
mixtures were concentrated and purified using a reverse phase Zip Tip pipette tips 
(Millipore). The peptides were eluted with 20 μl of a solution made of 50% 
acetonitrile, 0.1% formic acid in Milli-Q water. Peptide mixtures were analyzed either 
by MALDI-MS or capillary LC-MS/MS. 
MALDI-MS experiments were performed on a Voyager DE-STR MALDI-TOF mass 
spectrometer (Applied Biosystems, Framingham, MA) equipped with a nitrogen laser 
(337 nm). Typically, 1 μl of the total peptide mixture was mixed (1/1, v/v) with a 10 
mg mL-1 solution of R-cyano-4-hydroxycinnamic acid in acetonitrile/50 mM citrate 
buffer (3/2, v/v). The experimental mass values obtained were compared with 
calculated masses from the predicted tryptic digestion of the different subunit 
sequences, confirming the identities of the corresponding protein bands. 
The peptide mixtures were analysed using a CHIP MS 6520 QTOF equipped with a 
capillary 1200 HPLC system and a chip cube (Agilent Technologies, Palo Alto, Ca). 
After loading, the peptide mixture (8 µl in 0.1% formic acid) was first concentrated 
and washed at 4 µl/min in 40 nl enrichment column (Agilent Technologies chip), with 
0.1% formic acid in 2% acetonitrile as eluent. The sample was then fractionated on a 
C18 reverse-phase capillary column (75 µm x 43 mm in the Agilent Technologies 
chip) at flow rate of 400 nl/min, with a linear gradient of eluent B (0.1% formic acid in 
95% acetonitrile) in A (0.1% formic acid in 2% acetonitrile) from 7 to 60% in 50 min. 
 
II.5.6 Protein identification 
 
Peptide analysis was performed using data-dependent acquisition of one MS 
scan (mass range from 300 to 2000 m/z) followed by MS/MS scans of the five most 
abundant ions in each MS scan. Spectral data were analyzed using Mass Hunter 
software (Agilent Technologies) and raw data from nanoLC-MS/MS analyses were 
employed to query, using the licensed version of Mascot 2.1 (Matrix Science, Boston, 
USA), a non-redundant protein databases (NCBI, with taxonomy restriction to 
Bacteria), or an ad hoc created databases including only the sequences of PHK, 
PHL, PHM, PHN, PHO.  
The Mascot search parameters were bacteria as taxonomy restriction, “trypsin” as 
enzyme allowing up to 2 missed cleavages, carbamidomethyl as fixed modification, 
oxidation of M, pyroGlu N-term Q, as variable modifications, 10 ppm peptide 
tolerance and 0.6 Da MSMS tolerance and auto protein entries. Spectra with a 
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MASCOT score < 25 having low quality were rejected. The score used to evaluate 
quality of matches for MSMS data was higher than 30. 
 
 
II.6 Results 
 
II.6.1 Purification and properties of PHK 
 
The oligomeric state of PHK was assessed by analytical gel filtration on a 
Superdex 75 analytical column. The chromatographic profile resulted in a single 
peak, which eluted at an apparent molecular mass of about 25,500 ± 400 Da, 
suggesting the occurrence of a dimeric species (Fig.II.3).  
 
 
 
Fig.II.3. Characterization of PHK. Elution profile of analytical gel filtration chromatography of PHK. 
 
The accurate subunit molecular weight of PHK was determined by ESI-MS analysis. 
The experimental value of 10,235.27 ± 0.19 Da was in agreement with the molecular 
weight predicted from the sequence of PHK (10,235.7 Da).  
 
II.6.2 Inhibition of Phenol Hydroxylase activity by PHK 
 
Studies carried out at the Prof. di Donato‟s group demonstrated that the 
addition of purified PHK to phenol hydroxylase complex resulted in the inhibition of 
the phenol hydroxylase activity in a dose-dependent way. Specifically, a 10-fold 
excess of PHK to PH(LNO)2 led to retain only 16.8 ± 3.1% of the initial rate of 
catechol production. Interestingly, higher PHK:PH(LNO)2 ratios did not lead to 
complete inactivation of phenol hydroxylase activity.  
To gain further insight into this inhibition apparently mediated by the presence of the 
accessory protein PHK, we incubated, in a final volume of 500 µL of 25 mM MOPS 
pH 7.0, purified PHK 128 µM with the hydroxylase complex PH(LNO)2 2.6 µM at a 
final concentration of 57 µM in a molar ratio of 0.6:1 (PHK: PH(LNO)2). The mixture 
was incubated at room temperature for 90 minutes, and 15 µL were analyzed on a 
native 15% polyacrilamide gel (Fig.II.4.A). Compared to samples containing purified 
PH(LNO)2 and PHK (lanes 2 and 4), the sample containing both PH(LNO)2 and PHK 
showed the presence of an additional species (lane 3) characterized by a migration 
pattern similar to that observed for the trimeric form PH(LNO) associated to PHK 
(lane 1) and previously purified from cell extracts of E. coli/JM109 expressing plasmid 
pGEM3Z/phΔp. Protein components of this additional species were identified by 
peptide mass fingerprinting. The protein band from lane 3 was excised, digested in 
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situ with trypsin, and analyzed by MALDI-TOF MS. Mass values were mapped onto 
the anticipated sequences of PHL, PHN, PHO, PHM, and PHK subunits revealing the 
simultaneous presence of PHL, PHN, PHO, and PHK (Table II.1).  
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Fig.II.4. Characterization of the PH(LNO)2 complex in the presence of PHK. 
A) Native gel electrophoresis of a PH(LNO)2/PHK mixture. Lane 1,10 µg of the PHK-PH(LNO) 
complex as purified from the anion exchange chromatography. Lane 2, 20 µg of PH(LNO)2 active 
hexamer. Lane 3, 20 µg of PH(LNO)2 incubated in a 1:0.6 molar ratio with respect to PHK for 90 
minutes at room temperature. Lane 4, approximately 5 µg of purified recombinant PHK. The arrow 
indicates the additional band present in the incubated sample and absent in the starting protein 
samples. B) Elution profiles of analytical gel filtration chromatography of a mixture of 0.88 nmoles of 
PH(LNO)2 and 0.44 nmoles of PHK (black line), and of a mixture of 0.44 nmoles of PHM-PH(LNO)2 
and 0.88 nmoles of PHK (red line). 
 
 
Phenol Hydroxylase 
Component 
Matched Peptide Sequence 
Coverage (%) 
PHN 44 66 
PHL 29 71 
PHO 4 45 
PHK 8 68 
PHN 44 66 
 
Table II.1. Identification of the subunit components in the phenol hydroxylase complex 
fractionated by native gel electrophoresis. The protein band indicated with an arrow in Fig. II.4.A 
was excised from the gel and in situ digested with trypsin. The peptide mixture was analyzed by LC-
MS/MS and the experimental data used for searching the database with MASCOT software. 
 
Another 200 μl aliquot of the incubation mixture containing both PH(LNO)2 and PHK 
was loaded onto an analytical gel filtration carried out on a Superdex 200 column. 
The elution profile (Fig.II.4.B) reveals a protein peak with an apparent molecular 
weight of 220 kDa, corresponding to the PH(LNO)2 hexameric complex of the active 
hydroxylase. Also evident is a new species with an apparent molecular weight of 124 
kDa, likely corresponding to the trimeric PH(LNO) species complexed with PHK. Top 
peak fractions were analyzed by SDS-PAGE and mass spectrometry (data not 
shown), confirming the presence of PHK only in the peak eluting with the apparent 
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molecular weight of 124 kDa, whereas PHL, PHN, and PHO were observed in both 
peaks.  
Thus, the molecular species produced by the interaction of PHK with the hexameric 
hydroxylase PH(LNO)2 can be confidently identified as a PHK-PH(LNO) complex. 
This species was found to be devoid of both iron and catalytic activity on phenol, thus 
suggesting that the inhibition of the phenol hydroxylase activity, as observed in the in 
vitro assays and previously reported also in the case of accessory proteins DmpK 
and MMOD [26-27], depends on the formation of apo-trimers of the type PH(LNO), 
mediated by the intervention of PHK.  
Interestingly, incubation of PHK with complex PHM-PH(LNO)2, performed under the 
same experimental conditions described above, resulted in very little dissociation of 
the hexameric hydroxylase. In fact, little or no evidence of a PHK-PH(LNO) complex 
was found in the gel filtration profile (Fig.II.4.B), thus suggesting a stabilizing effect of 
PHM against hexamer dissociation. This protecting effect is also in agreement with 
the observation of a lower amount of PHK-PH(LNO) is formed when PH(LNO)2 is 
incubated at the same time with M and K in comparison the incubation with the single 
PHM component (data not shown). 
 
II.6.3 Role of PHK in iron uptake 
 
Since bacterial multicomponent monooxygenases (BMMs) are members of a 
wide family of nonheme, diiron enzymes which contain a (2Fe-2S)- centre that 
mediates transfer of electrons from NADH to the active site of the hydroxylase, we 
performed experiment in order to investigate a possible role of PHK in modulating 
iron uptake by the PHH hydroxylase moiety, by evaluating the distribution and 
composition in subunits of the species obtained in the gel filtration runs of several 
samples when iron depleted PH(LNO)2 (from now on referred to as apo-PH(LNO)2) 
has been incubated under different conditions. 
Apo-PH(LNO)2 was further purified by gel filtration on a Superdex-200 gel filtration 
column. Two different species were obtained and identified by means of both native-
PAGE analysis and analytical gel filtration which showed the presence of both 
hexameric apo-PH(LNO)2 and trimeric apo-PH(LNO) complexes. Iron uptake by 
these complexes was attempted by adding increasing amounts of a freshly prepared 
50 µM solution of Fe(NH4)2(SO4)2·6H2O in deionized water to both species. 
Immediately after, the other components of the phenol hydroxylase complex, 
oxidoreductase PHP and regulatory protein PHM, were added at a ratio of 2:1 and 
4:1, respectively, with respect to PH(LNO)2; this latter was used in the assay at a final 
concentration of 0.75 µM. 
In order to evaluate any potential role of iron in the dissociation of the hexameric 
complex upon incubation with PHK, we evaluated the distribution and composition in 
subunits of the species obtained in gel filtration experiments performed on iron 
depleted samples incubated under different conditions (Fig.II.5).  
The identity of the subunits eluting in the different peaks of the gel filtration profile 
was assessed by a proteomic approach: 1 mL fractions corresponding to the peak 
tops were digested with trypsin and analyzed by MALDI-TOF or, when ambiguous 
results were obtained, by capillary LC-MS/MS. Proteins were then identified by 
comparing the experimental data to an in-house built database where the protein 
sequences of PHL, PHN, PHO, PHK, and PHM had been inserted, using MASCOT 
software. 
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Fig.II.5. Characterization of the apo-PH(LNO)2 complex in the presence of PHK, PHM and iron. 
Elution profiles of analytical gel filtration chromatography separation of a 200 μL mixture of 2.5 μM of 
apo-PH(LNO)2 and 1.25 μM of PHK (red line), and of a mixture of 2.5 μM of apo-PH(LNO)2, 1.25 μM 
of PHK, and 10 μM of PHM in the presence of 10 μM Fe
2+
 (black line). PeakFit software was used to 
deconvolute the peaks.  
 
As observed with fully active holo-PH(LNO)2, incubation of 2.5 μM of apo-PH(LNO)2 
with 1.25 μM of PHK at room temperature for 90 min, in a final volume of 200 μL, 
induced the dissociation of the hexameric species and the subsequent formation of 
PHK-PH(LNO) complexes as measured by gel-filtration experiments (Fig.II.5, red 
line, and Table II.2). Addition of either iron (10 μM) or exogenous regulatory protein 
PHM (10 μM) to the incubation mixture did not significantly alter the dissociation 
profile (data not shown). 
Importantly, a significant increase of the relative abundance of active hexameric 
species was observed with respect to the inactive trimeric form when exogenous 
recombinant PHM (10 μM) and iron (10 μM) were added simultaneously to the 
reaction mixture containing apo-PH(LNO)2 and PHK (Fig.II.5, black line). Moreover, 
in the later experiment a significant fraction of the regulatory protein PHM was bound 
to the active hexameric PH(LNO)2 hydroxylase in a PHM-PH(LNO)2 complex (Fig.II.5, 
black line, and Table II.2).  
 
Sample Peak A Peak B  
Subunits N° of 
matched 
Peptides 
Sequence 
Coverage 
(%) 
Subunits N° of 
matched 
Peptides 
Sequence 
Coverage 
(%) 
Apo PH(LNO)2 incubated with 
PHK 
(FIG.II.6-red line) 
PHN
a 
PHL
a
 
PHO
a 
23 
22 
4 
46 
59 
33 
PHN
a 
PHL
a
 
PHO
a
 
PHk
a
 
24 
23 
5 
7 
46 
61 
38 
43 
Apo PH(LNO)2 incubated with 
PHK, PHM, and Fe
2+ 
(FIG.II.6-black line) 
PHN
b 
PHL
b
 
PHO
b
 
PHM
b 
22 
24 
5 
3 
47 
75 
46 
55 
PHN
a 
PHL
a
 
PHO
a
 
PHk
a
 
23 
24 
5 
9 
46 
63 
38 
64 
 
Table II.2. Identification of the subunits in the chromatographic peaks as separated in Fig.II.5.  
Proteins were identified in the peak top fractions after tryptic digestion and mass spectrometric 
analysis. 
a
 MALDI-TOF analysis. 
b
 Capillary LC-MSMS analysis. 
 
Unexpectedly, PHK did not bind to pre-formed, trimeric apo-PH(LNO). When apo-
PH(LNO) was incubated with PHK, up to a molar ratio of 1:8, we could not detect any 
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PHK co-eluting with the trimeric species, whereas all the three subunits PHL, PHN, 
and PHO could be easily identified by proteomics methods (data not shown).  
This result strongly suggests that PHK binds to the hexameric form (either apo- or 
holo-) of the hydroxylase before inducing dissociation to the PHK-PH(LNO) complex. 
 
II.6.4 Avidin pull-down assay using Pseudomonas sp. OX1 cell extract 
 
In order to gain further insight in this molecular process, to provide evidence 
for the specificity of the binding between PHK and the PHL, PHN, PHO subunits of 
the PH hydroxylase moiety, and to verify the possibility of other proteins interacting 
with PHK, we carried out an affinity purification strategy using an avidin pull-down 
assay on two different extracts of cells of Pseudomonas sp. OX1. One grown on 
phenol as unique carbon and energy source and the other grown on malat (the 
control), in this last condition the bacteria does not express any PHH complex. This 
approach required that recombinant PHK was biotinylated in controlled reaction 
conditions (not more than two biotin molecules introduced in average per PHK 
molecule) in order to avoid extensive modification of the protein. We biotinylated 3 
mg of PHK as described in the Experimental Procedures, section II.5.3, with Sulfo-
NHS-Biotin (sulfosuccinimidobiotin); an aliquot was loaded on RP-HPLC and 
analysed by ES-MS, showing that, in the experimental conditions used PHK was 
efficiently biotinylated (up to 3 biotins per molecule).  
The biotinylated PHK was immobilized on avidin beads that were subsequently 
incubated with total protein extracts from Pseudomonas sp. OX1 cells grown on 
phenol and on malat. These latter had been pre-cleaned on agarose beads to 
minimize non-specific binding on the cromatographic matrix during the pull-down 
procedure. After extensive washing, PHK recruited protein interaction partners were 
eluted in Laemmli buffer, separated on SDS-PAGE and stained with colloidal blue 
Coomassie (Fig.II.6). Stained gel displayed a number of discrete bands both in the 
control (Fig.II.6; lane 4) and sample lanes (Fig.II.6; lanes 3). By comparison of the 
electrophoretic patterns after elution (Fig.II.6; lanes 3 and 4), the sample profile 
showed enrichment of some specific bands. Three major proteins with molecular 
weight at approximately 12 kDa, 40 kDa and 60 kDa (Fig.II.6; lane 3) were pulled-
down. Interestingly, the band pattern observed from P.sp. OX1 pull down appeared 
to be similar to purified reference proteins (Fig.II.6, lane 5). Thus the bands present 
only in the sample were excised from the gel. Each slice was destained reduced, 
alkylated and digested in situ with trypsin. To check for nonspecific pull down, the 
same procedure was applied to the control sample. The resulting peptide mixtures 
were analyzed by LC/MSMS analysis. The data obtained were then used for protein 
identification searching the bacteria subset of NCBI database with the MASCOT 
software. 
All the corresponding protein bands, from the sample and control, were compared. 
However, all proteins identified in the control that were also detected in the sample, 
at the corresponding gel slices, were eliminated, in order to reduce the incidence of 
false positives. The three major proteins were confidently identified as PHL, PHO, 
PHN, beside the PHK bait. Thus, these results indicate a highly specific interaction of 
PHK with the LNO subunits of the hydroxylase moiety expressed in the native 
microorganism P.sp.OX1. Those proteins, identified by MASCOT search with at least 
2 peptides, and present exclusively in the sample lane were selected, providing a full 
list of PHK putative interactors [27,28]. Eight putative PHK-interacting proteins were 
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identified by the above criteria and are listed in Table II.3, together with their 
corresponding genes and the number of peptides used for their identification.  
 
 
 
Fig.II.6. SDS-PAGE fractionation of pull down experiment with biotinylated PHK. Colloidal blue-
stained gel for biotinylated PHK associated proteins from Pseudomonas sp. OX1 cells grown on 
phenol (lane 3) and malat (lane 4). Total P.sp.OX1 cell extract is loaded in lane 1 (grown on phenol) 
and 2 (grown on malat). An aliquot of PHM-PH(LNO)2, was loaded (lane 5) as a control. Biotinylated 
PHK associated proteins were analysed by SDS-PAGE followed by colloidal blue staining. A, B, and C 
labels in lane 3 indicate the three major proteins detected among the proteins pulled-down by 
biotinylated PHK. Protein bands occurring in the sample (lane 3) and in the control (lane 4) were 
submitted to mass spectral analyses. Common proteins identified in both the sample and the control 
gel slices were eliminated. Molecular weight markers are also shown. 
 
 
Gene 
Name 
ID Protein Name Number of 
Peptides 
MW (Da) Sequence 
coverage (%)  
fusA Q889X4 Elongation factor G 7 77170 13 
fadB Q4KFC4 Fatty acid oxidation complex subunit alpha 7 77124 15 
 Q88K15 
 
Isoquinoline 1-oxidoreductase, beta subunit, 
putative 
3 78675 43 
htpG Q4KFX8 Chaperone protein htpG 2 71349 6 
phN Q84AQ2 Phenol hydroxylase component phN 43 60141 77 
touA O87798 Toluene, o-xylene monooxygenase 
oxygenase subunit 
12 57725 33 
phO Q84AQ1 Phenol hydroxylase component O 3 13235 26 
touK Q93JV2 Putative uncharacterized protein touK 3 10078 26 
 
Table II.3. Full list of Phenol Hydroxylase component K (PHK) putative interactors identified by mass 
spectrometry. 
 
 
II.7 Discussion 
 
Microorganisms devote part of their genetic and biochemical resources to 
ensure the functional incorporation of metals into the active site of several enzymes 
whose catalytic chemistry requires metal ions. Proteins responsible for the tightly 
regulated homeostasis of metals are generally known as metallochaperones [20,29], 
proteins which, among others, have also a key role in confining toxic metals - such as 
iron and copper - to avoid non-specific interactions with cellular membranes, 
proteins, or DNA [30,31].  
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Based on data available for components similar to PHK from Pseudomonas sp. OX1, 
such as MMOD from M. capsulatus (Bath) and DmpK from P. sp.CF600 [18,19], 
several roles could be envisaged for this protein, including its role as a molecular 
chaperone, a metal delivery factor, or a metallochaperone. Interestingly, sequences 
homologous to that coding for PHK can be found in most of the phenol hydroxylase 
operons sequenced so far [8], thus clearly suggesting a critical role for a component 
with unclear functions in this specific subfamily of BMMs. 
Study carried out at the Prof. di Donato‟s group indicated that whole cells of E. coli 
strain JM109 coexpressing recombinant multicomponent phenol hydroxylase from 
Pseudomonas sp. OX1 and the accessory subunit PHK were characterized by an 
improved catalytic efficiency in converting phenol to catechol when compared to the 
same strain expressing the PH operon deprived of the gene phk. This difference was 
confirmed when crude extracts of induced cells, instead of whole cells, were used in 
the enzymatic assays. Whereas total iron content was similar in cells expressing the 
two different ph gene clusters, a significant difference was found in their phenol 
hydroxylase activity, measured as rate of catechol formation. Surprisingly, in cell 
extracts lacking recombinant PHK, increase of phenol hydroxylase activity could be 
obtained by the sole addition of an excess of exogenous iron (II) to the sample 
tested. This result is different from what previously observed with the recombinant 
hydroxylase of multicomponent PH from Pseudomonas sp. CF600 [18]. In this case, 
in fact, the hydroxylating activity of crude extracts of cells not expressing the 
accessory component DmpK could be detected only after addition of DmpK together 
with exogenous iron (II), thus supporting the hypothesis of a role of DmpK not only in 
the delivery but mainly in the correct assembly of iron into the active site of the 
hydroxylase [18].  
We provided this study with a structural approach to investigate the influence of PHK 
on phenol hydroxylase complex reconstituted from the purified components PHP 
(oxidoreductase), PHM (regulatory protein) and PH(LNO)2 (hydroxylase moiety) [6]. 
PHK was found to be as a dimeric protein, devoid of any metal or organic cofactor. 
PHK did not seem to be essential for the enzymatic activity of the PH complex on 
phenol, instead study carried out at the Prof. di Donato‟s group showed an inhibitory 
effect on the rate of hydroxylation of phenol to catechol, even when present at low 
ratios with respect to the hydroxylase moiety PH(LNO)2.  
An insight into the molecular details of this inhibition was obtained by screening the 
molecular species formed after incubating the hydroxylase complex PH(LNO)2 with a 
substoichiometric amount of purified PHK (Fig.II.4.A). Native gel electrophoresis, and 
gel filtration experiments followed by mass spectrometry identification of the species 
formed upon incubation, showed the presence of a novel molecular species, made 
up by PH(LNO) tightly associated with monomeric PHK. Biochemical assays 
revealed that this species is devoid of both iron and catalytic activity, providing an 
explanation for the inhibitory effect observed when exogenous PHK was added to 
reconstituted phenol hydroxylase in in vitro enzyme assays. The ability of PHK to 
promote dissociation of the hexameric complex PH(LNO)2 was confirmed by the 
observation that inactive PHK-PH(LNO) could be isolated upon purification of cell 
extract of E. coli-strain JM109 expressing the complete ph gene cluster from plasmid 
pGEM3Z/phΔk. In the same gel-filtration experiment, the yield of the PHK-PH(LNO) 
complex is significantly lower when complex PHM-PH(LNO)2 instead of PH(LNO)2 
was incubated with PHK (Fig.II.4.B). These results suggest a possible shielding 
effect of PHM towards the dissociation of the PH(LNO)2 hexamer mediated by PHK. 
This “protective role” of the coupling protein PHM, observed in different experiments 
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presented in this work, is similar to what previously described, amog others, for the 
homologous regulatory component MMOB in the sMMO system from Methylococcus 
capsulatus [29]. 
Further insight on the possible role of PHK came from experiments of iron uptake by 
iron-deprived PH(LNO)2 hydroxylase. Study carried out in collaboration with the Prof. 
di Donato‟s group showed that in the presence of the accessory protein PHK the 
recovery of the catalytic activity of apo-PH(LNO)2 occurs at stoichiometric 
concentration of iron (II). This observation is physiologically relevant because iron 
uptake and recovery of catalytic activity measured in the absence of PHK occurs at a 
much higher iron (II) concentration. 
Taking into account the data presented in this work and the information available in 
literature for the accessory components MMOD [19] and DmpK [18], a possible 
sequence of molecular events in which PHK might be involved can be hypothesized, 
which could be compatible with our data (Fig.II.7).  
 
 
 
Fig.II.7. Model showing a possible role for PHK. In white and light grey background is the part of 
the model suggested by the experiments described in this work and the data presented in literature for 
DmpK and MMOD accessory proteins [18,19] . In dark grey is the sequence of events that is still 
under investigation. The presence of the oxidoreductase PHP in the PH catalytic cycle, has been 
omitted in the scheme for clarity. 
 
Lacking any experimental evidence on early post-translational events, the model 
assumes apo-PH(LNO)2 as the starting point of the sequence of events in which PHK 
transiently binds to the apo-hexamer influencing the uptake of intracellular iron inside 
the active site, thus facilitating the formation of holo-PH(LNO)2 i.e., the active 
hydroxylase moiety.  
Based on the ability of PHM to “protect” the holo-PH(LNO)2 from dissociation caused 
by PHK (Fig.II.4 and Fig.II.5), our model proposes that the regulatory component 
PHM would bind to the holo-PH(LNO)2 complex, immediately after the PHK-facilitated 
insertion of iron (II). This event displaces PHK, which can then be immediately 
recycled to assist in iron insertion in newly assembled apo-PH(LNO)2 molecules.  
If inhibition of the phenol hydroxylase activity at PHK:PH(LNO)2 ratios higher than 0.5 
is of questionable physiological significance, the PHK-mediated inhibition of the 
catalytic activity of holo-PH(LNO)2 exerted at substoichiometric ratios, and not 
detected in the gel filtration experiments, might be a consequence of the fact that, 
after completion of the hydroxylation reaction, the regulatory protein PHM probably 
dissociates from the hydroxylase so that the reductase PHP can bind and reinitiate 
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the catalytic cycle, as previously suggested in literature [10]. The dissociation of the 
regulatory protein would allow the binding of PHK and the consequent formation of 
the PHK-PH(LNO) inactive complex.  
To support the presence of an interplay between the accessory and the regulatory 
proteins in BMMs, it should be taken also in account that Sazinsky and coworkers 
[25], using the purified components of the sMMO from M. capsulatus (Bath), 
highlighted, by means of ITC binding experiments, a higher affinity of the regulatory 
(MMOB) and the accessory (MMOD) proteins for the holo- and the apo- hydroxylase 
moiety MMOH, respectively. Moreover, Powlowski and coworkers [18] had previously 
advanced the hypothesis that the accessory component DmpK likely interferes with 
the interaction between the regulatory protein DmpM and the hydroxylase moiety 
Dmp(LNO)2. 
Once the regulatory component PHM is bound to the PH(LNO)2 active complex, the 
iron is protected inside the active site from accidental loss as indicated by depletion 
and reconstitution experiments performed on the PHM-PH(LNO)2 complex, and a 
new catalytic cycle on phenol can be initiated. 
The protective role of the regulatory component in the phenol hydroxylase system of 
P.sp. OX1 is particularly evident in the crystal structure of the PHM-PH(LNO)2 
complex [10], whose arrangement shows that PHM, among others, functions to block 
the entrance of the solvent and substrate to the diiron active site through the four-
helix bundle, offering some type of protection of the dioxygen-activated metal center 
as it traverses the reaction cycle [10]. 
Our current hypothesis is that PHK does not directly bind iron, as suggested by ITC 
experiments, but might be responsible for altering local conformation of apo-
PH(LNO)2, thus facilitating direct access of iron into the hydroxylase active site. It is 
actually under investigation whether this observation is related to the direct binding of 
iron to an apo-PH(LNO)2-PHK transitory complex or it is a consequence of a 
conformational modification induced by PHK in the iron depleted hydroxylase moiety 
apo-PH(LNO)2.  
Among others, the question arises, also evidenced in the scheme of Fig. II.7, on 
whether the PHK-PH(LNO) complex is of physiological importance. Our current 
hypothesis is that during repeated catalytic cycles this complex might lose iron and 
could be coupled to PHK to induce the formation of the PHK-PH(LNO) species we 
have observed in vitro (lower part of the scheme of Fig. II.7). These complexes might 
reorganize, with the aid of further, yet undiscovered, auxiliary proteins, to form apo-
PH(LNO)2 complexes. Alternatively, the presence of PHK might be necessary to 
avoid the occurrence in vivo of holo-PH(LNO)2 molecules in the absence of the 
regulatory protein PHM. In this case, in fact, the oxidoreductase PHP is still able to 
transfer electrons to the hydroxylase moiety [6], leading to an uncoupling, or a 
premature reduction of the oxygenated metal cluster, which would not only consume 
the reactive diiron species but also deplete the NADH supply of the cell in a wasteful 
manner [10]. 
At this stage we cannot exclude that formation of inactive PHK-PH(LNO) complexes 
could be just an artifact of our system due to the presence of high intracellular 
concentration of recombinant PH(LNO)2 and PHK. This phenomenon would shift the 
physiological association equilibrium toward the formation of the PHK-PH(LNO) 
species. Nevertheless, the stable PHK-PH(LNO) complex might be a valuable tool in 
the future to shed light on the molecular determinants responsible for the interaction 
between the accessory protein and the hydroxylase subunits PHL, PHN and PHO. 
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In conclusion, novel details on the role of accessory proteins in bacterial 
multicomponent monoooxygenases have been highlighted by the experiments 
described in this work which add to what has been previously observed in the case of 
accessory proteins MMOD and DmpK [18,19]. 
The similarities and the differences among the different accessory proteins 
characterized so far lead to the conclusion that in the BMMs family similar protein 
components but diverse strategies are present aimed at modulating the correct 
assembly of the diiron cluster in the active site of the hydroxylase moiety. 
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III. Molecular basis of schizophrenia: a multidisciplinary 
investigation to new diagnostic and therapeutic approaches 
 
 
III.1 Molecular basis of schizophrenia 
 
Schizophrenia is a chronic and severely debilitating psychiatric disorder 
affecting nearly 1% of the world‟s population and accounts for 2.5% of the 
healthcare costs of the European Community. It is characterized by positive 
symptoms that include hallucinations, delusions, and thought disorder, by negative 
symptoms comprised of affective flattening and social isolation, and by profound 
cognitive deficits in attention, learning, memory, and behavioural flexibility [1,2]. 
Current antipsychotic treatments for schizophrenia show success in reducing the 
severity of positive symptoms, but have limited efficacy in ameliorating negative and 
cognitive deficits [1]. Furthermore, antipsychotic regimes are often poorly tolerated, 
leading to poor compliance and symptomatic relapse [2]. 
In order to develop effective therapies, much effort has been made to further 
understand the molecular alterations involved in the pathophysiology of 
schizophrenia. Efforts to identify the underlying disturbances in schizophrenia are 
currently focused on three general lines of inquiry: (i) examination of the mechanism 
of action of the drugs that alleviate the symptoms of schizophrenia, (ii) examination of 
neuroanatomical abnormalities in the brains of schizophrenia patients, and (iii) 
examination of candidate genes that confer susceptibility to schizophrenia.  
Abnormalities in several neurotransmitter systems have been implicated in the 
pathophysiological processes underlying schizophrenia. The predominant theory has 
been the dopamine hypothesis, which postulates that schizophrenic symptoms arise 
from excessive dopaminergic transmission, particularly in the striatum, and the 
presence of dopaminergic deficits in prefrontal brain regions [3]. In addition to the 
dopaminergic abnormalities, N-methyl-D-aspartate of glutamate receptors (NMDAR) 
hypofunction has been proposed to be involved in schizophrenia [4-9].  
This theory originated from studies demonstrating that non-competitive NMDAR 
antagonists like phencyclidine (PCP) reliably and immediately induce a syndrome 
similar to schizophrenia in healthy individuals and exacerbate symptoms in 
schizophrenia patients [4,10]. Since these initial observations, convergent evidence 
has supported a role for aberrant NMDAR mediated neurotransmission in 
schizophrenia pathogenesis [11,12] and the glutamatergic system in schizophrenia is 
considered to be part of a larger complex framework involving the interaction of 
multiple neurotransmitters and risk genes. More recently, studies have indicated that 
the NMDAR D-serine/glycine binding site and its modulatory enzymes may be 
crucially involved in the glutamatergic dysfunction thought to occur [11,12].  
 
III.2 The NMDAR: structure and regulation 
 
NMDARs play a key role in excitatory synaptic transmission and have been 
implicated in many physiological processes, including learning and memory. 
NMDARs in the central nervous system (CNS) are heteromeric protein complexes 
composed of at least one NR1 subunit together with different combinations of NR2 
and/or NR3 subunits [13]. Alternative splicing of the Grin1 gene produces eight NR1 
isoforms and by associating with different constellations of NR2 (NR2A-D) and NR3 
subunits (NR3A and NR3B) form a multitude of different NMDAR receptors with 
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distinct biophysical properties [14] and specific patterns of expression during 
development and in the mature mammalian CNS [15]. NMDAR complexity is further 
enhanced through post-translational modifications, such as phosphorylation, 
glycosylation, and ubiquitination, affecting cellular localization and function of the 
receptor [16]. The NMDAR also contains a glutamate recognition site on the NR2 
subunit and a glycine or D-serine modulatory site on the NR1 subunit (Fig.III.1) [17]. 
The D-serine/glycine site on the NMDAR must be occupied for glutamate to activate 
the receptor [18]. 
 
 
 
Fig.III.1. The NMDA receptor. D-Serine is synthesized in astrocytes and released near NMDA 
receptors (NMDARs), where it regulates glutamatergic neurotransmission. NMDAR requires ligand 
binding at two sites to open an ion channel. Thus, glutamate binds to NMDAR only if the NMDAR 
glycine site is occupied by the agonist.  
 
Once activated, the NMDAR channel permits the influx of calcium, which stimulates 
intracellular signalling cascades that can subsequently affect synaptic plasticity and 
gene transcription [19]. NMDARs are present throughout the brain and are principally 
neuronal, though they can also be expressed on astrocytes. Beyond the glutamate 
and D-serine/glycine binding site, they contain several regulatory sites sensitive to 
polyamines, Zn2+, protons, and glutathione [13,16]. The numerous influences that 
converge on the NMDAR highlight the importance of these receptors in diverse brain 
functions. In NMDAR complexes containing NR1 and NR2 subunits, D-serine and 
glycine both have excitatory effects, with D-serine being up to three times more 
potent than glycine [20]. Binding to the D-serine/glycine site allosterically influences 
the NMDAR to enhance the affinity and efficacy of glutamate [21], delays receptor 
desensitization to increase the duration and frequency of the open channel state [22], 
and promotes NMDAR turnover through priming of the receptor for internalization 
[23]. As a coagonist with glutamate, D-serine mediates NMDAR responses and long-
term synaptic changes in the hippocampus, a region linked to learning and memory 
[24,25]. Interestingly, therapeutic trials with D-serine have been shown to significantly 
improve symptoms (positive, negative, and cognitive) in patients with schizophrenia, 
suggesting that D-serine may play an important role in the pathophysiology of 
schizophrenia [26-28]. 
The discovery of D-serine in the brain revolutionized the longstanding belief that only 
L-isomers of amino acids existed in mammalian tissues. It is now accepted that 
higher organisms produce D-amino acids (and in particular D-serine) by the enzyme 
serine racemase (SR), which directly converts L-serine to D-serine [29], in both 
astrocytes and neurons [30]. D-Serine was found to be a highly selective 
endogenous activator of the NMDAR D-serine/glycine site [24,31]. In the adult human 
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and rodent brain, D-serine and SR are predominantly localized to the forebrain, with 
high levels in the cerebral cortex and hippocampus, and minimal levels in the 
cerebellum and brainstem [32].  
The low D-serine concentrations in caudal brain areas coincide with the emergence 
of D-amino acid oxidase (DAAO), the D-serine catabolic enzyme [33]. 
 
III.3 D-amino acid oxidase (DAAO) and pLG72. Two proteins involved in 
schizophrenia pathology 
 
D-Amino acid oxidase (DAAO) is a FAD dependent flavoenzyme, localized in 
the peroxisome that at physiological pH catalyzes with a strict stereospecificity the 
oxidative deamination of D-amino acids to the corresponding imino acids, with 
concomitant reduction of FAD [34]. The reduced flavin is subsequently reoxidized by 
molecular oxygen generating H2O2 and the imino acid is released into solvent, where 
it spontaneously hydrolyzes to the corresponding α-keto acid and ammonia. 
(Fig.III.2). This enzymatic activity has been identified in most eukaryotic organisms, 
the only exception being plants.  
The human flavoenzyme can be distinguished from the other known DAAOs because 
it is a stable 80 kDa homodimer of 347 amino acid, even in the apoprotein form, 
because the non-covalent binding of the FAD cofactor is the weakest among the 
known DAAOs (Kd value is 8x10-6 M) [35,36] (Fig.III.3).  
 
 
 
Fig.III.2. Scheme of the reaction catalyzed by D-amino acid oxidase (DAAO). 
 
 
 
Fig.III.3. Human DAAO oloenzyme tridimensional model. (PDB code 2E4A). 
 
The brain distribution of DAAO is inversely related to that of endogenous D-serine 
concentrations, with the highest levels of DAAO in astrocytes, Golgi-Bergmann glia, 
and tanycytes of the hindbrain and cerebellum [37]. Lower levels of DAAO have been 
detected in the neurons of the prefrontal cortex, hippocampus, and substantia nigra 
[38]. In the periphery, DAAO is most highly expressed in the kidneys and liver [39]. 
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Modulating DAAO function is pLG72 (also known as LG72 or DAAO activator). 
pLG72 was initially identified by Chumakov et al. [40], who examined markers within 
a 5-Mb segment from chromosome 13q33, a region that had previously been linked 
to schizophrenia in earlier linkage analyses. Moreover, the genes encoding for 
human DAAO (hDAAO) and its putative binding partner pLG72 have been linked to 
schizophrenia susceptibility through genetic analysis of different human population 
[41].  
The gene G72 encodes for several splicing isoforms; pLG72 represents the longest 
open reading frame (153 amino acids), which is present only in primates and is 
mainly expressed in brain [41].   
A yeast two-hybrid screening experiment identified D-amino acid oxidase as the 
interacting partner of pLG72 and in vitro assays confirmed a regulatory effect of 
pLG72 on DAAO activity [41,42].  
The physiopathologic hypothesis proposed by Chumakov suggests pLG72 as an 
activator of DAAO (Fig.III.4 arrow 1), and therefore, they proposed that the onset of 
schizophrenia may result from the overexpression of pLG72, which induces 
hyperactivation of DAAO and, ultimately, decreases D-serine concentrations at the 
synapse resulting in hypofunction of NMDAR. 
A recent study carried out by Sacchi et al. indicates that pLG72 may instead repress 
hDAAO activity (Fig.III.4 arrow 2) [42]. By using gel filtration analysis and surface 
plasmon resonance, they demonstrated that in vitro pLG72 specifically interacts with 
both the holo- and apoprotein forms of hDAAO, yielding an ~200-kDa complex 
constituted by 2 hDAAO homodimers (2x80 kDa) and 2 pLG72 molecules (2x20 
kDa); Kd for the complex formation is ~8x10-6 M [42-43].  
 
 
 
Fig.III.4. Hypothesis of the role of DAAO and pLG72 on the D-serine bioavailability at 
glutamatergic synapses under normal and pathological conditions. Glutamate is released by the 
presynaptic neuron into the synaptic space after the depolarization of nerve terminals, yielding the 
activation of non-NMDA receptors on the membrane of the postsynaptic neuron and, subsequently, an 
increase in cytoplasmic concentration of Ca
2+
. D-Serine is then released by the glial cells and, 
together with glutamate, activates NMDA receptors on the membrane of the postsynaptic neuron, 
leading to the opening of ion channels. The Ca
2+
 entry induces several possible intracellular 
responses, e.g. it activates nitric-oxide synthase that produces NO, which can diffuse to the 
neighboring cells where it is proposed to inhibit serine racemase and (probably) activate DAAO, thus 
decreasing the local concentration of D-serine. (1) Hypothesis of involvement of DAAO and pLG72 in 
schizophrenia according to Chumakov et al. in which pLG72 is an activator of DAAO. (2) Sacchi‟s 
hypothesis, in which pLG72 modulates the amount of active hDAAO acting on the stability of the 
holoenzyme.  
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They demonstrated that pLG72 binding did not affect the catalytic efficiency and the 
kinetic parameters of the reaction catalyzed by the enzyme on D-serine, the affinity 
for coenzyme, or the rate constant of FAD binding to the apoprotein. The main effect 
observed was a faster time course of hDAAO inactivation when an excess of pLG72 
was present, which they attributed to the decrease in the amount of the active form of 
holoenzyme is solution. In fact, the amount of cofactor bound to the enzyme 
decreased after the pLG72-hDAAO complex was formed. In their hypothesis pLG72 
binding does not affect hDAAO functionality but, rather, modifies its tertiary structure 
and results in a time-dependent inactivation of the flavoenzyme. Furthermore, they 
confirmed in vivo the hDAAO-pLG72 interaction, by coimmunoprecipitation of the two 
proteins from human cortex extracts. By immunofluorescent assay they identified 
hDAAO and pLG72 in the same astrocytes and they demonstrated the partial 
subcellular colocalization of hDAAO and pLG72 in human glial cells. These finding 
support the possibility of interaction between these two proteins in vivo, suggesting 
that pLG72 might indirectly modulate NMDA receptor function (at least in cortex), 
controlling the levels of D-serine by acting on hDAAO. 
Therefore, they proposed a molecular mechanism (Fig.III.5) by which hDAAO and 
pLG72 are involved in schizophrenia susceptibility: an anomalous increase in hDAAO 
activity (e.g., related to pLG72 hypoexpression) will result in a decrease in the 
synaptic concentration of D-serine, thus causing hypofunctionality of NMDA receptor 
mediated neurotransmission. Importantly, and in agreement with the aforementioned 
model, hDAAO is now considered the target for a new class of drugs (hDAAO 
inhibitors) to treat schizophrenia [44-45]. 
 
 
 
 
Fig.III.5. Diagram illustrating the regulation of NMDA receptors by astrocytic D-serine. In brain, 
hDAAO oxidises D-serine, a molecule that acts on glutamate signalling pathway through the binding to 
the glycine-site of N-methyl-D-aspartate (NMDA) receptor. hDAAO and pLG72 proteins are involved in 
the molecular mechanism underlying schizophrenia by modulating the (cellular) levels of the 
neuromodulator D-serine and altering glutamatergic neurotransmission through an hypofunction of 
NMDA-receptors. 
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III.4. Aim of the project 
 
Schizophrenia is a multi-factorial disorder with both genetic and environmental 
contributions and up to now represented a puzzle for the researchers. In recent 
years, specific genes have been discovered that influence susceptibility to 
schizophrenia. The new challenge now is to identify the specific mechanisms by 
which the implicated genes (and protein products) alter the risk of schizophrenia and 
the molecular and cognitive processes that link these primary events to 
psychopathology. In recent years, the pLG72 protein and D-amino acid oxidase 
(DAAO) have been linked to schizophrenia [41]. 
This part of the work was aimed at providing structural details on the interaction 
between hDAAO and pLG72. These proteins control the concentration of important 
molecules (D-serine, L-proline and glutamate) involved in neurotransmission and 
thus this study is important for understanding the molecular basis of the onset of 
schizophrenia and, thereofore, for the development of therapeutic approaches as 
well as new specific drugs. 
The molecular mechanism by which DAAO expression and acquisition of the catalytic 
activity is regulated is still unknown. Moreover i) structural informations on pLG72 are 
lacking, ii) pLG72 is highly unstable (it is soluble only in presence of mild denaturant) 
and iii) no homologous protein has been structurally characterized so far. These 
features make the characterizations of the complex extremely challenging and hardly 
feasible by high resolution techniques [42]. 
This part of the work was focused on the structural characterization of the hDAAO-
pLG72 complex. Low resolution strategies, such as those based on the coupling of 
classical biochemistry approaches (limited proteolysis and chemical cross-linking) 
with mass spectrometric techniques, allowed for the in vitro analysis of the surface 
topology of pLG72-hDAAO complex, as well as the definition of the conformational 
changes of hDAAO associated to complex formation.  
Since hDAAO is likely to be finely regulated in its activation/inhibition by protein 
partners, we have also performed a proteomic approach on extracts from U87 cells 
expressing hDAAO as c-Myc tagged protein. Our purpose was defining hDAAO role 
in the schizophrenic pathology through a comprehensive analysis of its interactome. 
 
 
III.5 Material and Methods 
 
Recombinant hDAAO and pLG72 were expressed in E. coli and purified as 
previously reported in [35] and [43]. The water-soluble, amino group-selective 
bifunctional cross-linking reagent Bis(sulfosuccinimidyl)suberate (BS3) was from 
Pierce Biotechnology (Rockford, IL, USA). Trypsin TPCK-treated, trypsin proteomic 
grade, chymotrypsin, subtilisin and endoprotease Glu-C were purchased from Sigma. 
Acetonitrile Ultra gradient from Romil.  
 
III.5.1. Complementary and limited proteolysis experiments 
 
Enzymatic hydrolyses of hDAAO, pLG72, and hDAAO-pLG72 complex were 
performed at 37°C in 20 mM NaPPi pH 8.5, 150 mM NaCl, 5% glycerol, 0.06% NLS, 
40 µM FAD and 1 mM DTT, with either trypsin, chymotrypsin, subtilisin or 
endoprotease Glu-C, enzyme-to-substrate ratios ranging from 1:5000 to 1:100 (w/w). 
The time-course of proteolysis was monitored by sampling the reaction mixture at 
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different time intervals (from 1 to 30 min). The reaction was stopped by adding 1% 
TFA or denaturing buffer (300mM Tris-HCl, pH 8.0, 6M guanidine, 10mM EDTA) and 
the incubation mixtures at different interval times were separated by RP-HPLC on a 
Vydac C4 column (250 x 4.6 mm, 300 Å pore size) with a 10 - 65% acetonitrile linear 
gradient in 0.1% TFA over 30 minutes, at a flow rate of 1 mL/min. Elution was 
monitored at 220 nm and individual fractions were collected and analysed by ESI-MS 
on a ZQ single quadrupole instrument (Waters-Micromass). Protein solution was 
injected into the ion source at a flow rate of 10 µL/min. Data were elaborated using 
the MassLynx program (Waters-Micromass). Mass calibration was performed by 
means of multiply charged ions from a separated injection of horse heart myoglobin 
(Sigma, average molecular mass: 16951.5 Da); all masses are reported as average 
values. 
 
III.5.2. Chemical cross-linking experiments 
 
hDAAO, pLG72, and hDAAO-pLG72 complex were equilibrated in 20 µL of 20 
mM HEPES pH 8.0, 150 mM NaCl, 3 mM EDTA, 0.06% NLS and 1 mM DTT at 25°C 
for 15 minutes and then the cross-linking reaction was started by the addition of 
Bis(sulfosuccinimidyl)suberate (BS3). The reactions were incubated at 25 °C for 30 
min and terminated by quenching the excess of reagents with Laemmli sample 
buffer. Preliminary experiments were carried out on single hDAAO and pLG72 
proteins, and on the hDAAO-pLG72 complex to determine the optimal protein 
concentrations and the cross-linking reagent to protein molar ratios.  
 
III.5.3. In situ and in solution digestion 
 
The protein samples were heated at 100°C for 5 min and separated by 
electrophoresis on a 15% SDS polyacrylamide gel. Proteins were stained with 
Coomassie Brilliant Blue G-Colloidal (Pierce, Rockford, USA), and selected stained 
protein bands positive to the western blotting analysis were excised from the gel. 
Excised bands were destained by repetitive washes with 0.1 M NH4HCO3, pH 7.5, 
and acetonitrile. Samples were reduced with 10 mM DTT in 0.1 M NH4HCO3 buffer, 
pH 7.5, carboxyamidomethylated with 55 mM iodoacetamide in the same buffer. 
Enzymatic digestion was carried out with 100 ng of trypsin in 10 mM ammonium 
bicarbonate buffer, pH 7.8. Gel pieces were incubated at 4°C for 2 h. Trypsin solution 
was then removed and a new aliquot of the same solution was added. Samples were 
incubated for 18 h at 37°C. Peptides were then extracted by washing the gel particles 
with 10 mM ammonium bicarbonate and 1% formic acid in 50% acetonitrile at room 
temperature and then analyzed by capillary LC-MS/MS. 
As a parallel approach the cross-linking reaction was stopped by adding TFA 1% and 
an in solution hydrolysis with trypsin was perfomed (E/S 1/50 w/w) for 16 h at 37°C. 
The mixture was analysed by LC-MS/MS. 
 
III.5.4. Western blotting analysis 
 
For immunodetection, after SDS-PAGE, the gel was run in Tris-Glycine buffer 
at 15 V for 1 h, and transferred to a PVDF membrane (Hybond-P, Amersham 
Biosciences). The membrane was saturated with 5% non-fat milk in TBS (10mM Tris-
HCl pH 8.5, 0.5M NaCl), Tween® 0.1% for 1 h at room temperature and then 
incubated with rabbit polyclonal antibody anti-DAAO, or goat polyclonal antibody anti-
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pLG72 at 4°C for two hours. An anti-rabbit or donkey anti-goat IgG were used as a 
secondary antibody and Dura system was used (Thermo) for detection.  
 
III.5.5. Mass spectrometry analysis 
 
LC-MS/MS analyses were carried out on a CHIP MS 6520 QTOF equipped 
with a capillary 1200 HPLC system and a chip cube (Agilent Technologies, Palo Alto, 
Ca). After loading, the peptide mixture (8 µl in 0.1% formic acid) was first 
concentrated and washed at 4 µL/min in 40 nl enrichment column (Agilent 
Technologies chip), with 0.1% formic acid in 2% acetonitrile as eluent. The sample 
was then fractionated on a C18 reverse-phase capillary column (75 µm x 43 mm in 
the Agilent Technologies chip) at flow rate of 400 nL/min, with a linear gradient of 
eluent B (0.1% formic acid in 95% acetonitrile) in A (0.1% formic acid in 2% 
acetonitrile) from 7 to 60% in 50 min. Peptide analysis was performed using data-
dependent acquisition of one MS scan (mass range from 300 to 2000 m/z) followed 
by MS/MS scans of the five most abundant ions in each MS scan. Dynamic exclusion 
was used to acquire a more complete survey of the peptides by automatic recognition 
and temporary exclusion (30 sec) of ions from which definitive mass spectral data 
was previously acquired. Nitrogen at a flow rate of 3 L/min and heated to 325°C was 
used as the dry gas for spray desolvation. MS/MS spectra were measured 
automatically when the MS signal surpassed the threshold of 1000 counts. Double 
and triple charged ions were preferably isolated and fragmented over single charged 
ions. Spectral data were transformed in MzData format using Mass Hunter software 
(Agilent Technologies) and analysed using the licensed version of Mascot 2.1 (Matrix 
Science, Boston, USA), in a local database or using Protein Prospector software. 
Putative cross-linked peptides were identified with the strategy developed by Chu et 
al. by searching for arbitrary mass modifications greater than 138 Da on Lys residues 
or at protein N-termini using Protein Prospector version 5.6. These searches were 
performed with parent mass tolerance of 10 ppm, and a fragment tolerance of 0.6 
ppm. Carbamidomethyl cysteine was searched as a constant modification. Variable 
modifications included: methionine oxidation, and peptide N-terminal glutamine 
cyclization to pyroglutamate. Mass modifications of any integer value between 138 
Da (corresponding to intramolecular cross-linking) and 5000 Da on lysine residues or 
protein N-termini were searched as variable modifications. Mass modification 
searches were performed against a restricted database consisting of only hDAAO 
and pLG72. 
 
III.5.6. Immunoaffinity Purification of hDAAO-Associated Proteins 
 
hDAAO complexes were affinity purified from 8 mg of total extracts prepared 
from human U87 glioblastoma cells transfected with expression vectors encoding for 
Myc-hDAAO fused proteins. U87 cells were disrupted by sonication in lysis buffer 
(50mM Tris-HCl, pH 8.0, 0.15 M NaCl, 0.1% Triton X-100, 1mM EDTA, 1mM DTT, 
1mM PMSF) and protease inhibitors cocktail (Sigma Aldrich). The extracts were 
centrifuged at 12,000 rpm for 30 min at 4°C and filtered with 0.45 µm PVDF filter. 
Total protein cell extracts, quantified with the BioRad protein assay, were incubated 
with 160 µl of mouse anti-IgG agarose conjugated beads (Sigma) overnight at 4ºC 
(preclining step). Beads were pretreated with 5% non-fat milk. After clarification, 
extracts were centrifuged at 3000 rpm for 5 min at 4°C. Cell extracts were then 
incubated overnight with polyclonal anti-Myc IgG conjugated agarose beads (Santa 
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Cruz). The beads were washed extensively with lysis buffer. Control samples were 
prepared in parallel using untransfected cell extracts. Protein samples were eluted 
with Myc competitor peptide (200 μg/mL), precipitated in methanol/ clorophormium, 
resuspended in Laemmli sample buffer. Samples were analyzed by SDS–PAGE 
(12.5 % - 20 cm x 20 cm), and proteins were stained with Coomassie Brilliant Blue G-
Colloidal (Pierce, Rockford, USA). 
 
III.5.6.1. In situ digestion and Western Blotting Analysis 
 
Identification of complex subunits was carried out on trypsin digested samples 
by in situ digestion after fractionation on polyacrilamide gel electrophoresis as 
previously described (sections III.5.3). Each step of the experimental procedure was 
paralleled by Western blotting step, as previously described III.5.4 section. After 
blotting the PVDF membrane was incubated with mouse monoclonal antibody anti-C-
Myc (Santa cruz) at 4°C for two hours. An anti-mouse peroxidase-conjugated 
secondary antibodies (Sigma) was used as a secondary antibody and Dura system 
was used (Thermo) for detection.  
 
II.5.6.2. Mass spectrometry analysis and protein identification 
 
The peptide mixtures were analysed by LC-MS/MS analysis as previously described 
(section III.5.5). The Mascot search parameters were Human as taxonomy 
restriction, trypsin as enzyme allowing up to 2 missed cleavages, carbamidomethyl 
as fixed modification, oxidation of M, pyroGlu N-term Q, as variable modifications, 10 
ppm peptide tolerance and 0.6 Da MS/MS tolerance and auto protein entries. 
Spectra with a MASCOT score < 25 having low quality were rejected. The score used 
to evaluate quality of matches for MSMS data was higher than 30. 
 
 
III.6. Results 
 
III.6.1. Complementary and limited proteolysis 
 
Limited proteolysis experiments were designed to study the surface topology 
of hDAAO-plG72, on the basis that the portions of the protein that are involved in 
highly structured regions or are located at the inter-subunits interface are protected 
from proteases. In order to properly define the changes induced in the single protein 
components upon formation of the complex, the experiments were in parallel carried 
out on the isolated proteins. 
 
III.6.1.2 Complementary and limited proteolysis of hDAAO 
 
hDAAO, 1 nmol in 200 µL of 20mM sodium pyrophosphate pH 8.5, 150mM 
NaCl, 5% glycerol 0.06% NLS, 40 µM FAD and 1mM DTT, was individually incubated 
at 37°C with trypsin (enzyme-to-substrate ratio (E/S) 1/100 w/w), chymotrypsin (E/S 
1/100 w/w), subtilisin (E/S 1/500 w/w), and endoprotease GluC (E/S 1/500 w/w). 
The extent of the enzymatic hydrolysis was monitored on a time-course basis by 
sampling the incubation mixture at different interval times followed by RP-HPLC 
analysis. The fragments released from the hDAAO molecule were identified on the 
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basis of the accurate molecular mass determined by ES/MS, leading to the 
assignment of cleavage sites. 
As an example, Fig.III.6, shows the RP-HPLC chromatograms of hDAAO aliquots 
withdrawn at 0, 5, and 15 min after endoprotease Glu-C addition. As expected, most 
of the protein remained undigested (fraction 1) and only two fragments were detected 
in the chromatograms. ES/MS analysis identified fractions 2 and 3 as peptides 1-249 
and 250-347, respectively, generated by a single proteolytic cleavage at Glu249.  
Fig.III.7 shows the absorbance profiles of the RP-HPLC analysis of the aliquots 
withdrawn at 0, 5, 15 min of digestion with trypsin. Peak 1 was identified as the 
mixture of undigested protein (1-347) and the peptide 1-341 (experimental mass 
value 38811.56 ± 1.70 Da, theoretical mass value 38811.16 Da). The hDAAO protein 
is immediately cleaved at Arg341 with the removal of C-terminal hexapeptide. The 
flexibility and accessibility of the C-terminal region deduced from these data is 
consistent with the three-dimensional structure of the protein determined by X-ray 
analysis, which could not be solved in the C-terminal portion due to the high flexibility 
of this region. 
Because of the very fast proteolysis at the C-terminal end, and with the confidence of 
the structural data that represent the C-terminal arm as an exposed peptide not 
stably interacting with the hDAAO molecule, we confidently assumed that the loss of 
the 342-347 peptide does not significantly alter the native conformation of the protein. 
Therefore, in the experiments with trypsin, the truncated form 1-341 was considered 
as the basic molecule of hDAAO, on which subsequent primary hydrolysis occurred. 
Fractions 2 and 3 were identified as peptides 1-191 and 192-341, respectively, 
indicating the occurrence of another further cleavage site at Arg191.  
Similar limited proteolysis experiments were then carried out using subtilisin and 
chymotripsin: these proteases identified cleavage sites at Gly 249 and at Leu 189, 
Leu 194 and Leu 230, respectively (see Table 1). 
The overall results of the limited proteolysis experiments on hDAAO are summarized 
in Table III.1. 
 
 
Protease  
 
(Protease/Substrate 
ratio (w/w)) 
Identified 
Peptide 
Experimental mass 
value (Da) 
Theoretical 
mass value (Da) 
Proteolytic 
site 
Trypsin 
(1/100) 
1-341 38811.56±1.70 38811.16 R
341
 
1-191 
192-341 
21763.63±1.46 
17066.90±1.00 
21762.60 
17066.50 
R
191
 
 
Chymotrypsin 
(1/100) 
1-250 
251-347 
28392.60±1.75 
11098.27±0.37 
28393.20 
11098.7 
L
250
 
1-194 
195-347 
22089.81±1.99 
17404.48±1.75 
22088.0 
17404.0 
L
194
 
1-189 
190-347 
21476.70±1.53 
18013.41±1.60 
21478.3 
18013.7 
L
189
 
Glu-C 
(1/500) 
1-249 
250-347 
28280.49±1.69 
11211.94±1.03 
28280.49 
11211.90 
E
249
 
Subtilisin 
(1/500) 
1-189 
190-347 
21478.68±1.22 
18041.14±0.59 
21478.3 
18013.7 
L
189
 
 
Table III.1. Peptides generated in the digestions of hDAOO with proteases and identified by ES/MS 
analysis after fractionation by RP-HPLC. 
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Fig.III.6. Time-course analysis of hDAAO digested with endoprotease Glu-C under controlled 
conditions using an enzyme/substrate ratio of 1:500 (w/w). HPLC chromatograms of the aliquots 
withdrawn from the incubation mixture at (A) 0 min, (B) 5 min, and (C) 15 min. Individual fractions 
were collected and analyzed by ES/MS. 
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Fig.III.7. Time-course analysis of hDAAO digested with trypsin under controlled conditions 
using an enzyme/substrate ratio of 1:100 (w/w). HPLC chromatograms of the aliquots withdrawn 
from the incubation mixture at (A) 0 min, (B) 5 min, and (C) 15 min. Individual fractions were collected 
and analyzed by ES/MS. 
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III.6.1.3. Complementary and limited proteolysis of pLG72 
 
The same experimental strategy described above was used to investigate the 
surface topology of the pLG72 protein. The optimal enzyme-to-substrate ratio was 
1/2000 for trypsin, chymotrypsin and endoprotease Glu-C, and 1/5000 for subtilisin. 
In all cases, the time course of fragments formation was investigated by RP-HPLC 
followed by molecular mass determination by ES/MS analysis.  
As an example, Fig.III.8 shows the absorbance profiles of the RP-HPLC analysis of 
the aliquots withdrawn following 0, 5, 15 min of trypsin digestion. Only two fragments 
were released from the intact protein after 5 min of incubation. On the basis of their 
accurate molecular mass, as determinate by ES/MS analysis, the fragments could be 
identified as peptides 1-128 and 129-153 which accumulated rapidly as the digestion 
time increases. These fragments were generated by the single proteolytic event at 
Arg128.  
The overall results of the limited proteolysis experiments on pLG72 are summarized 
in Table III.2. 
With the only exception of cleavage at site Trp 61 by chymotripsin, all the employed 
proteases acted on residues belonging to the C-terminal end of this small protein. 
 
 
Protease  
 
(Protease/Substrate 
ratio (w/w)) 
Identified 
Peptide 
Experimental mass 
value (Da) 
Theoretical 
mass value 
(Da) 
Proteolytic 
site 
Trypsin 
(1/2000) 
1-128 
129-153 
15110.15±1.49 
2988.58±0.15 
15109.22 
2988.28 
R
128
 
 
Chymotrypsin 
(1/2000) 
1-61 
62-153 
7030.38±0.38 
11066.37±0.73 
7030.08 
11067.41 
W
61
 
1-134 
135-153 
15908.85±1.12 
2188.96±1.40 
15908.20 
2189.34 
W
130
 
Glu-C 
(1/5000) 
1-146 17347.57±1.22 17948.66 E
146
 
Subtilisin 
(1/2000) 
1-150 17751.44±1.51 17751.11 T
150
 
1-116 
117-153 
13643.55±0.99 
4454.52±1.00 
13642.59 
4454.89 
Y
116
 
 
Table III.2. Peptides generated in the digestions of pLG72 with proteases and identified by ESI-MS 
analysis after fractionation by RP-HPLC. 
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Fig.III.8. Time-course analysis of pLG72 complex digested with trypsin under controlled 
conditions using an enzyme/substrate ratio of 1/2000 (w/w). HPLC chromatograms of the aliquots 
withdrawn from the incubation mixture at (A) 0 min, (B) 5 min, and (C) 15 min. Individual fractions 
were collected and analyzed by ES/MS.  
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III.6.1.4. Complementary and limited proteolysis of DAAO-pLG72 complex 
 
When the experiments were carried out on the hDAAO-pLG72 complex, in 
order to ensure that all of flavoenzyme was complexed with pLG72, we worked with a 
molar excess of pLG72 protein. Consequently, it is not possible to deduce any 
structural information about the pLG72 regions involved in the complex because 
most of the pLG72 molecules are not complexed with hDAAO, providing therefore 
results that have to be ascribed to free pLG72. 
The hDAAO-pLG72 complex was formed by incubating hDAAO (4 nmol) with a 5:1 
molar excess of pLG72 (20 nmol) protein at 0°C prior to proteolytic enzyme addition. 
Formation of the complex was confirmed by native gel analysis (data not shown). 
The optimal enzyme-to-substrate ratio was 1/2000 for trypsin, chymotrypsin and 
endoprotease Glu-C, 1/10000 for subtilisin. 
Fig.III.9 shows the RP-HPLC analysis of the aliquots withdrawn at 0, 5, 15 min of 
digestion with subtilisin. ES/MS determination identified peaks 1 and 2 as hDAAO 
and pLG72 intact proteins, respectively. Fractions 3 and 4 were identified as 
fragments 1-167 and 1-180 of hDAAO protein, respectively, and fraction 5 contained 
the complementary peptides 168-347 and 181-347. 
The overall results of the limited proteolysis experiments on the hDAAO-pLG72 
complex are reported in Table III.3 and compared to those obtained on the isolated 
hDAAO in Figure III.12. 
 
 
Protease  
 
(Protease/Substrate 
ratio (w/w)) 
Identified 
Peptide 
Experimental mass 
value (Da) 
Theoretical 
mass value 
(Da) 
Proteolytic 
site 
Trypsin 
(1/2000) 
1-297 
298-347 
34004.15 ± 1.51 
5488.24 ± 0.32 
34003.70 
17066.50 
R
297
 
 
Chymotrypsin 
(1/2000) 
1-35 
36-347 
3851.66±0.13 
35640.87±1.0 
3851.62 
35640.35 
Y
35
 
1-55 
56-347 
6056.99±0.5 
3343.86±1.48 
6057.07 
33434.90 
Y
55
 
1-296 
297-347 
33846.89±1.39 
5644.50±0.43 
33847.51 
5644.47 
L
296
 
Glu-C 
(1/2000) 
1-336 38138.09±1.10 38198.39 E
336
 
Subtilisin 
(1/10000) 
1-167 
168-347 
19237.07±0.82 
20255.54.±1.81 
20619.31 
18872.69 
F
167
 
1-180 
181-347 
20619.58±0.84 
18872.35±0.64 
20619.31 
18872.69 
N
180
 
 
Table III.3. Peptides generated in the digestions of hDAAO when in complex with pLG72, with 
proteases and identified by ESI-MS analysis after fractionation by RP-HPLC. 
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Fig.III.9. Time-course analysis of hDAAO/pLG72 complex digested with subtilisin under 
controlled conditions using an enzyme/substrate ratio of 1/10000 (w/w). HPLC chromatograms of 
the aliquots withdrawn from the incubation mixture at (A) 0 min, (B) 5 min, and (C) 15 min. Individual 
fractions were collected and analyzed by ES/MS.  
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III.6.2. Chemical crosslinking of hDAAO-pLG72 complex 
 
A general strategy of studying the contact regions in protein complexes is by 
chemical crosslinking. 
In this study, the interacting regions in the hDAAO-pLG72 complex were investigated 
by chemical cross-linking with the homobifunctional reagent 
Bis(sulfosuccinimidyl)suberate (BS3), that contains an amine-reactive N-
hydroxysulfosuccinimide (NHS) ester at each end of an 8-carbon spacer arm. 
hDAAO and pLG72 (1 nmol and 5 nmol, respectively, in 20 µL) were incubated in ice. 
After 10 min, BS3 was added to the cross-linking reaction and incubated at 25°C for 
30 min. For quenching the reactions 20 mM NH4HCO3 was added to each aliquot. 
Several concentrations of BS3 and different reaction times were tested and the final 
experimental conditions were selected as those resulting in the formation of an 
hDAAO-pLG72 heterodimeric complex, avoiding formation of high molecular mass 
oligomers and preventing excessive cross-linking.  
As an example, Fig.III.10, panel A, shows the electrophoretic analysis of the cross-
linking reaction on hDAOO-plG72 complex, obtained by mixing hDAOO and pLG72 
in a 1:5 molar ratio (monomer of hDAOO:plG72) treated with 5, and 50 molar excess 
of BS3 in respect to hDAOO monomer. The reaction was carried out for 30 min at 
25°C. However, upon cross-linking treatment we could only detect (lane 6 and 8 of 
panel A, Fig.III.10), the appearance of a specie migrating at an apparent molecular 
weight of about 37 kDa, an apparent molecular weight that is even lower than 
monomeric hDAAO (migrating at about 40 kDa). 
 
 
 
 
Fig.III.10. hDAAO-pLG72 complex cross-linking with BS
3
. A) SDS-PAGE of reaction mixtures of 
hDAAO (12.5 μM) and pLG72 (62.5 μM) with BS
3
. The samples are labelled as follows: 1)hDAAO 2) 
pLG72 3) hDAAO with BS
3
 62.5 μM 4) pLG72 with BS
3 
62.5 μM, 5) hDAAO-pLG72 complex with BS
3
 
62.5 μM 6) hDAAO with BS
3 
625 μM 7) pLG72 with BS
3 
625 μM 8) hDAAO-pLG72 complex with BS
3
 
625 μM. All the reactions were carried out at 25°C for 30 min in 20 mM Hepes pH 8.0 and stopped by 
the addition of Laemmli sample buffer. Western blotting analyses with an antibody directed against 
pLG72 B) and against hDAAO C). 
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As a further analysis, the different mixtures of products generated by the cross-
linking reaction were analyzed by Western blotting with anti-pLG72 and anti-hDAAO, 
as shown in Fig.III.10, panel B and C, respectively. It can be observed that the band 
at about 37 kDa is positive to anti-DAAO staining, while immunodetection with anti-
pLG72 antibodies indicates that, upon treatment with BS3 pLG72 is also present in a 
band at about 40 kDa, comigrating with hDAAO, probably due to two molecules of 
pLG72 cross-linked. 
The identity of the gel band was definitively assessed by identification of the protein 
components by in situ digestion followed by mass spectrometry analysis. The protein 
bands were excised from the gel and subjected to enzymatic in situ digestion with 
trypsin. The resulting peptide mixture was directly analyzed by LC-MS/MS and the 
corresponding mass values were mapped onto the anticipated sequences of hDAAO 
and pLG72 revealing the simultaneous presence of both proteins.  
In order to locate the crosslinks in the protein molecules, the general strategy is the 
in situ digestion of the gel band where both proteins are present and that is 
generated upon treatment with the cross-linking agent, followed by LC-MS/MS 
analysis of the petide mixture and careful inspection of the MS/MS spectra. Usually, 
the advantage of in situ digestion is that the cross-linked sample can be isolated from 
not cross-linked materials, thus reducing the complexity of the mixture.  
A possible disadvantage is that it is difficult to extract from the gel band some 
peptides, manly the cross-linked ones, because of their dimensions. We decided, 
therefore, to perform, as an alternative approach, an in-solution digestion of the 
cross-linked hDAAO-pLG72 complex, in order to improve sample recovery. The 
mixture was analysed by LC-MS/MS in presence of an exclusion list created with the 
theoretical tryptic hDAAO and pLG72 peptides. The exclusion list would favour the 
instrument to select low abundant species, such as the cross-linked ones, in respect 
to the highly abundant ions generated by the expected and canonical digestion of the 
proteins.  
This strategy, coupled with the use of the open mass modification option in the 
Prospector software, allowed to identify several putative ion species that could 
account for cross-linked peptides, either intermolecular or intramolecular, whose 
spectra manual inspection is currently in progress. As an example, Fig.III.11 shows 
the MS/MS spectrum of the triply charged ion [M+3H]3+ at m/z 546.29 that can be 
interpreted as an intramolecular cross-link between the peptides K163VESFEEVAR172 
and M1R2of the hDAAO. The fragment ions corresponding to these peptides are 
therefore with either the α or β subscript, respectively, to indicate the peptide of 
origin. The only amines in these two sequences that would have been available for 
cross-linking in the intact protein are Lys-163 and the amino-terminus of M-1. The 
MS/MS spectrum revealed a complete y-ion series for the 163-172 peptide chains, 
indicated with y1α-9α. Moreover there are three ions originate from cleavage reactions 
involving both peptide chains, i.e., m/z 671.39 (b2αb2β; KV-MR), m/z 800.44 (b3αb2β; 
KVE-MR) and 887.46 (b4αb2β; KVES-MR). It is important to notice the specie at m/z 
444.23 corresponding to the MR peptide plus 138 Da, which is the mass of the 
spacer arm of BS3 cross-linker. 
The strategy described above produced promising data, that are suggestive of some 
distinct putative cross-links between hDAAO and pLG72, but the careful manual 
inspection of the spectra collected is still in progress.  
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Fig.III.11. ESI-MS/MS spectra of cross-linked peptides KVESFEEVAR and MR of hDAAO with 
cross-link between N-term of M-1 and Lys-163. Tandem mass spectra of the precursor ion 
[M+3H]
3+
 at m/z 546.29. Fragments from peptide KVESFEEVAR are labelled with an α subscript, 
those from peptide MR with a β subscript. The cross-linked sites on the sequence are indicates with a 
crossed line. 
 
 
III.6.3. Identification of novel human DAAO-interacting proteins in neuronal cells 
 
Proteins specifically interacting with hDAAO were identified in neuronal cells 
(U87, human glioblastoma-astrocytoma, epithelial-like cell line) by a functional 
proteomics approach, using transfected Myc-tagged hDAAO protein as bait. Total 
protein extract (8 mg) from Myc-tagged hDAAO transfected U87 cells was precleared 
with underivatized agarose beads to minimize non-specific binding on the 
cromatographic matrix during the immunoaffinity procedure. The unbound material 
was immunoprecipitated with polyclonal anti-Myc IgG conjugated agarose beads. 
After extensive washing, proteins specifically retained were extensively washed and 
eluted with a solution of Myc peptide. Control experiments were carried out, in 
parallel, using extracts from untransfected U87 cells (Figure III.12.B, lane 1 and lane 
2). Following each step of the procedure, Western blotting was performed on a 
sample aliquot using anti-Myc antibodies as a control (Figure III.12.A). The protein 
mixture from the Myc elution was subjected to SDS-PAGE and visualized with 
Coomassie Blue staining (Figure III.12.B). Stained gel displayed a number of discrete 
bands both in the control and sample lanes (lanes 1 and 2, respectively). A band 
occurring at approximately 55 kDa, absent in the pool of non-specifically bound 
proteins and in the control, was positive to the western blotting staining with anti-Myc 
antibodies, as well as anti-hDAAO antibodies. (Fig.III.12, panel A).  
Because of the complexity of the gel patterns and the low resolution of 1D 
electrophoresis, several proteins can occur in the same gel band. Therefore, protein 
bands specifically present in the sample lane and absent in the control lane cannot 
be identified by simply comparing the two gel profiles. Thus, the entire lanes from the 
sample and the control were cut in 38 slices each and the slices were destained, 
reduced, alkylated and digested with trypsin. The resulting peptide mixtures were 
analyzed by LC-MS/MS analysis generating sequence information on individual 
peptides. The obtained data were then used for protein identification searching the 
human subset of NCBI database with the MASCOT software. 
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Fig.III.12. Western blotting and SDS-PAGE fractionation of immunoprecipitation experiment 
with Myc-hDAAO. (A) Western blotting of extracts from Myc-hDAAO transfected human U87 cells 
(sample). Untransfected human U87 cell extracts were used as control. Aliquots (20 μg) corresponding 
to each step of the experimental procedure were subjected to Western blotting and revealed with anti-
Myc and peroxidise conjugated secondary antibodies. Whole cell extract control (lane 1) and sample 
(lane 2). Unbound control (lane 7) and sample (lane 8). Elutions with Myc-peptide competitor, control 
(lanes 3 and 5), sample (lanes 4 and 6). (B) SDS-PAGE fractionation of hDAAO protein complexes. 
hDAAO protein complexes were isolated by immunoprecipitation experiment, sample (lane 2) and 
control (lane 1). Molecular weight markers are also shown.  
 
All the gel bands from the sample and control lanes were then compared on the 
basis of the proteins effectively identified in each gel slice. Common proteins 
identified both in the control and the sample slices were discarded and only those 
proteins solely identified in the sample slices and absent in the control were 
considered. As further selection criteria, only the proteins, identified by MASCOT 
search with at least 2 peptides, providing a full list of putative hDAAO interactors. 
This strategy let us to obtain more confident identification of truly hDAAO binding 
candidates minimizing the number of false positives.  
A total of 48 proteins are listed in Table III.4 together with their corresponding genes 
and the number of peptides used for their identification. Protein identification 
procedures confirmed that the band at about 55 kDa corresponds to the bait hDAAO.  
As a preliminary screening of the results obtained, we extensively searched the 
literature and protein interaction databases for known interactors. Two pricipal 
distinct functional clusters were represented: one (cell morphology, cellular assembly 
and organization) which covers the 67% of the total proteins and the other composed 
by amino acid metabolism, post-traslational modification, small molecule 
biochemistry, which is the 29% of the total proteins (Fig.III.13). The most important 
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finding is that the statistical analysis revealed that 27 proteins are involved in 
neurological disorder, as assessed by experiments of genome wide expressions, 
SNPS, differential proteomics on post-mortem tissues from brains of patient suffering 
for schizophrenia or other neurological disorders. 
 
Gene 
Name 
ID Protein Name Location Number of 
Peptides 
MW (Da) 
NNT Q13423 NAD(P) transhydrogenase, 
mitochondrial 
Mitochondrion inner 
membrane 
4 113896 
FLNC Q14315 Filamin C Cytoplasm 
cytoskeleton 
16 291022 
CAD P27708 CAD protein Cytoplasm 3 242984 
MYH9 P35579 Myosin 9 Cytoplasm 9 226532 
CLTC Q00610 Clathrin heavy chain 1 Plasma Membrane 3 191615 
IMMT Q16891 Mitofilin - Mitochondrial inner 
membrane protein 
Mitochondrion inner 
membrane 
7 83678 
CLPTM1 O96005 Cleft lip and palate 
transmembrane protein 1 
Plasma Membrane 9 76097 
LMNA P02545 Prelamin-A/C Nucleus 9 74139 
POR P16435 NADPH-cytochrome P450 
reductase 
Endoplasmic reticulum 
membrane; Peripheral 
membrane protein 
17 76690 
HSPA5 P11021 78 kDa glucose-regulated protein Endoplasmic reticulum 12 72333 
EWSR1 Q01844 RNA-binding protein EWS Nucleus 2 68478 
NDUFS1 P28331 NADH-ubiquinone 
oxidoreductase 75 kDa subunit, 
mitochondrial 
Mitochondrion inner 
membrane 
7 79468 
ALB P02768 Serum albumin Extracellular Space 5 69367 
ATAD3A Q9NVI7 ATPase family, AAA domain 
containing 3A 
Nucleus 6 71369 
PIGT Q969N2 GPI transamidase component 
PIG-T 
(Phosphatidylinositol-glycan 
biosynthesis class T protein) 
Endoplasmic reticulum 
membrane 
4 65700 
VPS45 Q9NRW
7 
Vacuolar protein sorting-
associated protein 45 
Golgi apparatus membrane; 
Peripheral membrane 
protein 
13 65388 
GALNT2 Q10471 Polypeptide N-
acetylgalactosaminyltransferase 
2 
Golgi apparatus  12 64733 
TOR1AIP1 Q5JTV8 Torsin-1A-interacting protein 1 Nucleus 3 66248 
FAF2 Q96CS3 Fas associated factor 2 Cytoplasm 3 52623 
B4GALT1 P15291 Beta-1,4-galactosyltransferase 1 Golgi apparatus  2 43920 
FKBP8 Q14318 Peptidyl-prolyl cis-trans 
isomerase FKBP8 
Mitochondrion membrane 3 44562 
SAMM50 Q9Y512 Sorting and assembly machinery 
component 50 homolog 
Mitochondrion outer 
membrane 
6 52270 
SPTLC1 O15269 Serine palmitoyltransferase 1 Endoplasmic reticulum 
membrane 
3 52744 
UFSP2 Q9NUQ
7 
UFM1-specific protease 2  3 53261 
HNRNPF P52597 Heterogeneous nuclear 
ribonucleoprotein F 
Nucleus 2 45672 
DAO P14920 D-amino-acid oxidase Peroxisome 
 
7 39474 
PREB Q9HCU
5 
Prolactin regulatory element-
binding protein 
Nucleus 4 45468 
NDUFS2 O75306 NADH dehydrogenase 
[ubiquinone] iron-sulfur protein 2, 
mitochondrial 
Mitochondrion inner 
membrane 
4 52546 
HNRNPC P07910 Heterogeneous nuclear 
ribonucleoproteins C1/C2 
Nucleus 7 33670 
ANXA2 B4DNH8 Annexin A2 Plasma Membrane 13 21670 
SCD D3DR68 Stearoyl-CoA desaturase (Delta-
9-desaturase), isoform CRA_c 
Membrane 3 41505 
RDH14 Q9HBH
5 
Retinol dehydrogenase 14  Cytoplasm 3 36865 
GNB1 P62874 Guanine nucleotide-binding 
protein G(I)/G(S)/G(T) subunit 
Plasma Membrane 3 37377 
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beta-1 
NAPA P54920 Alpha-soluble NSF attachment 
protein (SNAP-alpha) 
Membrane 13 33233 
MLEC Q14165 Malectin Endoplasmic reticulum 
membrane 
2 32234 
GAPDH  P04406 Glyceraldehyde-3-phosphate 
dehydrogenase 
Cytoplasm 2 36053 
CYC1 P08574 Cytochrome c1, heme protein, 
mitochondrial 
Mitochondrion inner 
membrane 
3 35422 
RALA P11233 Ras-related protein Ral-A Cytoplasm 3 23567 
FAM3C Q92520 Protein FAM3C Cytoplasmic vesicle 2 24680 
RAB5C P51148 Ras-related protein Rab-5C Cytoplasm 2 23483 
RAB11B Q15907 Ras-related protein Rab-11B Cytoplasm 3 24489 
RAB18 Q9NP72 Ras-related protein Rab-18 Cytoplasm 3 22977 
RAC1 P63000 Ras-related C3 botulinum toxin 
substrate 1 
Cytoplasm 4 21450 
SPCS2 Q15005 Signal peptidase complex 
subunit 2 
Cytoplasm 2 25003 
CYB5B O43169 Cytochrome b5 type B  Mitochondrion outer 
membrane 
2 16332 
LCN1 P31025 Lipocalin Extracellular Space 2 19250 
LYZ P61626 Lysozyme Extracellular Space 2 16537 
CISD2 Q8N5K1 CDGSH iron-sulfur domain-
containing protein 2 
Endolasmic reticulum or 
mitochondrion outer 
membrane 
2 15278 
 
Table III.4. Full list of hDAAO putative interactors identified by mass spectrometry. The proteins 
in green are involved in neurological disorder. 
 
  
 
 
Fig.III.13. Functional clusters of hDAAO interacting partners. Schematic representation of the 
interactors identified in the proteomic screening. The interactors identified by proteomics are grouped 
in different functional categories on the basis of their reported biological activities. 
 
 
III.7. Discussion 
 
III.7.1. Structural characterization 
 
Since the causes of schizophrenia are still unknown, current treatments focus 
on eliminating the symptoms of the disease, rather than curing the disease. 
Antipsychotic medications have been available since the mid-1950s, and they 
effectively alleviate the positive symptoms of schizophrenia. The older antipsychotic 
medications include chlorpromazine, haloperidol, perphenazine, and fluphenzine, 
and can cause extrapyramidal side effects, such as rigidity, persistent muscle 
spasms, tremors, and restlessness. In the 1990s, new drugs, called atypical 
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antipsychotics (such as clozapine), that rarely produced these side effects, were 
developed. Clozapine treats psychotic symptoms effectively but it can produce a 
serious problem called agranulocytosis, a loss of the white blood cells that fight 
infection. Medical evidence supporting the role of NMDA receptor hypofunction in 
schizophrenia has prompted clinical trials of agents that enhance NMDA receptor 
functionality [46,47]. For example, schizophrenia patients receiving D-serine (an 
allosteric activator of NMDA-type glutamate receptor) together with antipsychotics 
showed significant improvement in their positive, negative, and cognitive symptoms 
[48]. In human brain hDAAO is the main perpetrator of oxidation of the gliotransmitter 
D-serine. Modulating DAAO function is pLG72 which was initially identified by 
Chumakov et al. [40], who by a yeast two-hybrid screening experiment identified D-
amino acid oxidase (DAAO) as the interacting partner of pLG72. Structural 
characterization of both proteins isolated and in complex is a challenging task for the 
understanding of the molecular basis of schizophrenia.  
Integrated strategies such as limited proteolysis and chemical cross-linking coupled 
to Mass Spectrometry (MS) were used for the in vitro analysis of the surface topology 
of pLG72-hDAAO complex, as well as for the definition of the conformational 
changes of hDAAO associated to complex formation. 
The optimal conditions for the in vitro complex formation were obtained incubating in 
ice for 10 min a 5 molar excess of pLG72 respect hDAAO.  
As first approach proteolysis experiments on the two separated protein have been 
carried out, in order to obtain low resolution structural characterization of the two 
proteins and to define the portions of the proteins involved in conformational changes 
after the complex formation. 
Several considerations can be drawn: i) hDAAO is more accessible to proteases 
when in complex with pLG72 than as single protein, as assed by the lower 
enzyme/substrate ratio used than the single hDAAO protein; ii) a significative 
conformational change is induced in the hDAAO molecule by the formation of the 
complex with pLG72, as can be deduced by the completely different patterns of 
preferential proteolytic sites observed for hDAAO in the presence and in absence of 
pLG72. Specifically, the peptide bonds following L189, R191, L194 E249 and L250 
that were proteolitically hydrolyzed in the isolated hDAAO, were not recognized in the 
presence of pLG72: on the contrary, the Y34, Y55, F167, N180, L296 and R297 sites 
were hydrolyzed only in the hDAAO-pLG72 complex (Fig.III.14). 
 
 
 
Fig.III.14. Schematic representation of complementary proteolysis results of isolate hDAAO 
(upper panel) and in complex with pLG72 (lower panel). The results of the trypsin experiments are 
in green, the ones of the chimotripsin in brown, the ones of the Glu-C in pink and subtilisin in red. 
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Because of the lower protease/substrate ratio adopted with respect to the 
experiments carried out on the isolated hDAAO, and the molar excess of pLG72 
present in the reaction mixture, in the experiments carried out on the hDAAO-pLG72 
complex we confidently refer the proteolytic sites observed to hDAAO molecules 
actually complexed with pLG72.  
The increased accessibility of hDAAO when in complex with pLG72 is rather peculiar 
as, generally, proteins in complexes show reduced flexibility and accessibility to 
proteases.  
Overall, in the complex, the C-terminal portion of hDAAO is folded in a compact 
structure not accessible to proteolytic enzymes, differently from the isolated hDAAO. 
Cleavage most consistently occurred at sites located in different portions of the 
protein.  
As far as pLG72 component is concerned, we remind that a crystallographic structure 
of pLG72 is not available because of its highly instability (it is soluble only in 
presence of mild denaturant) and no homologous protein has been structurally 
characterized so far.  However our results are in agreement with circular dicroism 
data [35], as the proteolytic sites are localised on region predicted to be at the 
extremes of secondary structure or in loops (data not shown). In Fig.III.13 are 
indicated the preferential hydrolysis sites of pLg72 carried out on the isolated protein. 
 
 
 
Fig.III.13. Schematic representation of complementary proteolysis results of isolate pLG72. The 
results of the trypsin experiments are in green, the ones of the chimotripsin in brown, the ones of the 
Glu-C in pink and subtilisin in red. 
 
Unfortunately, we cannot draw any consideration on conformational changes 
occurring on pLG72 when in complex with hDAAO, since the experiments were 
carried out in presence of a molar excess of pLG72 that was therefore present in 
solution also in the non complexed form, although, in the presence of hDAAO, the 
general impression was a reduced accessibility of pLG72 to proteases.  
To give more structural details, when the hydrolysis sites were mapped on the 3D-
structure of a monomer of hDAAO, (Fig.III.14, in green the sites identified on isolated 
hDAAO, in red the sites identified on the hDAAO molecule when in complex with 
pLG72) it is possible to notice that i) the preferential hydrolysis residues are all 
localised in proximity of the binding site of the flavinic cofactor and in a defined 
portion of the three-dimensional structure, ii) it can be assumed that the formation of 
the complex with pLG72 determines the protection of the specific region of the 
molecule while exposing sites that are however in the immediate surroundings of that 
region. The exact definition of the contact regions between the two molecules by 
chemical cross-linking is still in progress.  
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Fig.III.14. Three-dimensional model of the hDAAO monomer. The flavinic cofactor is reported in 
yellow, the preferential hydrolysis sites of the isolated protein are in green and the ones of the protein 
involved in the complex in red.   
 
III.7.2 Identification of novel protein partners of human DAAO 
 
hDAAO is likely to be finely regulated in its activation/inhibition by protein 
partners. A number of recent studies focused on the development of new and 
effective hDAAO inhibitors as a treatment strategy for schizophrenia by modulating 
D-serine concentrations in the brain [44,45,49,50]. 
However, the mechanistic aspects of how hDAAO accomplishes its function are still 
enigmatic and controversial. To meet this aim, we have performed a comprehensive 
analysis of the interactome of hDAAO by a functional proteomic approach. Human 
U87 glioblastoma cells has been transfected with an expression vector encoding for 
Myc-hDAAO fused protein. To identify protein specifically interacting with hDAAO, we 
performed immunoprecipitation and mass-spectrometry analysis. We identified a total 
of 48 proteins, in particular, 27 proteins of which had been previously reported to be 
involved in neurological disorder (Table III.4). 
Among them, we focus out attention on the members of the Rab family of small 
GTPases are key mediators of intracellular membrane sorting in eucariotic cell and 
they have been implicated in the pathology of multiple human deseases. Rabs, in 
conjunction with their effectors and regulators, participate in central nervous system 
development (Rab23), polarized neurite growth (Rab8 and Rab11), endocytosis and 
axonal retrograde transport (Rab5 and Rab7). Rab-mediated membrane traffic 
processes in neurons and glia may be sensitive to certain pathological factors [51]. 
Through a GDP-GTP exchange cycle, Rabs function as molecular switches to 
mediate vesicular transport along the cytoskeleton by engaging specific motor 
proteins, ensuring efficient tethering and docking of vesicles to target membranes, 
and timing vesicle fusion with the engagement of soluble N-ethylmaleimide sensitive 
factor (NSF) attachment receptor (SNARE) proteins.  
We have found two member of the family, Rab 5 and Rab 11, which are correlated 
with the synaptic plasticity. This process, which is widely thought to be the cellular 
correlate for cognitive functions, such as learning and memory, consist of a 
continuously remodelling of the synaptic connections between neurons in some 
region of the brain in response to neuronal activity. Not surprisingly, the dysfunction 
of synapses has emerged as a major etiologic factor in many brain disease including 
widespread neurodegenerative, neurodevelopmental and psychiatric conditions 
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(schizophrenia depression). In particular, Rab 5, which is localized both to synaptic 
vesicles and endosomal intermediates involved in synaptic vesicle recycling, has 
been implicated in protein transport from plasma membrane to early endosomes 
during clathrin-dependent endocytosis in a variety of cellular systems.  
Rab5 is activated downstream by Ca2+ binding after NMDAr opening. Its activation 
drives the specific internalization of synaptic AMPA receptors. Neuronal activity-
dependent insertion or removal of AMPA receptors from the postsynaptic plasma 
membrane underlies the phenomenon of long-term depression (LTD), which is 
experimental manifestation of synaptic plasticity. 
Although the details remained elusive, the emerging rough picture is that synaptic 
activity activates Rab5, which in turn drives the removal of AMPA receptors from 
synapses into endosomes. 
Moreover, Rab5 has some effects on the activity of Rac1, another hDAAO interacting 
partner which we have found, and which is essential for actin remodelling. Actin is 
the principal component of the synaptic dendritic spines and directly determines the 
morphology of the spines and allows them to be highly dynamic in shape and size. 
Synaptic spines are dynamic structures that regulate neuronal responsiveness and 
plasticity. The cytoskeleton of dendritic spines is particularly important in their 
synaptic plasticity; without a dynamic cytoskeleton, spines would be unable to rapidly 
change their volumes or shapes in responses to stimuli. Disturbances in neuronal 
connectivity, particularly in glutamatergic synaptic connections, underlie 
schizophrenia and associated disorders. Neuropathological studies with autopsied 
brains from individuals with schizophrenia have reported reduced numbers of 
dendritic spines. Morphological changes of the dendritic spine are directly correlated 
with its functional deficits [52]. Rac1 is one of main upstream regulators of JNK. c-
Jun N-terminal kinase (JNK) regulates the morphological changes of migrating 
neurons through the promotion of microtubule dynamics and actin reorganization. It 
serves as important mediators of spine enlargement and constitutive Rac1 activation 
decreases spine size [53]. This mechanism likely underlies disturbances in 
glutamatergic neurotransmission that have been frequently reported in schizophrenia 
that can lead to alteration of dendritic spines with consequential major pathological 
changes in brain function.  
Rab11 appears to have a specific role in neuronal and neuroendocrine cells as a 
GTP-dependent switch that could shunt certain cargoes between the regulated and 
constitutive secretory pathways. Rab11 endosomes are key trafficking intermediates 
that control vesicle exocytosis and membrane growth during the process of 
cellularization. It is therefore presumably important for developmental processes in 
particular for synaptic morphogenesis. 
Among the other putative interactors that we have identified, there is mitofilin, which 
has a role in neurological disorder, also called mitochondrial inner membrane protein, 
(IMMT). First identified and characterized in the 1990s [54,55], mitofilin is essential to 
normal mitochondrial function and morphology.  
Mitochondria play critical roles in fundamental cellular processes, encompassing 
energy production, programmed cell death, Ca2+ homeostasis, and monoamine 
metabolism. Intriguingly, mitochondrial dysfunction has also been found to be 
associated with various psychiatric disorders, including schizophrenia.  
For example, a reduction in the number of mitochondria, an abnormal morphology of 
mitochondria, and likely, as a consequence, defects in the process of oxidative 
phosphorylation have been reported in postmortem brain studies of schizophrenia 
patients [56,57]. More recently, gene expression studies using the postmortem brains 
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of schizophrenia patients also suggest a role of mitochondrial dysfunction in the 
development of schizophrenia [58,59]. Intriguingly, it has recently been shown that 
Mitofilin is associated with the general protein complex involved in the import of 
mitochondrial proteins such as metaxin1, metaxin2 and sorting and assembly 
machinery component 50 homolog (SAM50) [60], a protein which we have identified 
as an interactor of DAAO.  
A last example of interesting putative interactors, there is CAD, a trifunctional protein 
which is associated with the enzymatic activity of the first three enzymes in the 
pyrimidine biosynthesis: carbamoyl phosphate synthetase, aspartate 
transcarbamoylase, and dihydroorotase. Uracil, one of the three pyrimidines, is 
converted to uridine, which has been reported to have an antidepressant effect. A 
large-scale clinical trial of uridine (RG2417) for bipolar depression is underway. It has 
been reported that biosynthesis of pyrimidine is inhibited in the depressive state. 
Reduced uridine biosynthesis is involved in the biochemical basis of depressive state 
in relevance to the clinical effect of uridine [61]. 
Some proteins we have identified are enzymes involved the regulation of energy 
metabolism. Their altered levels can lead to an overall disturbance, and ultimately 
contribute to the establishment of pathological states.  
Enzymes with functions in glycolysis such as GAPDH (Glyceraldehyde-3-phosphate 
dehydrogenase) were found to be very likely to affect the glucose metabolism in 
schizophrenic patients. Alterations in the glucose metabolism have been extensively 
reported as a central component of schizophreina and are unlikely due to 
antipsychotic effects. A highly altered energy metabolism profile within the 
schizophrenia brain was observed, particularly implying an increased demand for 
glucose, resulting in increased glycogen catabolism. 
Abnormal serum glucose profiles in first-onset schizophrenia patients have been 
reported and the prevalence of diabetes type II is significantly increased in 
schizophrenia patients where there is substantial evidence for an increased glucose 
demand and/or cellular hypoxia within the schizophrenia prefrontal cortex [62]. 
The panel of putative interactors is extremely promising and demands for further 
studies that might elucidate the functional links among the different component, and 
most importantly, to understand the specific role of hDAAO in such mechanism. 
These are preliminary results and the next step will be to define how these proteins 
interact each other in the cell, in order to define a pathway who can elucidate the 
molecular basis of schizophrenia.  
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IV. UV Laser Cross-linking. Characterization and new strategy for 
industrial applications 
 
 
IV.1. Shining a light on UV Laser Cross-linking 
 
The detection and analysis of protein-protein interactions is one of the central 
tasks of proteomics in the post-genomic era. 
Protein-protein interactions are among the essentials that make up life. Most 
biological processes are controlled by dynamic molecular network of enormous 
complexity rather than by individual proteins. Mapping of protein interactions on a 
proteome-wide scale is therefore essential for fully understanding what‟s going on in 
living cells. Characterization of protein interactions is indeed an extremely 
challenging task since many protein interactions are not stable, most interactions are 
transient, and multiprotein complexes possess no common factors or physical 
properties that can be used as an analytical handle.  
Chemical cross-linking strategies combined with mass spectrometric (MS) analysis 
have been pursued for many years with the goal to fulfil two primary needs in 
proteomics research: (i) identification of protein interaction network and (ii) low-
resolution mapping of protein and protein complex structures [2,3]. Both are 
important and both represent unique opportunities to provide critical information on 
biological systems. Cross-linking has been widely applied in protein-protein 
interaction studies due to the inherent potential these approaches hold for stabilizing 
and freezing labile interactions with covalent bonds. Chemical cross-linking also has 
significant advantages for structural characterization of individual purified proteins 
and protein complexes where the identified cross-linked residues/peptides provide 
distance constraints that help define 3-D structural models. However, identification of 
cross-linked peptides is not trivial even for purified protein complexes which may be 
available in large quantity. In this regard, the challenges associated with cross-linking 
approaches arise primarily from three aspects: (i) enormous complexity inherent in 
the cross-linked samples which contain predominantly unmodified peptides, inter-
cross-linked peptides, intra-cross-linked peptides, dead-end labelled peptides, 
multiple-labelled peptides, and non-specific labelled peptides; (ii) low abundance of 
the cross-linked species; and (iii) data complexity of MS/MS spectra. Significant effort 
has been dedicated to designing novel cross-linkers that allow improved capability for 
cross-linked peptide identification via a signature pattern in the data or reduction of 
sample complexity by enrichment. Alternative efforts have also been applied to 
informatics software development with the use of the conventional cross-linkers [4].  
As an alternative approach to classical chemical cross-linking is the UV laser cross-
linking. It is already well documented that UV irradiation with a high-intensity 
femtosecond pulsed laser results in an efficient protein-nucleic acid cross-linking [5-
7]. 
The mechanism leading to UV laser cross-linking induces the excitement of the 
electronic state of the biomolecules which culminates with the creation of a stable 
bond between them. Several investigations have concluded that the drawbacks of 
UV irradiation could be overcome by using high-intensity UV lasers [8-11]. These 
studies found that the total yield of cross-linked material is one to two orders of 
magnitude greater with pulsed UV lasers (pulse durations ~20 ps to 10 ns) than with 
usual continuous wave (CW) sources. These data indicated that the cross-linking 
reaction yield is enhanced by a two-step process [12] in a simplified energy level 
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diagram (Fig.IV.1) [6,7]. A first UV photon excites the DNA base from the singlet S0 
ground state to the first excited S1 manifold. From the excited S1 level the molecule 
can absorb a second photon which promotes the DNA base to high lying singlet SN 
levels. There is, however, a finite probability for an intersystem crossing to the lowest 
triplet state T1, which has a longer lifetime compared to the S1 state. Absorption of a 
second photon then leads to a transition to high lying TN levels above the ionization 
limit. From both the SN and TN levels cross-linking can be induced [13]. The ratio 
between excitation via the singlet and triplet paths is a critical function of the laser 
parameters and cross-linking efficiency can be maximized by optimizing the relevant 
laser parameters. By changing the pulse length, the path leading to cross-linking can 
be chosen.  
 
 
 
Fig.IV.1. Simplified energy level diagram. The pathways leading to cross-linking via the singlet S1 
and the triplet T1 states are indicated. After excitation of the singlet S1 state the bases are promoted 
either directly with a second photon to high lying SN states above the ionization threshold or, after 
intersystem crossing to the T1 level, to states TN. 
 
The practical use of UV lasers, however, depends on the efficiency of the cross-
linking reaction as well as on the availability of methods adequate to determine DNA-
protein contact points [14] and the identity of cross-linked proteins along the DNA 
sequences [15,16]. Although several techniques [16] have been used in the past, a 
major breakthrough, which will make the method generally attractive, has not yet 
been achieved. Considerable effort has been devoted in the last few years to 
studying these questions in various biological models using different laser systems, 
including nanosecond Nd:YAG lasers [15,17], picoseconds mode-locked Nd:YAG 
lasers [18,19] and excimer lasers. 
All these studies put much emphasis on the nucleic acid side, neglecting the 
possibility that also proteins could be susceptible of photo-excitation by exposure UV. 
UV-laser cross-linking could therefore offer, as a novel zero length protein-protein 
cross-linker, an alternative, potentially powerful tool to investigate such protein-
protein interactions. UV-laser cross-linking could obviate many of the problems 
associated with standard chemical cross-linking reagents, and put cross-linking in a 
proteome-wide position from the characterizations of protein-protein interactions, 
especially transient interactions, because the number of photons required for 
covalent complex formation can be delivered very rapidly, in nano-, pico- or even 
femtosecond intervals, and the high energy of the pulses should result in efficient 
cross-linking. The rationale of the approach is that light irradiation of the target 
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protein(s) should mediate the rapid production of cross-linked species. 
Schematically, photo-excitation abstracts an electron from a protein residue to 
produce a protein radical. The radical should form preferentially at the amino acids 
side chains that offer stabilization through aromatic group, mainly tyrosine, 
phenylalanine and tryptophane residues. Once the protein radical is created, it can 
react with neighbouring molecules to create either intermolecular or intramolecular 
cross-links with the extremely rapid kinetics of reaction typical of the chemistry of 
radicals. 
 
 
IV.2. Laser set-up 
 
Light Amplification by Stimulated Emission of Radiation (LASER or laser) is a 
mechanism for emitting electromagnetic radiation, often visible light, via the process 
of stimulated emission. The emitted laser light is (usually) a spatially coherent, 
narrow low-divergence beam, which can be manipulated with lenses. In laser 
technology, "coherent light" denotes a light source that produces (emits) light of in-
step waves of identical frequency, phase, and polarization. The laser's beam of 
coherent light differentiates it from light sources that emit incoherent light beams, of 
random phase varying with time and position. Laser light is generally a narrow-
wavelength electromagnetic spectrum monochromatic light.  
A laser consists of three principal parts: i) an energy source (usually referred to as 
the pump or pump source), ii) a gain medium or laser medium, iii) two or more 
mirrors that form an optical resonator or optical cavity (Fig.IV.2).  
 
 
 
Fig.IV.2. Schematic rapresentation of a typical laser, showing the three major components.  
 
The process of supplying the energy required for the amplification is called pumping. 
The energy is typically supplied as an electrical current or as light at a different 
wavelength. Most practical lasers contain additional elements that affect properties 
such as the wavelength of the emitted light and the shape of the beam. 
The gain medium is a material with properties that allow it to amplify light by 
stimulated emission. It is a material of controlled purity, size, concentration, and 
shape, which amplifies the beam by the process of stimulated emission. It can be of 
any state: gas, liquid, solid or plasma. The gain medium absorbs pump energy, which 
raises some electrons into higher-energy (excited) quantum states. When the 
number of particles in one excited state exceeds the number of particles in some 
lower-energy state, population inversion is achieved and the amount of stimulated 
emission due to light that passes through is larger than the amount of absorption. 
Hence, the light of a specific wavelength is amplified (increases exponentially in 
power). The gain medium will amplify any photons passing through it, regardless of 
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direction; but only the photons aligned with the cavity manage to pass more than 
once through the medium and so have significant amplification. Each stimulated 
emission event returns a particle from its excited state to the ground state, reducing 
the capacity of the gain medium for further amplification. When this effect becomes 
strong, the gain is said to be saturated. The balance of pump power against gain 
saturation and cavity losses produces an equilibrium value of the laser power inside 
the cavity; this equilibrium determines the operating point of the laser.   
The optical resonator, or optical cavity, in its simplest form contains a coherent beam 
of light between two parallel mirrors placed around the gain medium, so that the light 
passes through the gain medium more than once before it is emitted from the output 
aperture or lost to diffraction or absorption. Typically one will be a high reflector, and 
the other will be a partial reflector. The latter is called the output coupler, because it 
allows some of the light to leave the cavity to produce the laser's output beam.  
The beam in the cavity and the output beam of the laser, if they occur in free space 
rather than waveguides (as in an optical fiber laser), are, at best, low order Gaussian 
beams.  
The output of a laser may be a continuous constant-amplitude output (known as cw 
or continuous wave); or pulsed, by using the techniques of Q-switching, modelocking, 
or gain-switching. In pulsed operation, much higher peak powers can be achieved. 
Some types of lasers, such as dye lasers and vibronic solid-state lasers can produce 
light over a broad range of wavelengths; this property makes them suitable for 
generating extremely short pulses of light, on the order of a few femtoseconds (10−15 
s). 
 
IV.2.1. Nd:glass laser 
 
The laser system used is a Nd:glass, which produces pulses with energy up to 
4.3 mJ at wavelength of 1055 nm (pulse duration 1 ps). The Nd:Glass is a solid state 
laser whose active medium is constituted by Nd3+ ions installed as impurities in a bar 
of glass. It constitutes a variation of the Nd:YAG laser where the ions of Neodimium 
replace the ions Y3+ in some of the sites of the Y3Al2O15 crystal. In such systems the 
laser oscillation happens on many longitudinal ways that can be locked in phase for 
producing ultrashorts impulses. The infrared pulse is doubled in frequency by a II-
type KDP crystal in which also a temporal compression down to 200 fs takes place 
(energy up to 1 mJ and wavelength of 527 nm). The green pulse frequency is 
subsequently doubled by a non-linear II HG crystal getting a wavelength of 267 nm 
with variable intensity (between 350 µJ and 30 µJ). 
In detail, this laser utilizes the chirped pulse amplification technique (CPA) to deliver 
ultra-short, ultra-intense pulses with no damage to the employed optics. Hence, it is 
constituted of four parts: i) laser oscillator, ii) pulse stretcher, iii) regenerative 
amplifier and iv) pulse compressor (Fig.IV.3). 
The oscillator is composed by two active medium rods and it‟s optically pumped by 
Xe flash-lamps. After the pumping, it delivers a pulse train having time spacing of 
some microseconds, few µJ being the pulse energy and 1 ps the pulse duration. This 
pulse then goes to the stretcher. It is an optical device composed by two diffraction 
gratings. 
The first grating implies spatial dispersion whereas the second one has the role of 
spatially re-collimating the previously dispersed spectral component of the pulses.  
The stretcher‟s role is to extend the temporally duration of pulse and so to reduce the 
power of the peaks. Peaks with low power can be amplified in the regenerative 
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amplifier with no risk of damages for the active medium and the optics of the 
regenerative amplifier. 
 
 
 
Fig.IV.3. Diagramatic scheme of chirped pulse amplification. 
 
The pulse leaves the stretcher, having a length of 300 ps and goes to the 
regenerative amplifier, which is a laser cavity itself. The pulse coming from the 
stretcher gets strongly amplified by passing back and forth into the amplifier laser 
rod. The pulse oscillates within the amplifier cavity until it becomes amplified by a 
factor of about 104. It is, then, ejected from the regenerative amplifier cavity by 
means of an electro-optic ultra-fast switch. The amplified pulse is, then, sent to the 
compressor. It works in the opposite way with respect to the stretcher, so it 
compensates for the dispersion introduced by the stretcher through two diffraction 
gratings. This time, those colors which had traveled a longer distance into the 
stretcher and were, therefore, delayed take a shorter path and are re-phased in time 
with colors that arrive first.  
The compressor is made of all-reflection optics so it can generate a pulse with a peak 
great power with no risk of damages. 
The recompressed pulse has duration of 1 ps, energy of about 4 mJ and a repetition 
frequency of 33 Hz. 
 
 
 
Fig.IV.4. Schematic diagram of the experimental set-up. 
 
Such laser source is followed by a second harmonic generator (SHG), where the 
infrared pulse is doubled in frequency and a temporal compression down to 200 fs 
takes place (energy up to 1 mJ and wavelength of 527 nm) (Fig.IV.4). Second 
harmonic generation (SHG; also called frequency doubling) is a nonlinear optical 
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process, in which photons interacting with a nonlinear material (in this case two non-
linear crystals of KDP, potassium dihydrogen phosphate crystal) are effectively 
"combined" to form new photons with twice the energy, and therefore twice the 
frequency and half the wavelength of the initial photons. It is able to generate ultras-
short visible laser pulses starting with an infrared longer laser source. 
The SHG produces pulses with duration of 250 fs, central wavelength of 527 nm and 
with a repetition frequency of 33 Hz. 
The green pulse frequency is subsequently doubled by a non-linear II HG crystal 
getting a wavelength of 267 nm with variable intensity (between 350 µJ and 30 µJ). 
 
 
IV.3. Reaction mechanism 
 
In the hypothesis that the most likely reaction mechanism for protein-protein 
UV induced cross-linking is a radicalic one, we took advantages of the established 
strategies that have been developed to investigate the molecular mechanisms of 
radicalic reactions. Protein radical species have been generally detected using 
electron paramagnetic resonance spectroscopy (EPR). The technique of spin 
trapping was developed in the late 1960s to facilitate the detection of reactive free 
radicals by EPR spectroscopy [20]. Because most radicals are very reactive, and 
thus, short-lived (i.e., μsec to secs), the spin-trapping approach has been more 
widely used. With the spin-trapping approach, spin trap molecules can react with 
radical sites in proteins in situ and in real time. During this reaction, the spin trap 
forms a covalent bond at the radical site in the protein primary sequence forming a 
protein-spin trap radical adduct. In doing so, the radical adduct is, essentially, 
footprinting where the radical was initially formed and consequently trapped in the 
protein. The protein radical adduct is more stable and, consequently, more long lived 
(i.e. secs to minutes) than a protein radical, but decays to form an ESR-silent spin 
trap protein nitrone adduct in which the spin trap is covalently-bound to the protein. 
Though spin trapping was developed initially to examine reactive radicals formed 
from low-molecular-mass compounds [20], developments over the last three decades 
have shown that this methodology can also be used to study radical formation on 
proteins and other macromolecules in both isolated and complex biological systems.  
Nitroso spin traps, of which 2-methyl-2-nitrosopropane (MNP) (Fig.IV.5), have the 
advantage that the reactive radical attaches directly to the nitroso nitrogen atom, and 
is therefore in close proximity to the unpaired electron which is located primarily on 
the nitroxide function. 
 
 
                                                      
Fig.IV.5. Structures of 2-methyl-2-nitrosopropane (MNP) and 5,5-dimethyl-1-pyrroline N-oxide 
(DMPO) and their reaction with transient radicals to give nitroxide adducts.  
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The most popular of these spin traps is 5,5-dimethyl-1-pyrroline N-oxide (DMPO) 
(Fig.IV.5), which often form long lived adducts with a wider range of radical types 
(e.g., carbon-, oxygen-, sulfur-, and nitrogen-centered species). With nitrone traps 
such as DMPO, the reactive protein radical adds to a carbon atom adjacent to the 
nitrogen atom of the spin trap (Scheme 1). When DMPO traps a protein radical, a 
nitroxide radical adduct is formed with a covalent bond from DMPO to the protein 
(Scheme 1). The atom at which this bond is formed is a site of high electron spin 
density (or localization), which is sterically accessible to DMPO. Nitrone-derived 
adducts exist in three redox forms (Scheme 1): (1) the nitroxide radical adduct, (2) 
the corresponding hydroxylamine formed by one-electron reduction of the radical 
adduct, and (3) the corresponding nitrone formed by one-electron oxidation of the 
radical adduct. Of these, only the nitrone species is a stable product. At high enough 
concentrations, two nitroxide radical adducts will disproportionate to the 
hydroxylamine and the nitrone adducts [20,21].  
 
 
 
Scheme 1 
 
To take advantage of the more stable, trapped adducts, the Mason‟s research group 
reported the development of an antibody with specificity for the nitrone adduct, which 
is the only stable product of trapping radicals with DMPO [22]. Using this DMPO-
specific antibody (immuno-spin trapping), they have successfully detected DMPO 
adducts in several heme-containing proteins [23-25]. In proteins, however, structural 
assignment of the specific amino acid residue or residues that form radical adducts 
with the spin trap molecule is difficult with immuno-spin trapping or ESR; thereby, 
requiring the use of additional biochemical techniques, such as site-directed 
mutagenesis and amino acid derivatization. These methods, however, suffer from 
potential drawbacks, such as perturbation of the protein‟s stability and conformation 
by mutations or derivatization. Hence, the formation of the amino acid radical(s) 
and/or transfer of the radical may be affected. 
Recently, mass spectrometry has been utilized to study protein free radicals [26-29]. 
The spin trap molecules form a covalent bond with the protein resulting in a new 
nitroxide radical, which may be stable under electrospray ionization mass 
spectrometry conditions. By using a combination of peptide mapping by mass 
spectrometry it is possible to investigate the formation and the structures of radical 
adducts generated on proteins. To identify the precise amino acid residues (i.e. 
radical site) trapped by spin trap, mass spectrometry-based sequencing can be used.  
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IV.4. Aims of the project 
 
The main goal of this work is to shape UV ultrashort laser pulses to induce 
efficient protein-protein cross-linking through the quantum control of molecular 
excitation. This would have a strong impact on the possibility study transient 
interactions among proteins, to map molecular interfaces in protein complexes, to 
gain dynamic information regarding how the contacts within a multi-protein complex 
might change over the time, because the number of photons required for covalent 
complex formation can be delivered very rapidly. Such photo-physical approach 
could obviate many of the problems associated with standard chemical cross-linking 
reagents, and put cross-linking in a proteome-wide position for the characterizations 
of protein-protein interactions in vivo in intact cells, since no chemical reagent has to 
enter the cell.  
Essential to this aim is the multidisciplinary nature of this new bio-laser science, 
which benefits from the huge progresses in ultrashort laser physics. Due to the 
universality of computer-controlled learning optimization of ultrashort laser pulses, a 
broad field of applications opens up in all areas which use femtosecond laser 
technology. Among them, applications in complex systems, such as many biological 
systems, will greatly progress as there will be no requirement of a pre-constituted, 
theoretical model of the complex system under exam, unfeasible in most cases due 
to high degree of complexity.  
In the first part of the work we have investigated the role played by different 
parameters characterizing the ultrashort laser source in peptide-petide photo-cross-
link. We have varied laser pulse energy, the duration of exposition to the laser, laser 
beam focussing geometry and sample concentration in order to i) study the physical 
process of UV excitation of petide (proteins) and ii) maximize the peptide-peptide 
cross-linking absolute yield. 
Moreover, since the software for the analysis of the cross-linked proteins require the 
mass shift introduced by the chemical modification, in order to put this strategy on a 
proteomics perspective, we have investigated the molecular details of the reactions. 
For this purpose we have studied the effect of the UV laser on peptides in absence 
and in presence of spin trap. The product of reaction was analysed by high resolution 
mass spectrometry in order to localize the amino acidic residues involved in the 
covalent bond formed after the irradiation.  
The final aim of protein cross-linking is to introduce covalent bonds where non 
covalent interactions already exist, without affecting the three-dimensional structure 
by excessive introduction of “non physiological” bonds. The final goal of the “cross-
linking project” will be to use the cross-linking reaction as a tool to “freeze” such 
“physiological” and transient interactions in protein complexes in vivo. 
With these aims in mind, we have choose an oligomeric protein as the model protein 
in our tests: the stabilization of intersubunit interactions by cross-links would be 
“physiologically correct”, and the cross-link formation detected by SDS-PAGE 
analysis as the formation of species at molecular weight higher than the reference 
sample. 
Finally we have applied this approach also to intact cell, in order to optimize the 
experimental parameter in a more complex contest and to define, in future, the 
molecular partners of a selected protein of interest.  
The results herein presented were obtained in a collaborative and interdisciplinary 
project with the research group of Prof. Raffaele Velotta from the Dipartimento di 
Scienze Fisiche, Università di Napoli Federico II, the research group of Prof. Renata 
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Piccoli from the Dipartimento di Biologia Strutturale e Funzionale, Università di Napoli 
Federico II, and the research group of Prof. Catherine Costello from the Departments 
of Biochemistry, Biophysics and Chemistry, Boston University School of Medicine, 
Boston, USA. 
In particular, I acknowledge the “Programma di scambi internazionali” of Università di 
Napoli Federico II”, for funding my permanence in the lab of Prof. Costello. 
A manuscript about the peptides section is in preparation. 
 
 
IV.5. Material and Methods 
 
Xenopsin, angiotensin, interleukin, Alcohol dehydrogenase (ADH)  from 
Saccaromyces cerevisiae, 5,5-dimethyl-1-pyrroline N-oxides (DMPO) and the 2-
methyl-2-nitrosopropane (MNP), dithiothreitol (DTT), L-ascorbic acid, trypsin, MALDI 
matrix α-cyano-4-hydroxycinnamic acid, iodoacetamide (IAM) and ammonium 
bicarbonate (AMBIC) were purchased from Sigma. Trifluoroacetic acid (TFA) is from 
Carlo Erba, Formic acid from Baker and Acetonitrile (ACN) Ultra gradient from Romil; 
Comassie Brilliant Blue was from Pierce.  
The standards of molecular weight for the calibration of the Voyager-DE STR system 
has been purchased from Applied Biosystems.  
The monobasic sodium phosphate (NaH2PO4) was purchased from Sigma. 
  
IV.5.1. UV laser peptide-peptide cross-linking 
 
Standard peptides (10 nmol of angiotensin, xenopsin, interleukin) individually 
or mixed together were dissolved in 6 µl of ammonium bicarbonate buffer (10 mM pH 
7.0) and irradiated with a laser energy of 110 µJ, at a frequency of 2 kHz and at a λ 
of 267 nm, at room temperature for different time intervals from 1 sec to 3 min. The 
reaction was stopped by adding 4 µl of ascorbic acid at final concentration of 20 mM 
dissolved in the same buffer immediately before use.  
The same conditions were used to irradiate each single peptide in presence of 4 µl 
DMPO (final concentration 100 mM and 10 mM) or MNP (final concentration 10 mM). 
Sample concentration and desalting were performed using a reverse phase C18 Zip 
Tip pipette tips (Millipore). The peptides were eluted with 20 μl of a solution made of 
50% Acetonitrile, 0.5% Formic acid in Milli-Q water at a final concentration of 25 µM. 
 
IV.5.2. UV laser protein-protein cross-linking 
 
Alcohol deidrogenase (2 µg/µl) was dissolved in ammonium bicarbonate buffer 
(10 mM pH 7.0) in presence of ascorbic acid 1mM and fractions of 18 µl (1 nmol of 
monomer) were exposed to the laser in the same previously conditions for time 
intervals of 7 sec and 15 sec. After the irradiation ascorbic acid at final concentration 
of 20 mM was added to stop the radical reaction. The same experiments were 
performed on 500 µl of a diluite ADH solution (72 ng/µl) in the same buffer.  
The protein samples were concentrated and purified using Amicon® Ultra-0.5 mL 
Centrifugal Filter Devices (Millipore) with 30 kDa. The proteins were resuspended 
with 20 μl of a solution made of 50% Acetonitrile, 0.5% Formic acid in Milli-Q water, 
at a final concentration of 10 µM or resuspended in Laemmli sample buffer and 
analysed by SDS-PAGE. 
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IV.5.3. UV laser in vivo 
 
Recombinant Human ApoA-I, cloned in the expression vector pGEX-4T-3, was 
expressed in Hep75 human cells. Each pellet containing 200.000 cells was 
resuspended in 500 µL of PBS buffer (13.7 mM NaCl, 0.27 mM KCl, 10 mM 
Na2HPO4, 0.2 mM KH2PO4) and irradiated at this different laser energy, frequency 
and time conditions (110 µJ, 0,2 kHz for 2 minutes; 110 µJ, 2 kHz for 12 seconds; 55 
µJ, 2 kHz for 12 seconds; 55 µJ, 0,2 kHz for 2 minutes; 110 µJ, 2 kHz for 1 minute). 
After irradiation the cells were centrifugated at 13,000 rpm for 5 minutes. The pellet 
was resuspended in 100 µL of PBS buffer, NP40 1% and protease inhibitors cocktail 
(Sigma Aldrich), incubated for 30 min at 4°C and lysed by sonication. The extracts 
were centrifuged at 12,000 rpm for 30 min at 4°C and the pellet was resuspendend in 
Laemmli sample buffer.  
 
IV.5.4. SDS-PAGE analysis 
 
Proteins were separated on SDS-PAGE on 12.5% polyacrylamide gel (Laemli, 
1970). Proteins were detected by Coomassie Brilliant Blue G-Colloidal (Pierce, 
Rockford, USA). Bands of interest were excised and subjected to in situ digestion 
with trypsin (100 ng in 50 µL of 10 mM ammonium bicarbonate pH 7.0) for 16 h at 
37°C. 
 
IV.5.5. Hep75 human cells western blotting analysis 
 
For immunodetection, after SDS-PAGE, proteins were electroblotted on a 
Hybond-ECL membrane (GE Healthcare) for 1 h at 15 V. The membrane was 
saturated with 5% non-fat dry milk for 1 h at room temperature and then incubated 
with anti-human ApoA-I polyclonal antibodies (Dako) at 4°C for two hours. An anti-
rabbit was used as a secondary antibody and a chemiluminescence detection system 
(West Pico, Pierce) was used to visualise immunopositive proteins. The amount of 
recombinant ApoA-I was estimated densitometrically on blots by means of ImageJ 
1.40 g software. Signals were compared to those obtained with serial dilutions of 
commercial ApoA-I. 
 
IV.5.6. MALDI-TOF analysis 
 
MALDI-TOF mass spectra were recorded using an Applied Biosystem 
Voyager STR instrument equipped with a nitrogen laser (337 nm). 1 µL of the analyte 
mixture was mixed (1/1, v/v) with a 10 mg/mL solution of R-cyano-hydroxycinnamic 
acid in acetonitrile/50 mM citrate buffer (2/3, v/v) and was applied to the metallic 
sample plate and dried down at room temperature. Acceleration and reflector voltage 
were set up as follows: target voltage at 20 kV, grid at 66% of target voltage, delayed 
extraction at 150 ns to obtain the best signal to-noise ratios and the best possible 
isotopic resolution. Mass calibration was performed using external peptide standards 
purchased from Applied Biosystems. Raw data were analyzed using the computer 
software provided by the manufacturer as monoisotopic masses. 
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IV.5.7. MS/MS analysis 
 
The cross-linked product was analyzed in MS and MS/MS mode by high 
resolution mass spectrometry using hybrid Qh/FTICR (SolariX equipped with a 12 T 
actively shielded magnet, Bruker Daltonics, Billerica, MA, USA). This instrument was 
equipped with a nano-spray source operated in positive mode. The high voltage used 
for ionization was between 1,000 and 1,500 V and nitrogen was used as a counter 
current drying gas with a temperature maintained at 180°C. To record the spectrum 
the ECD a current of 1.6 A, an ECD bias of 1.5 V and an electron pulse length of 
0.07s was employed. For the CID spectrum the collision voltage was set between 8 
and 15 V. The collision gas was argon at a pressure reading of 6x10-6 mbar. In the 
ETD mode, radical negative ions of fluoranthene, produced in the CI source, are 
used as the reagent ions. During the ETD experiments, the crucible is heated to 
about 60°C so as to sublime the fluoranthene. The fluoranthene gas then passes into 
the CI chamber where it is ionized via chemical ionization with methane. Negatively 
charged fluoranthene ions are then extracted out of the CI source via a set of lenses. 
The methane was connected to the CI source with stainless steel tubing. The 
filament was set to emit a 3 µA. The acceleration time of reagent was 50-100 ms and 
the reaction time was 20 ms. 
Mass spectra were acquired in the positive-ion mode over the m/z range 200-2000 at 
a resolution of 60,000. Mass accuracy was within 1 ppm. Compass Data analysis 
software (Bruker Daltonics) was used for data analysis; peptide sequencing and 
cross-linking site assignments were conducted manually employing a 1 ppm error on 
the fragment ions. 
 
 
IV.6. Results 
 
IV.6.1. Laser UV-induced peptide-peptide cross-linking 
 
The first priority of this study was to verify whether an ultrashort UV pulsed 
laser is able to induce an efficient cross-link in simple model such as peptide and to 
localize the amino acid involved in the formed bond. We assumed that upon 
absorption of the ultraviolet light the chemical moieties of amino acids (above all 
tyrosines, phenylalanines and tryptophans) can produce radicals that are then able to 
react and eventually introduce covalent bonds between peptides. 
To induce the cross-link we used as source of powerful UV radiation the Nd:glass 
one, which produces pulses with energy up to 4.3 mJ at wavelength of 1055 nm 
(pulse duration 1 ps). The infrared pulse is doubled in frequency by a II-type KDP 
crystal in which also a temporal compression down to 200 fs takes place (energy up 
to 1 mJ and wavelength of 527 nm). The green pulse is subsequently doubled by a 
non-linear II-type KDP crystal getting a wavelength of 267 nm with variable intensity 
(between 350 μJ and 30 μJ). The repetition rate of the whole laser source is 33 Hz.  
Samples of different peptides were exposed to the UV laser at a laser energy of 110 
μJ and different irradiation time (1 sec-3 min), purified by a reverse phase C18 Zip 
Tip and subsequently analysed by MALDI-TOF mass spectrometry, in order to detect 
the formation of dimeric species due to the introduction of intermolecular cross-links.  
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IV.6.1.1 MS spectra 
 
As an example, the MALDI-TOF spectra of a mixture of xenopsin, interleukin 
and angiotensin that have been exposed to the UV-laser light for 10 sec are reported 
in comparison to the spectra obtained for the same mixture before the exposure to 
the laser (Fig.IV.6, panel B) Two signals are generated upon UV-laser exposure: 
(Fig.IV.6, panel A) the peak at m/z 1958.13 could account for two molecules of 
xenopsin cross-linked -2 Da, and the signal at m/z 2274.24 that correspond to one 
molecule of xenopsin cross-linked to one molecule of angiotensin, -2 Da. The other 
three signals present in the spectrum correspond to the [M+H]+ of the standard 
peptides (m/z 980.57 for xenopsin, m/z 1005.44 for interleukin and m/z 1296.69 for 
angiotensin). It should be noted that, apparently, interleukin (that has no aromatic 
residue) is not involved in any of the species generated upon UV exposure, as also 
confirmed when the same experiment was carried out with interleukin as unique 
peptide model, where no species but monomeric interleukin could be detected. On 
the contrary, the same experiment performed in presence of isolated angiotensin 
shows the presence of the homodimer of the angiotensin (data not shown).  
In order to verify the specificity of the observed homodimer and heterodimer, a 
mixture of xenopsin, interleukin and angiotensin without performing UV cross-linked 
irradiation was analysed by MALDI-MS in the similar conditions than those of the 
previous samples. No homodimer and heterodimer was evidenced confirming the 
specificity of cross-linking species observed after UV irradiation.  
 
 
 
Fig.IV.6. MALDI-TOF m/z spectrum of mixture of xenopsin (980.54), interleukin (1005.49) and 
angiotensin (1296.69) not irradiated (panel A) and irradiated for 10 sec (panel B). The peaks at 
m/z 1958.13  corresponding to two molecules of xenopsin cross-linked and the peak at m/z 2274.24  
at one molecule of xenopsin cross-linked with one molecule of angiotensin. 
 
Only aromatic side chain containing peptides seemed to be affected by the exposure 
to UV-laser light suggesting a new concept: the reaction mechanism requires the 
aromatic amino acid. 
In order to verify this view, the amino acids covalently linked were identified by 
tandem mass spectrometry experiments.  
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IV.6.1.2 Tandem mass spectrometry 
 
Tandem mass spectrometry experiments were carried out on the Solarix 
(Bruker Daltonics, Billerica, MA, USA) using a 25 µM solution of the peptide mixture 
exposed to the UV-laser as described above, dissolved in 50% acetonitrile, 0.5% 
formic acid was directly infused in the nano-spray source. After isolation of interested 
ions in the Quadripole/hexapole, they were fragmented by CID, ECD and ETD mode. 
Displayed in Fig IV.7 and IV.8 are the CID (panel A) and ECD (panel B) MS/MS 
spectra generated from (M+3H)3+ ion (m/z 653.38) of the homodimer of xenopsin and 
(M+4H)+4 ion (m/z 569.31) of the heterodimer of angiotensin-xenopsin.  
Single cleavage products are present in these spectrum that can be assigned as 
originating from both of the two peptide chains, primarily type a-, b-, and y-ions. The 
fragment ions corresponding to these two peptides are, therefore, designated with 
either the α or the β subscript to indicate the peptide of origin.  
Fragmentation observed in the low-energy CID spectrum of the homodimer (Fig.IV.7, 
panel A) is dominated by ions corresponding to a, b and y ions.  
In the ECD spectrum of this study, the signal corresponding to the charge reduced 
molecular ions [M+nH](n-1)+· was observed. As expected, these spectra were 
dominated by c and z· ion series andthe ECD spectrum (Fig.IV.7, panel B) is more 
informative than the low-energy CID spectrum.  
In both spectra in addition to short z- and a,b,c-ion series, it is possible to observe 
several yαyβ, zαzβ, bαbβ, cαcβ-ions detected in their single and doubly charged states. 
For example in the ECD spectrum of the cross-linked xenopsin EGKRPWIL, two c-
ions are present at m/z 314.18 (c3) and 567.33 (c5). Moreover, fragment ions 
originating from cleavages involving both peptide chains were observed at m/z 
1730.94 (a8αa6β), 865.98 (c8αc6β)
2+, 1884.02 (a8αa7β), 922.52 (c8αc7β)
2+, 1392.78 
(z3αz8β), 1645.93 (z5αz8β), 823.47, 887.52, 916.03 (z5-7αz8β)
2+. 
The z3αz8β, (c8αc6β)
2+ and a8αa6β ions at m/z 1392.78, 865.98 and 843.47 constituted 
the key signals to univocally assess that the Trp is the amino acid involved in the 
cross-link induced upon laser exposure. 
The tandem mass spectra of the angiotensin (α-chain) cross-linked to xenopsin (β-
chain), shown in Fig.IV.8, generated a pattern similar to the example described 
above, and consisted of dominant b,y-series ions for the CID spectrum and c,z-series 
ions for the ECD spectrum. The only putative aromatic amino acids in these two 
sequences are Tyr-4 and Phe-8 on the angiotensin and the Trp-6 on the xenopsin. 
The MS/MS spectra of the quadruply charged ion at m/z 569.31 revealed several 
ions for both peptide chains; y2α at m/z 269.16, z3α at m/z 400.21, y4α at m/z 513.27 
and z5α at m/z 634.32 (α-chain) and c3β at m/z 314.18, b4β at m/z 453.25 and b5β at 
m/z 567.33 (β-chain). However a nearly complete a,b and z,y-ion series originate 
from cleavage reactions involving both peptide chains are also present, i.e., m/z 
944.50 and 994.03 (z7-8αz8β)
2+, m/z 938.51 and 1012.05 (c7-8αz8β)
2+, 764.92 and 
821.46 (c4-5αz8β)
2+, 981.53, 697.38 and 716.39 (z10αz5-7β)
2+.  
The c10αc6β
3+ at m/z 697.38, (z10αz3β)
2+ at m/z 854.95, (z7αz8β)
2+ at m/z 938.51, and 
(c4αz8β)
2+ at m/z 764.91 ions constituted the key signals to univocally assess that the 
Tyr-4 and the Trp-6 are the amino acids involved in the cross-link induced upon laser 
exposure.  
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Fig.IV.7. ESI-CID (panel A) and ESI-ECD (panel B) m/z spectra of xenopsin homodimer. The (M + 
3H)
3+
 peak at m/z 653.38 was selected as the precursor ion.The asterisk indicates the residues imply 
cross-linking sites. The cross-linked sites on the sequence are indicates with a crossed line. 
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Fig.IV.8. ESI-CID (panel A) and ESI-ECD (panel B) m/z spectra of angiotensin-xenopsin 
heterodimer. The (M + 4H)
4+
 peak at m/z 569.31 was selected as the precursor ion. The asterisk 
indicates the residues imply cross-linking sites. The cross-linked sites on the sequence are indicates 
with a crossed line. 
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IV.6.2. Characterization of the reaction mechanism 
 
The most likely reaction mechanism for UV induced cross-linking is a radicalic 
one. Protein radical species can be spin trapped to give an adduct more stable than 
the primary radical. Nitrone spin traps, of which 5,5-dimethyl-1-pyrroline-N-oxide 
(DMPO) is the most commonly employed, and nitroso spin traps, such as 2-methyl-2-
nitrosopropane (MNP), often form long-lived adducts that can be easily detected by 
EPR. Moreover, the spin trap molecules form a covalent bond with the protein 
resulting in a new nitroxide radical. 
Therefore, in order to investigate the molecular nature of the intermediates involved 
in the process, UV-laser induced peptides cross-linking experiments were carried out 
as described above for either 10 sec or 1 min but in the presence of radical spin trap 
molecules, either 5,5-dimethyl-1-pyrroline N-oxide (DMPO), or 2-methyl-2-
nitrosopropane (MNP). Similar experiments were also carried out on aliquots where 
the spin traps were added only after the exposure to the UV-laser beam for some 
extent (30 - 60 sec).  
 
IV.6.2.1 MS spectra 
 
MALDI-MS analysis of the xenopsin irradiated in presence of 10 mM DMPO 
(Fig.IV.9, panel B) showed, compared to the same sample not exposed to laser 
(Fig.IV.9, panel A), the presence of an additional signal at a 1091.61 m/z value, 
which is shifted of +111.07 Da in respect to the theoretical mass of the unmodified 
peptide. These data suggest that a single DMPO molecule is trapped on the 
xenopsin peptide. The DMPO nitrone adduct is a specific marker for where the 
radical is formed.  
 
 
 
Fig.IV.9. MALDI-TOF m/z spectrum of mixture of xenopsin (980.54) not irradiated (panel A) and 
irradiated in presence of DMPO for 10 sec (panel B). The signals at 1091.60 m/z value 
corresponding to one molecule of xenopsin cross-linked with one molecule of DMPO. 
 
IV.6.2.2 Tandem mass spectrometry 
 
To validate the specificity of DMPO binding and to determine which amino 
acids contained a trapped DMPO molecule, we perfomed MS/MS analyses of the 
same mixture on the Solarix (Bruker Daltonics, Billerica, MA, USA) using CID, ECD 
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and ETD activation modes as described above. As an example the ECD spectrum of 
the (M + 2H)2+ ion (m/z 546.32) is visualised in figure IV.10. 
Some b and c (b4, c5, c6) series ions were observed that accounts for cleavages of 
amino acids from the N-terminus of the peptide backbone. In addition, a peak 
corresponding to the charge reduced molecular ion [M+2H]+· at m/z 1092.61 and 
fragment ion of m/z 1075.60 (labelled as -H2O), corresponding to the loss of water 
molecule from the peptide, were observed. Several ions are observed which 
correspond to a fragment ion plus a DMPO molecule. For example, the ion of m/z 
639.38 (labelled as y4DMPO) corresponds in mass to a y4 ion plus DMPO and the ion 
of m/z 960.54 (labelled as b7DMPO) corresponds in mass to a b7 ion containing DMPO. 
Moreover, it is possible to notice the presence of different internal fragments of the 
peptide plus one DMPO molecule (i.e. KRPW+DMPO at m/z value 679.38).   
The concomitant presence of the series ions y4DMPO, b6
2+
DMPO and c5 indicates the 
DMPO adduct on Trp-6 in the xenopsin peptide. It should be noted that 
fragmentations didn‟t occurred only on the peptide backbone because few ions (y 
and c type) resulting from the cleavage of DMPO binding site were observed. 
 
 
 
Fig.IV.10. ESI-ECD m/z spectra of xenopsin cross-linked with DMPO. The (M + 2H)
2+·
 peak at m/z 
546.32 was selected as the precursor ion. The asterisk indicates the residues imply cross-linking sites. 
In red are indicated the ion series found in the CID spectrum. 
 
Similar MS/MS analyses were performed for the same peptide irradiated in presence 
of 10 mM MNP (Fig. IV.11). 
Again, the fragment ions preserving the MNP allowed to assess univocally that the 
Trp-6 is the amino acid involved in the bond with MNP.  
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Displayed in Fig.IV.12 and IV.13 are ECD spectra generated from (M + 3H)3+ ion 
(m/z 469.92 and 461.92) of angiotensin peptide linked to DMPO and MNP 
respectively. We can assume analogous consideration for the angiotensin peptide 
linked to the spin trap molecule. A closely examination of both spectra shows the 
presence of fragment ions originating from cleavages involving the peptide chains 
plus the spin trap molecule. The interpretation of these data was more difficult 
because of competition of the backbone peptide cleavage with the DMPO binding 
cleavage. Nevertheless, the product ions preserving the DMPO allowed the 
assignment of the DMPO and MNP molecule to the Tyr-4 residue of the angiotensin. 
 
 
 
Fig.IV.11. ESI-ECD m/z spectra of xenopsin cross-linked with MNP. The (M + 2H)
2+·
 peak at m/z 
534.32 was selected as the precursor ion. The asterisk indicates the residues imply cross-linking sites. 
In red are indicated the ion series found in the CID spectrum. 
 
It is worth mentioning that addition of the spin trap immediately after UV-laser 
exposure did not result in any spin trap-peptide adduct. This suggests that radical 
species that have formed during UV-laser exposure, extinguished within the 
exposure time, and no long-lasting radical is formed that survives the exposure time.  
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Fig.IV.12. ESI-ECD m/z spectra of angiotensin cross-linked with DMPO. The (M + 3H)
3+·
 peak at 
m/z 469.92 was selected as the precursor ion. The asterisk indicates the residues imply cross-linking 
sites. In red are indicated the ion series found in the CID spectrum. 
 
 
Fig.IV.13. ESI-ECD m/z spectra of angiotensin cross-linked with MNP. The (M + 3H)
3+·
 peak at 
m/z 461.92 was selected as the precursor ion. The asterisk indicates the residues imply cross-linking 
sites. In red are indicated the ion series found in the CID spectrum. 
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IV.6.3. Laser UV-induced protein-protein cross-linking 
 
In our experiments, the alcohol dehydrogenase from Saccaromyces cerevisiae 
(ADH) was used as protein model: It is a homo-tetrameric, not glycosylated protein 
containing several aromatic amino acids, whose three-dimensional structure has 
been solved at high resolution (PDB code 2HCY). The stabilization of intersubunit 
interactions by cross-links would be “physiologically correct” and, none the less, the 
intersubunit cross-link formation can be easy monitored by SDS-PAGE analysis as 
the formation of species at molecular weight higher than the reference sample. The 
availability of a three-dimensional model will be helpful in the analysis of the 
“physiological significance” of the introduced cross-links.  
Samples of ADH were exposed to the UV laser with different combinations of laser 
energy (30-350 μJ) and irradiation time (0.5-5 min), the SDS-PAGE analysis of 
selected samples of preliminary experiments carried out with 0.2 nmols of protein in 
12 μl sodium-phosphate buffer 10 mM PH 7.0 (data not shown). 
Depletion of the species with the apparent MW corresponding to ADH subunit was 
observed in all the conditions tested. Moreover, in all the samples is evident the 
formation of aggregates with high molecular weight, that did not penetrate inside the 
meshes of the gel. 
Parameters such as protein concentration, exposure time and laser energy were 
therefore further varied in order to optimize cross-linking conditions. Moreover, 
considering the radicalic nature of the mechanism for the cross-linking reaction, we 
tested whether we could modulate the extent of this reaction by addition of a 
common antioxidant, such as the ascorbic acid, to the mixture. 
Several tests were performed varying the laser energy (30-350 μJ), the concentration 
of ascorbic acid (0,1-20 mM), exposure time (0.5-30 min), and protein concentration 
(0.5-30 mM) (data not shown), in order to modulate and optimize the cross-linking 
reaction.  
The best condition tested was exposure of ADH to the laser beam at an energy of 
220 μJ with the addition of ascorbic acid to a final concentration 5 mM after 1 min 
exposure. After laser exposure the reaction mixture was separated by SDS-PAGE 
followed by Comassie blue staining (Fig.IV.14, panel A). Distinctive bands above the 
ADH subunit are clearly observed, located at an apparent molecular weight of about 
70 kDa (compatible with a dimeric form of ADH). Dimeric species were considered 
our target for further analysis of the cross-linked protein, since they correspond to the 
simplest product of covalent oligomerization and therefore, the chance of cross-links 
to perturb the conformation of the protein is reduced to a minimum.  
These bands were excised and subjected to enzymatic in-gel digestion with trypsin 
over night. For comparative purposes, the gel bands from lane corresponding to the 
monomer in the exposed sample as well as from the reference sample were also 
excised and in situ trypsin digested. The tryptic digests were then analysed by 
MALDI-MS and the experimentally obtained mass values were mapped onto the 
anticipated sequence of ADH, thus confirming the identity of the protein bands.  
Fig.IV.14, panel B reports the signals, distinctive of the dimeric bands that could not 
be assigned to any linear peptide within the amino acid sequence of ADH and that 
could tentatively be ascribed to cross-linking products. As an example the signal at 
2384,8 (Fig.IV.14, panel C), that is absent in the digest of the corresponding 
monomeric species (Fig.IV.14, panel D) as well as in the reference sample, can be 
interpreted as peptide 192-196 (m/z 597,3) cross-linked to peptide 303-318 (m/z 
1791), with the loss of two atoms of hydrogen. 
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 However, identification of the amino acids actually cross-linked, could not be 
possible simply on MALDI-MS data, and further analyses by MSMS are currently in 
progress. 
 
 
 
 
Fig.IV.14. Molecular characterization of the cross-linked ADH dimer. (A) Electrophoretic 
separation of the UV-cross-linked dimer. UV-laser irradiated ADH (0.2 nmol in Na-phosphate 10mM, 
pH 7.1 quenched with 5 mM ascorbic acid after exposure for 1 min to the laser beam (E=220 μJ)) 
(lane 1). 0.1 nmol of ADH as reference sample, not irradiated (lane 2). Molecular weight standards 
(lane M). The gel was stained with Coomassie Blue. (B) Putative cross-linked peptides as determined 
from MALDI mass mapping. MALDI-TOF-MS spectrum from m/z 2333 to 2466 of the tryptic digest of 
the UV-laser cross-linked ADH (C), and of the reference sample, not irradiated. 
 
IV.6.4. Laser UV-induced in vivo cross-linking 
 
What learnt so far on peptides and protein models in  in vitro studies, was 
useful for setting up experiments in vivo. We have applied this approach also to intact 
cells, in order to exploit this technique as the final, most attractive future perspective, 
and tremendously powerful tool for the definition of the molecular partners of a 
selected protein of interest.  
We have performed the in vivo experiment on Hep75 human cells expressing the 
apolipoprotein A-I (ApoA-I), our bait, which is known to be responsible for hereditary, 
systemic amyloidoses, when specific mutations occur in the ApoA-I gene. The 13 
amyloidogenic variants of ApoA-I described so far are directly associated with in vivo 
formation of amyloid deposits [30] that accumulate in tissues and organs, such as 
heart, kidney or liver, with severe consequences [31].  
Samples of ApoA-I recombinant Hep75 cells in PBS buffer were exposed to the UV 
laser with different combination of laser energy (55 and 110 μJ), frequency (0.2 and 2 
KHz) and irradiation time (12 sec to 2 min). Fig.IV.15 shows the SDS-PAGE and 
western blotting analysis of total cellular extract after exposure to the UV laser. 
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In each lane of the western blotting, it is possible to observe the Apo-A1 protein band 
at the molecular weight of 25 kDa. Moreover, in the lanes 2 and 3 the presence of 
aggregates at high molecular weight is evident. These species would correspond to 
covalent adducts of proteins with the bait ApoA-1.  
The strongly encouraging results obtained demonstrate: 1) the exposure of intact 
cells to UV-laser induces the formation of covalent adduct inside the cell; 2) the 
phenomena can be modulated since the responses are function of the time of the 
exposure, the intensity of the laser beam, the frequency of the impulse. 
These positive preliminary results will lead to further development of the project to be 
carried out as follows: 1) Human cells expressing the apolipoprotein A-I (ApoA-I) will 
be irradiated by laser beam; 2) the cells are lysed; 3) proteins covalently cross-linked 
to the bait protein will be co-purified by immunoaffinity chromatography using an anti-
human ApoA-I polyclonal antibody linked to a resin; 4) the proteins eluted from the 
resin will be then identified by ordinary proteomics strategies.  
 
 
 
 
Fig.IV.15. SDS-PAGE fractionation and Western blotting analysis of Hep 75 cells irradiated 
under different conditions. (A) Electrophoretic separation of the UV-cross-linked Hep75 cells 
transfected with Apo-A1 protein. Not irradiated human Hep75 cell extracts were used as control (lane 
1). UV-laser irradiated Hep75 cells (buffer) after exposure for 2 min to the laser beam (E=110 μJ, 
ν=0.2 KHz) (lane 2); exposure for 12 sec (E=110 μJ, ν=2 KHz) (lane 3); exposure for 12 sec (E=55 μJ, 
ν=2 KHz) (lane 4); exposure for 2 min (E=55 μJ, ν=0.2 KHz) (lane 5); exposure for 1 min (E=110 μJ, 
ν=2 KHz) (lane 6). (B) Western blotting. Aliquots were subjected to SDS-PAGE and revealed with anti-
Apo and peroxidise conjugated secondary antibodies. Molecular weight markers are also shown. 
 
 
IV.7. Discussion 
 
The development of novel strategies and methodologies that could help in 
depicting the complex traffic map of the rapidly changing sets of protein interactions, 
what has been defined as the “the molecular sociology of the cell” [32], is still of 
extraordinary importance for understanding cellular processes.  
Chemical cross-linking is potentially a powerful alternative to genetic analyses of 
protein-protein interactions, such as the two hybrid system, and complement pull-
down experiments. Despite the apparent straightforwardness of the cross-linking 
approach, cross-linking has always been a trial and error process for a particular 
protein or protein complex and identification of cross-linking products can be 
hampered by the complexity of the cross-linking reaction mixture. This is due largely 
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to the propensity of common bivalent cross-linking reagents to provide false positives 
and negatives. Clearly, false positives cause serious complications in building a 
model for a complex of unknown architecture from cross-linking data. On the other 
hand, the relatively modest reactivity of commonly used electrophilic moieties in 
cross-linkers (a necessity because the chemistry is carried out in aqueous solution) 
means that many interactions are not detected by common cross-linkers.  
Moreover, the use of cross-linking to study multi-protein complexes or to search for 
binding partners has been limited by the relative slow and often inefficient chemistry 
employed by most classical cross-linkers.  
The purpose of this study was to investigate the feasibility of exploiting UV-laser 
induced cross-linking as a tool for the analysis of protein-protein interactions on an 
extremely rapid time scale and with a good efficiency. If cross-linking was very rapid, 
the strategy might be useful for probing the dynamics of transient protein-protein 
interactions in a particular complex. Moreover, a light triggered reaction would be 
useful for probing protein-protein interactions in living cells or in crude extract, 
circumventing the problems of false positive detection due to unspecific artefacts. If 
successful, UV-induced laser cross-linking would result in a key strategy that will 
allow to capture and identify weakly interacting proteins in vivo.  
Photochemical cross-linking of proteins to the nucleic acid has been applied to study 
a variety of nucleic acid binding proteins, but this methodology has not been ever 
used so far to analyse protein-protein interaction. Irradiation with UV light of 
wavelength near 267 nm can produce a “zero-length” covalent bond between contact 
points inside protein complexes and it is believed to produce less perturbation to 
structure than chemical cross-links. Moreover protein integrity is crucial for analysis 
of cross-linked products. Irradiation with a nanosecond laser was shown to degrade 
up to 25% of proteins in vitro [15]; however, a pico-second laser did not degrade 
proteins in vitro at three to four times higher doses [9]. Lejnine and co-workers [33] 
demonstrated that almost no degradation of proteins has been found after DNA-
protein irradiation. 
Moreover, it was not considered in any of the studies so far carried out investigating 
the laser UV induced DNA-protein cross-linking, the hypothesis that the high 
molecular aggregation could originate from reactions “born” on the protein side rather 
than on nucleic acid one. In all the papers investigating DNA-protein UV cross-
linking, excitation upon absorption of UV light is always ascribed to nucleic acid 
bases [34,35]. 
The start up of this project was to test if 2 kHz, 267 nm pulsed laser was able to 
induce protein-protein cross-link. 
We firstly demonstrated that it is possible to induce a cross-link when peptides are 
exposed to UV-laser. We observed that a covalent bond is formed only in the 
presence of aromatic amino acids in the peptide sequence. In order to verify which 
amino acids are involved we have performed high resolution tandem spectra of the 
cross-linked products. The obtained results asses univocally that the amino acids 
involved in this reaction are only the aromatic ones. The next step was to define 
which reaction mechanism is activated by ultra short UV laser. Since the most likely 
reaction mechanism is a radicalic one, we have performed femtosecond laser 
irradiation in the presence of spin trap molecules. After irradiation we observed the 
formation of covalent adducts with spin trap molecules, demonstrating the radical 
nature of the reaction mechanism. The specific location of the adducts on the model 
peptides was determined by high resolution mass spectrometry, demonstrating that 
radicalic adducts occurs only on aromatic side chain.  
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Once assessed the possibility to induce cross-link upon exposure to laser UV in 
peptides, the simplest model available, we have applied the same methodology to a 
more complicate model, an oligomeric protein, the alcohol dehydrogenase from 
Saccaromyces cerevisiae. 
In preliminary experiments we have observed, upon exposure to laser UV, the 
formation of high molecular aggregates that do not enter the gel or stay at the 
stacking interface of a discontinuous gel, as has also been observed in DNA-protein 
UV-laser cross-linking experiments [35]. 
Therefore, in order to optimize cross-linking conditions, we have varied different 
parameters such as protein concentration, exposure time, laser energy and, because 
of the radicalic nature of the cross-linking reaction, we have added ascorbic acid.  
In several conditions, bands that could be assigned to dimeric form (apparent 
molecular weight of 70 kDa) of ADH induced by the formation of one or more events 
of cross-link was observed (Fig.IV.14 panel A). The portions of the protein involved in 
the cross-link were defined by a classical proteomics approach. By means of it a 
discrete number of couple of peptides has been considered involved in the covalent 
bond induced by the laser. However, the validation of these hypotheses needs to 
MS/MS information. 
In this perspective, preliminary results were obtained with intact Hep75 human cells, 
recombinant for apolipoprotein A-I (ApoA-I), that is involved in the systemic 
amyloidoses. It is worth observing that exposure time as short as just 12 sec to a 
femtosecond laser irradiation are enough to “freeze” some ApoA-I complexes. These 
times are not yet compatible with complex formation kinetics or with transient 
interactions, but certainly photo cross-linking with UV laser delivers high-power 
monochromatic light in a rapid and well controlled manner. Moreover the exposure 
times are reduced compared to classical chemical cross-linking, which require 
incubation times not less than 30 min. The laser version of the UV light is not popular 
yet, but its obvious potential as a protein-protein cross-linking agent will hopefully 
stimulate many scientists to develop the use of this technique for various purposes.    
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Abstract 
 
Proteomic strategies are herein proved to be a complementary approach to the well established 
amino acid composition analysis for the characterization of the aging and deterioration phenomena 
occurring to proteinaceous materials in works-of-art.  
Amino acid analyses on several samples demonstrated that proteins in the frescoes from the 
Camposanto Monumentale in Pisa are deteriorated as revealed by the decrease in Met, Lys and Tyr 
content and by the presence in all the samples of amino malonic acid as the results of Ser, Phe and 
Cys oxidation. Proteomic analysis identified deamidation at Asn and Gln as a further major event 
occurred. 
This work paves the way to the exploitation of proteomic strategy for the investigation of the 
molecular effects of aging and deterioration in historical objects. Results show that proteomic 
searches for deamidation by LC-MSMS could constitute a routine analysis for paintings or any 
artistic and historic objects where proteins are presents. Two peptides, namely peptide 106-
YLGYLEQLLR-115 from alpha S1 casein (P02662) and peptide 189-FALPQYLK-196 from alpha-
S2 casein (P02663), were identified after a careful inspection of several candidates, to be used as 
molecular markers when casein is present.  
 
Introduction 
 
Safeguarding our Cultural Heritage is an important duty to ensure that future generations will have 
the opportunity to appreciate art masterpieces. Conservation must therefore be seen as one of the 
most exciting new fields and science can provide tools for the chemical, physical, and structural 
characterisation of the materials used to create a work-of-art, and on the basis of this knowledge, 
ongoing degradation processes can be highlighted. 
Among the materials composing the art object, organic materials used as binding media or 
protective coatings are the most subject to degradation phenomena or ageing. Traditionally, a 
number of naturally occurring substances have been used in artworks given their ability to form 
homogeneous and flexible thin films when mixed with pigments and colouring materials on the 
appropriate supports1. Inevitably, these materials degrade with age, with the result that some 
features of the artist’s work are more difficult to appreciate. Identification of the organic binders is 
of primary importance, and characterising degradation products of the organic material and 
identifying specific markers which describe the degradation and aging processes undergone the 
work-of-art is fundamental to better understand the history of a painting and to design appropriate 
restoration processes. The knowledge of original materials present in a work of art can in fact 
influence its cleaning, treatment and storage, and may also assist in the attribution of a painting to a 
particular workshop or artist. 
The physico-chemical analysis of paintings is particularly challenging due to the vast range of 
inorganic and organic materials which often constitute a work-of-art: canvas fibres, wooden 
supports and inorganic fillers, mixtures of binding media and pigments, metal decorations, 
varnishes, modern polymer treatments, and protective layers. The most common and often reliable 
analytical approaches for the analysis of organic painting materials are based on GC-MS and Py-
GC-MS2-4 analyses. However, although the paint media can be often reliably identified, changes in 
the composition, degradation phenomena, formation of minor components, and molecular 
modifications that have occurred cannot be completely understood by using only these approaches. 
The application of proteomics strategy to the characterization of proteinaceous binders in paintings 
has been recently reported in the literature5-8. So far, these studies were dedicated to the 
identification of proteinaceous paint media, rather than understanding modifications and 
degradation phenomena of the binders themselves.  
Very little is known about ageing and modifications induced in the proteinaceous binders. 
Proteinaceous materials loose water as soon as they are applied as a thin film in a paint layer. The 
most likely modification event of proteinaceous material is then oxidation. Aminomalonic aldehyde 
and acid are considered oxidation products of Ser, Phe, and Cys9. The oxidation of other amino 
acids was observed by fluorescence and Raman spectroscopy, suggesting that photooxidation of 
paint films can produce several fluorescent compounds, such as dityrosine, N formil kyneurine 
(NFK) and 3,4-dihydroxy-phenyl alanine (DOPA), also depending on the simultaneous occurrence 
of pigments10. Moreover, it has been shown that the solubility of proteinaceous materials decreases 
with time, and that some cations can give rise to analytical interferences, suggesting the formation 
of strong complexes with proteins4.  
This paper presents some significant results obtained from the systematic characterization of 
proteinaceous binders aimed at identifying molecular markers to be used in detecting aged and 
degraded proteinaceous binders by LC-MSMS. LC-MSMS analysis has the potential to reveal 
chemical modifications undergone by proteinaceous materials in a painting at a molecular level, 
which cannot be achieved with any other analytical technique.  
In this respect deamidation of asparagine and glutamine was detected as a major modification 
undergone by milk and animal glue in a sample collected from the Camposanto Monumentale in 
Pisa. Deamidation is a spontaneous nonenzymatic post-synthetic modification of proteins. It plays 
an important role in protein degradation and is postulated to function as a timer in aging11-14. 
Deamidation introduces negative charges and results in a +0.984-Da mass shift, which can be 
detected by MS techniques15-18, and MSMS methods can also provide very specific information on 
deamidation sites. 
In the contest of the samples herein characterized, deamidation could be related to the reactions 
taking place between the proteinaceous binder and the other materials used in the past restoration as 
well as to the ageing of the proteinaceous binders.  
EXPERIMENTAL SECTION 
 
Materials. Ammonium hydrogen carbonate (AMBIC), Ethylenediaminetetraacetic acid (EDTA) 
and iodoacetamide were purchased from Fluka; Tri(hydroxymethyl)aminomethane (TRIS), urea, 
dithiothreitol (DTT), TPCK-treated trypsin were from Sigma; Formic acid from Baker and 
Acetonitrile (ACN) were purchased from Romil. Deionised water was obtained with a Millipore 
cartridge equipment.  
 
Painting samples. Replicas were prepared using whole milk and fresh whole egg, and rabbit skin 
glue. Animal glue was dissolved in warm water; whole egg was slightly beaten to obtain a fluid 
homogeneous medium; whole milk was used without any treatment. The pigments (Prussian blue 
Fe4[Fe(CN)6]3, verdigris Cu(CH3COO)22Cu(OH)2, minium Pb3O4, cadmium yellow CdS+ZnO] 
were mixed with the fluid binder in ratios ranging approximately between 1 part pigment and 2-3 
parts fluid binder. The paint was then applied with a brush on tiles covered by a layer of plaster, 
which were prepared in the summer 2003. The paint replicas were prepared in spring 2008, and 
stored at ambient temperature in the darkness since then.  
All samples of painting layers were available as few milligrams fragments (1-3 mg).  
 
Sample treatment. Samples and blank reference sample were digested in heterogeneous phase 
incubating for 4 or 16 h, approximately 1-3 mg of solid sample, in ammonium bicarbonate 10 mM 
pH 7.5, containing trypsin 0.16 µM. The supernatant was then recovered by centrifugation, dried in 
vacuum, resuspended in 10 µl in 0.1% formic acid, and the peptide mixture analysed by LC-MSMS. 
 
LC-MSMS analysis. The peptide mixtures were analysed using a CHIP MS 6520 QTOF equipped 
with a capillary 1200 HPLC system and a chip cube (Agilent Technologies, Palo Alto, Ca) as 
previously reported7. Raw data from nano LC–MSMS analyses were employed to query non-
redundant protein databases (UniprotSprot with taxonomy restriction to Chordata) using in house 
MASCOT software (Matrix Science, Boston, USA). 
 
RESULTS 
 
The Camposanto Monumentale, a 13th century cemetery located alongside the Leaning Tower in 
Pisa (Italy), was decorated with important frescoes painted by Benozzo Gozzoli, Taddeo Gaddi, 
Spinello Aretino and Buonamico Buffalmacco, amongst others. During the Second World War an 
incendiary bomb exploded in the cemetery, burning the wood and melting the lead of the roof. 
During the restoration following the Second World War, the paintings (i.e., paint layer and plaster) 
were detached from the wall using animal glue, and was subsequently glued onto another canvas 
using non water soluble glues. At this stage, in most cases casein was used, but its quality was very 
poor and, with the passing of time it has slowly lost its adhesive properties19. In addition to prevent 
it from rotting quickly during the restorations, formaldehyde was often added: unfortunately in 
some cases this gave rise to cross-linking reactions, transforming all the paint layers into a unique 
insoluble and waterproof block20. Slaked lime was generally mixed with the casein, in order to 
increase the strength of the glue after carbonation of the calcium hydroxide, but it has since been 
proven that the carbonation was still not at all complete even 20-30 years later.  
 
GC-MS analyses of the paint samples. In several samples from the restoration campaign, the 
proteinaceous content was analysed by GC-MS procedure based on the acidic hydrolysis of the 
samples assisted by microwave, followed by derivatisation with a silylating agent3. Purification 
from inorganic materials was also performed when necessary3. This procedure permits to evaluate 
the quantitative amino acidic content of 14 amino acids. Animal glue was used to detach the 
paintings and casein was used as glue to the new support. As a result, one of these materials, or both 
of them, are always found in the samples collected from these paintings. Animal glue can be easily 
identified due to the presence of Hyp. Moreover it is characterised by high contents of Gly. Casein 
is characterised by a high content of Glu and a relatively high content of Pro. To identify a 
proteinaceous binder by GC-MS, the relative amino acid percentage content of a sample is 
compared to a dataset of reference samples by means of Principal Component Analysis (PCA).  
Table 1 reports an example of the aminoacidic compositions observed in some samples of the mural 
paintings compared to the average profiles of reference samples of animal glue, egg and casein 
obtained with the same analytical procedure.  
Samples GUsp1, GUsp4 and Ab show the occurrence of animal glue, as indicated by the presence 
of Hyp. By processing the samples with PCA (Score Plot in Figure 1) it is possible to evaluate that 
all samples contain casein as well, as indicated by their position in the score plot. Finally it is 
important to stress that some samples do not show any Met (GUsp1, GUsp4 and Ab), some any Tyr 
(GUsp1, CSG16, A6S1a and CSG-C bis), and some others any Lys (CSG16, A6S1a and CSG-C 
bis). Ser and Glu are also extremely low in CSG-C bis. Finally in all samples amino malonic acid, 
which is considered to be the degradation product of Ser, Phe, and Cys21, was identified  
The situation shown here with few examples is typical of the samples collected from the mural 
paintings of the Camposanto Monumentale in the course of the years. Although in most cases 
identification of the proteinaceous binder is still possible, most part of the samples analysed show 
modified profiles. But there is no information about how and where these modifications occur in the 
protein sequence and which can thus be the consequences from point of view of the stability of the 
materials and the conservation of the work of art itself. 
 
Proteins Identification in painting samples by proteomic strategies. The identification of the 
proteinaceous material in the painting sample from the Camposanto Monumentale of Pisa, was 
carried out following the minimally invasive proteomic analytical procedure previously described7 
and reported in the experimental section.  
A preliminary search in the UniprotSprot database for protein identification was carried out in the 
MASCOT software without the insertion of any variable chemical modification but oxidation of 
methionine and the possible formation of pyroglutammic acid from glutamine residues at the N-
terminal position of peptides. The identification of 6 proteins form bovine milk and two bovine 
collagens confirmed the use of casein and bovine animal glue as natural adhesives20, 22.  
Because of the presence of collagens, hydroxylation on proline and lysine residues, a post–
translational modification extensively found in collagen chains, were subsequently inserted as 
variable modifications in the database search. This resulted in a much higher confidence in the 
identification of proteins from the animal glue component. As an example, addition of 
hydroxylations as variable modifications increased the identification score from 204 to 780 for 
collagen alpha-1 (I) chain (P02453, entry in the UniprotSprot Database,) and the number of 
identified peptides increased from 5 to 30. In the Supplementary materials, Table S1 reports the 
results on the sample from the Camposanto Monumentale of Pisa, introducing oxidation of 
methionine, hydroxylation of proline and lysine, pyro-Glu formation from Gln at the N-terminus of 
peptides as variable modifications.  
Similar analyses were carried out on reference materials (i.e. dried skimmed milk, model samples 
prepared with caseins and animal glue as binders), and database searches were performed in the 
same conditions as above. Proteins identified in the different samples are quite always the same. In 
all the samples that contain milk, bovine beta, alpha S1, alpha S2, and kappa caseins were identified 
as well as beta lactoglobulin with high confidence. In all the samples containing bovine glue the 
presence of collagen alpha 1 (I) chain and collagen alpha 2 (I) chain was confidently assessed. 
These results are fully in agreement with the screening and statistical analysis carried out by 
Fremout and colleagues on the most common identified proteins in paint replicas8. 
 
Identification of Modification Events in Proteins in Painting Samples. Database searches were 
successively carried out, on the sample form the Camposanto Monumentale in comparison to 
reference materials, with the insertion of several additional variable chemical modifications, one or 
two at a time, because of search algorithm optimization. Kynurenine, formyl-kynurenine, 
hydroxykynurenine, oxidation of His, Trp, Arg, Lys, nitration of Tyr, beta elimination of Ser and 
Thr, oxidation of Cys to cysteic acid, and formation of amino malonic acid from Ser, Phe and Cys 
were all tested as possible modifications of the proteins present in the samples  Best search results 
were obtained by trial and error. As expected, and in agreement with the results obtained by amino 
acid analysis, formation of amino malonic acid from Ser (predominantly), Phe, and Cys was 
observed in several peptides (data not shown). On the contrary, oxidation of sulphur containing 
aminoacids, or modifications of tryptophan was not significantly detected.   
When deamidation was considered as variable modification, several of the Gln and Asn containing 
peptides that had been identified in the sample from the Camposanto Monumentale, were also 
found as deamidated peptides (Table 2). As an example, 6 of the 10 peptides belonging to the 
bovine beta casein were also detected in the deamidated form. Similarly, 9 of the 15 peptides 
mapping the Alpha-S1-casein were also found as deamidated peptides. We were therefore prompted 
to investigate the occurrence of deamidation as a marker for deterioration and aging of the materials. 
It is worth mentioning that deamidation escapes detection in amino acids analysis because the 
extreme acidic conditions in the hydrolysis of the proteins systematically transform all the Gln and 
Asn into Glu and Asp, respectively.  
Systematic database searches were therefore eventually repeated including deamidation on 
glutamine and asparagine as variable modification and Table 2 reports the number of deamidated 
peptides observed in the single proteins identified in the sample from the Camposanto 
Monumentale, in a sample of skimmed milk and in the test models.  
 
Assessment of deamidation. Deamidation introduces a small (+0.984 Da) mass shift that overlaps 
with isotopic pattern. Moreover, non-deamidated and deamidated peptides behave quite similarly 
during reverse-phase chromatography, with deamidated peptides eluting at moderately higher 
concentration of acetonitrile than non-deamidated ones.  
Peptide fragmentation does facilitate detection of deamidation and provide very specific 
information on deamidation sites. We manually inspected several MS and MSMS spectra originated 
by deamidated peptides as indicated by Mascot software, in order to confirm software assignments.  
However, as has been shown by a large number of authors (e.g., ref. 23), many post-synthetic 
modifications including deamidation, can occur in vitro during proteomics sample handling.  
Moreover, as Li and coworkers demonstrated30, artificial deamidation occurring during the tryptic 
digestion can be reduced with faster trypsin digestion: digestion carried out for up to 4 h generally 
would not introduce additional detectable deamidations, even for rapidly deamidating peptides. 
To reduce the incidence of artifactual deamidation, we therefore subjected the samples to a short 
trypsin digestion (∼4 h) as a systematic strategy. 
Despite the shorter hydrolysis time, proteins could be confidently identified in all the samples 
(Table 2).  
 
Identification of peptides to be considered as aging/deterioration signatures. Deamidation was 
found widespread over most of the identified proteins, both from the old sample and the reference 
materials, (Table 2). A systematic analysis was carried out to individuate peptides that could be 
sorted out as aging/deterioration signatures for further investigation.   
We designed specific criteria for the identification of candidate peptides as follows: 1) Peptides 
should have been identified in all the samples analysed with good scores; 2) fragmentation spectra 
should be of good quality in all the samples tested; 3) when deamidation was detected, 
fragmentation spectra of the deamidated peptide should be of good quality as well.  
The limited variability of the proteins identified in the different samples (Table 2) (i.e., as 
highlighted above, the same proteins were identified in the sample from the Camposanto 
Monumentale of Pisa as well as in the reference samples) was instrumental in our search for 
biomarkers of the material deterioration. We could screen a large panel of peptides common to all 
samples, with a wide range of physico-chemical characteristics, looking for candidates that do 
satisfy the prerequisites.  
Table 3 lists all the glutamine or asparagine containing peptides that had been detected in the 
sample from the Camposanto Monumentale of Pisa, and, for each of them, the occurrence of 
deamidation is indicated and compared to the other samples. Table 3A and Table 3B list the 
peptides of the milk derived proteins and in the animal glue component, respectively. 
Several deamidated peptides detected in the sample from the Camposanto Monumentale of Pisa 
were not deamidated either in the model samples or in the skimmed milk sample, (Table 3A and 
Table 3B). Moreover, peptides with multiple deamidations were detected in the sample from the 
Camposanto Monumentale of Pisa, whereas only singly or not deamidated in model samples or in 
the skimmed milk sample.  
A preliminary analysis of the peptides identified in the different samples clearly indicates that 
peptides from caseins are better candidates than collagen fragments. The co-presence of a variable 
extent of hydroxylations on almost all of the collagen peptides enormously increases the 
heterogeneity of these fragments decreasing the relative abundance of the single species and thus 
making the confident assignment of deamidation of these peptides more challenging. 
Our survey produced at least two possible candidates, whose mass and fragmentation spectra for 
both the normal and deamidated peptides are reported in Fig. 2 and 3, respectively.  
Peptide 106-YLGYLEQLLR-115 from alpha S1 casein (P02662) was considered a good candidate 
for a number of considerations. This peptide is present in all the casein containing samples, it 
contains only one deamidation site, it was found to be deamidated only in the sample from the 
Camposanto Monumentale of Pisa, and deamidation could be easily visualised in the corresponding 
fragmentation spectra. 
Figure 2 (panel A) shows the MSMS spectra of the doubly charged ion at 634.36 m/z of the 
YLGYLEQLLR peptide from alpha S1 casein (P02662), in the sample from Camposanto 
Monumentale of Pisa. Panel B shows the MSMS of the doubly charged ion at 634.85 m/z 
corresponding to the deamidated form of the same peptide. Deamidation at Gln113 can be readily 
assessed since all the signals from the y series containing the Gln residue are shifted by one unit in 
the fragmentation spectra of the deamidated form, with deviation of the experimental data from the 
expected values within the 1-21 ppm range (Table S2, Supplementary materials). 
The second candidate peptide was defined as the 189-FALPQYLK-196 peptide from alpha-S2 
casein (P02663) on the basis of the same considerations as discussed above. Deamidation could be 
readily assessed since all the signals from the y series containing the Gln residue are shifted by one 
unit in the fragmentation spectra (Figure S1, supplementary materials), with deviation of the 
experimental data from the expected values within the 1-30 ppm range (Table S2).  
 
 
DISCUSSION 
 
Only in recent years proteomic approaches have been proposed as valuable tool for the 
identification of the proteinaceous constituents of artistic and historic objects. Herein, these 
procedures proved to be extremely promising also for the characterization of the natural and 
artificial aging and deterioration products in the proteins in masterpieces. 
We worked on the 14th century frescoes from the Camposanto Monumentale in Pisa, that were 
detached in 1945 from the wall and relocated on an asbestos cement supports, using a glue based on 
a mixture of casein, animal glue and calcium hydroxide. Amino acid analyses on several samples 
demonstrated that proteins in the frescoes were deteriorated as revealed by the decrease in Met, Lys 
and Tyr and by the presence of amino malonic acid as the results of oxidation of Ser, Phe and Cys 
in all the samples.  
Proteomic analyses confirmed the presence of amino malonic acid, and identified deamidation at 
Asn and Gln of proteinaceous binders as a major deterioration event. Deamidation is a spontaneous 
nonenzymatic post-synthetic modification of proteins and cannot be assessed by aminoacidic 
analysis because of the extreme conditions of the acidic hydrolysis that convert all the amide 
moieties into the corresponding acids. It plays an important role in protein degradation and is 
postulated to function as a timer in aging11-14.   
Deamidation at Asn residues takes place much more rapidly than at Gln (up to ten times faster), and 
the reaction mechanisms of nonenzymatic deamidation have been extensively studied. Asn 
deamidation proceeds through the formation of a succinimide ring, which in turn opens up to give a 
mixture of aspartic and iso-aspartic residue11. Gln deamidation, similarly, can proceed through 
formation of a glutarimide moiety, but, since this reaction is relatively slow, direct hydrolysis also 
contribute significantly11. 
The systematic analysis of the samples herein reported indicate extensive deamidation occurring on 
most of the peptides identified, suggesting that the miniature molecular clock, as Robinson and 
Robinson defined any amide residue present in peptides or proteins11, might well be used as 
molecular marker in artworks. 
However, many factors can influence deamidation, such as protein sequence14, 24, 25, secondary 
structure26, local three-dimensional structure27, pH, temperature, ionic strength, buffer ions, 
turnover of the protein, and other solution properties28, 29. Moreover, in this respect, it must be kept 
in mind that the sample taken into consideration was collected from a work of art. Milk is an 
emulsion, and is already in the liquid form. To use casein, which is sold as a powder, as an art 
material, a fluid must be obtained, which can be achieved by using an alkaline solution as a solvent. 
In the case of the Camposanto Monumentale, it is known that slaked lime was added to casein, to 
solubilise it and to obtain a stronger glue, after the carbonatation of the lime took place. Slaked lime 
is extremely alkaline, and it must be expected that this has reacted with casein during years, 
although a reduced reaction rate must be expected when the glue was dried and water thus 
evaporated. 
It is therefore clear that the modifications detected here have to be considered as the results of the 
work of art preparation, the treatment itself (i.e. the presence of slaked lime) and the actual aging, 
without any possibility, at this stage, of distinguishing the different phenomena. 
Our data indicate that, whenever caseins are present, several peptides can constitute the molecular 
signatures of degradation, and we identified, after a careful inspection of several candidates, two 
peptides that can be used as markers, namely peptide 106-YLGYLEQLLR-115 from alpha S1 
casein (P02662) and peptide 189-FALPQYLK-196 from alpha-S2 casein (P02663).  
Interestingly, both the selected peptides present Gln as the deamidation site. We suggest that Gln 
deamidation, intrinsically slower than deamidation at Asn site, might reveal to be more useful in the 
quantitative perspective on historical object: Asn deamidation might occur too fast to be used for 
the actual evaluation of the aging of the object itself. 
Awareness and measurement of deamidation could constitute a routine analysis for paintings or any 
artistic and historic objects where proteins are presents. However, a contribution in the level of 
deamidation due to artwork preparation itself, and deamidation artifacts produced during the 
analysis must be carefully guarded against and considered. Future works will be devoted to the 
quantitative analysis of deamidation as function of aging and to deeply investigate and possibly 
separate the contributions of actual aging and/or the preparation and treatment of the work-of art.  
In conclusion, our data identified deamidation as an extensive deterioration process occurring in 
pictorial objects, and pave the way to the identification of molecular signatures that can be useful in 
characterizing of artworks that contain proteins and, suggest to further exploit proteomic strategy 
for the investigation of aging molecular effects.  
 
Supplementary materials 
The full list of the peptides and the corresponding proteins identified in the sample of the 
Camposanto Monumentale of Pisa is available free of charge via the Internet at http://XXXXXX. 
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LEGENDS TO FIGURES 
 
Figure 1: Score plot obtained by comparing the reference samples of animal glue, casein and egg 
with the samples from the Camposanto Monumentale. 
 
Figure 2: MSMS spectra of the doubly charged ions at m/z 634.36 (A) and 634.85 (B) of the 
peptide 106-YLGYYLEQLLR-115 from bovine alpha S1 casein (P02662) and its deamidated form, 
respectively, identified in the analysis of the sample from Camposanto Monumentale of Pisa. The 
product ions are indicated with the observed masses.  
 
 
 
 
Table 1. Aminoacidic composition in samples from the Monumental Cemetery. 
 
      Aminoacid 
Sample 
Ala Gly Val Leu Ile Met Ser Pro Phe Asp Glu Lys Hyp Tyr 
GUsp1 6.8 17.8 6.0 8.4 4.8 0.0 3.6 10.6 4.1 8.1 17.3 2.0 10.3 0.0 
GUsp4 7.4 12.4 11.1 14.8 8.4 0.0 4.4 16.4 6.5 4.3 10.6 0.7 2.6 0.3 
Ab 3.7 6.3 7.1 10.0 4.9 0.0 5.1 14.3 2.1 10.3 27.3 0.2 8.3 0.4 
CSG16 6.6 14.5 6.8 8.9 5.1 2.4 2.9 12.6 2.4 9.0 28.8 0.0 0.0 0.0 
A6S1a 5.2 6.0 8.1 13.8 7.9 4.8 3.6 6.5 6.4 9.1 28.5 0.0 0.0 0.0 
CSG-C bis 8.2 5.1 15.5 18.3 12.7 7.5 1.7 14.0 10.5 3.8 1.8 0.0 0.0 0.0 
Glue 14.3 23.1 5.0 6.0 2.4 1.3 5.1 12.6 3.1 5.3 7.8 3.7 9.2 1.2 
Casein 3.7 1.9 6.6 11.5 7.0 3.5 7.1 11.7 6.9 8.8 25.7 2.0 0.0 3.6 
Egg 8.6 4.7 10.1 14.7 8.6 6.0 7.6 4.4 8.7 11.8 10.3 3.7 0.0 0.8 
 
 
 
Table 2. Identification of the proteins in painting samples by trypsin digestion in 
heterogeneous phase. Proteins were identified searching UniprotSprot database with MSMS Ion 
search Mascot software (Matrix Science). Chordata was used as taxonomy restriction, deamidation 
on Gln and Asn, oxidation on Met, hydroxylation on Lys and Pro as variable modifications. Only 
proteins identified with at least two peptides were considered as significative. 
 
Overnight trypsin digestion 4 h trypsin digestion 
SAMPLE Identified protein 
(Accession number) 
Number of 
identified 
peptidesb
Number of 
deamidated 
peptidesc
Number of 
identified 
peptides 
Number of 
deamidated 
peptides 
 
Sample from 
Cimitero 
Monumentale 
of Pisa a
Beta-casein1 (P02666) 
Alpha-S1-casein (P02662) 
Collagen alpha-2 (I) chain  (P02465) 
Collagen alpha-1 (I) chain (P02453) 
Kappa-casein (P02668) 
Alpha-S2-casein (P02663) 
Beta-lactoglobulin (P02754) 
Lactadherin (Q95114) 
10 
15 
26 
35 
4 
11 
7 
3 
6 
9 
7 
9 
2 
7 
0 
0 
8 
11 
33 
40 
5 
9 
6 
- 
6 
7 
11 
16 
2 
6 
0 
- 
 
 
Model on 
intonaco with 
casein 
Beta-casein (P02666) 
Alpha-S1-casein (P02662) 
Beta-lactoglobulin (P02754) 
Alpha-S2-casein (P02663) 
Kappa-casein (P02668) 
Serum albumin (P02769) 
Polymeric immunoglobulin receptor 
(P81265) 
6 
8 
4 
5 
2 
4 
2 
3 
4 
1 
2 
0 
0 
0 
7 
9 
6 
6 
2 
2 
- 
3 
3 
1 
3 
0 
0 
- 
Model on 
intonaco with 
animal glue 
Collagen alpha-2 (I) chain (P02465) 
Collagen alpha-1 (I) chain (P02453) 
Collagen alpha-1(III) chain (P04258) 
26 
34 
10 
12 
15 
6 
38 
38 
13 
13 
17 
6 
 
 
 
Skimmed 
milk 
Alpha-S1-casein (P02662) 
Serum albumin (P02769) 
Beta-lactoglobulin (P02754) 
Kappa-casein (P02668) 
Beta-casein (P02666) 
Lactotransferrin (P24627) 
Alpha-S2-casein (P02663) 
Butyrophilin subfamily 1 member A1 
(P18892) 
Glycosylation-dependent cell 
adhesion molecule I (P80195) 
9 
13 
7 
3 
4 
4 
4 
3 
3 
1 
0 
2 
1 
1 
0 
2 
0 
0 
8 
6 
9 
4 
- 
3 
6 
1 
3 
2 
0 
- 
0 
- 
0 
1 
- 
0 
 
 
Model on 
glass with 
casein 
Alpha-S1-casein (P02662) 
Beta-casein (P02666) 
Beta-lactoglobulin (P02754) 
Alpha-S2-casein (P02663) 
Kappa-casein precursor (P02668) 
16 
12 
7 
14 
3 
7 
6 
1 
4 
2 
9 
5 
- 
7 
3 
2 
1 
- 
2 
2 
Model on 
glass with 
animal glue 
Collagen alpha-2 (I) chainI (P02465) 
Collagen alpha-1 (III) chain (P04258) 
Collagen alpha-1 (I) chain (P02453) 
53 
27 
49 
27 
14 
27 
36 
11 
48 
12 
5 
18 
a An extended version of the table, with the sequence of the identified peptides, is reported in the Supplementary 
material, S1 
b The number of peptides was calculated regardless the presence of modifications, i.e., for this purpose, if a peptide 
was observed  both as modified and not modified, herein it is considered as a single peptide. 
c The number of deamidated peptides was herein calculated regardless the number of deamidations observed on the 
peptide, i.e., for this purpose, if a peptide was observed a singly or multiply deamidated, it is herein considered as a 
single modification.  
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Table S1. Identification of the proteins in the sample from the Cimitero Monumentale of Pisa by 
overnight trypsin digestion in heterogeneous phase and LCMSMS analysisa. Proteins were 
identified searching UniprotSprot database, with Chordata as taxonomy restriction, with MSMS Ion 
search Mascot software (Matrix Science). Only identification of proteins with at least two peptides were 
considered as significative. 
 
Identified 
protein 
(Accession number) 
Total 
scorea
Sequence 
coverage 
(%) 
Matched sequence
(Only oxidation of methionine, hydroxylation of proline and lysine, 
pyro-Glu formation at Gln at the N-terminus of peptides were inserted 
as variable modifications in the MSMS Ion Search Program).  
Beta-casein precursor 
(P02666) 
 
 
 
 
 
 
 
 
 
Casein alpha-S1 
(P02662) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Collagen alpha-1(I) chain 
(P02453) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Kappa-casein precursor 
(P02668)  
 
1689 
 
 
 
 
 
 
 
 
 
 
1464 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
780 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
646 
 
 
75 
 
 
 
 
 
 
 
 
 
 
50 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
35 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
26 
 
 
EMPFPK 
VLPVPQK 
AVPYPQR 
VLPVPQKAVPYPQR 
FQSEEQQQTEDELQDK 
DMPIQAFLLYQEPVLGPVR 
DMPIQAFLLYQEPVLGPVRGPFPIIV 
AVPYPQRDMPIQAFLLYQEPVLGPVR 
IHPFAQTQSLVYPFPGPIPNSLPQNIPPLTQTPVVVPPFLQPEVMGVSK 
YPVEPFTESQSLTLTDVENLHLPLPLLQSWMHQPHQPLPPTVMFPPQSVLSLSQSK 
 
TTMPLW 
EDVPSER 
EKVNELSK 
YLGYLEQLLR 
HIQKEDVPSER 
FFVAPFPEVFGK 
VPQLEIVPNSAEER 
FFVAPFPEVFGKEK 
HQGLPQEVLNENLLR 
YKVPQLEIVPNSAEER 
EDVPSERYLGYLEQLLR 
HPIKHQGLPQEVLNENLLR 
EPMIGVNQELAYFYPELFR 
EGIHAQQKEPMIGVNQELAYFYPELFR 
 
GAAGLPGPK 
GFSGLDGAK 
GSEGPQGVR 
GVVGLPGQR 
GFPGADGVAGPK 
GVQGPPGPAGPR 
GVPGPPGAVGPAGK 
GQAGVMGFPGPK 
GLTGSPGSPGPDGK 
GPSGPQGPSGPPGPK 
GFPGLPGPSGEPGK 
GEPGPAGLPGPPGER 
GSAGPPGATGFPGAAGR 
GETGPAGPAGPIGPVGAR 
GLTGPIGPPGPAGAPGDK 
GSPGEAGRPGEAGLPGAK 
EGAPGAEGSPGRDGSPGAK 
GPPGPMGPPGLAGPPGESGR 
VGPPGPSGNAGPPGPPGPAGK 
GEPGPTGIQGPPGPAGEEGK 
SGDRGETGPAGPAGPIGPVGAR 
GEPGPTGIQGPPGPAGEEGKR 
TGPPGPAGQDGRPGPPGPPGAR 
GAPGADGPAGAPGTPGPQGIAGQR 
GEPGPPGPAGFAGPPGADGQPGAK 
GETGPAGRPGEVGPPGPPGPAGEK 
GAPGDRGEPGPPGPAGFAGPPGADGQPGAK 
GFSGLQGPPGPPGSPGEQGPSGASGPAGPR 
GLTGPIGPPGPAGAPGDKGEAGPSGPAGPTGAR 
GVPGPPGAVGPAGKDGEAGAQGPPGPAGPAGER 
GLPGPPGAPGPQGFQGPPGEPGEPGASGPMGPR 
 
YIPIQYVLSR 
HPHPHLSFMAIPPK 
HPHPHLSFMAIPPKK 
 
 
Collagen alpha-2(I) chain 
(P02465) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Casein alpha-S2  
(P02663) 
 
 
 
 
 
 
 
 
 
 
 
Beta-lactoglobulin 
(P02754) 
 
 
 
 
 
 
Lactadherin (Q95114) 
 
 
 
592 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
275 
 
 
 
 
 
 
 
 
 
 
 
 
129 
 
 
 
 
 
 
 
52 
 
 
 
30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
46 
 
 
 
 
 
 
 
 
 
 
 
 
33 
 
 
 
 
 
 
 
9 
 
SPAQILQWQVLSNTVPAK 
 
GVVGPQGAR 
GPSGPQGIR 
VGAPGPAGAR 
GLVGEPGPAGSK 
GEPGNIGFPGPK 
IGQPGAVGPAGIR 
GPAGPSGPAGKDGR 
GIPGPVGAAGATGAR 
GFPGSPGNIGPAGK 
GIPGEFGLPGPAGAR 
GDGGPPGATGFPGAAGR 
SGETGASGPPGFVGEK 
GEPGPAGAVGPAGAVGPR 
GAAGLPGVAGAPGLPGPR 
GPPGESGAAGPTGPIGSR 
GELGPVGNPGPAGPAGPR 
GSTGEIGPAGPPGPPGLR 
RGSTGEIGPAGPPGPPGLR 
EGPVGLPGIDGRPGPIGPAGAR 
GLPGVAGSVGEPGPLGIAGPPGAR 
GPPGASGAPGPQGFQGPPGEPGEPGQTGPAGAR 
 
 
VIPYVR 
LNFLKK 
NMAINPSK 
FALPQYLK 
VIPYVRYL 
AMKPWIQPK 
NAVPITPTLNR 
RNAVPITPTLNR 
ALNEINQFYQK 
TVDMESTEVFTK 
FALPQYLKTVYQHQK 
FPQYLQYLYQGPIVLNPWDQVK 
 
ALPMHIR 
IDALNENK 
VLVLDTDYK 
VLVLDTDYKK 
TPEVDDEALEK 
TPEVDDEALEKFDK 
VYVEELKPTPEGDLEILLQK 
 
VTGIITQGAR 
QFQFIQVAGR 
DFGHIQYVAAYR 
a Ions score is -10*Log(P), where P is the probability that the observed match is a random event. Protein 
scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. 
(http://www.matrixscience.com/help/interpretation_help.html) 
 
Table S2: Main series matches of the fragmentation spectra reported in Figure 1 and Figure 2. Those ions 
containing the deamidation site are highlighted reported in bold.  
 YLGYLEQLLR YLGYLEQ*LLR FALPQYLK FALPQ*YLK 
Daughter ion m/z m/z m/z m/z 
y1 175.1213 175.1188  147.1142 147.1164 
y2 288.2069 288.2066 260.2044 260.1990 
y3 401.2924 401.2823 423.2609 423.2469 
y4 529.3491 530.3313 551.3244 552.2882 
y5 658.3893 659.3660 648.3701 649.3549 
y6 771.4714 772.4542 761.4525 762.4367 
y7 934.5386 935.5100 832.4970 833.4685 
y8 991.5664 992.5379   
y9 1104.6354 1105.6353   
b2 277.1605 277.1568 219.1142 219.1140 
b3 334.1784 334.1803 332.2001 332.1984 
b4 497.2403 497.2425 429.2483  
b5 610.3256 610.3282   
b6 739.3653  720.3621  
b7 867.4202    
b8 980.4983    
b9 1093.6009 1094.5944   
 
 
Figure S1: MSMS spectra of the doubly charged ions at m/z 490.28 (A) and 490.78 (B) of the peptide 
189-FALPQYLK-196 from bovine alpha-S2 casein (P02663) and its deamidated form, respectively, 
identified in the analysis of the sample from Camposanto Monumentale of Pisa. The product ions are 
indicated with the observed masses.  
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Abstract 
White-rot basidiomycetes, the most common wood-rotting organisms, are 
characterized by their ability to produce extracellular oxidative enzymes, which are 
mainly involved in the degradation of lignin. A non specific reaction mechanism 
characterizes lignin-modifying enzymes allowing them to be also able to degrade a 
wide range of environmental pollutants, such as polycyclic aromatic hydrocarbons, 
chlorophenols, and aromatic dyes. Due to their broad substrate range, these 
oxidative enzymes are being increasingly evaluated for a variety of biotechnological 
applications. In particular, in the last decades the physiological role of laccases and 
their use in several industrial fields has been deeply investigated. However, large 
amounts of enzyme are required both for fundamental studies and for their practical 
application at industrial scale. Nevertheless, laccases secreted from wild-type fungal 
organisms may not be suitable for commercial purposes mainly because of low yields 
of production and high costs of preparation procedures.  
In the present work the white rot fungus Pleurotus ostreatus has been used as 
organism for classical breeding experiments. The genome of this basidiomycete has 
been recently sequenced and several genes coding for laccase isoenzymes have 
been annotated. Besides recombinant heterologous expression, classical breeding is 
an useful alternative method to OGM either to improve ligninolytic enzymes 
production and to increase isoenzymatic variability. In particular, starting from two 
different P. ostreatus variants, three laccase higher-producing dikaryotic strains have 
been obtained through crossing compatible characterized monokaryons. The three 
selected strains reached expression levels of 100,000 U/L, increasing the trite of 
parental strains up to four folds. Furthermore, this work allowed production of a new 
isoenzyme, the laccase POX1, whose cDNA was previously isolated, but the 
corresponding native protein was not identified yet. 
 
Introduction: 
White-rot fungi (WRF) have been widely recognized as the most efficient lignin 
degraders [1]. This ability results from the production of various isoforms of 
extracellular ligninolytic enzymes including manganese peroxidases, lignin 
peroxidases and laccases [2, 3]. The latter are involved in a variety of physiological 
roles including morphogenesis, fungal plant pathogen/host interactions, stress 
defence and lignin degradation [3-5]. Furthermore, due to their broad substrate 
range, laccase enzymes can play a role not only in the degradation of lignin in their 
natural lignocellulosic substrates but also in the degradation of various xenobiotic 
compounds [6]. Thus, WRF and their enzymes are widely considered to have 
potential for industrial purposes. As a fact, laccases offer industrially useful 
advantages of great interest for biotechnological applications such as biodegradation 
of environmental pollutants (e.g. like textile dye or explosives), bioconversion of lignin 
and detoxification of agricultural by-products, including olive mill wastes or coffee 
pulp [7].  
Laccases secreted from native sources are usually not suitable for large scale 
applications, mainly due to low production yields and high cost of preparation and 
purification procedures. To successfully utilize laccases for biotechnological 
purposes, production of large quantities of enzymes at low cost is required. Only few 
examples of industrial uses of laccases currently exist and most of them utilize 
genetically modified tailored laccase, produced by recombinant expression [8].  
Therefore, any attempt to increase the production of enzymes from microbial sources 
could be of considerable industrial interest. 
The constantly growing popularity of the edible fungus P. ostreatus, as well as the 
significantly increased knowledge of its ligninolytic enzymatic system, render 
worthwhile spending efforts for obtaining strains, derived from this mushroom, 
improved for phenoloxidases production at large-scale.  
So far, eight members of the P. ostreatus laccase multigene family have been 
isolated and sequenced [9, 10] and up to 12 members of this family have been 
identified in the released P. ostreatus genome databank. However, the redundancy 
of laccase genes raises the question about their respective functions in vivo, and this 
question is even more pertinent since cDNAs or proteins for some of these genes 
have not been found yet [9]. 
Several methods have been carried out for strain improvement in Pleurotus including 
selection, hybridization and gene transformation [11-14]. However, based on current 
legislation (European Directive 2001/18/CE), genetic transformation and mutagenic 
treatments produce strains not suitable for “natural or safe processes”. Therefore, the 
construction of genetically modified organisms can not be chosen to improve the 
addressed quality of the fungus, and breeding should be based on classical genetic 
approaches. This technique is based on the mating of two monokaryotic compatible 
strains, whose hyphae are able to fuse and give rise to a dikaryotic mycelium in 
which the two parental nuclei remain independent [13, 14]. Production of 
tmonokaryotic strain, germinating from uninucleate basidiospores, is achieved when 
the fungus enters into the reproductive phase triggering basidiocarp formation: during 
basidia formation, karyogamy takes place immediately before the onset of the 
meiosis, giving rise to four uninucleate basidiospores. At this stage, genetic 
recombination occur, although some reports have also suggested the occurrence of 
parasexual somatic recombination in higher basidiomycetes [15]. As a fact, dykariotic 
strains derived from single spore germinating monokaryons could result in improved 
specific multifactorial traits like mycelium growth, colony fitness and protein 
expression or secretion.  
Chaudhary et al. [16] developed single spore isolates from the white-rot fungi 
Pleurotus djamor, P. ostreatus var. florida, Pleurotus citrinopileatus and Hypsizygus 
ulmarius. The hybrids showed improved mycelial growth rate compared to that of the 
parental strains. In another work, Sawashe and Sawant [17] developed hybrid 
cultures which required a significantly shorter period for spawn run as compared to 
the parent species. In the frame of improvement of quantity and variability of 
enzymatic expression, selection of new hybrid strains for laccase production could be 
viewed as a solution to make the entire process cost effective. Till now only few data 
in literature have been reported to improve laccase production by classical breeding 
in P. ostreatus [18]. To the best of our knowledge, increasing of extracellular laccase 
activities have ever been not correlated to the production of phenoloxidase 
isoenzymes, previously unexpressed.   
In the present work, improvement of different strains of P. ostreatus obtained by 
classical breeding and screening for their laccase productivity has been performed. 
The obtained dikaryotic strains, in according to European legislation, are considered 
generally recognized as safe (GRAS) and therefore they could be good candidates 
for their use in bioproduction as natural strains. We have performed dikaryotization 
through crossing of characterized basidiospore-derived monokaryons of two P. 
ostreatus variants in order to increase the trite and the expressed pattern of laccase 
isoenzymes.  
 
Materials and methods 
Substrates and chemicals 
Unless otherwise specified, all substrates and chemicals were purchased from 
Sigma-Aldrich. 
 
Organism  
All P. ostreatus monokariotyc and dikaryotic strains were maintained through periodic 
serial transfers and kept at 4°C on agar plates in the presence of 2.4% potato 
dextrose and 0.5% yeast extract (PDY) (Difco).  
 
Culture conditions 
Shacked submerged cultivation was carried out in 100 ml Erlenmeyer flasks (125 
rpm) containing 30 ml of PDY supplemented with copper sulphate (final 
concentration 150 μM) and ferulic acid 2 mM (dissolved in ethanol and added at the 
second day of growth). The flasks were inoculated with four agar plugs (8 mm 
diameter) cut from the actively growing part of the colony on a Petri dish and 
incubated for at least 15 days at 28° C in the dark.  
 
Fructification and basidiospores isolation 
P. ostretus mushrooms were cultivated in 500 mL flasks containing 400 g of wheat-
straw (65% water content), which were twice autoclaved for 1 h at 121 °C separated 
by a period of 24 h at room temperature. Each flask was inoculated with four agar 
plug (13 mm diameter), and left to grow at 28 °C for 30 days in the dark. Fructification 
was promoted by opening the jars, and placing them in presence of daylight in a 
chamber at 15±5 °C and 90% relative humidity. Primordia appeared after a further 15 
days of growth, and basidiocarps were harvested 7 days later and weighed [10]. 
P. ostreatus basidiospores were collected by sporal print on a glass Petri dish, 
previously sterilised in autoclave (1 h at 121°C). A fresh healthy fruit body of P. 
ostreatus was attached to the cap by eukit® resin under aseptic conditions in such a 
way that the gills of the fruit body were facing underneath. After 24 h, the lid was 
removed from the top of the Petri dish holding the spore print.  
A spore suspension was prepared in 1 mL of sterile physiological salt solution (0.9% 
NaCl). Sporal concentration was estimated by counting them in a Thoma chamber on 
optical microscopy. The basidiospores suspension was plated on PDY solid medium 
in Petri dishes after appropriate dilution to obtain distinct monosporic colonies and 
incubated at 28°C. Colonies formed were transferred onto agar slants and tested for 
production of ligninolytic enzymes. 
 
 
Mating test 
Small pieces of mycelium of two monokaryons (agar plugs 5 mm diameter) were 
inoculated close to each other on 2% malt extract (Difco) agar plates; after 5–7 days 
growth the presence of clamp connections, in the interaction zone was checked 
microscopically. 
 
Enzyme assays 
Phenol-oxidase activity was assayed at 25°C using 2,2‟ –azinobis-(3-
ethylbenzothiazoline-6-sulfonic acid) (ABTS) as substrate [19]. The assay mixture 
contained 2 mM ABTS and 0.1 M sodium-citrate buffer, pH 3.0. Oxidation of ABTS 
was followed by absorbance increase at 420 nm (ε = 36,000 M-1 cm-1) for 1 minute. 
Enzyme activity was expressed in IU. 
Enzyme activity was measured in the filtrates from four parallel flasks after removing 
the mycelia. All measurements were repeated at least in triplicate. 
 
Native polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis (PAGE) was carried out at alkaline pH under non 
denaturing conditions. The resolving and stacking gels contained 9% and 4% 
acrylamide, respectively. The buffer solution used for the resolving gel contained 50 
mM Tris-HCl (pH 9.5), and the buffer solution used for the stacking gel contained 18 
mM Tris-HCl (pH 7.5). The electrode reservoir solution contained 25 mM Tris and 
190 mM glycine (pH 8.4). Gels were stained to visualize laccase activity by using 
ABTS as substrate, in 0.1M sodium citrate buffer pH3.0. Samples containing 0.015 
laccase unities were loaded on each lane.  
 
Laccase isoenzyme fractionation 
Ultra-filtrated protein samples were analyzed against 50mM Tris–HCl and were 
loaded on a Resource Q (GE Healthcare 1mL) column equilibrated with the same 
buffer. The column was washed at a flow rate of 1 ml/min with 3 column volume (cv)  
of buffer, and a 0–0.5 M NaCl linear gradient (20 cv) was applied. Fractions 
containing laccase activity were pooled and concentrated. 
 
Protein identification by mass spectrometry 
Protein band corresponding to the laccase of interest was excised from the native 
gel. Slices of interest were destained by washes with 0.1 M NH4HCO3 pH 7.5 and 
acetonitrile, reduced for 45 minutes with 100 μl of 10 mM dithiothreitol in 0.1 M 
NH4HCO3 buffer pH 7.5 and carboxyamidomethylated for 30 minutes in the dark with 
100 μl of 55 mM iodoacetamide in the same buffer. Tryptic digestion was performed 
by adding for each slice 100 ng of enzyme in 10 μl of 10 mM NH4HCO3 pH 7.5 for 2 
hours at 4 °C. The buffer solution was then removed and were added 50 μl of 10 mM 
NH4HCO3 pH 7.5 for 18 hours at 37 °C. Peptides were extracted by washing the gel 
slices with 10 mM NH4HCO3 and 1% formic acid in 50% acetonitrile at room 
temperature. 
The peptide mixtures were filtered by using 0.22 μm PVDF membrane (Millipore) and 
analysed using a 6520 Accurate-Mass Q-TOF LC/MS System (Agilent Technologies, 
Palo Alto, CA) equipped with a 1200 HPLC system and a chip cube (Agilent 
Technologies). After loading, the peptide mixture was first concentrated and washed 
in 40 nL enrichment column (Agilent Technologies chip), with 0.1% formic acid in 2% 
acetonitrile as the eluent. The sample was then fractionated on a C18 reverse –
phase capillary column (Agilent Technologies chip) at flow rate of 400nl/min, with a 
linear gradient of eluent B (0.1% formic acid in 95% acetonitrile) in A (0.1% formic 
acid in 2% acetonitrile) from 7 to 80% in 50 min. Peptide analysis was performed 
using data - dependent acquisition of one MS scan (mass range from 300 to 180 0 
m/z) followed by MS/MS scans of the five most abundant ions in each MS scan. 
Dynamic exclusion was used to acquire a more complete survey of the peptides by 
automatic recognition and temporary exclusion (0.5 min) of ions from which definitive 
mass spectral data had previously acquired. Nitrogen at a flow rate of 3 L/min and 
heated to 325°C was used as the dry gas for spray desolvation. MS/MS spectra were 
measured automatically when the MS signal surpassed the threshold of 50000 
counts. Double and triple charged ions were preferably isolated and fragmented over 
single charged ions. The acquired MS/MS spectra were transformed in mz.data 
format and used for proteins identification with a licensed version of MASCOT 2.1 
(Matrix Science, Boston, USA). Raw data from nanoLC–MS/MS analyses were used 
to query the P. ostreatus database and the Mascot search parameters were: trypsin 
as enzyme, allowed number of missed cleavage 3, carbamidomethyl as fixed 
modification, oxidation of methionine, pyro-Glu N-term Q, as variable modifications, 
10 ppm MS tolerance and 0.6 Da MS/MS tolerance, peptide charge, from +2 to +3. 
Individual ions scores >32 indicate identify or extensive homology (p<0.005). Protein 
scores are derived automatically by MASCOT  Software from ions scores as non-
probabilistic for ranking protein hits.   
 
Analysis of protein sequence  
The predicted protein sequence of newly identified laccase POX1 was analyzed by 
comparison with those of the previously defined Pleurotus ostreatus laccases. 
Alignments of amino-acidic sequences were generated with ClustalW2 
(http://www.ebi ac.uk/Tools/clustalaw2/index.html). Signal peptide was predicted with 
SignalP V2.0 (http://www.cbs.dtu.dk/services/). The amino-acid conservation scoring 
among the laccase signature sequences was performed by PRALINE 
(http://www.ibi.vu.nl/programs/pralinewww/). 
 
 
Results  
Production of P. ostreatus monokaryotic strains 
Two varieties of the fungus P. ostreatus, var. florida (ATCC MYA-2306) and var. 
ostreatus (D1208), have been used as parental dikaryotic strains. The two varieties 
show different morphological and physiological features like size, temperature 
tolerance, colour, etc., and have been previously extensively characterized for their 
ability to produce oxidative enzymes [9, 20, 21],  hydrophobins [22, 23], and natural 
compounds [24]. In order to produce new dikaryotic hybrids with increased 
production capabilities, basidiospores-derived monokaryons, obtained from each 
variety, have been isolated and analysed. Collected spores from the two different 
basidiocarps were successfully germinated in solid medium. Microcolonies progeny 
was microscopically analyzed and monokaryotic state was confirmed by the absence 
of mycelial clamp connections, as reported by Eichlerov´a I. and Homolka L. [18]. 
Isolated monokaryons (marked “A” and “D”, for strains derived from the parental 
dikaryons ATCC MYA2306 and D1208, respectively) were inoculated in PDY 
submerged culture in order to detect laccase activity during fungal fermentation. Time 
courses analysis of extracellular laccase activities showed high variability among the 
strains and a maximum of production between the 9th and the 10th day of growth. 
Among twenty-eight randomly chosen germinating spores, three monokaryons (5A, 
6A, 18A) from the parental strain P. florida and three monokaryons (3D, 9D, 11D) 
from the parental strain P. ostreatus exhibit higher or comparable production levels 
than the two parental strains. Corresponding data are reported in table.1 (a) and (b), 
derived from three independent experiments and the mean values were taken. The 
standard deviation for the experiments was less than ±10%. As also reported by 
Eichlerov´a and Homolka [18], the isolates differ also in morphology and growth rate 
when they grew on solid media. However, these colony appearances were transient 
and, in general, not connected with laccase production levels. 
Isoenzymatic pattern analyses were performed on the samples derived from 
extracellular medium of monokaryotic fungal cultures. Native PAGE of laccase 
isoenzymes stained for laccase activity were carried out and the identity of the 
laccase isoenzymes was ascertained on the basis of the different electophoretic 
mobility. Analysis of samples withdrawn from the media at different growth times 
showed that the activity is associated mainly to the production of three isoenzymes 
POXA1b, POXA3, and POXC, [9] as reported in figure 1. 
Moreover, the monokaryon 6A secretes a new isoform, previously never identified 
(figure 1). When the protein band, corresponding to the new laccase was excised 
and analyzed by tandem mass spectrometry, 5 peptide (sequence coverage, 20%; 
protein summary score, 286) could unambiguously be identified. P. ostreatus 
database search with the raw MS/MS data identified the protein encoded by the 
predicted laccase transcript POX1. The cDNA of this „new‟ native laccase was 
previously isolated [25], but the corresponding produced protein in an active form 
was not identified yet. 
 
Dikaryotization of P. ostreatus generated by classical crossing 
Because laccase production is regulated by multifactorial and mutiallelic expression 
systems which are dependent on extra- and intra-cellular regulations [13, 14, 26, 27], 
all crossings among the six monokaryotic strains were performed in order to obtain 
new high laccase-producers dikaryotic strains (table 2). Anastomosis induction 
followed by formation of clamp connections (figure 2) was confirmed microscopically 
at ×45 magnification, indicating that compatibility among two strains and subsequent 
formation of the corresponding dykarion.   
New dikaryotic hybrids derived from the two parental strains were obtained through 
crossing of selected strains, excepting 5AX9D, that results incompatible. Time course 
analysis on laccase activity produced by the new dikaryotic strains grown in 
submerged cultures were perfomed. Six out of the eight dikaryons produced a higher 
amount of laccase activity. Moreover, three of them (5AxD3, 5AxD11 and 6AxD11) 
reached a production level of up to 70,000 U/L (figure 3), and were chosen for further 
investigations. 
Effect of ferulic acid inducer [28] on the selected dikaryotic hybrids 5AxD3, 5AxD11 
and 6AxD11 was also analyzed. Addition of the inducer to the culture broth positively 
affects extracellular laccase activity of the analyzed strains. Nevertheless, results 
indicate that hybrids differentially responded to the inducer presence (figure 4). As a 
fact, all the selected hybrids were more sensitive to the presence of ferulic acid than 
the parental strains. Moreover, the 5AXD3 strain resulted the best laccase producer 
also in inducing conditions, reaching a laccase expression of up to 110,000 U/L. 
 
Laccase fractionation  
Time course of the isoenzymatic pattern of the selected dikaryons was performed 
analyzing the extracellular medium of fungal culture by native PAGE stained for 
laccase activity. Analysis of samples withdrawn from the media at different growth 
times confirmed the presence of the three isoenzymes POXA1b, POXA3, and POXC, 
as reported above for the corresponding monokaryotic parents, either in the 
presence or in the absence of inducer.   
Furthermore, the strain 6AxD11, in both conditions, secretes the new isoform POX1, 
previously detected in the monokaryotic parental strain 6A. Relative quantification of 
laccase isoenzymes, in basal conditions, were also carried out in correspondence of 
laccase activity peak (9th day). Fungal cultures were harvested and fractionated by 
anionic exchange chromatography ResourceQ (table 3). The fractions were pooled, 
concentrated, assayed and analyzed by electrophoretic separation on native PAGE 
gels stained for laccase activity. The extracellular enzyme mixtures of the strains 
5AxD3 and 5AxD11 were showed to contain POXA3 and POXC isoenzymes, the 
latter being the most abundant (> 90%). Performing the same analysis on the 
isoenzymatic pattern of 6AxD11, POXA1b laccase and a significant production of 
POX1 were also detected (35% relative abundance).  
 
Discussion  
Laccase enzymes exhibit an extraordinary range of natural substrates (phenols, 
anilines, inorganic/organic metal compounds, etc) which is the major reason of their 
attractiveness for several biotechnological applications [29].  More than one laccase 
isoenzyme, either constitutive or inducible, has been detected in most white-rot fungi 
[3, 30]. Nevertheless, constitutive extracellular phenoloxidase from basidiomycetes 
are produced only in small amounts. In according to Galhaup et al. [31], one of the 
major limitations for the large-scale industrial applications of fungal laccases is the 
low production yields by both wild type and recombinant fungal strains and, as 
consequence, the high costs for enzyme production [32, 33]. To successfully utilize 
laccases in industrial applications, the production of large quantities of enzyme at low 
cost is required, and therefore, any attempt to increase their production from 
microbial sources could be of considerable interest. 
In our study improvement of P. ostreatus laccase production was achieved by 
classical breeding. In particular, basidiospores-derived monokaryons, obtained from 
P. ostreatus var. florida and var. ostreatus, were isolated and analyzed. Crossing 
were performed in order to produce hybrids with favourable cultural characteristics, 
applicable in large-scale production. 
Comparison of the morphological characteristics and laccase levels production of the 
randomly isolated monokaryons indicated a significantly high genetic variation. The 
surprisingly high variability between monokaryotic strains for the laccase production 
may indicate an heterozygosity in genes responsible for the synthesis and secretion 
of the analyzed enzymes [18]. 
Moreover, isoenzymatic variety was deeply investigated and a novel laccase protein 
was identified in one of the selected monokaryotic strains, undetectable in parental 
dykarion P. florida. The new laccase protein was unambiguously identified as POX1 
through MS/MS analysis and querying of the P. ostreatus genome data bank. 
Discovery of POX1 proves the production of a functional protein by the related 
encoding transcript, previously identified by Giardina et al. [25]. The new isoenzyme 
POX1 was also expressed by one of the selected dikaryotic strains, the 6AxD11, 
either in basal and inductive analyzed conditions. Not surprisingly, the 6A phenotype 
related to the laccase expression resulted co-dominant in the corresponding 
dikayriotic strain 6AxD11. As a fact, during P. ostreatus dikaryotization process and 
dikaryotic mitotic division, the two parental nuclei remain independent and probably 
silencing on the homologous loci coding for laccase enzymes does not occur [34].   
All compatible crossings were performed and allowed the identification and 
characterization of three new high laccase producer P. ostreatus strains. Laccase 
production levels of the dikaryotic hybrids increased up to 4 folds respect to the 
maximum level of dikaryotic parents. The extraordinary enhanced laccase activity in 
dikaryotic strains (hybrid of high-yielding monokaryons), as well as certain 
physiological differences, may be due to genetic recombination effects, occurred 
during basidia formation [15].  
As well as reported by Chaudhary et al. [16] and Sawashe and Sawant [17], results 
indicate that classical breeding is an useful method for obtaining isolates with 
interesting combination of enzyme and growth characteristics without inducing 
physics or chemical mutagenization. The classical natural method of hybrid 
preparation represents a considerable advantage in comparison with the other 
common methods (e.g. mutagenization), because undesirable side-effects (e.g. 
pleiotropic) can be avoided. In addition, new generated dikaryotic strains, in 
according with current legislation (European Directive 2001/18/CE) are still 
considered as GRAS and thus could be good candidates for their use in 
bioprocesses as natural strains.  
This study also extends recent reports [9, 10] that demonstrated the production of 
multiple laccase isoforms in the basidiomycete white rot fungus P. ostreatus, 
enlarging the assortment of these industrially useful enzymes. Further investigations 
will reveal the peculiar molecular aspects and the biochemical properties of POX1 
laccase.  
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Table 1: Maximum laccase production of basidiospore-derived monokaryons: (a) 
monokaryons A from parental strain P.ostreatus MYA-2306; (b) monokaryons D from 
parental strain P.ostreatus D1208 
 (a)                                                                         (b) 
Strain Activity (U/mL ) 
    9
th
  day 
Parental strain 
MYA-2306 
17.3 
1A 1 
2A 3.36 
3A 2.6 
4A 2.44 
5A 36.6 
6A 17.10 
7A 17.11 
8A 7.33 
9A 3.18 
11A 9.17 
13A 2.66 
15A 12.5 
17A 2.08 
18A 26.3 
 
    
Table 2: Compatibility tables of selected higher laccase producers monokaryons: A X D 
crossing  
Strain 3D 9D 11D 
5A + + + 
6A + + + 
18A + - + 
 
 
 
Table 3: Laccase isoenzymes produced by dikaryotic hybrids cultures. Fractionation 
was performed by anionic exchange chromatography ResourceQ. Relative 
quantification of laccase isoenzymes were carried out in correspondence of laccase 
activity peak (9
th
 day), in basal condition. 
 
Strains Activity U/L (day) Isoenzymatic  
5AxD3 
 
47,000 ±18,000 (9) 
 
POXA3 <1% 
POXC 99% 
 
 
6AxD11 
 
 
 
53,000 ± 13,000 (9) 
POXA1b 2% 
POXA3 15% 
POXC 48% 
POX1 35% 
Strain Activity (U/mL ) 
    9
th
  day 
Parental strain 
D1208 
15.8 
D1 0.65 
D2 4.2 
D3 5.1 
D4 0.015 
D5 0.03 
D6 3.3 
D7 1.3 
D8 1.02 
D9 16.6 
D10 1.21 
D11 7.8 
D12 0.83 
D13 1.49 
D14 0.38 
D15 2.62 
5AxD11 
 
45,000 ± 8,000 (9) 
 
POXA3 2,2% 
POXC 97,8% 
Parentale 
 
17,000 ± 2,000 (9) 
POXA3 20% 
POXC 80% 
 
 
 
 
                
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1: Zymograms of laccase isoenzymes produced by the selected monokaryotic 
strains in PDY culture broth. Samples containing 0.015 U of laccase activity collected in 
the day of maximum production (9
th
 days) were used. Known laccase isoforms POXA1b, 
POXA3 and POXC were loaded as standards. (b) Zoom of POX1 laccase identified in 
the monokaryotic strain 6A. 
 
 
 
 
  
 
 
 
 
 
 
 
  
Figure 2: (A) P. ostreatus monokaryotic hyphae observed on optical microscope (×45 
magnification); (B) P. ostreatus dikaryotic hyphae having clamp connections. Clamp 
structure is highlighted in red.  
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Figure 3: Time course analysis on extracellular laccase activity produced by dikaryotic 
strains, in basal condition (PDY+150 µMCuSO4).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Time course analysis on extracellular laccase activity produced by dikaryotic 
strains, in addiction of ferulic acid (2mM final concentration).  
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a b s t r a c t
Laccases (benzenediol:oxygen oxidoreductases, EC 1.10.3.2) are blue multicopper oxidases,
catalyzing the oxidation of an array of aromatic substrates concomitantly with the reduc-
tion of molecular oxygen to water. Most of the known laccases have fungal or plant origins,
although few laccases have been also identified in bacteria and insects. Most of the fungal
laccases reported thus far are extra-cellular enzymes, whereas only few enzymes from
fruiting bodies have been described so far. Multiple isoforms of laccases are usually se-
creted by each fungus depending on species and environmental conditions. As a fact, a lac-
case gene family has been demonstrated in the white-rot fungus Pleurotus ostreatus.
This work allowed identification and characterization of the first laccase isoenzyme from
the fruiting body of P. ostreatus. Discovery through mass spectrometry of LACC12 proves
the expression of a functional protein by the related deduced encoding transcript. The to-
pology of phylogenetic tree of fungal laccases proves that LACC12 falls in cluster with the
members of P. ostreatus LACC10 (¼POXC) subfamily, although lacc12 deduced introneexon
structure differs from that of the subfamily members and the related locus is located in
a different chromosome. Results show that the evolutionary pattern of lacc12 and that of
the other laccase isozyme genes may have evolved independently, possibly through dupli-
cationedivergence events.
The reported data add a new piece to the knowledge about P. ostreatus laccase multigene
family and shed light on the role(s) played by individual laccase isoforms in P. ostreatus.
ª 2010 The British Mycological Society. Published by Elsevier Ltd. All rights reserved.
Introduction
Laccase is one of the very few enzymes that have been studied
since the end of 19th century. It was first identified in the exu-
dates of Rhus vernicifera, the Japanese lacquer tree (Yoshida
1883). A few years later its presence was also demonstrated
in fungi (Bertrand 1896). Laccases are thought to be nearly
ubiquitous among fungi, and their presence has been
documented in virtually every fungus examined thus far
(Mayer & Staples 2002). More recently, proteins with features
typical of laccases have been identified in insects (Dittmer
et al. 2004) and prokaryotes (Claus 2003).
Laccases are multicopper-containing enzymes belonging
to the group of blue oxidases, along with ascorbic oxidases
and ceruloplasmins (Giardina et al. 2010). These enzymes
are being increasingly evaluated for a variety of
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biotechnological applications due to their broad substrate
range. The catalysis carried out by all members of this family
is guaranteed by the presence of different copper centres. In
particular, all blue multicopper oxidases (MCOs) are charac-
terized by the presence of one type-1 (T1) copper, together
with at least three additional copper ions: one type-2 (T2)
and two type-3 (T3) copper ions, arranged in a trinuclear
cluster.
Fungal laccases have been associated with delignification
(Baldrian 2004), fruiting body structuring (Chen et al. 2004), pig-
ment formation during asexual development (Tsai et al. 1999),
and pathogenesis (Litvintseva & Henson 2002; Missal et al.
2005). Themajority of fungal laccases are extra-cellularmono-
meric globular proteins of approximately 60e70 kDa with
acidic isoelectric point (pI) around pH 4.0; they are generally
glycosylated, with an extent of glycosylation ranging between
10 % and 25 % and only in a few cases higher than 30 %
(Giardina et al. 2010). As a fact, to the best of our knowledge,
among fungal laccases characterized thus far, only few of
them have been reported as enzymes specifically purified
from fruiting bodies. Laccases have been isolated from fruiting
bodies of Lentinula edodes (Nagai et al. 2003), Cantharellus cibar-
ius (Ng & Wang 2004), Hericium erinaceum (Wang & Ng 2004a),
Albatrella dispansum (Wang & Ng 2004b), Tricholoma giganteum
(Wang & Ng 2004c), Ganoderma lucidum (Wang & Ng 2006a),
Pleurotus eryngii (Wang & Ng 2006b), Pleurotus cornucopiae
(Wong et al. 2009), and Ganoderma sp. MK05 (Khammuang &
Sarnthima 2009).
Many fungi produce several laccase isoenzymes
endowed with different catalytic properties, being the phys-
iological significance of this multiplicity still unknown. Like-
wise, fungi belonging to Pleurotus genera display this feature
(Giardina et al. 2010). As a fact, four laccase gene members
have already been isolated in Pleurotus sajior-caju (Soden &
Dobson 2001), two in P. eryngii (Rodrı´guez et al. 2008), and
seven in Pleurotus ostreatus (Pezzella et al. 2009). In this latter
fungus, the existence of a “laccase subfamily” consisting of
three members has been postulated, based on sequence
similarity, and introneexon structure. Furthermore, a care-
ful investigation of the recently released genome of this
fungus by the DOE e Joint Genome Institute (http://
www.jgi.doe.gov/sequencing/why/50009.html, DOE e JGI)
suggested an even more complex MCO family. New genes,
putatively coding for previously uncharacterized laccases,
have been identified, enriching the panel up to 12 members
(unpublished data).
In this work the identification of a new laccase isoenzyme
from the fruiting body of the white-rot fungus P. ostreatus has
been achieved through the detection of six tryptic peptides by
mass spectrometry. The identity of the functional laccase
protein has been confirmed with the translated genomic
sequence of P. ostreatus laccases.
Experimental/materials and methods
Organism and culture conditions
White-rot fungus Pleurotus ostreatus (type: Florida ATCC no.
MYA-2306) was maintained through periodic transfer at 4 C
on potato dextrose agar plates (Difco) in the presence of
0.5 % yeast extract (Difco). Inoculum for liquid culture
was prepared by pre-inoculating 300 mL of PDY broth in
a shaken flask with P. ostreatus mycelia at 28 C. Then, 50 mL
of a 5-d-old culture was transferred to 1-L flasks containing
450 mL of PDY broth, supplemented with different inducer
(150 mM CuSO4, 1 mM vanillic acid dissolved in ethanol, and
2 mM ferulic acid dissolved in ethanol and added at the sec-
ond day of growth). Cultures were incubated in the dark at
28 C on a rotary shaker at 120 rpm.
Fruiting body production
Pleurotus ostreatus mushrooms were cultivated in 500 mL jars
containing 400 g of wheat-straw (65 % water content), which
were twice autoclaved for 1 h at 121 C separated by a period
of 24 h at room temperature. Each jar was inoculated with
four agar plugs (13 mm diameter), and left to grow at 28 C
for 30 d in the dark. Fructification were promoted by opening
the jars, and placing them in presence of daylight in a chamber
at 15 5 C and 90 % relative humidity. Primordia appeared af-
ter a further 15 d of growth, and basidiocarps were harvested
7 d later and weighed.
Laccase extraction
Total extracts from the mycelium of Pleurotus ostreatus grown
on wheat-straw were prepared as follows: lyophilized cells
were ground in a mortar with a pestle. The ground material
was resuspended in cold extraction buffer (200 mM TriseHCl
pH 8, 400 mM (NH4)2SO4, 10 mMMgCl2, 1 mM EDTA, 10 % glyc-
erol, 1 mMphenylmethanesulphonylfluoride (PMSF)) followed
by centrifugation at 4 C for 1 h at 13000g.
Fungal proteinswere extracted by homogenizing P. ostreatus
fruiting bodies in a Waring blender in the presence of 50mM
sodium phosphate buffer (pH 6.5) containing 1 mM PMSF.
Laccase purification
Fungal proteins extracted by fruiting bodies were centrifuged
at 13000g for 30 min at 4 C, and the supernatant was filtered
through cheesecloth. Proteinswere precipitated by addition of
(NH4)2SO4 up to 80 % saturation at 4 C and centrifuged at
10000g for 40 min. The ammonium sulphate precipitate
was resuspended in 50 mM sodium phosphate (pH 6.5) and af-
ter extensive dialysis against the same buffer was loaded onto
a Hi Trap DEAE Fast Flow column (GE Healthcare) in a fast pro-
tein liquid chromatography system (AKTA Explorer, Amer-
sham Biosciences). Four fractions containing laccase activity
were recovered with the equilibrating buffer and during the
linear gradient from 0 to 0.4 M NaCl. They were separately
pooled, concentrated and desalted on an Amicon PM-10mem-
brane. Fraction 3 was equilibrated in 50 mM TriseHCl pH 8.0
and loaded onto an anion exchange Resource Q column
(Amersham Biosciences) equilibrated with the same buffer.
Three fractions containing laccase activity were recovered
during the linear gradient from0 to 0.4 MNaCl. Theywere sep-
arately pooled, concentrated and desalted on an Amicon
PM-10 membrane.
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Protein determination
Protein concentration was determined using the Bio-Rad
protein assay with bovine serum albumin as standard.
Assay of laccase activity
Phenol-oxidase activity was assayed at 25 C using 2,2-azi-
nobis-(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS),
2,6-dimethoxyphenol (DMP) and syringaldazine as sub-
strates, in the condition previously optimized (Palmieri
et al. 1997) as below indicated.
The assaymixture contained 2 mMABTS and 0.1 M sodium
citrate buffer, pH 3.0. Oxidation of ABTS was followed by ab-
sorbance increase at 420 nm (3¼ 36 000 M1 cm1). The assay
mixture contained 1 mM DMP and the McIlvaine’s buffer ad-
justed to pH 5.0. Oxidation of DMP was followed by an absor-
bance increase at 477 nm (3¼ 14 800 M1 cm1). The assay
mixture contained 0.5 mM syringaldazine (dissolved in meth-
anol) and 50 mM phosphate buffer, pH 6.0 Oxidation of syrin-
galdazine was followed by an absorbance increase at 525 nm
(3¼ 65000 M1 cm1). Enzyme activity was expressed in IU.
KM were calculated assaying laccase activity in these condi-
tions by nonlinear regression fitting with the GraphPad Prism
version 3.00 for Windows, GraphPad Software, San Diego, CA,
USA (www.graphpad.com).
Native polyacrylamide gel electrophoresis
Polyacrylamide gel electrophoresis (PAGE)was performed at al-
kaline pH under non-denaturing conditions. The resolving and
stacking gels were, respectively, at 9 and 4 % acrylamide, corre-
sponding buffer solutions were 50 mM TriseHCl (pH 9.5) and
18mM TriseHCl (pH 7.5) respectively. The electrode reservoir
solution was 25mM Tris, 190 mM glycine, pH 8.4. Gels were
stained for laccase activity using ABTS as substrate. Samples
containing 0.015 laccase unities were loaded on each lane.
Protein identification by mass spectrometry
Protein band corresponding to the laccase of interest was ex-
cised from the native gel. Slices were destained by washes
with 0.1 M NH4HCO3 pH 7.5 and acetonitrile, reduced for
45 min with 100 mL of 10 mM dithiothreitol in 0.1 M NH4HCO3
buffer pH 7.5 and carboxyamidomethylated for 30 min in the
dark with 100 mL of 55 mM iodoacetamide in the same buffer.
Tryptic digestion was performed by adding for each slice
100 ng of enzyme in 10 mL of 10 mM NH4HCO3 pH 7.5 for 2 h
at 4 C. The buffer solution was then removed and 50 mL of
10 mM NH4HCO3 pH 7.5 were added for 18 h at 37 C. Peptides
were extracted bywashing the gel sliceswith 10 mMNH4HCO3
and 1 % formic acid in 50 % acetonitrile at room temperature.
The peptide mixtures were filtered by using 0.22 mm PVDF
membrane (Millipore) and analyzed using a 6520 Accurate-
Mass Q-TOF LC/MS System (Agilent Technologies, Palo Alto,
CA) equippedwith a 1200HPLC systemanda chip cube (Agilent
Technologies). After loading, the peptide mixture was first
concentrated and washed in 40 nL enrichment column (Agi-
lent Technologies chip), with 0.1 % formic acid in 2 % acetoni-
trile as the eluent. The sample was then fractionated on a C18
reverse-phase capillary column (Agilent Technologies chip) at
flow rate of 400 nL/min,with a linear gradient of eluent B (0.1 %
formic acid in 95 % acetonitrile) in A (0.1 % formic acid in 2 %
acetonitrile) from 7 % to 80 % in 50 min. Peptide analysis was
performed using data-dependent acquisition of one MS scan
(mass range from 300 to 1800 m/z) followed by MS/MS scans
of the five most abundant ions in each MS scan. Dynamic ex-
clusionwasused to acquireamorecomplete surveyof thepep-
tides by automatic recognition and temporary exclusion
(0.5 min) of ions from which definitive mass spectral data
had previously acquired. Nitrogen at a flow rate of 3 L/min
and heated to 325 Cwas used as the dry gas for spray desolva-
tion. MS/MS spectra were measured automatically when the
MS signal surpassed the threshold of 50000 counts. Double
and triple charged ions were preferably isolated and frag-
mented over single charged ions. The acquired MS/MS spectra
were transformed in mz.data format and used for proteins
identification with a licensed version of MASCOT 2.1 (Matrix
Science, Boston, USA). Raw data from nanoLCeMS/MS analy-
ses were used to query the Pleurotus ostreatus database (Filtered
Models (“best”) Proteins: PleosPC15_1_GeneModels_Filtered
Models5_aa.fasta.gz e http://genome.jgi-psf.org/PleosPC15_1/
PleosPC15_1.download.ftp.html) and the Mascot search pa-
rameters were: trypsin as enzyme, allowed number of missed
cleavage 3, carbamidomethyl as fixed modification, oxidation
of methionine, pyro-Glu N-term Q, as variable modifications,
10 ppm MS tolerance and 0.6 Da MS/MS tolerance, peptide
charge, from þ2 to þ3. Individual ions scores >32 indicate
identity or extensive homology ( p< 0.05). Protein scores are
derived automatically by MASCOT Software from ions scores
as a non-probabilistic basis for ranking protein hits.
Analysis of protein sequence
The predicted protein sequence of newly identified laccase
LACC12 was analyzed by comparison with those of the previ-
ously defined Pleurotus ostreatus laccases. Alignments of
amino-acidic sequences were generated with ClustalW2
(http://www.ebi.ac.uk/Tools/clustalw2/index.html). Signal
peptide was predicted with SignalP V2.0 (http://
www.cbs.dtu.dk/services/). The amino-acid conservation
scoringamong the laccasesignaturesequenceswasperformed
by PRALINE (http://www.ibi.vu.nl/programs/pralinewww/).
Phylogenetic analysis
Phylogenetic analysis was carried out on Pleurotus ostreatus
laccases using basidiomycete laccase sequences reported in
Hoegger et al. (2006) and more recently released laccase
sequences. The sequences were aligned with ClustalW using
default settings for multiple sequence alignments. Based on
this alignment, a Neighbour Joining tree was constructed us-
ing MEGA version 4 (Tamura et al. 2007). Bootstrapping was
carried out with 1000 replications.
Results
Whole proteins extracted from fruiting bodies were analyzed
by native electrophoresis gel and four laccase isoforms could
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be identified. Besides the already studied laccases (LACC10,
LACC6 (¼POXA1b) and LACC2 (¼POXA3)) (Palmieri et al.
2003), one new isoform, exclusively present in fruiting body
extract, was also detected (Fig 1A, lane 8).
In order to characterize this new isoform, phenol-oxidases
extracted from fruiting body were successfully separated into
four distinct pools of protein fractions on a DEAE Sepharose
column at pH 6.5. When analyzed by native PAGE, the pool
of active fractions eluted at 0.2 M NaCl included the new iso-
enzyme (Fig 1B, lane 2). This new isoform was then success-
fully separated from LACC10 and LACC2 enzymes by anion
exchange chromatography Resource Q column (Amersham
Biosciences) (Fig 1B, lane 3).
When the protein band, corresponding to the new laccase,
was excised and analyzed by tandem mass spectrometry, six
peptides (sequence coverage, 18 %; protein summary score,
282) could unambiguously be identified. Pleurotus ostreatus da-
tabase search with the raw MS/MS data unambiguously iden-
tified the protein encoded by the predicted laccase transcript
lacc12.
LACC12predictedproteinsequencecontainsN-terminal se-
cretion signal (23 amino-acids), conforms to the typical
sequences of eukaryotic proteins (Nielsen et al. 1997), the con-
served 10 histidine and 1 cysteine residues of the copper-bind-
ing centres of laccases, the fungal laccase signature
sequences L1eL4 (Fig 2A), as defined by Kumar et al. (2003).
Compared to the defined signature sequences, the only rele-
vant substitutions observed in LACC12 are a phenylalanine to
tyrosine change in L1, and a valine to isoleucine change in L4.
Sequence of the substrate binding loops, previously
described for other isoforms of the same family (Pezzella et al.
2009), are not conserved among P. ostreatus proteins (Fig 2B).
The molecular mass of LACC12, predicted from its whole
deduced amino-acid sequence as 55 kDa, was confirmed by
SDS-PAGE followed by Western-blotting analysis (data not
shown).
Kinetic proprieties of LACC12 with respect to three sub-
strates (ABTS, DMP, and syringaldazine) were determined
and compared with those of the other known members of
the P. ostreatus laccase isoenzyme family (Table 1).
Discussion
Pleurotus ostreatus is an active lignin degrader that lives as
a saprophyte on dead or decaying wood (Moncalvo et al.
2002). Within its ligninolytic enzymatic system, 7 members
of the P. ostreatus laccase multigene family have been isolated
and sequenced (Pezzella et al. 2009). Furthermore, up to 12
members of this family have been identified in the recently re-
leased P. ostreatus genome database (unpublished data). How-
ever, the redundancy of laccase genes raises the question
about their respective functions in vivo, and this question is
even more pertinent since cDNAs or proteins for some of
these genes have not been found yet (Pezzella et al. 2009).
Laccases LACC10, LACC6, and LACC2 constitute the typical
isoenzymatic patternexpressedby P. ostreatus in any condition
analyzed thus far (i.e. solid/liquid state, presence of laccase in-
ducers, etc.) (Palmieri et al. 2000; Giardina et al. 2002; Palmieri
et al. 2005). In the present work a new laccase protein was iso-
lated from P. ostreatus fruiting body and unambiguously iden-
tified as LACC12 through MS/MS analysis and querying of the
P. ostreatus genome data bank. Discovery of LACC12 proves
the expression of a functional protein by the related hypothet-
ical encoding transcript. The new laccase isoform LACC12
seems to be exclusively expressed in the fruiting body stage
as we have never detected it in the active mycelium, even
when it is overgrown on the lignocellulosic substrate wheat-
straw (Fig 1A, lanes 1e7). Thus, a specific role for this isoen-
zyme, possibly involved in the development of fruiting body,
may be hypothesized. Indeed, a particular physiological role
in gill browning for the fruiting body laccase LCC4 has been as-
sumed in Lentinula edodes (Nagai et al. 2003). On the other hand,
laccase genes inVolvariella volvacea (Chen et al. 2004) and Lacca-
ria bicolor (Courty et al. 2009) are differentially expressed as
a function of the developmental stage.
LACC12 affinity (KM value) towards typical laccase
substrates follows the rank order syringaldazi-
ne>DMP>ABTS (Table 1). It is almost of the same order of
magnitude respect to those of the other known members of
Fig 1 e A. Zymograms of Pleurotus ostreatus laccase isoen-
zymes. Laccases from mycelium grown in the presence of:
no inducer (lane 1); CuSO4 (lane 2); ferulic acid (lane 3);
CuSO4 and ferulic acid (lane 4); vanillic acid (lane 5); CuSO4
and vanillic acid (lane 6); laccases extracted from the fungus
overgrown on wheat-straw: active mycelium (lane 7); and
fruiting body (lane 8) e B. Zymograms of fruiting body lac-
cases. Ammonium sulphate precipitated (lane 1); fraction
eluted at 0.2 M NaCl from DEAE Sepharose column (lane 2);
laccase after Resource Q column (lane 3). Known laccase
isoforms LACC6, LACC2, and LACC10 are loaded as
standards.
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the family, in agreement with what reported for other known
fungal laccases (Baldrian 2006).
The protein sequence contains all the L1eL4 laccase con-
sensus signatures and can be classified as a laccase in sensu
stricto. LACC12 sequence displays the substitution phenylala-
nine to tyrosine (F97Y), already found in LACC4 (¼POX3)
(Pezzella et al. 2009) and in laccases belonging to Coprinopsis
cinerea subfamily (Kilaru et al. 2006), being this a conserved po-
sition among many basidiomycete laccase sequences. The
substitution of valine to isoleucine in loop 4, present in
LACC12 in position 490, has also been found in the laccase se-
quences of Coprinus cinereus (Ducros et al. 2001), Trametes versi-
color (Piontek et al. 2002) and C. cinerea (Kilaru et al. 2006).
LACC12 shares the highest protein sequence identity (68 %
identity) with a laccase from Cyathus bulleri (ABW75771)
(Salony et al. 2008) and with laccase 2 from C. cinerea
(AAR01243) (Kilaru et al. 2006). As far as P. ostreatus laccase
family is concerned, the new laccase LACC12 shares the high-
est percents of identity with members of LACC10 subfamily
(Pezzella et al. 2009), 68 % with LACC1 (¼POX4), and 67 %
with LACC9 (¼POX1) and LACC10. As a fact, based on Neigh-
bour Joining tree of basidiomycete laccases (Fig 3), LACC12
falls in cluster with the members of P. ostreatus LACC10 sub-
family. On the contrary, this enzyme is more distantly related
to the L. edodes fruiting body laccase LCC4 (Nagai et al. 2003).
Concerning P. ostreatus laccase genes distribution in the ge-
nome, a cluster of 7 out of 12 laccase genes has been recently
mapped by Pe´rez et al. (2009) in the sub-telomeric region of
chromosome VI. The existence of MCO genes clustering has
also been observed in the fungi Phanerochaete chrysosporium
(Larrondo et al. 2004), Agaricus bisporus (Smith et al. 1998), Rhi-
zoctonia solani (Wahleithner et al. 1996) and C. cinerea (Kilaru
et al. 2006). Since sub-telomeric regions are genome areas
where important rearrangements and gene regulation mech-
anisms occur, Pe´rez et al. (2009) suggested an evolutionary re-
lationship among laccases located in this region, permitting
the fungus to adapt rapidly to new lignocellulosic substrates.
While all the members of the LACC10 subfamily lie in the
gene cluster of the sub-telomeric region of chromosome VI,
lacc12 locus is located in a different chromosome (XI) (Antonio
G. Pisabarro, pers. comm.). Moreover, deduced lacc12 gene
structure differs from that of themembers of LACC10 subfam-
ily. Thus, LACC12, specifically expressed in fruiting bodies,
might have evolved independently from the subfamily, possi-
bly through duplicationetransposition events, probably to ful-
fil a key role in basidiocarp development.
This study shows for the first time the identification of
a laccase from the fruiting body of P. ostreatus. The reported
data add a new piece to the knowledge about P. ostreatus lac-
case multigene family. The enzymes e secreted and non-se-
creted forms e even though coming from the same source
A
B
Y
Fig 2 e A. Comparison of the laccase signature sequences from the Pleurotus ostreatus laccases LACC9, LACC10, LACC6,
LACC2, LACC4, and LACC1 with LACC12. The fungal laccase signature sequences (L1eL4) are shown together with the fungal
laccase consensus sequence. The amino-acid conservation scoring is performed by PRALINE (http://www.ibi.vu.nl/programs/
pralinewww/). Residue shading has been applied from scoring 10 (black) to 7 (grey). The Y97 residue in L1 is boxed -
B. Sequence alignment of the potential substrate binding loops of the P. ostreatus laccases. Loops L1 sequence at positions
182e192, B4eB5 at positions 230e235, B7eB8 at positions 288e297, C1eC2 at positions 357e368, C4eC5 at positions 413e421
and C7eC8 at positions 479e488.
Table 1 e Affinity constants of purified LACC12 towards
ABTS, syringaldazine and DMP substrates compared to
those of the other members of the isoenzyme family.
LACC12 LACC10 LACC6 LACC2
KM ABTS (mM) 15 102 3.9 102 47 102 7.4 102
KM DMP (mM) 27 102 0.76 102 38 102 880 102
KM syringaldazine (mM) 5.5 102 2.0 102 22 102 7.9 102
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might not share the same characteristics and/or may play dif-
ferent physiological roles. A further progress towards a more
intelligible picture of the role(s) played by individual laccase
isoforms in P. ostreatus has been attained with this work.
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a b s t r a c t
Bacterial multicomponent monooxygenases (BMMs) are members of a wide family of diiron enzymes
that use molecular oxygen to hydroxylate a variety of aromatic compounds. The presence of genes encod-
ing for accessory proteins not involved in catalysis and whose role is still elusive, is a common feature of
the gene clusters of several BMMs, including phenol hydroxylases and several soluble methane monoox-
ygenases. In this study we have expressed, puriﬁed, and partially characterized the accessory component
PHK of the phenol hydroxylase from Pseudomonas sp. OX1, a bacterium able to degrade several aromatic
compounds. The phenol hydroxylase (ph) gene cluster was expressed in Escherichia coli/JM109 cells in the
absence and in the presence of the phk gene. The presence of the phk gene lead to an increase in the
hydroxylase activity of whole recombinant cells with phenol. PHK was assessed for its ability to interact
with the active hydroxylase complex. Our results show that PHK is neither involved in the catalytic activ-
ity of the phenol hydroxylase complex nor required for the assembly of apo-hydroxylase. Our results sug-
gest instead that this component may be responsible for enhancing iron incorporation into the active site
of the apo-hydroxylase.
 2010 Elsevier Inc. All rights reserved.
Introduction
Aromatic hydrocarbons released in the biosphere by human
activities are today a major threat not only to the environment
but also to human health due to their potential carcinogenicity
[1]. By utilizing various catabolic pathways, microorganisms can
use a wide array of aromatic compounds as the sole carbon and en-
ergy source, thus providing a set of diversiﬁed tools that can be
used in bioremediation of contaminated environments [2,3]. In
aerobic microorganisms, processing of aromatic compounds is ini-
tiated by oxygenases, in the so-called upper pathway [1,2]. These
enzymes are responsible for the insertion of one or more oxygen
atoms in the aromatic rings that, once activated, are further trans-
formed by ring-cleavage dioxygenases that are part of a metabolic
route called lower pathway [1,2]. The resulting products are then
converted into metabolites of the tricarboxylic acid cycle (TCA),
and eventually mineralized to carbon dioxide and water [1–4].
Bacterial multicomponent monooxygenases (BMMs)1 are key
enzymes of the upper pathway and catalyze the hydroxylation of
the aromatic ring at different positions [4,5]. They usually consist
of a 200–250 kDa hydroxylase component organized in a (abc)2 qua-
ternary arrangement, a 10–16 kDa regulatory protein devoid of any
cofactor and enhancing catalytic turnover, and a FAD- and (2Fe-2S)
containing reductase that mediates electron transfer from NADH to
the active site of the hydroxylase [4–6]. An additional Rieske protein
may be present to assist the electron transfer between the reductase
and hydroxylase components [4,7,8]. The hydroxylation chemistry
takes place at a non-heme carboxylate-bridged diiron center coordi-
nated by four glutamate and two histidine residues from a four-helix
bundle [4–6,10]. Although the four-helix bundle motif and the diiron
center are part of a conserved framework probably present in all
BMMs [4,9], these enzymes differ considerably in subunit composition
and dimension, arrangement of the coding sequences, and genomic
localization which can be either chromosomic, or plasmidic [4,11].
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Two different multicomponent monooxygenases, toluene o-xy-
lene monooxygenase (ToMO) and phenol hydroxylase (PH) [12–
20], have been identiﬁed in the genome of Pseudomonas sp. OX1,
a bacterium able to grow on a wide spectrum of hydroxylated
and non-hydroxylated aromatic compounds [12]. PH is a BMM
composed of ﬁve polypeptides: PHL, PHM, PHN, PHO, PHP. These
ﬁve polypeptide chains are organized as three components [20].
PHP is the NADH-oxidoreductase responsible for supplying elec-
trons to the diiron cluster housed in the active site of the hydrox-
ylase component. The hydroxylase comprises three polypeptides
(L, N, O) organized in a quaternary structure of the type (LNO)2. Fi-
nally, PHM has been shown to be a regulatory protein, devoid of
any cofactor or metal, that is essential for efﬁcient catalysis [20].
A comparative analysis of the polypeptide sequences of PH poly-
peptides showed a signiﬁcant degree of identity with the compo-
nents of the multicomponent phenol hydroxylase encoded by the
dmp genes in Pseudomonas sp. CF600 [21–24], and with the constit-
uents of toluene-o-monooxygenase (TOM) from Burkholderia cepa-
cia G4 [25].
When the nucleotide sequence of the ph locus coding for the
multicomponent phenol hydroxylase of Pseudomonas sp. OX1
was ﬁrst determined, its 50 region revealed the presence of a puta-
tive open reading frame (orf) whose deduced amino acid sequence
shared 62.6% identity (74% similarity) to DmpK [21,26], a protein
translated from an orf located at the 50 of the gene cluster coding
for the multicomponent phenol hydroxylase from Pseudomonas
sp. CF600. DmpK has been shown not to be essential for in vitro
phenol hydroxylase activity, but several lines of biochemical evi-
dence suggested a major role for this protein in the expression of
active recombinant hydroxylase [26].
DmpK is not a unique case among multicomponent monooxy-
genases. In fact, genes expressing a group of proteins usually indi-
cated as accessory or auxiliary proteins, are frequently clustered
together with the orfs coding for the other components of the
BMMs [4,5]. These components share several common features:
they are small proteins with a molecular mass of about 10 kDa,
do not harbor any inorganic or organic cofactors, are expressed
at low levels in their respective native organisms, and inhibit en-
zyme activity in vitro when present in stoichiometric amounts
[27]. Despite these common aspects, the roles of the accessory pro-
teins in BMMs have been elusive so far, although they have been
hypothesized to be involved in the assembly of the active form of
the hydroxylase component. This function is exempliﬁed by bio-
chemical studies of the protein MMOD, which was isolated from
the methanotrophic bacterium Methylococcus capsulatus (Bath)
and is part of the soluble methanemonooxygenase (sMMO) system
[6,27]. Despite a lack of sequence homology, similar genes encod-
ing small proteins of unknown function have been identiﬁed across
many different groups of BMMs [4,5,28–30], suggesting that the
involvement of additional protein factors in the assembly of the ac-
tive hydroxylase diiron centers might be more widespread than
currently believed.
Accessory proteins recruited for the assembly of the metal
cofactor in the active site are not a unique feature of BMMs, be-
cause proteins with similar roles have been described as common
molecular tools to allow correct or efﬁcient insertion of metals into
the active sites of other metalloenzymes including Fe/S proteins,
nitrogenase, urease and hydrogenase [26,31,32]. Different molecu-
lar mechanisms employed to facilitate the insertion of metal sites
into target proteins have been reported in literature [32]. However,
none of the mechanisms described so far have been unambigu-
ously assigned to individual proteins such as DmpK and MMOD.
In this paper we describe a set of experiments aimed at gaining
insight into the role of PHK, the accessory protein of phenol
hydroxylase from Pseudomonas sp. OX1. The phenol hydroxylase
gene cluster was cloned and expressed in Escherichia coli in the ab-
sence or presence of the orf coding for PHK. In the latter case, re-
combinant cells showed an increased phenol hydroxylase activity
compared to cells not expressing PHK, suggesting a positive effect
of the accessory protein on the enzymatic activity of phenol
hydroxylase. Active PH(LNO)2 and PH(LNO)2/PHM complexes were
puriﬁed from the soluble extract of cells expressing the complete
ph gene cluster including phk. Additionally, we isolated a stable
complex formed by PHK bound to a PH(LNO) trimer that was de-
void of iron and hydroxylase activity and could not be reactivated
under our experimental conditions. To elucidate the role of PHK,
we subcloned and overexpressed this component in E. coli and
characterized its interaction with the active hydroxylase moiety,
PH(LNO)2, showing that the protein is not directly involved in
the catalytic activity of the phenol hydroxylase complex, as for
MMOD and DmpK. However, PHK does not appear to be required
for the production of active recombinant hydroxylase as observed
previously for DmpK [26]. PHK seems instead to be involved in
increasing the apparent afﬁnity of apo-PH(LNO)2 for iron, thus pos-
sibly facilitating the incorporation of the crucial transition metal
into the active site of the protein.
Experimental procedures
Materials and general procedures
Bacterial cultures, plasmid puriﬁcations and transformations
were performed according to Sambrook et al. [33]. The pET22b(+)
expression vector and E. coli-strain JM109 were purchased from
Novagen, whereas E. coli-strain BL21(DE3) was from Invitrogen.
Platinum Pfx DNA polymerase used for PCR ampliﬁcation was from
Life Technologies. Enzymes and other reagents for DNA manipula-
tion were from New England Biolabs. The oligonucleotides were
synthesized at the MWG-Biotech (http://www.mwgdna.com).
Q-Sepharose Fast Flow, Sephacryl S300 High Resolution, Sephadex
G75 Superﬁne, Superdex columns and disposable PD10 desalting
columns were from Pharmacia. All other chemicals were from
Sigma. Ammonium hydrogen carbonate (AMBIC), Ethylenedi-
aminetetraacetic acid (EDTA) and iodoacetamide were purchased
from Fluka; Tri(hydroxymethyl)aminomethane (Tris), urea, dithio-
threitol (DTT), and sequencing-grade trypsin were from Sigma.
Formic acid and Acetonitrile (ACN) were purchased from Romil.
Expression and puriﬁcation of recombinant PHM, PHP and
C2,3O from Pseudomonas sp. OX1 are described elsewhere
[20,34]. DNA fragments were sequenced at the MWG-Biotech
(http://www.mwgdna.com).
Construction of expression vectors
The plasmid pGEM3Z/phDk containing the ph-lmnop orfs was
kindly supplied by Dr. Valeria Cafaro (Dipartimento di Biologia
Strutturale e Funzionale, Università Federico II, Napoli, Italy). The
plasmid pGEM7Z/k containing the ph-klm orfswas a gift of Dr. Carla
Caruso (Dipartimento di Agrobiologia e Agrochimica, Università
della Tuscia, Viterbo, Italy).
To allow the expression of the complete ph gene cluster, the
DNA sequence encoding the PHK component was subcloned from
plasmid pGEM7Z/k into vector pGEM3Z/phDk to create a construct
containing the phk, phl, phm, phn, pho and php genes. A DNA frag-
ment comprising the entire phk gene and part of the phl genes was
ampliﬁed from the pGEM7Z/k vector using standard PCR proce-
dures. A SalI restriction site was inserted at the 50 end of the phk
gene. The 30 primer was designed to amplify an internal region of
the gene phl, 180 nucleotides downstream of the ATG start codon,
incorporating a MluI restriction site. The resulting recombinant
plasmid, named pGEM3Z/ph, was veriﬁed by DNA sequencing. To
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construct plasmid pGEM3Z/phDp, pGEM3Z/ph was digested with
the restriction endonuclease EcoRV which cuts the php gene at
nucleotides 196 and 335 causing the deletion of a 140 bp fragment.
In order to overexpress PHK, a third construct was prepared
that contained only the phk gene. The gene phk was ﬁrst ampliﬁed
using plasmid pGEM7Z/k as template and a PCR method that in-
serted NdeI and BamHI restriction sites at the 50 and 30 ends of
the gene, respectively. The ampliﬁed fragment was digested with
endonucleases NdeI and BamHI, ligated with the pET22b(+) vector
previously cut with the same enzymes. The resulting recombinant
plasmid, named pET/phkwas veriﬁed by DNA sequencing and used
to transform BL21(DE3) competent cells.
Expression of PHK and PH(LNO)2
The gene products of plasmids pGEM3Z/phDk and pGEM3Z/
phDp were expressed in E. coli-JM109 cells. PHK was expressed
from pET/phk in E. coli BL21(DE3) cells. All recombinant strains
were routinely grown in Luria–Bertani (LB) medium [33] supple-
mented with 100 lg mL1 of ampicillin. Expression of recombinant
proteins was induced by adding isopropyl-b-D-thiogalactopyrano-
side (IPTG) at a ﬁnal concentration of 0.2 mM for pGEM3Z/phDk
and pGEM3Z/phDp, and 0.1 mM for pET/phk. At the time of induc-
tion, Fe(NH4)2(SO4)26H2O was added at a ﬁnal concentration of
0.2 mM, except in the case of PHK from pET/phk. Growth was con-
tinued in all cases for 3 h at 37 C. Cells were collected by centrifu-
gation, washed in 25 mM of 3-(N-morpholino)propanesulfonic acid
(MOPS), pH 7.0, containing 5% glycerol, and 2 mM L-cysteine
(Buffer A). The cell paste was stored at 80 C until needed.
Puriﬁcation of the expression products of pGEM3Z/phDp
The paste from a 2 L culture of induced cells was suspended in
40 mL of buffer A. Cells were disrupted by sonication (10 times for
a 1-min cycle, on ice). Cell debris were removed by centrifugation
at 18,000g for 60 min at 4 C. The supernatant was immediately
fractionated as described below. The soluble fraction from a 2 L
culture of JM109 cells expressing the gene products of plasmid
pGEM3Z/phDp or pGEM3Z/phDk was loaded onto a Q-Sepharose
Fast Flow column (1  18 cm) equilibrated in buffer A containing
0.08 M NaCl at a ﬂow rate of 10 mL h1. Elution was performed
with a 500 mL linear salt gradient from 0.12 to 0.5 M NaCl in buffer
A, at a ﬂow rate of 18 mL h1. Fractions containing the proteins of
interest were pooled, concentrated by ultraﬁltration on an YM30
membrane, and loaded onto a Sephacryl S300 High Resolution col-
umn (2.5  50 cm) equilibrated in buffer A containing 0.2 M NaCl,
at a ﬂow rate of 8 mL h1. Fractions were pooled, concentrated by
ultraﬁltration on YM30 membranes, and stored under nitrogen at
80 C. Unless otherwise stated, all chromatographic steps were
performed at 4 C. Buffers were purged by repeated cycles of ﬂush-
ing with nitrogen. Column operations were not strictly anoxic.
Puriﬁcation of PHK
The soluble fraction from a 2 L culture of cells expressing the
gene product of plasmid pET22b(+)/phk was loaded onto a
Q-Sepharose Fast Flow column (1  18 cm) equilibrated in buffer
A at a ﬂow rate of 10 mL h1. Proteins were eluted with a 400 mL
linear salt gradient from 0 to 0.45 M NaCl, at a ﬂow rate of
10 mL h1. Relevant fractions were pooled, concentrated by ultra-
ﬁltration on YM10 membranes, and loaded onto a Sephadex G75
Superﬁne column (2.5  50 cm) equilibrated in buffer A containing
0.2 M NaCl at a ﬂow rate of 8 mL h1. Fractions containing electro-
phoretically pure PHK were pooled, purged with N2, concentrated
by ultraﬁltration on YM10 membranes, and stored at 80 C.
Enzymatic assays
Enzymatic activities were measured as previously described
[17] using phenol as a substrate and monitoring the production
of catechol in a continuous coupled assay with recombinant cate-
chol 2,3-dioxygenase from Pseudomonas sp. OX1 [34], which
cleaves the catechol ring and produces 2-hydroxymuconic semial-
dehyde. Formation of this product, having an extinction coefﬁcient
of 12,000 M1 cm1, can be monitored spectrophotometrically at
410 nm.
(i) Assays of reconstituted PH components. Conditions for this
enzyme assay probing the activity of the reconstituted PH
complex are reported elsewhere [17,20]. PH(LNO)2 concen-
trations employed in the assay were typically 0.25–
0.75 lM. Components PHP and PHM were added in a ratio
of 2:4:1 compared to PH(LNO)2 concentration. Semialde-
hyde yields were determined by measuring the absorbance
at 410 nm. Speciﬁc activity (S.A.) was deﬁned as nanomoles
of substrate converted per minute per milligram (mU/mg) of
PH(LNO)2 hexamer at 25 C.
(ii) Whole-cells assays. Whole-cells assays were performed as
previously described [20] using E. coli-JM109 cells trans-
formed with the plasmid of interest. One milliunit was
deﬁned as the amount of catalyst that oxidized 1 nmol of
phenol per min at 25 C.
(iii) Assays on crude extracts. Crude extracts of JM109 expressing
either pGEM3Z/ph or pGEM3Z/phDk were prepared by soni-
cating the cell suspension at an optical density at OD600 of
about 7 in buffer A (3 times for a 1-min cycle, on ice). Cell
debris was removed by centrifugation at 18,000g for
30 min at 4 C. The supernatant was carefully decanted,
and kept on ice. The reaction was carried out in 0.1 M
Tris–HCl pH 7.5 in the presence of 0.25 mM NADH and
0.5 mM phenol. Semialdehyde yields were determined as
noted.
Iron removal from PH(LNO)2
Removal of iron from the hydroxylase component was
performed as previously described [35] with the following
modiﬁcations. A 1.2 mL solution of 10 lM PH(LNO)2, 0.5 mM
1,10-phenanthroline in 0.05% HCl, and 0.8 mM methyl viologen
in 25 mM MOPS (pH 7.0), was prepared in a glass vial ﬁtted with
a rubber septum and purged with nitrogen. A 20 lL aliquot of a
350 mM sodium dithionite solution, previously purged with a con-
tinuous ﬂow of nitrogen, was added and the reaction mixture was
incubated at room temperature for 3 h under a continuous ﬂow of
nitrogen. Apo-PH(LNO)2 was separated from the reagents and from
the [Fe(o-phen)3]2+ complex by using a disposable PD10 desalting
column (Pharmacia) equilibrated with a buffer containing 25 mM
MOPS (pH 7.0), 200 mM NaCl, 5% glycerol and 2 mM L-cysteine
(Buffer D). The mixture containing apo-PH(LNO)2 (10 lM) was
made anaerobic by purging the solution with nitrogen. Fractions
of interest were pooled, concentrated and stored at 80 C.
Isothermal titration calorimetry (ITC)
ITC experiments were performed on a Nano-ITC, CSC 5300 cal-
orimeter from Calorimetry Science Corporation (Lindon, UT), hav-
ing a cell volume of 1.3 mL. Calorimetric titrations were carried
out at 25 C, by injecting 10 lL aliquots of a 130 lM ligand solution
into a 11 lM PHK solution at 200 s intervals for a total of 25 injec-
tions. The solution was stirred at 1000 rpm.
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Analytical gel ﬁltration
Analytical gel-ﬁltration experimentswere carried out as follows:
200 lL of a protein sample was loaded on a Superdex 200 HR 10/30
or on a Superdex 75 HR 10/30 column previously equilibrated in
25 mM Tris–HCl, 5% glycerol, 0.2 M NaCl and 2 mM L-cysteine, pH
7.0 installed on an AKTA™FPLC™ (GE Healthcare Life Science). The
sampleswere eluted isocratically at room temperature at a ﬂow rate
of 0.5 mL min1. Protein separation was monitored at 280 nm. A
molecularweight calibrationwas conducted in the samebufferwith
the following proteins of known molecular weight: apotransferrin
(400 kDa), alcohol dehydrogenase (150 kDa), bovine serumalbumin
(66,000 Da), ovalbumin (45,000 Da), carbonic anhydrase (29,000
Da), trypsinogen (24,000 Da), cytochrome c (12,400 Da). When
necessary, the area of each peak was estimated by nonlinear
curve-ﬁtting of the elution proﬁle using PeakFit software (Systat
Software).
Biotinylation of PHK
PHK (3.0 mg, in 25 mM MOPS pH 7.0, 5% glycerol, 0.2 M NaCl)
was incubated with 1.37 mg of sulfosuccinimidobiotin (Sulfo-
NHS-Biotin) (Pierce) dissolved in the same buffer at a molar ratio
of 20:1, on ice in the dark for 2 h. The reaction was quenched with
0.1 M Tris–HCl pH 7.0 and the non-reacted biotin reagent was re-
moved by size exclusion chromatography on a PD-10 column
(GE-Healthcare) in 0.1 M Sodium Phosphate pH 7.2, 0.15 M NaCl.
Absorbance at 220 and 280 nm was monitored to identify PHK-
containing fractions. Appropriate fractions were pooled and added
to Avidin Agarose Resin (settled gel, Pierce) in order to immobilize
the biotinylated protein.
Immobilization of biotinylated PHK on avidin and ‘‘Pull down” assays
A 450 lL aliquot of resin was equilibrated with ﬁve volumes of
Binding Buffer (0.1 M Sodium Phosphate pH 7.2, 0.15 M NaCl) and
incubated with biotinylated PHK (3 mg biotinylated PHK per mL of
settled avidin agarose resin) at 4 C for 1 h. The resin was washed
with 10 volumes of Binding Buffer.
Pseudomonas sp. OX1 cells grown on M9 minimal medium con-
taining 5 mM phenol as a unique carbon and energy source were
disrupted by sonication in 25 mM MOPS pH 7.0, 0.15 M NaCl, 5%
glycerol, 1 mM PMSF containing a protease inhibitors cocktail
(Sigma Aldrich). The extracts were centrifuged at 12,000 rpm for
1 h and ﬁltered with a 0.45 lm polyvinylidene ﬂuoride (PVDF)
membrane. Total protein cell extracts, quantiﬁed using the BioRad
protein assay, were incubated with 125 ll of mouse anti-IgG aga-
rose conjugated beads (Sigma) overnight at 4 C (preclining step).
Cell extracts were then incubated with 450 lL of biotinylated-
PHK immobilized on avidin resin and were incubated overnight
at 4 C. The resin was washed with 10 volumes of Binding Buffer
and the protein samples were eluted with 70 lL of Laemmli sam-
ple buffer. Samples were analyzed by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS–PAGE) (12.5%, 20 cm 
20 cm), and proteins were stained with Coomassie Brilliant Blue
G-Colloidal (Pierce, Rockford, USA).
Mass spectrometric analysis
Identiﬁcation of complexed subunits was carried out on trypsin
digested samples either by digestion in solution or in situ after sep-
aration by polyacrilamide gel electrophoresis. Proteins were de-
tected on the gel using a colloidal Coomassie kit (Invitrogen Life
Technologies). Excised bands were destained, reduced with
10 mM dithiothreitol (DTT), carbamidomethylated with 55 mM
iodoacetamide in 0.1 M NH4HCO3 buffer, pH 7.5 and subjected to
tryptic in-gel digestion for 16 h at 37 C, by adding 100 ng of tryp-
sin. Peak center fractions from analytical gel-ﬁltration experiments
(1 mL) were lyophilized, resuspended in 100 ll of H2O, and di-
gested at 37 C for 16 h with 100 nmoles of trypsin. Reactions were
quenched by lowering the pH to about 1 with formic acid, and the
resulting peptide mixtures were concentrated and puriﬁed using a
reverse phase Zip Tip pipette tips (Millipore). The peptides were
eluted with 20 lL of a solution comprising 50% acetonitrile and
0.1% formic acid in deionized water. Peptide mixtures were ana-
lyzed either by matrix-assisted laser-desorption/ionization mass
spectrometry (MALDI-MS) or capillary liquid chromatography with
tandem mass spectrometry detection (LC-MSMS).
MALDI-MS experiments were performed on a Voyager DE-STR
matrix-assisted laser-desorption ionization-time of ﬂight
(MALDI-TOF) mass spectrometer (Applied Biosystems, Framing-
ham, MA) equipped with a nitrogen laser (337 nm). Typically,
1 lL of the total peptide mixture was mixed (1/1, v/v) with a
10 mg mL1 solution of R-cyano-4-hydroxycinnamic acid in aceto-
nitrile/50 mM citrate buffer (2/3, v/v). The experimental mass val-
ues obtained were compared with calculated masses from the
predicted tryptic digestion of the different subunit sequences, con-
ﬁrming the identities of the corresponding protein bands.
The peptide mixtures were analyzed using a CHIP MS 6520
QTOF equipped with a capillary 1200 HPLC system and a chip cube
(Agilent Technologies, Palo Alto, Ca). After loading, the peptide
mixture (8 ll in 0.1% formic acid) was ﬁrst concentrated and
washed at 4 lL/min in a 40 nL enrichment column (Agilent Tech-
nologies chip), with 0.1% formic acid in 2% acetonitrile as the sol-
vent. The sample was then fractionated on a C18 reverse-phase
capillary column (75 lm  43 mm in the Agilent Technologies
chip) at ﬂow rate of 400 nL/min with a linear gradient of eluent
B (0.1% formic acid in 95% acetonitrile) in A (0.1% formic acid in
2% acetonitrile) from 7% to 60% over 50 min.
Peptide analysis was performed using data-dependent acquisi-
tion of one MS scan (mass range from 300 to 2000 m/z) followed
by MS/MS scans of the three most abundant ions in each MS scan.
Raw data from nanoLC-MSMS analyses were employed to query,
using MASCOT software (Matrix Science, Boston, USA), a non-
redundant protein databases (NCBI, with taxonomy restriction to
Bacteria), or an ad hoc created databases including only the se-
quences of PHK, PHL, PHM, PHN, PHO.
Other methods
Polyacrylamide gel electrophoresis was carried out using stan-
dard techniques [33,36]. Tris–glycine gels (18% and 15%) were
run under denaturing and native conditions respectively. SDS–
PAGE ‘‘wide range” (200–6.5 kDa) molecular weight standard was
from Sigma. Homology studies were performed by searching the
public nucleotide and protein databases with BLAST. Total iron
content was determined colorimetrically by complexation with
Ferrozine [37]. Protein concentrations were determined colorimet-
rically with the Bradford Reagent [38] from Sigma, using 1–10 lg
of bovine serum albumin (BSA) as a standard.
Results
Activity assays of whole cells of E. coli-JM109 expressing recombinant
phenol hydroxylase in the presence or absence of PHK
To evaluate the inﬂuence of PHK on the phenol hydroxylase
activity of PH, we initially investigated the catalytic activity of
whole cells of E. coli-JM109 expressing the complete ph l-m-n-o-p
gene cluster with or without phk, and compared the rate of conver-
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sion of phenol to catechol by the induced cells in the presence or in
the absence of the phk gene product.
To this purpose, the orf encoding PHK was ampliﬁed from plas-
mid pGEM7Z/k and subcloned into plasmid pGEM3Z/phDk (see
Construction of expression vectors). The primers used in the PCR
reaction were designed to incorporate the putative PHK ribosome
binding site (rbs) at the 50 of the phk gene. This rbs was previously
located at 8–10 bp upstream of the ATG start codon in the native 50
UTR region of the ph gene cluster.
SDS–PAGE analysis of the crude extracts of induced cells
expressing either pGEM3Z/phDk or pGEM3Z/ph revealed that the
hydroxylase components PHL, PHN and PHO were expressed at
high levels from both plasmids. Additionally, no signiﬁcant
difference in the expression levels of PHM and PHP was observed.
However, whole cells expressing the plasmid pGEM3Z/ph, showed
a 2- to 4-fold increase in the rate of catechol production when
compared to those lacking the expression product of gene phk.
The latter had a speciﬁc activity of 0.8 ± 0.1 mU/OD600; in the pres-
ence of gene phk the value of the activity with phenol was of
3.1 ± 0.5 mU/OD600.
Similar results were obtained when crude extracts of E. coli-
JM109 expressing either pGEM3Z/ph or pGEM3Z/phDk were
analyzed for catechol production. Recombinant E. coli cells harbor-
ing either plasmid were induced with 0.2 mM IPTG at 37 C for
90 min and were collected by centrifugation. Crude extracts were
prepared and used in continuous coupled assays as described in
Enzymatic assays. A 2–3-fold higher phenol hydroxylase activity
was observed for crude extracts of E. coli expressing the ph gene
cluster including gene phk than for those expressing the ph gene
cluster in the absence of phk. Surprisingly, the activity of crude ex-
tract of E. coli-JM109 expressing pGEM3Z/phDk could be restored
to pGEM3Z/ph levels by adding 5 lM of exogenous iron (II). These
results contrast those previously described for recombinant DmpK,
where the addition of exogenous iron (II) was not sufﬁcient to re-
store the enzymatic activity of the hydroxylase component in the
absence of the auxiliary protein [26]. The total iron contents of
crude extracts of cells expressing either pGEM3Z/ph or pGEM3Z/
phDk is similar, with 3.7 ± 0.7 nmol Fe/mg total protein and
4.2 ± 0.8 nmol Fe/mg total protein respectively, suggesting that
PHKmight be involved in directing intracellular iron to the hydrox-
ylase moiety rather than inﬂuencing total amount of iron in the
cell.
Puriﬁcation and characterization of the expression products of
pGEM3Z/phDp
The results obtained on whole cells and on cells extracts of in-
duced E. coli cells, described in the previous section, suggested a
positive inﬂuence of the accessory protein PHK on the enzymatic
activity of the phenol hydroxylase complex.
To gain additional insight into the role of PHK, we decided to
purify PHK and all the other components of the phenol hydroxylase
system from cells of E. coli expressing plasmid pGEM3Z/ph.
First a derivative of plasmid pGEM3Z/ph, having a partial dele-
tion of the php gene, was constructed (see Construction of expres-
sion vectors). This construct was generated to avoid accumulation
of indigo in the cell culture [39], which is the result of the hydrox-
ylation of cellular aromatics by the active phenol hydroxylase sys-
tem during induction of transformed E. coli cells.
Fractionation of the crude extracts of JM109 cells expressing
pGEM3Z/phDp was performed as described in the ‘‘Experimental
procedures” section. Three distinct peaks eluted from the ﬁrst anio-
nic exchange column and were collected separately. As shown in
Fig. 1A, all threepeakscontained thePHL,PHNandPHOpolypeptides
of the hydroxylase protein, when analyzed by SDS–gel [20]. In peak
1, an additional protein band, with the molecular weight expected
for PHK, was evident. In contrast the contents of peak 3 revealed a
protein with the molecular weight expected for the regulatory pro-
tein PHM. The identities of the proteins of these three peaks were
conﬁrmed by peptide mass ﬁngerprinting after in situ digestion of
the bands excised from the gel and MALDI-TOF analyses.
Contents of the three peaks were further puriﬁed on a S-200 gel
ﬁltration column followed by anionic exchange chromatography
on a Mono-Q column. Even after these puriﬁcation steps, the com-
position and the ratio of the PH subunits of the three peaks re-
mained as such, as evidenced by SDS–PAGE and mass
spectrometry. These results strongly suggest the formation of sta-
ble complexes between the LNO subunits and PHK in peak 1, and
between the LNO subunits and PHM in peak 3.
The protein complexes of all three peaks were individually
characterized for iron content, molecular weight, and speciﬁc
activity using phenol as a substrate. As shown in Table 1, the puta-
tive PHK-hydroxylase complex of peak 1 was devoid of both iron
and enzymatic activity. The molecular weight of the putative com-
plex measured by using a Superdex 200 gel ﬁltration column ac-
counted for a complex in which one molecule of PHK binds a
trimeric LNO species. From now on we will refer to this complex
as PHK-PH(LNO).
The same analyses carried out on peaks 2 and 3 (Table 1), re-
vealed that peak 2 contains the hexameric hydroxylase with a qua-
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Fig. 1. Expression products of plasmid pGEM3Z/phDp. (A) Q-Sepharose chromato-
gram and SDS–PAGE. MW, molecular weight standard ranging from 200 to 6.5 kDa
(see Immobilization of biotinylated PHK on avidin and ‘‘Pull down” assays, for
details). Lane 1, peak 1. Lane 2, peak 2. Lane 3, peak 3. Lane 2 contains the
polypeptides PHN (60 kDa), PHL (38.3 kDa) and PHO (13.1 kDa). The arrows in lane
1 and 3 indicate the additional polypeptides, PHK and PHM respectively, that co-
elute with the hydroxylase formed by subunits PHN, PHL and PHO. (B) Effect of
different concentrations of regulatory protein PHM with respect to the hydroxylase
PH(LNO)2 on the rate of catechol production. The experiment was performed in the
presence of either PHM–PH(LNO)2 (empty triangles) complex isolated from peak 3,
or PH(LNO)2 (ﬁlled circles) isolated from peak 2. Optimized PHP/PH(LNO)2 ratio of
4:1 was kept constant during the titration.
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ternary structure of the type PH(LNO)2, whereas peak 3 contains a
complex in which two molecules of PHM binds the dimer (LNO)2,
from now on referred as PHM–PH(LNO)2. The putative PHM–
PH(LNO)2 complex in peak 3 was fully active with phenol after
the addition of an optimized ratio of the oxidoreductase compo-
nent PHP (see Enzymatic assays and Fig. 1B). For peak 2, both the
oxidoreductase and the recombinant component PHM, puriﬁed
and characterized as described in Cafaro et al. [20], had to be added
to obtain an optimally active catalytic system. In these latter
experiments, 4 equiv. of PHMwere added to PH(LNO)2 for maximal
activity (Fig. 1B). For both peak 2 and peak 3, adding higher con-
centrations of the regulatory component PHM inhibited the rate
of phenol hydroxylation (Fig. 1B), [20].
Attempts to purify adequate amounts of PHK from cells
expressing the whole ph gene cluster from pGEM3Z/ph were
unsuccessful. Recombinant PHK was always found to be ﬁrmly
bound to the trimeric complex PH(LNO) eluting in peak 1 and
could not be dissociated unless strong denaturing conditions were
used.
Puriﬁcation and properties of PHK
To purify and characterize PHK, we subcloned the orf encoding
this protein and expressed it in E. coli, strain BL21(DE3) (see Con-
struction of expression vectors). Recombinant PHK was puriﬁed
to homogeneity from E. coli harboring pET22b(+)/phk by an initial
anionic exchange chromatography on a Q-Sepharose FF resin fol-
lowed by a gel ﬁltration step on a G-75 column (see Puriﬁcation
of PHK).
The oligomeric state of PHK was assessed by analytical gel ﬁl-
tration on a Superdex 75 analytical column. The chromatographic
proﬁle resulted in a single peak, which eluted at an apparent
molecular weight of about 25,500 ± 400 Da, suggesting the occur-
rence of a dimeric species. The accurate subunit molecular weight
of PHK was determined by electrospray ionization mass spectrom-
etry (ESI–MS); the experimental value of 10,235.27 ± 0.19 Da is in
agreement with the molecular weight predicted from the sequence
of PHK (10,235.7 Da).
Puriﬁed PHK was found to be devoid of iron and did not contain
any redox active prosthetic groups such as ﬂavin, heme, or iron–
sulfur centers. Incubation of PHK with an excess of ferrous iron
and subsequent puriﬁcation of the sample by using either a PD10
desalting column or dialysis did not lead the protein to retain
any of the metal bound (data not shown).
Isothermal titration calorimetry (ITC) was then performed to as-
sess whether PHK binds iron (II). 1 mL of puriﬁed 11 lM PHK in
25 mM MOPS pH 7.0 containing 5 mM L-ascorbic acid was titrated
with the same buffer having 250 lL of 130 lM Fe(NH4)2
(SO4)26H2O. L-ascorbic acid was added to both samples to avoid
oxidation of iron (II) to iron (III) during the experiment. No binding
isotherm was detected under the conditions reported in Materials
and methods. To exclude the possibility that this result could arise
from the oxidation of iron during the course of the experiment, the
same experiment was repeated using a solution containing 130 lM
MnCl2 in 25 mM MOPS pH 7.0. Manganese (II) has already been
used for replacing native iron (II) in several proteins ([35] and ref-
erences therein). This metal is similar to iron (II) in charge and io-
nic radius and can exist in different oxidation states, but most
notably its oxidation state (II) is much more stable at pH 7.0 when
compared to iron (II). ITC experiments performed under conditions
described above did not provide any evidence of binding between
isolated PHK and manganese.
To provide evidence for the speciﬁcity of the binding event be-
tween PHK and the LNO subunits observed in the PHK-PH(LNO)
complex isolated after the puriﬁcation of the expression products
of pGEM3Z/phDp (see Puriﬁcation and characterization of the
expression products of pGEM3Z/phDp and Fig. 1A), we carried
out an afﬁnity puriﬁcation strategy using an avidin pull-down as-
say with extracts of cells of Pseudomonas sp. OX1 grown on phenol
as a unique carbon and energy source (Fig. 2). This approach re-
quired recombinant biotinylated PHK. We biotinylated 3 mg of
PHK as described in Biotinylation of PHK, with Sulfo-NHS-Biotin
(sulfosuccinimidobiotin). To conﬁrm that PHK was efﬁciently bio-
tinylated under the experimental conditions, an aliquot was ana-
lyzed by RP-HPLC/ES-MS, which show that PHK contained up to
3 biotins per molecule. Biotinylated PHK was immobilized on avi-
din beads that were subsequently incubated with total protein ex-
tracts from Pseudomonas sp. OX1 cells grown on phenol; these
latter had been pre-cleaned on agarose beads to minimize non-
speciﬁc binding on the cromatographic matrix during the pull-
down procedure. After extensive washing, PHK-recruited protein
interaction partners were eluted in Laemmli buffer, separated on
SDS–PAGE, and stained with colloidal blue Coomassie (Fig. 2).
Three major proteins with molecular weights of 12, 40 and
60 kDa (Fig. 2; lane 2) were identiﬁed. These proteins ran simi-
larly to puriﬁed PHO, PHL and PHN standards on the gel (Fig. 2,
lane 3). The three protein bands were excised from the gel, re-
duced, alkylated and digested in situ with trypsin. The resulting
peptide mixtures were analyzed by LC-MSMS and the identities
of the proteins were conﬁrmed as PHO, PHL and PHN by comparing
the MS patterns to those contained within the bacteria subset of
Table 1
Pool Fe2+/(LNO)2 Speciﬁc activity (mU/mg) Calculated MW (kDa) Expected MW (kDa)
1. PHK–PH(LNO) NDa NDa 136.30 ± 9.53 122.16
2. PH(LNO)2 3.5 ± 0.2 254 ± 46 248.07 ± 2.31 223.58
3. PHM–PH(LNO)2 4.2 ± 0.1 329 ± 17 259.30 ± 1.81 244.54
a ND, not detectable.
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Fig. 2. Pull down experiment with biotinylated PHK. Colloidal blue-stained gel for
biotinylated PHK associated proteins from Pseudomonas sp. OX1 cells grown on
phenol (lane 2). Total Pseudomonas sp.OX1 cell extract is loaded in lane 1. An aliquot
of PHM-PH(LNO)2, was loaded (lane 3) as a control. Biotinylated PHK associated
proteins were analyzed by SDS–PAGE followed by colloidal blue staining. A, B, and C
labels in lane 3 indicate the three major proteins detected among the proteins
pulled-down by biotinylated PHK.
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the NCBI database using MASCOT software (Table S1, Supplemen-
tary Material). These results indicate a highly speciﬁc interaction of
PHK with the LNO subunits of the hydroxylase moiety.
PHK-mediated inhibition of phenol hydroxylase activity
Once obtained the puriﬁed recombinant protein, the role of PHK
was investigated by studying its inﬂuence on the phenol hydroxy-
lase complex reconstituted from the puriﬁed components. Addi-
tion of puriﬁed PHK to the phenol hydroxylase complex
reconstituted in vitro displayed a dose-dependent effect (Fig. 3).
These assays contained PHP, PHM and PH(LNO)2 at optimized ra-
tios or PHP and the PHM–PH(LNO)2 from peak 3 at optimized ratios
with no exogenous recombinant PHM (see Enzymatic assays).
Hydroxylation of phenol to catechol catalyzed by the in vitro recon-
stituted PH complex was measured at varying ratios of PHK to
PH(LNO)2. In all cases, addition of PHK resulted in the inhibition
of the phenol hydroxylase activity (Fig. 3). Speciﬁcally, a 10-fold
excess of PHK to PH(LNO)2 resulted in only 16.8 ± 3.1% of the initial
rate of catechol production. Interestingly, higher PHK:PH(LNO)2 ra-
tios did not lead to complete inactivation of phenol hydroxylase
activity. A Kd value of 0.61 ± 0.15 lM over ﬁve different prepara-
tions of hydroxylase was obtained.
To gain further insight into the mechanism by which PHK inhib-
its enzymatic activity, we incubated 57 lM of PH(LNO)2 with
0.6 equiv. of puriﬁed PHK, in 500 lL of 25 mM MOPS pH 7.0. The
mixture was let sit at room temperature for 90 min after which a
15 lL aliquot was analyzed on a native 15% polyacrilamide gel
(Fig. 4A). Similar to a sample containing the partially puriﬁed
PHK–PH(LNO)2 complex from peak 1 (lane 1), the sample in which
recombinant PHK was added to PH(LNO)2 showed the presence of a
high molecular weight species (lane 3) attributed to the trimeric
form PH(LNO) associated to PHK (lane 1). Protein bands corre-
sponding to the hydroxylase complex and uncomplexed PHK were
also identiﬁed (lane 3) by comparison to a partially puriﬁed sample
of PH(LNO)2 (lane 2) and PHK (lane 4). The protein components of
this putative identiﬁed PHK–PH(LNO) species were conﬁrmed by
peptide mass ﬁngerprinting. The protein band from lane 3 was ex-
cised, digested in situ with trypsin, and analyzed by MALDI-TOF
MS. Mass values were mapped onto the anticipated sequences of
PHL, PHN, PHO, PHM, and PHK subunits conﬁrming the presence
of all four polypeptides (Table S2, Supplementary Material).
The contents of the reaction mixture containing both PH(LNO)2
and PHK were also analyzed by analytical gel ﬁltration chromatog-
raphy. A 200 lL aliquot of the mixture was run onto a Superdex
200 column. The elution proﬁle (Fig. 4B) revealed a protein peak
with an apparent molecular weight of 220 kDa, corresponding to
the PH(LNO)2 hexameric complex of the active hydroxylase, as as-
sessed by running an authentic standard of PH(LNO)2. Also evident
is a species with an apparent molecular weight of 124 kDa, likely
corresponding to the trimeric PH(LNO) species complexed with
PHK. Fractions located in the peak centers were analyzed by
SDS–PAGE and mass spectrometry (data not shown), conﬁrming
the presence of PHK only in the peak eluting with the apparent
molecular weight of 124 kDa, whereas PHL, PHN, and PHO were
observed in both peaks.
The molecular species produced by the interaction of PHK with
the hexameric hydroxylase PH(LNO)2 can be conﬁdently assigned
as a PHK-PH(LNO) complex. The observation that this species is de-
void of both iron and catalytic activity with phenol, suggests that
the inhibition of the phenol hydroxylase activity, demonstrated
in in vitro assays and previously reported in the case of accessory
proteins DmpK and MMOD [26,27], depends on the formation of
apo-trimers of the type PH(LNO) and is mediated by the interven-
tion of PHK.
Interestingly, incubation of PHK with the PHM–PH(LNO)2 com-
plex (peak 3 in Fig. 1), performed under the same experimental
conditions, resulted in very little dissociation of the hexameric
hydroxylase (Fig. 4B).
The PHK-PH(LNO) complex, obtained either from fractionation
of crude extract of E. coli/pGEM3ZDp (Fig. 1A) or from the incuba-
tion of puriﬁed component PHK with hexameric PH(LNO)2 complex
(Fig. 4), could not be reactivated by any of our experimental
procedures. In one of these experiments a 1.2 mL solution
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Fig. 3. Effect of increasing concentration of PHK on phenol hydroxylase activity of
PH(LNO)2. Activity assays were performed as described in Experimental Procedures.
Filled squares represent experiments performed with the pre-formed PHM–
PH(LNO)2 complex. Empty circles are experiments with the PH(LNO)2 complex
employing exogenous recombinant PHM added at a 4:1 ratio with respect to the
hydroxylase.
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Fig. 4. Characterization of the PH(LNO)2 complex in the presence of PHK. (A) Native
gel electrophoresis of a PH(LNO)2/PHK mixture. Lane 1, 10 lg of the PHK-PH(LNO)
complex puriﬁed from peak 1 of the anion exchange chromatographic separation of
Fig. 1. Lane 2, 20 lg of PH(LNO)2 active hexamer. Lane 3, 20 lg of PH(LNO)2
incubated with 0.6 equiv. of PHK for 90 min at room temperature. Lane 4,
approximately 5 lg of puriﬁed recombinant PHK. The arrow indicates the
additional band present in the incubated sample that is absent in the starting
protein samples. (B) Elution proﬁles from analytical gel ﬁltration chromatographic
separation of a 200 lL mixture of 4.4 lM of PH(LNO)2 and 2.2 lM of PHK (black
line), and of a 200 lL mixture of 2.2 lM of PHM–PH(LNO)2 and 4.4 lM of PHK (red
line). (For interpretation of the references to color in this ﬁgure legend, the reader is
referred to the web version of this article.)
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containing 10 lM of PHK–PH(LNO) complex and 0.8 mM methyl
viologen in 25 mMMOPS pH 7.0, was prepared in a glass vial ﬁtted
with a rubber septum and purged with nitrogen. Next, 20 lL of a
350 mM solution of sodium dithionite in 25 mMMOPS pH 7.0, pre-
pared as described in Iron removal from PH(LNO)2, and 24 lL of a
freshly prepared 5 mM solution of Fe(NH4)2(SO4)26H2O in deion-
ized water, were added. The reaction mixture was incubated at
room temperature for 3 h under a continuous ﬂow of nitrogen. Ex-
cess, unbound iron was removed by gel ﬁltration on a PD10 desalt-
ing column (Pharmacia) equilibrated in 25 mM MOPS pH 7.0,
having 200 mM NaCl, 5% glycerol and 2 mM L-cysteine. Enzymatic
assays performed on fractions containing the puriﬁed PHK–
PH(LNO) complex revealed that no catalytic activity could be
recovered under these conditions (Fig. 5A). Moreover, colorimetric
assays using ferrozine to detect iron (see Other methods) demon-
strated that the metal was not present in the protein sample tested
(Fig. 5B).
In contrast, addition of excess iron to iron-depleted PH(LNO)2 or
PHM-PH(LNO)2 complexes resulted in the signiﬁcant recovery of
both enzymatic activity and iron content of the puriﬁed protein
(Fig. 5). Recovery of the maximal speciﬁc activity was of
35.1 ± 3.5% for PH(LNO)2 and 78.9 ± 2.5% for PHM–PH(LNO)2. The
reason for the different values for the PH(LNO)2 and PHM–
PH(LNO)2 complexes can be explained by the fact that while the
formation of apo-hydroxylase from the PH(LNO)2 species resulted
in the complete removal of iron from the sample, 50% of the ori-
ginal iron was retained when the metal depletion procedure was
conducted with PHM–PH(LNO)2. Importantly, these results were
not dependent of the ratio of PHK to PH(LNO)2 employed in the
iron reconstitution procedures.
Role of PHK in iron uptake of apo-PH(LNO)2
Iron-depleted PH(LNO)2, hereafter referred to as apo-PH(LNO)2,
was further puriﬁed by gel ﬁltration on a S-200 gel ﬁltration col-
umn. Two different species were obtained and identiﬁed by na-
tive-PAGE analysis and analytical gel ﬁltration, which showed the
presence of both hexameric apo-PH(LNO)2 and trimeric apo-
PH(LNO) complexes. Attempts to reconstitute the complexes with
iron were performed by adding aliquots of a freshly prepared
50 lM solution of Fe(NH4)2(SO4)26H2O in deionized water to
0.75 lM of either species in a 1 mL quartz cuvette. Immediately
following iron addition, the other components of the phenol
hydroxylase complex, the oxidoreductase PHP and the regulatory
protein PHM, were added at a ratio of 2:1 and 4:1 with respect
to PH(LNO)2. Spectrophotometric continuous coupled assays were
performed using phenol as substrate to monitor the rate of cate-
chol formation.
Iron quantization of iron-reconstituted samples of apo-
PH(LNO)2 and apo-PH(LNO), in the absence or in the presence of
PHK, always resulted in the measure of non-speciﬁc binding of iron
to the hydroxylase. This is a common problem of in vitro iron
reconstitution procedures. Since the enzymatic activity of the
hydroxylase is related to the amount of iron correctly incorporated
in the active site, we decided to indirectly measure iron binding by
monitoring the increase in activity upon metal addition.
In the case of apo-PH(LNO) no enzymatic activity could be
recovered after incubation with increasing concentration of iron
(0–10 lM), neither in the presence of various amounts of recombi-
nant PHK nor in its absence.
In the case of apo-PH(LNO)2, different results were obtained in
the absence and presence of PHK, which was added in a optimized
ratio of 0.35:1 with respect to the iron-depleted hydroxylase pro-
tein (Fig. S1, Supplementary Material). As shown in Fig. 6, in the
presence of PHK, addition of stoichiometric quantities of iron (II)
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Fig. 5. Effect of iron depletion and reconstitution on the different puriﬁed
hydroxylases expressed from plasmid pGEM3Z/phDp. Iron content and phenol
hydroxylase activity were measured as described in Materials and methods.
Histogram A and B show the iron content and the residual phenol hydroxylase
activities of the samples before and after depletion/reconstitution procedure,
respectively.
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Fig. 6. Effect of increasing concentration of Fe(NH4)2(SO4)2 on the phenol hydrox-
ylase activity of PH. Activity assays were performed as described in the Experi-
mental procedures section in the presence (ﬁlled squares) or in the absence (ﬁlled
triangles) of 0.35 equiv. of PHK with respect to apo-PH(LNO)2. Values are normal-
ized to the maximum speciﬁc activity obtained in the presence of accessory protein
PHK.
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to apo-PH(LNO)2 resulted in the recovery of a maximal speciﬁc
activity. Conversely, in the absence of PHK, only partial recovery
(50%) of apo-PH(LNO)2 was possible when excess iron (II) was
added to the reaction mixtures.
We cannot exclude the possibility that addition of a greater ex-
cess of iron (II) to apo-PH(LNO)2 might allow for recovery of 100%
of the activity obtained in the presence of PHK. Oxidation of iron
(II) to iron (III) during the enzymatic assay hinders the use of high
concentration of exogenous iron due to a background effect on the
ABS410 monitored during the course of the reaction (see Enzy-
matic assays).
PHK-independent iron insertion into the hydroxylase at high
iron (II) concentration was also demonstrated by the iron reconsti-
tution experiments performed on whole cell extracts expressing
either pGEM3Z/ph or pGEM3Z/phDk and described in Activity as-
says of whole cells of E. coli-JM109 expressing recombinant phenol
hydroxylase in the presence or absence of PHK. Using the same
experiments performed on puriﬁed proteins and described in
PHK-mediated inhibition of phenol hydroxylase activity (Fig. 5),
apo-PH(LNO)2 recovered speciﬁc activity with values comparable
to those obtained in the presence or in the absence of accessory
protein PHK when excess of exogenous iron (II) was added to the
cell extracts. Together, these results suggest that PHK might facil-
itate iron uptake in the hexameric apo-PH(LNO)2 complex, espe-
cially when the transition metal is present at low concentrations.
To evaluate the potential role of iron in the possible dissociation
of the hexameric complex upon incubation with PHK, we moni-
tored the distribution and subunit composition of the species
obtained from gel-ﬁltration experiments performed on iron-de-
pleted samples incubated under different conditions (Fig. 7).
The identities of the subunits eluting in different peaks were as-
sessed by a proteomic approach: 1 mL fractions taken from peak
centers were digested with trypsin and analyzed by MALDI-TOF
or, when ambiguous results were obtained, by capillary LC-MSMS.
Proteins were then identiﬁed by comparing the experimental data
to an in-house database using the MASCOT software. The protein
sequences of PHL, PHN, PHO, PHK, and PHM were included in the
search.
As observed with fully active holo-PH(LNO)2, incubation of
2.5 lM of apo-PH(LNO)2 with 1.25 lM of PHK at room temperature
for 90 min, in a ﬁnal volume of 200 lL, induced the dissociation of
the hexameric species and facilitated the subsequent formation of
PHK-PH(LNO) complexes, as measured gel-ﬁltration experiments
(Fig. 7, red line, and Table S3, Supplementary Material). Addition
of either iron (10 lM) or exogenous regulatory protein PHM
(10 lM) to the incubation mixture did not signiﬁcantly alter the
dissociation proﬁle (data not shown).
Importantly, a signiﬁcant increase of the relative abundance of
active hexameric species was observed with respect to the inactive
trimeric formwhen exogenous recombinant PHM (10 lM) and iron
(10 lM) were added simultaneously to the reaction mixture con-
taining apo-PH(LNO)2 and PHK (Fig. 7, black line). Moreover, in
the later experiment a signiﬁcant fraction of the regulatory protein
PHM was bound to the active hexameric PH(LNO)2 hydroxylase in
a PHM-PH(LNO)2 complex (Fig. 7, black line, and Table S3, Supple-
mentary Material).
Unexpectedly, PHK did not bind to pre-formed, trimeric apo-
PH(LNO). When apo-PH(LNO) was incubated with PHK, up to a mo-
lar ratio of 1:8, we could not detect any PHK co-eluting with the
trimeric species. In these experiments the three hydroxylase sub-
units PHL, PHN, and PHO could be easily identiﬁed by proteomics
methods (data not shown).
This result strongly suggests that PHK binds to the hexameric
form (either apo- or holo-) of the hydroxylase before inducing dis-
sociation to the PHK-PH(LNO) complex.
Discussion
Microorganisms devote part of their genetic and biochemical
resources to ensure that cofactors are properly inserted into the ac-
tive sites of metalloenzymes. Proteins responsible for the tightly
regulated homeostasis of metals are generally known as metallo-
chaperones [31,32]. These proteins also play a key role in prevent-
ing toxic metals – such as iron and copper – from engaging in non-
speciﬁc interactions with cellular membranes, proteins, or DNA
[32,40,41].
Based on biochemical studies of small BMM proteins similar to
PHK from Pseudomonas sp. OX1, such as MMOD from M. capsulatus
(Bath) and DmpK from Pseudomonas sp. CF600 [26,27], several
roles could be envisaged for PHK. Possible functions include a
molecular chaperone, a metal delivery factor, or a metallochaper-
one. Interestingly, sequences with high homology to that encoding
PHK have been identiﬁed in most of the phenol hydroxylase oper-
ons sequenced so far [4,5], clearly suggesting a critical role for
these components in this speciﬁc subfamily of BMMs.
We initially observed that E. coli-strain JM109 cells co-express-
ing recombinant multicomponent phenol hydroxylase from
Pseudomonas sp. OX1 as well as the accessory subunit PHK were
characterized by an improved catalytic ability to convert phenol
to catechol when compared to the same strain expressing the PH
operon devoid of the phk gene. This difference was conﬁrmed
when crude extracts of induced cells were used in the enzymatic
assays instead of whole cells. Whereas total iron content was sim-
ilar in cells expressing the two different ph gene clusters, a signif-
icant difference was observed in the ability of the cells to
hydroxylate phenol. Surprisingly, cell extracts lacking recombinant
PHK demonstrated an increase in hydroxylase activity when excess
iron (II) was added. This result is different from what was previ-
ously observed with the recombinant hydroxylase of multicompo-
nent PH from Pseudomonas sp. CF600 [26]. In this case the activity
of crude extracts of cells not expressing the accessory component
DmpK could be detected only after exogenous iron (II) and DmpK
were both added, supporting the hypothesis that DmpK is involved
not only in the delivery but also the proper insertion of iron into
the active site of the hydroxylase [26].
The role of PHK was investigated here by initially studying its
inﬂuence on the phenol hydroxylase complex reconstituted from
the puriﬁed PHP (oxidoreductase), PHM (regulatory protein) and
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Fig. 7. Characterization of the apo-PH(LNO)2 complex in the presence of PHK, PHM
and iron. Elution proﬁles of an analytical gel ﬁltration chromatographic separation
of a 200 lL mixture of 2.5 lM of apo-PH(LNO)2 and 1.25 lM of PHK (red line), and
of a mixture of 2.5 lM of apo-PH(LNO)2, 1.25 lM of PHK and 10 lM of PHM in the
presence of 10 lM Fe2+ (black line). (For interpretation of the references to color in
this ﬁgure legend, the reader is referred to the web version of this article.)
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PH(LNO)2 (hydroxylase) components [20]. PHK was puriﬁed to
homogeneity and found to be expressed as a dimer, devoid of
any metal or organic cofactor. PHK was not essential for the enzy-
matic activity of the PH complex, when assayed with phenol, and
instead inhibited the reaction even when present at low ratios with
respect to the hydroxylase PH(LNO)2 (Fig. 3).
An insight into the mechanism of phenol hydroxylase inhibition
by PHK was obtained by characterizing the molecular species
formed after incubating the hydroxylase complex PH(LNO)2 with
a sub-stoichiometric amount of puriﬁed PHK (Fig. 4). Native gel
electrophoresis and gel-ﬁltration experiments followed by mass
spectrometric identiﬁcation of the species formed upon incuba-
tion, showed that this is a novel molecular species comprised of
PH(LNO) tightly associated with monomeric PHK. Biochemical as-
says revealed that this species is devoid of both iron and catalytic
activity, providing an explanation for the inhibitory effect observed
when exogenous PHK was added to reconstituted phenol hydroxy-
lase in in vitro enzyme assays. The ability of PHK to promote disso-
ciation of the hexameric complex PH(LNO)2 was conﬁrmed by the
observation that inactive PHK–PH(LNO) could be isolated upon
puriﬁcation of cell extract of E. coli-strain JM109 expressing the
complete ph gene cluster from plasmid pGEM3Z/phDp (Fig. 1). In
the same gel-ﬁltration experiment the yield of the PHK–PH(LNO)
complex was signiﬁcantly lower when complex PHM–PH(LNO)2
instead of PH(LNO)2 was incubated with PHK (Fig. 4B). These re-
sults suggest a possible shielding effect of PHM towards the
PHK-mediated dissociation of the PH(LNO)2 hexamer, likely occur-
ring in the absence of catalytic activity (Fig. 3).
Unexpectedly, experiments aimed at reactivating the PHK–
PH(LNO) complex by the addition of exogenous iron (II) were not
successful. Iron removal and restitution of PH(LNO)2 and PHM-
PH(LNO)2 was possible when excess iron (II) was added, results
that were somewhat independent of PHK (Fig. 5). Interestingly,
iron removal from the hydroxylase was incomplete when PHM
was present (Fig. 5). This ‘‘protective role” of the coupling protein
PHM, observed in several experiments presented here, is similar to
what previous reports of many BMMs described, as in the case of
the sMMO system from M. capsulatus (Bath) [35].
Further insight on what appeared as contradictory results on
the possible role of PHK came from attempts to incorporate iron
into apo-PH(LNO)2 hydroxylase. In the presence of the accessory
protein PHK, complete recovery of the catalytic activity of apo-
PH(LNO)2 occurred when a stoichiometric concentration of iron
(II) was added to the reaction mixture (Fig. 6). This observation is
likely to be physiologically relevant. Notably, iron uptake and
recovery of catalytic activity occurred at a much higher iron (II)
concentration in the absence of PHK, a condition that is probably
not compatible with the physiological concentration of this transi-
tion metal in the cell. This consideration also explains the observa-
tion that enzymatic activity was recovered when cell extracts of
pGEM3Z/phDk were incubated with iron (II), results that suggest
the possibility that iron (II) can be inserted into apo-PH(LNO)2
without the addition of exogenous PHK only when high concentra-
tions of iron were present. In fact, many experiments probing PH
were performed in the presence of an excess of Fe(NH4)2(SO4)2.
Given the result presented here it is possible that these unnatural
conditions might have prevented detection of the physiological
role of PHK-like proteins in early experiments on BMMs. These
experiments presented here show that at least in the PH from
Pseudomonas sp. OX1, the accessory protein PHK is not necessary
for proper diiron cluster assembly in vitro, a result that is different
from what has been shown for the related component DmpK in
Pseudomonas sp. CF600 [26].
Taking into account the data presented in this work and the
information available in the literature for the accessory compo-
nents MMOD [27] and DmpK [26], a possible mechanism (albeit
incomplete) that does account for most of the observations and
in which PHK might be involved can be hypothesized (Fig. 8).
Lacking experimental evidence on early post-translational
events, the model assumes apo-PH(LNO)2 as the starting point of
the sequence of events. PHK transiently binds to the apo-hexamer,
inﬂuencing the insertion of intracellular iron in the active site, and
Fig. 8. Model showing a possible role for PHK. A possible model suggested by the experiments described in this paper and the data presented in literature for DmpK and
MMOD accessory proteins [26,27]. In dark grey is the sequence of events that is still under investigation. The presence of the oxidoreductase PHP in the PH catalytic cycle has
been omitted in the scheme for clarity.
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thereby facilitating the formation of holo-PH(LNO)2, the active
hydroxylase complex.
Based on the ability of PHM to ‘‘protect” holo-PH(LNO)2 from
PHK-mediated dissociation (Fig. 4 and Fig. 7), our model proposes
that the regulatory component PHM binds to the holo-PH(LNO)2
complex immediately after the PHK-facilitated insertion of iron
(II). This event displaces bound PHK, which can then be immedi-
ately recycled to assist in iron insertion in newly assembled apo-
PH(LNO)2 molecules.
In support of the existence of an interplay between the acces-
sory and the regulatory proteins in BMMs, it should be underlined
that Sazinsky and coworkers [35], using the puriﬁed components
of the sMMO from M. capsulatus (Bath), highlighted, by means of
ITC binding experiments, a preferential binding of the regulatory
protein MMOB to the holo-hydroxylase complex MMOH and of
the accessory protein MMOD to the apo-MMOH complex. More-
over, Powlowski and coworkers [26] had previously proposed that
the accessory component DmpK likely interferes with the interac-
tion between the regulatory protein DmpM and the hydroxylase
moiety Dmp(LNO)2.
Once the regulatory component PHM is bound to the PH(LNO)2
active complex, the iron cofactor is protected within the active site
from accidental loss, as indicated by our iron (II) removal and
reconstitution experiments performed on the PHM–PH(LNO)2
complex (Fig. 5). A new catalytic cycle can then be initiated (Fig. 8).
The protective role of the regulatory component in the phenol
hydroxylase system of Pseudomonas sp. OX1 is particularly evident
in the crystal structure of the PHM–PH(LNO)2 complex [19]. This
structure revealed that PHM blocks the entrance of solvent and
substrate to the diiron active site, possibly offering protection of
species formed at the dioxygen-activated metal center as it pro-
ceeds through its reaction cycle [19].
Our current hypothesis is that PHK does not directly bind iron,
as suggested by ITC experiments, but instead might be responsible
for altering the local conformation of apo-PH(LNO)2, thus facilitat-
ing direct access of iron into the hydroxylase active site. We are
currently investigating whether this observation is related to the
direct binding of iron to an apo-PH(LNO)2–PHK transitory complex
or is a consequence of a conformational change induced by PHK in
the iron-depleted hydroxylase moiety apo-PH(LNO)2. The presence
of iron in the active site of the PH(LNO)2 hydroxylase could be
made irreversible by rapid addition of O2 once the two irons are
in place, as already suggested in literature [42,43].
Among others, the question arises whether the PHK–PH(LNO)
complex is of physiological importance. Our current hypothesis is
that during repeated catalytic cycles the hydroxylase might lose
iron which could induce the formation of the PHK–PH(LNO) spe-
cies we observed in vitro (lower part of the scheme in Fig. 8). These
complexes might reorganize, with the aid of further, yet undiscov-
ered, auxiliary proteins, to form apo-PH(LNO)2 species. Alterna-
tively, the presence of PHK might be necessary to avoid the
occurrence of holo-PH(LNO)2 molecules in vivo in the absence of
the regulatory protein PHM. In this case, the oxidoreductase PHP
would still be able to transfer electrons to the hydroxylase moiety
[20], leading to an uncoupling of NADH consumption and product
formation, or a premature reduction of the oxygenated metal clus-
ter, which would not only consume the reactive diiron species but
also deplete the NADH supply of the cell in a wasteful manner [19].
At this stage we cannot exclude the possibility that formation of
inactive PHK–PH(LNO) complexes could be just an artifact of our
system due to the presence of high intracellular concentrations
of recombinant PH(LNO)2 and PHK. This phenomenon would shift
the association equilibrium toward the formation of the PHK–
PH(LNO) species. Nevertheless, the stable PHK–PH(LNO) complex
might be a valuable tool to shed light on the molecular determi-
nants responsible for the interaction between the accessory pro-
tein and the hydroxylase subunits PHL, PHN and PHO in future
experiments.
In conclusion, novel details of the role of the accessory proteins
in bacterial multicomponent monoooxygenases have been high-
lighted in the experiments presented here. These results add to
what has been previously reported for accessory proteins MMOD
and DmpK [26,27].
The similarities and differences between the different accessory
proteins characterized to date lead to the conclusion that in the
BMMs family seemingly similar protein components can have
notably different ways of inﬂuencing the assembly of the diiron
cluster in the active site of the hydroxylase moiety.
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Table S1. Biotinylated PHK partners isolated by avidin pull-down and identified by LC-
MSMS mass spectrometry. Proteomic identification of the major protein bands detected in 
the pull-down assay (Fig.2) using biotinylated PHK and cell extracts of P.sp.OX1 grown on 
phenol as unique carbon and energy source. 
Protein 
band 
Identified protein Accession 
No. 
matched peptides sequence 
coverage        
(%) 
A 
 
B 
 
C 
PHN 
 
PHL 
 
PHO 
 
PHK 
gi|28848925 
Q84AQ2 
gi|28848923 
Q84AQ4 
gi|28848926 
Q84AQ1 
gi|28848922 
Q93JV2 
40 
 
27 
 
3 
 
4 
77 
 
82 
 
26 
 
26 
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Phenol Hydroxylase 
component 
matched peptides sequence coverage        
(%) 
PHN 44 66 
PHL 29 71 
PHO 4 45 
PHK 8 68 
Table S2.  Identification of the subunit components in the phenol hydroxylase complex 
fractionated by native gel electrophoresis. The protein band indicated with an arrow in 
Fig. 4A was excised from the gel and digested in situ with trypsin. The peptide mixture 
was analyzed by LC-MS/MS and the experimental data used for searching the database 
with MASCOT software. 
 
 3 
 
Peak A Peak B  
 
Sample 
Subunits N° of 
matched 
peptides 
sequence 
coverage 
(%) 
Subunits N° of 
matched 
peptide 
sequence 
coverage 
(%)  
Apo PH(LNO)2 incubated 
with PHK  
(Fig.5A-red line) 
PHN a 
PHL a 
PHO a 
23 
22 
4 
46 
59 
33 
PHN a 
PHL a 
PHO a 
PHK a 
24 
23 
5 
7 
46 
61 
38 
43 
Apo PH(LNO)2 incubated 
with PHK, PHM and Fe2+  
(Fig. 5A-black line) 
PHN b 
PHL b 
PHO b 
PHM b 
22 
24 
5 
3 
47 
75 
46 
55 
PHN a 
PHL a 
PHO a 
PHK a 
23 
24 
5 
9 
46 
63 
38 
64 
Table S3. Identification of the subunits in the chromatographic peaks as separated in Fig. 7. 
Proteins were identified in the peak top fractions after tryptic digestion and mass spectrometric 
analysis. 
a
 MALDI-TOF analysis.  
b
 Capillary LC-MSMS analysis. 
 4 
 
Figure S1 
Fig. S1..Effect of different concentrations of accessory 
protein PHK with respect to the apo-PH(LNO)2  
hydroxylase complex on the rate of catechol production. 
The experiment was performed in the presence of 5 µM of 
Fe(NH4)2(SO4)2 and in the experimental conditions described 
in section 3.5 
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ABSTRACT: IF1, the natural inhibitor protein of FOF1ATP synthase able to regulate the ATP hydrolytic
activity of both mitochondrial and cell surface enzyme, exists in two oligomeric states depending on pH: an
inactive, highly helical, tetrameric form above pH 6.7 and an active, inhibitory, dimeric form below pH 6.7
[Cabezon, E., Butler, P. J., Runswick,M. J., andWalker, J. E. (2000) J. Biol. Chem. 275, 25460-25464]. IF1 is
known to interact in vitrowith the archetypal EF-hand calcium sensor calmodulin (CaM), as well to colocalize
with CaM on the plasma membrane of cultured cells. Low resolution structural data were herein obtained in
order to get insights into the molecular interaction between IF1 and CaM. A combined structural proteomic
strategy was used which integrates limited proteolysis and chemical cross-linking with mass spectrometric
analysis. Specifically, chemical cross-linking data clearly indicate that the C-terminal lobe of CaM molecule
contacts IF1 within the inhibitory, flexible N-terminal region that is not involved in the dimeric interface in
IF1. Nevertheless, native mass spectrometry analysis demonstrated that in the micromolar range the
stoichiometry of the IF1-CaM complex is 1:1, thereby indicating that binding to CaM promotes IF1 dimer
dissociation without directly interfering with the intersubunit contacts of the IF1 dimer. The relevance of the
finding that only the C-terminal lobe of CaM is involved in the interaction is two fold: (i) the IF1-CaM
complex can be included in the category of noncanonical structures of CaM complexes; (ii) it can be inferred
that the N-terminal region of CaM might have the opportunity to bind to a second target.
Bovine IF1, the natural inhibitor protein of FOF1ATP
synthase, consists of an 84 residue long monomer which folds
into a single cationic amphiphilic R-helix (1). In solution, two IF1
molecules dimerize by forming an antiparallel R-helical coiled-
coil structure in the C-terminal region, leading the N-terminal
regions to be available for binding to FOF1 (1) and other putative
partners (2). The dimer is the predominant form at acidic pH,
while at pH 6.5, it is in equilibrium with a tetrameric form which
becomes predominant at basic pH (3).
Pedersen andCarafoli groups had previously reported that IF1
is a target for Calmodulin (CaM1) (4, 5), the archetypal EF-hand
calcium sensor (6-9). CaM interacts and regulates numerous
target proteins that are structurally and functionally unrelated,
including metabolic enzymes, structural proteins, transcription
factors, ion channels, and pumps, andmodulates a wide range of
cellular processes in response to calcium (10-12). The list of
known CaM-dependent proteins is extensive, exceeds 300 in
number (13-15), with the diversity of targets being strictly
dependent on the ability of CaM to interact with its targets in
different ways (11, 15-17).
The best known mode of interaction of CaM with the target is
the classical wrap-around mode with the target peptide engulfed
in a hydrophobic channel (18) and the two lobes of CaM coming
close to one other (18-21). Although the wrap-around binding
model was initially assumed to be the predominant structural
mechanism for CaM binding to its targets, a growing body of
evidence demonstrated that CaM can also bind to targets in an
unusual compact or extended conformations in some instances
with less than a full complement of bound calcium ions, as well as
with novel stoichiometries (10, 20). In the case of the plasma
membrane Ca2þ-pump, 4Ca2þ-CaM binding to its peptide C20W
involves only the C-terminal lobe, as a consequence of a missing
hydrophobic anchor residue with respect to the common target
sequences (22). A radically novel target-binding mode has been
revealed with the crystal structure of 2Ca2þ-CaM in complex with
a fragment of Kþ-channel (23) and exotoxin from Bacillus
anthracis (23). In all these structures, CaMmaintains an extended,
open conformation after binding to its target.
Our in vitro fluorimetric analyses clarified that both the bovine
inhibitor protein of FOF1ATP synthase IF1 and yeast inhibitors
IF1 and STF1 interact with Ca
2þ-saturated CaM with a 1:1 ratio
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over a wide pH range. Moreover, sequence visual inspection,
together with binding studies of CaM with bovine IF1 synthetic
peptides, revealed the presence of a conserved putative CaM-
binding motif within the N-terminal of IF1 from bovine and
yeast (2).
In addition, we have reported that IF1 expressed on the cell
surface colocalizes with CaM in human HepG2 cells (25),
suggesting the hypothesis that the interaction may occur in vivo
at this level. Such a hypothesis is reinforced by recent reports
documenting that IF1 located on the plasmamembrane is able to
regulate the activity of FOF1ATP synthase expressed on the cell
surface (25-27).
As mentioned above, IF1 exists in two oligomeric states
depending on pH: an inactive, highly helical, tetrameric form
above pH 6.7 and an active, inhibitory, dimeric form below pH
6.7 (3). In the IF1 dimer, the twomonomers associate through an
extended antiparallel R-helical coiled-coil in the C-terminal
region, while the inhibitory active portion is in the N-terminal
region (28). Structural data are needed in order to understand
whether the binding of CaM overlaps the inhibitory portion as
well as the stoichiometry of the IF1-CaM complex. The aim of
the present work was to characterize the complex between IF1
and Ca2þ-CaM, by defining the stoichiometry and topology of
the protein complex, in the experimental conditions in which the
IF1 is in the dimeric, inhibitory form, i.e., pH 5.
We investigated the stoichiometry of the IF1-CaM complex
by native ESI-MS analyses. Complex topology was investigated
by a combined strategy, which integrates limited proteolysis and
cross-linking experiments with mass spectrometric analyses.
Our data indicated that IF1 and CaM in the physiological
micromolar range form a 1:1 complex, with four calcium ions
bound, and clearly demonstrated that only the C-terminal lobe of
CaM is involved in the formation of the complex and contacts IF1
within the inhibitory, flexible N-terminal region.
MATERIALS AND METHODS
Materials.Recombinant IF1 was provided byMRCMedical
Research Council (Centre Cambridge). Recombinant bovine
calmodulin, TPCK treated trypsin, endoprotease Glu-C, chymo-
trypsin, the cross-linking reagent 1-ethyl-3-(3-dimethylamino-
propyl)-carbodiimide (EDAC), R-cyano-4-hydroxycinnamic acid,
and sinapinic acid were purchased from Sigma. Acetonitrile was
HPLC-grade from Baker.
Biotinylation of IF1. IF1 (344 μg, in 50 mM MES, pH 5.0)
was incubated with 8 μg of Sulfo-NHS-Biotin (sulfosuccinimido-
biotin) (Pierce) (molar ratio 1:1), dissolved in the same buffer, on
ice in the dark for 2 h. The reaction was stopped with 0.1 M Tris
at pH7.0, and the excess of nonreacted biotin reagentwas removed
by size exclusion chromatography on PD-10 columns (GE-
Healthcare) in 0.1 M sodium phosphate at pH 7.2 and 0.15 M
NaCl, following absorbance at 220 and 280 nm to single out IF1-
containing fractions. These fractions were pooled, and the extent
of biotinylation was verified by ESI-MS on an aliquot corre-
sponding to∼1 nmol of IF1 protein previously purified by reverse-
phase HPLC on a ZORBAX Eclipse XDB-C8 column (150 
4.6 mm, 80 A˚ pore size) with a 25-65% acetonitrile linear
gradient in 0.1% TFA over 10 min, at a flow rate of 1 mL/min.
Elution was monitored at 220 nm, and individual fractions were
collected and analyzed by electrospray mass spectrometry on a
QUATTROMicroLC-MS/MS system equippedwith aZ-SPRAY
source and a triple quadrupole analyzer (Waters-Micromass).
Protein solution was injected into the ion source at a flow rate of
10 μL/min. Calibration of the instrument was achieved with the
multicharge distribution of the equine myoglobin. Data were
elaborated using the MassLynx program (Waters-Micromass).
Immobilization of Biotinylated PHK on Avidin and the
Pull Down Assay. Two hundred microliters of avidin agarose
resin (settled gel, Pierce) was equilibrated with five volumes of
binding buffer (0.1 M sodium phosphate at pH 7.2 and 0.15 M
NaCl) and incubated with biotinylated IF1 (2 mg of biotinylated
IF1 per mL of settled avidin agarose resin) at 4 C for 1 h. The
resin was washed with 10 volumes of 50 mMMES at pH 5.0.
CaM (200 μL, 5 μM in 50 mM MES, pH 5.0) was incubated
with 200 μL of biotinylated-IF1 immobilized on avidin agarose
resin and incubated overnight at 4 C. The resin was washed with
10 volumes of 50 mM MES at pH 5.0, and the retained species
were elutedwith 30 μLof denaturing buffer (15.6mMTris, 1.25%
SDS, 2.5%Glycerol, 0.2MDTT). Sampleswere analyzedbySDS-
PAGE (12.5%-10 cm  10 cm), and proteins were stained with
Coomassie Brilliant Blue G-Colloidal (Pierce, Rockford, USA).
Gel Filtration. Gel filtration experiments were carried out as
follows: 50 μL of the 20 μMsample in 50mMammonium acetate
at pH 5.0, 0.15 M NaCl, and 100 μM CaCl2 were loaded on a
Superdex 75 PC (3.2 300mm) gel filtration column installed on
Smart System (Pharmacia LKB) and isocratically eluted at 25 C
at a flow rate of 75 μL/min. The column had been previously
calibrated in 50 mM sodium phosphate at pH 7.5 and 0.15 M
NaCl with the following proteins of known molecular mass:
bovine serum albumin (66000 Da), ovalbumin (45000 Da),
carbonic anhydrase (29000 Da), trypsinogen (24000 Da), and
cytochrome c (12400 Da).
Native Mass Spectrometry. IF1 and the IF1-calmodulin
mixture (1/1, mol/mol) were analyzed on a Q-TOF hybrid mass
spectrometer equipped with a nano Z-spray source (Waters,
Manchester, UK). Protein solutions, 10 μM in 10 mM ammo-
nium acetate at pH 5.0 and 100 μMCaCl2, were injected into the
ion source at a flow rate of 1 μL/min. Data were elaborated using
the MassLynx program (Waters-Micromass). Calibration of the
instrument was achieved with the multicharge distribution of the
bovine pancreatic tripsinogen.
Complementary Proteolysis Experiments. Enzymatic hy-
drolyseswere performed at 37 Cby incubating the 10 μMsample
in 10 mM ammonium acetate at pH 5.0 and 100 μMCaCl2 with
either trypsin, chymotrypsin, or endoproteaseGlu-C, enzyme-to-
substrate ratios ranging from 1:4000 to 1:100 (w/w). The extent of
proteolysis wasmonitored on a time-course basis by sampling the
reaction mixture at different time intervals from 1 to 60 min and
directly analyzing the released peptides by MALDI-MS. For
each measurement, an aliquot of 1 μL of peptide mixture was
applied to a sample slide and mixed with 4 μL of a 10 mg/mL
sinapinic acid solution in acetonitrile/0.2% TFA (70:30, v/v)
before air drying. The samples were then analyzed on a linear
Voyager DE MALDI-TOF mass spectrometer (Applied Biosys-
tems, Foster City, CA). The mass range was internally calibrated
with the [M þ H]þ and [M þ 2H]2þ ions from the entire IF1
protein present in the proteolytic mixture.
Chemical Cross-Linking Experiments. Cross-linking reac-
tions on the IF1 dimer were carried out in a total volume of 20 μL
of 50 mMMES at pH 5.0. IF1 (0.5 nmol) was incubated at 37 C
for 15 min and then treated with 1-ethyl-3-(3-dimethylamino
propyl)-carbodiimide (EDAC) cross-linking reagent for 30 min.
Cross-linking reactions on the IF1-calmodulin complex were
carried out in a total volume of 20 μL of 50 mMMES at pH5.0,
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1 mM CaCl2, and 0.15 M NaCl. Then, 0.5 nmol of IF1 and
0.5 nmol of CaM were incubated at 37 C for 15 min and then
treated with 1-ethyl-3-(3-dimethylamino propyl)-carbodiimide
(EDAC) cross-linking reagent for 30 min.
Preliminary experiments were carried out both for the IF1
dimer and the IF1-CaM complex to determine the optimal
excess of EDAC. Cross-linking reactions were terminated by
quenching the excess of reagentswith gel loading buffer (15.6mM
Tris-HCl, 1.25%SDS, 2.5%glycerol at pH6.8, and 0.2MDTT).
The protein samples were heated at 100 C for 5 min and
separated by electrophoresis on a 15% SDS-polyacrylamide
gel. Proteins were detected by colloidal Coomassie, and selected
positively stained protein bands were excised from the gel, in situ
digested with trypsin, and analyzed by MALDI-MS for protein
identification.
In IF1 dimer cross-linking experiments on a preparative scale,
6 nmol in 120 μL of IF1 were incubated at 37 C for 15 min and
then treated with a 10-fold molar excess of EDAC for 30 min at
37 C. The reaction was stopped by acidification with 1% TFA.
The cross-linked protein was purified by reverse-phase HPLC on
a ZORBAX Eclipse XDB-C8 column (150  4.6 mm, 80 A˚ pore
size) with a 15-65% acetonitrile linear gradient in 0.1% TFA
over 30min, at a flow rate of 1mL/min. Elutionwasmonitored at
220 nm, and individual fractions were collected and analyzed by
electrospraymass spectrometry on aQUATTROMicroLC-MS/
MS system equipped with a Z-SPRAY source and a triple
quadrupole analyzer (Waters-Micromass). Protein solution was
injected into the ion source at a flow rate of 10 μL/min.Datawere
elaborated using the MassLynx program (Waters-Micromass).
The cross-linked protein fraction was evaporated to dryness in a
Speed Vac concentrator (Savant), resuspended in 10 mM ammo-
nium bicarbonate at pH 8.0, digested with trypsin at 37 C
(E/S, 1:50 (w/w)) overnight, and subjected to MALDI-MS and
LC-MS/MS analysis.
In the cross-linking experiment, the IF1-CaM complex on a
preparative scale, 15 nmol of both IF1 and calmodulin was
incubated in 400 μL of 50 mMMES at pH 5, 1 mM CaCl2, and
0,15 MNaCl at 37 C for 15 min and then treated with a 10-fold
molar excess of EDAC for 30 min. The reaction was stopped by
acidificationwith 1%TFA.The cross-linked proteinwas purified
by reverse-phase HPLC on a Phenomenex Jupiter C4 column
(250 4.6 mm, 300 A˚ pore size) with a linear gradient of 5-65%
acetonitrile in 0.1%TFAover 40min, at a flow rate of 1mL/min.
Elution was monitored at 220 nm, and individual fractions were
collected and analyzed by electrospray mass spectrometry on a
Quattro-Micro triple quadrupole mass spectrometer (Waters-
Micromass). Protein solutionwas injected into the ion source at a
flow rate of 10 μL/min. Data were elaborated using the Mas-
sLynx program (Waters-Micromass). The cross-linked protein
fraction was digested with CNBr in 70%TFA overnight at room
temperature under an inert atmosphere in the dark using a large
weight excess of the reagent over protein. The sample was then
diluted 10-fold with water and evaporated to dryness in a Speed
Vac concentrator (Savant). The sample was then fractionated by
reverse-phaseHPLConaPhenomenex Jupiter C4 column (250
2.00mm, 300 A˚ pore size), and individual fractionswere collected
and analyzed by electrospray mass spectrometry. Selected frac-
tions were digested with trypsin in 50 mM ammonium bicarbo-
nate at pH8 at 37 C (E/S, 1:50 (w/w)) overnight and subjected to
MALDI-MS and LC-MS/MS analysis.
MALDI mass spectra were recorded on an Applied Biosys-
tems Voyager DE-PRO mass spectrometer equipped with a
reflectron analyzer and used in delayed extraction mode. One
microliter of the peptide sample was mixed with an equal volume
of R-cyano-4-hydroxycynnamic acid as matrix (in acetonitrile/
50 mM citric acid (70:30, v/v)), applied to the metallic sample
plate, and air-dried.Mass calibrationwas performed by using the
standard mixture provided by the manufacturer.
LC-MS/MS analyses were performed on a Q-TOF hybrid
mass spectrometer equipped with a Z-spray source and coupled
online with a capillary chromatography system CapLC (Waters,
Manchester, UK). After loading, the peptide mixture (4 μL) was
first concentrated and washed at 10 μL/min onto a reverse-phase
precolumn using 0.2% formic acid as eluent. The sample was
then fractionated onto a C18 reverse-phase capillary column
(75 μm 20 mm) with 10-50% acetonitrile in 0.2% formic acid
over 40min, at a flow rate of 280 nL/min. Themass spectrometer
was setup in a data-dependent MS/MS mode where a full scan
spectrum (m/z acquisition range from 400 to 1400 Da/e) was
followed by a tandem mass spectrum (m/z acquisition range
from 100 to 2000 Da/e). Peptide ions were selected as the three
most intense peaks of the previous scan. Suitable collision
energy was applied depending on the mass and charge of the
precursor ion.
RESULTS
Structural Characterization of IF1. Oligomeric State
of IF1.The oligomeric state of IF1was assessed by direct ESI-MS
measurement under native conditions. An aliquot of IF1 (20 μM)
was incubated in 10 mM ammonium acetate at pH 5.0 at 37 for
30 min and then directly injected into the electrospray source of a
hybrid Q-TOF type mass spectrometer. Figure 1 shows the multi-
ply charged ion spectrum of native IF1, showing the presence of
mass signal distribution encompassing z = þ9 to z = þ6 ions.
The measured molecular mass calculated from the ESI-MS spec-
trum was 19166.3( 0.3 Da, in excellent agreement with the expe-
cted value for a dimeric IF1 species ((IF1)2 = 19163 Da).
Limited Proteolysis. Limited proteolysis experiments were
designed to study the surface topology of (IF1)2 on the grounds
that the portions of the protein that are involved in highly
FIGURE 1: Native ESI-MSmass spectrum of the IF1 dimer, showing
the predominant dimeric ions.
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structured regions or are located at the intersubunits interface are
protected from proteases (29).
(IF1)2 (20 μM) was individually incubated with trypsin, chymo-
trypsin, or endoprotease Glu-C, as conformational probes. The
extent of the enzymatic hydrolysis was monitored on a time-
course basis by sampling 1 μL aliquots of the incubation mixture
at different interval times followed by MALDI-MS analysis.
Fragments released from the dimer were identified on the basis of
their unique mass values and the specificity of the proteolytic
enzyme. Identification of the two complementary peptides follo-
wing a single proteolytic event led to the assignment of the
preferential cleavage sites (29). In Supporting Information, an
example of the MALDI-TOF analysis of the time course experi-
ments with Glu-C endoprotease is reported.
The overall results of the limited proteolysis experiments are
summarized in Table 1 and Figure 2, from which a number of
considerations can be drawn. Preferential cleavage sites in (IF1)2
gathered into specific regions of the protein, the most exposed
segment being the N-terminal portion spanning Glu31-Arg37.
Interestingly, no cleavage sites were detected in the C-terminal
region. These data are in perfect agreement with NMR data on
the 44-84 C-terminal coiled-coil IF1 domain (30), and with the
crystallographic structure of the IF1 mutant H49K (1) that could
not be resolved in the N-terminal portion due to the high
flexibility of this region. The high resolution data depict a central,
highly structured, and, therefore, likely inaccessible, antiparallel
coiled-coil structure formed by the opposite pairing of the two
C-terminal regions with the two, very flexible and exposed
N-terminal arms protruding at each end. This structural organi-
zation perfectly justifies our results.
Chemical Cross-Linking of (IF1)2. The interacting contact
regions in the IF1 dimer complex were further investigated by
chemical cross-linking. Cross-links were introduced with the
heterobifunctional reagent EDAC (1-ethyl-3-(3-dimethylamino-
propyl) carbodiimide) that forms zero-length isopeptidic bonds
between the carboxylic group of Glu residues and the ε-amino
group of lysines or the free N-terminus of the protein.
(IF1)2 (20 μM) was incubated in 50 mMMES buffer at pH 5.0
and treated with EDAC at 37 C. Several concentrations of
EDAC and different reaction times were tested and the final
experimental conditions were accurately selected to result solely
in the formation of dimeric species, avoiding the formation of
high molecular mass oligomers and distortion of the tertiary
structure by excessive cross-linking. The cross-linking reaction
mixtures were separated by monodimensional SDS-PAGE and
the resulting gel stained with colloidal Coomassie Blue. Figure 3
shows the electrophoretic analysis of (IF1)2 treated with 10, 100,
500 molar excess of EDAC for 30 min at 37 C. A protein band
with an apparent molecular mass of 19 kDa was clearly detected
in lanes 2, 3 and 4, which could tentatively be assigned to a
covalent dimer of IF1. IF1 was also analyzed on the gel without
treatment with EDAC as the control (Figure 3, lane 1). A thin
band corresponding to a dimeric species could also be observed in
these conditions, demonstrating the peculiar stability of the
noncovalent (IF1)2 dimer, which can resist even to the highly
denaturant conditions of the SDS-PAGE analysis. A 10-fold
molar excess of EDAC was considered enough to introduce
cross-links in a sufficient amount to freeze the dimeric IF1 species
FIGURE 2: Preferential cleavage sites observed in the dimeric form of IF1. The diagram shows the results obtained with trypsin (highlighting in
gray), chymotrypsin (highlighting in black), and Glu-C (boxed residue). In all cases, the proteolytic cleavage took place between the indicated
residue and the following one in the sequence.
Table 1: Peptides Generated in the Digestions of the Dimeric Form of IF1
with Proteases and Identified by MALDI-TOF Analysis
protease
(enzyme/IF1
ratio, w/w)
identified
peptide
experimental
[MHþ] mass
value (Da)
theoretical
[MHþ] mass
value (Da)
Glu-C (1/400) 1-31 3125.69 3125.19
32-84 6476.55 6476.28
trypsin (1/500) 1-9 919.70 920.90
1-16 1548.81 1549.59
1-25 2409.17 2409.52
1-32 3281.35 3281.38
1-35 3748.26 3747.92
1-37 3975.7 3975.19
38-84 5626.54 5626.29
36-84 5853.75 5853.56
33-84 6319.74 6320.10
26-84 7191.11 7191.95
17-84 8051.82 8051.89
10-84 8680.66 8680.58
chymotrypsin (1/1000) 1-33 3444.10 3444.56
1-34 3591.45 3591.73
35-84 6009.01 6009.75
34-84 6156.44 6156.92
FIGURE 3: (IF1)2 cross-linkingwithEDAC. SDS-PAGEof reaction
mixtures with different (IF1)2/EDAC ratios: (1) (IF1)2 without
EDAC; (2) (IF1)2/EDAC 1/10; (3) (IF1)2/EDAC 1/100; (4) (IF1)2/
EDAC 1/500; (M) protein molecular weight markers; molecular
weights are reported in kDa on the side. All of the reactions were
carried out at 37 C for 30 min in 50 mM Na-MES at pH 5.0 and
stopped by the addition of the SDS-PAGE sample buffer.
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for subsequent analysis, while higher excesses of EDAC gener-
ated higher molecular weight bands, thus suggesting aggregation
of the protein caused by excessive cross-linking.
The dimeric protein band was excised from lane 2 and subje-
cted to enzymatic in-gel digestion with trypsin. For comparative
purposes, the monomeric IF1 band from the reference sample
FIGURE 4: MS/MS spectra of the cross-linked peptides AKEQLAALKK and LKQSEDDD. Tandem mass spectra of the precursor ion [M þ
3H]3þ = 677.4. Fragments from the peptide AKEQLAALKK are labeled with an R subscript and those from peptide LKQSEDDD with a
β subscript. Most ion assignments are indicated on the peptide sequence in the figure. Panels A and B represent enlargements of different mass
ranges of the same MS/MS spectrum.
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(lane 1) was also excised and treated in the same manner. The
tryptic digests were then analyzed by MALDI-MS, and the
experimentally obtained mass values were mapped onto the anti-
cipated IF1 sequence, confirming the identity of the protein bands
and the absence of any contaminants.
The MALDI-MS fingerprint of dimeric IF1 showed the
occurrence of three signals that could be assigned to putative
cross-linked products. The signal at m/z 2030.1 was assigned to
the cross-linked peptides 38-47 and 77-84; the signal at m/z
2257.2 was interpreted as arising from either the peptide 36-47
linked to the peptide 77-84 or the peptide 36-46 joined to the
peptide 76-84; the signal at m/z 3349.7 was assigned to the
peptides 38-58 and 77-84. Although the IF1 regions involved in
the cross-link were clearly outlined by these data, discrimination
on which amino acids were actually covalently linked could not
be obtained by MALDI-MS data. A second aliquot of cross-
linked IF1 was then purified by HPLC and analyzed by ESI-MS
providing the expected molecular mass of 19145.7( 0.7 Da. The
sample was digested with trypsin and the resulting peptide
mixture analyzed by nano LC-MS/MS. The multiply charged
ions corresponding to the putative cross-linked species were
isolated and fragmented by collision induced dissociation (CID).
An example of the quality of the data is provided in Figure 4
where the fragmentation spectra of the triply charged ion at m/z
677.4 (corresponding to the MHþ 2030.1) are shown.
The daughter ion spectra exhibited almost the entire y ion series
for the two peptides 38-47 and 77-84. The y1β and y8R ions
constituted the key signals to assess the covalently linked residues.
The former corresponds to the entire 38-47 peptide linked to
Asp84, whereas the latter represents the residual 40-47 fragment
following the release of Asp84 and the dipeptide Ala38-Lys39.
These data unequivocally indicated that the cross-linked
species consisted of peptides 38-47 and 77-84 covalently linked
by an isopeptide bond joining Asp84 to Lys39. Tandem mass
spectra of ions corresponding to the other signals identified in the
MALDI-MS analysis of the tryptic digests confirmed Asp84 and
Lys 39 as the aminoacids involved in the cross-linked product.
This isopeptide bond does not fit with the data of the IF1 crystal
structure. However, fragmentation spectra reported in Figure 4
can be unequivocally interpreted as such. The apparent discre-
pancy could be explained taking into account the conditions of
our experiments, performed in solution at pH 5 and at low IF1
concentration, rather different from the crystallization ones.
Moreover, as stated by Walker’s group (3), the region in wild-
type IF1 predicted to be in the coiled-coil extends from residues 37
to 84, consistent with our experimental observation, whereas for
the IF1-H49Kmutant, for which the three-dimensional structure
has been solved at high resolution (1), the coiled-coil region is
predicted to be shorter (involving only residues 47-84), in good
agreement with the structural data. It should be noted that we
worked with the wild-type IF1 only, thus possibly explaining the
discrepancy between the cross-linked residues observed and the
high resolution data.
Structural Characterization of the IF1-CaM Complex.
IF1-CaM Pull Down. The existence of a IF1-CaM complex,
as suggested by the Pedersen and Carafoli groups (4, 5) and
characterized by spectroscopic analysis (2) was further prelimi-
narily assessed by a pull down assay exposing immobilized biotin
labeled IF1 to CaM.
Biotinylation of IF1 was carried out with Sulfo-NHS-Biotin
(sulfosuccinimidobiotin) and Biotin-IF1 was immobilized on
avidin, as described in the Materials and Methods. An aliquot
ofBiotin-IF1was purified byRF-HPLCan analized byES-MS in
order to assess the biotinilation yield showing that in the
experimental conditions used IF1 was efficiently biotinylated
(up to 2 biotins per IF1 monomer).
The biotinylated IF1 was immobilized on avidin beads that
were subsequently incubated with CaM in 50 mMMES buffer at
pH5.0. After extensivewashing, the CaM that had been recruited
by immobilized IF1 was eluted in denaturing buffer, separated
on SDS-PAGE and stained with colloidal blue Coomassie
(Figure S2, Supporting Information). In a control experiment,
an aliquot of CaM was loaded on avidin beads in the absence of
immobilized IF1, and treated as above: no CaM was unspecifi-
cally retained by avidin beads, thus unequivocally demonstrating
the existence of a specific interaction between IF1 and calmodulin.
Stoichiometry of the IF1-CaM complex. The stoichiom-
etry of the IF1-calmodulin (CaM) complex was investigated by
native electrospray mass spectrometry analyses. Preliminary size
exclusion chromatography analysis was used to inspect the
hydrodynamic behavior of the complex. Approximately equi-
molar amounts of IF1 and CaM (20 μM of each protein) were
incubated at 37 for 30 min at pH 5.0 and then loaded onto a
Superdex 75 size exclusion column. The chromatography resulted
FIGURE 5: IF1-CaM complex is a heterodimer. (A) Size exclusion
chromatography on a Superdex-75 column of an equimolar mixture
of IF1 and CaM. In the inset, a zoom of the elution profile of IF1-
CaM (black line) is overlaid on those of isolated (IF1)2 (red line) and
CaM (green line) obtained in the same chromatographic conditions
(50 mM ammonium acetate at pH 5.0, 0.15 M NaCl, and 100 μM
CaCl2). (B) Native ESI-MS mass spectrum of the IF1-CaM com-
plex, showing the predominant heterodimeric ions.
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in a single peak, which eluted at an apparent molecular mass of
about 26000 Da (Figure 5, panel A; elution volume, 1.30 mL; see
the inset in the figure), suggesting a 1:1 stoichiometry of the
complex. Peak top fractions were analyzed by MALDI-TOF,
revealing the presence of both proteins, i.e., IF1 and CaM (data
not shown).Most importantly, no peak eluting at a volume corres-
ponding to a higher apparent molecular weight was observed,
thus suggesting that, in these experimental conditions, the com-
plex is present in a single predominant homogeneous oligomeric
state. However, a reliable definition of the stoichiometry of the
complex from size exclusion analysis is impaired by the elongated
shape of both components, which significantly alters the hydro-
dynamic behavior of the two isolated proteins (in the same
experimental conditions, (IF1)2 elutes with an apparent molecular
weight of 30000 Da (Figure 5, panel A; elution volume, 1.25 mL;
see the inset in the figure) and CaM with an apparent molecular
weight of 23000 Da (Figure 5, panel A; elution volume, 1.32 mL;
see the inset in the figure), in fairly good agreement with the
apparent molecular weight reported by other authors (31, 32)).
Therefore, this issue was further addressed by native mass
spectrometry, which is not affected by the elongated conforma-
tion of the singular components. An equimolar amount of the
two proteins (20 μMof each protein) was mixed at 37 for 30 min
and then directly injected into the electrospray source of a hybrid
Q-TOF type mass spectrometer under native conditions. Panel B
in Figure 5 shows the enlargement of the full spectrum exhibiting
the presence of a clear distribution of mass signals encompassing
z = þ12 to z = þ8 ions that was assigned to the IF1-CaM
complex containing 4 calcium ions. The measured molecular
mass of this species was 26527.3( 0.7 Da, in excellent agreement
with the expected value for one IF1 molecule bound to one CaM
molecule bearing four calcium ions (expected molecular mass =
26528.0 Da). This result clearly indicated a 1:1 stoichiometry for
the IF1-CaM complex.
Chemical Cross-Linking. The interacting regions in the
IF1-CaM complex were investigated by chemical cross-linking
with the heterobifunctional reagent EDAC, using a procedure
similar to the procedure described above for the IF1 dimer.
IF1 and CaM (20 μM of each protein) were incubated as
reported in the Materials and Methods section, and then treated
with a 10-fold molar excess of EDAC at 37 C for a further
30 min. Isolated CaM and IF1 were also individually incubated
with EDAC under the same conditions as the control. Several
concentrations of EDACand different reaction timeswere tested,
and the final experimental conditions were accurately selected to
result in the formation of an IF1-CaM heterodimeric complex,
avoiding the formation of high molecular mass oligomers and
preventing excessive cross-linking.
The different mixtures of products generated by the cross-
linking reaction were analyzed by SDS-PAGE, as shown in
Figure 6 for the reaction carried out with a 10-fold molar excess
of EDAC. A protein band with an apparent molecular mass of
26 kDa was clearly detected in lane 6. This band was absent both
when equimolar amounts of IF1 and CaM were mixed without
the cross-linking reagent (lane 5) and when CaM and IF1 were
individually treated with EDAC (lanes 2 and 4, respectively).
Aggregation of proteins caused by excessive cross-linkingwas not
observed as demonstrated by the absence of any band in the
higher mass range.
The identity of the 26 kDa gel bandwas definitively assessed by
identification of the protein components by mass spectral anal-
ysis. The protein band was excised from the gel and subjected to
enzymatic in-gel digestion with trypsin. The resulting peptide
mixture was directly analyzed by MALDI-MS and the corre-
sponding mass values were mapped onto the anticipated seque-
nces of IF1 and CaM revealing the contemporaneous presence of
both proteins. These results strongly supported the formation of
a covalent IF1-CaM complex following EDAC treatment and
confirmed previous mass spectral data on the stoichiometry of
the complex.
A second aliquot of the cross-linked IF1-CaM complex was
fractionated by reverse phase HPLC and the collected fractions
analyzed by ESI-MS. The covalent IF1-CaM complex eluted in
two fractions exhibiting molecular masses of 26353.5 ( 1.0 Da
and 26336.1( 1.6Da, the latter being aminor component. These
mass values correspond to the molecular masses of the two
FIGURE 6: IF1-CaMcross-linking with EDAC. SDS-PAGEof reactionmixtures of IF1 (20 μM) andCaM (20 μM)with EDAC (200 μM). The
samples are labeled as follows: (M) protein molecular weight markers, (1) CaM, (2) CaM with EDAC, (3) IF1, (4) IF1 with EDAC, (5) IF1 and
CaMmixture, and (6) IF1 andCaMmixturewithEDAC.All of the reactionswere carried out at 37 C for 30min in 50mMNa-MESatpH5.0 and
stopped by the addition of the SDS-PAGE sample buffer.
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proteins minus 18.01 and 36.02 Da, indicating the presence of the
1:1 IF1-CaM complex containing one and two cross-linking
bonds.
Identification of the cross-linked residues in both IF1 andCaM
proteins was achieved following the strategy outlined in Figure 7
on the fraction containing the IF1-CaM species where one
covalent cross-link had been introduced. The rationale behind
this strategy is based on the absence of methionine residues in the
IF1 sequence that is then unreactive withCNBr. Chemical hydro-
lysis of the complex would have therefore left the undigested IF1
molecule covalently linked to CaM peptides, making these
fragments immediately detectable by mass spectrometry.
The complex was then subjected to CNBr hydrolysis in 70%
TFA at room temperature overnight, and the resulting peptide
mixture was fractionated by HPLC. Individual fractions were
manually collected and directly analyzed by ESI-MS. The frac-
tion containing the species with a molecular mass 11280.2 (
0.5 Da could be tentatively interpreted as IF1 linked to peptide
110-124 of CaM (theoretical mass value 11280.3 Da). Two
minor fractions containing the species with a molecular mass of
13560.3 ( 0.6 Da and 15063.0 ( 0.9 Da were also observed and
interpreted as IF1 linked to peptides 110-144 and 77-124,
respectively (corresponding theoretical mass values of 13560.8
and 15061.5 Da, respectively).
The major component was further hydrolyzed with trypsin at
37 C overnight, and the resulting peptide mixture directly analy-
zed by both MALDI-MS and nano LC-MS/MS. MALDI-MS
spectra displayed the presence of three signals, at m/z 2594.1,
2636.1, and 3465.4 that could not be assigned to any linear
peptide within the aminoacid sequence of either IF1 or CaM.
These species were then considered as putative cross-linked frag-
ments and tentatively interpreted as the IF1 peptides 17-25, 1-9,
and 17-32 linked to the CaM fragment 110-124 (theoretical
mass values 2594.2Da, 2636.1Da, and 3465.57Da, respectively).
Validation of these hypotheses and identification of the IF1
andCaMamino acids covalently linkedwere achieved by tandem
mass spectrometry experiments. The peptide mixture was analy-
zed by nano LC MS/MS, and the multiply charged ions corres-
ponding to the three putative cross-linked species were isolated
and fragmented by collision induced dissociation (CID). Figure 8
shows the fragmentation spectra of the triply charged ion at m/z
879.3 (corresponding to the MHþ 2636.1). The complete y-ion
series attributed to the IF1 peptide 1-9 and part of the b-ion
series spanning the sequence 116-122 of theCaM fragment 110-
124 could be detected, thus confirming the interpretation of the
MALDI data. The specific fragmentation of the two peptides was
certainly dictated by the presence of a trimethyl-lysine residue at
position 115of theCaMpeptide and anArg residue located at the
C-terminus of the IF1 fragment, both endowedwith a high charge
retention propensity.
The individual residues of the two proteins effectively involved
in the covalent linkage could also be assessed by theMS/MSdata.
The two key signals in the spectrum were identified atm/z 1486.5
and 1265.5. The former belongs to the b-ion series and corre-
sponds to the loss of the CaMGlu123-Met124 dipeptide together
with the entire IF1 1-9 fragment from the cross-linked species.
On the contrary, the y-ion at 1265.5 accounts for the whole IF1
fragment covalently bound to the CaM tripeptide Asp122-
Glu123-Met124, with the positive charge retained on the Arg9
residue.
These data unequivocally indicated that the cross-linked species
consisted of the 1-9 N-terminal peptide of IF1 and the 110-124
fragment covalently linked by an isopeptide bond joining Glu123
in the CaM molecule to the IF1 N-terminal amino group.
Similar analyses were carried out on the other two cross-linked
species, demonstrating their identity as the IF1 peptides 17-25
and 17-32 linked, respectively, to the CaM 110-124 fragment.
Moreover, the cross-linked bond could be shown to involve the
CaM Glu123 residue and the ε-amino group of IF1 Lys 24.
Altogether, the cross-linking experiments pointed to an IF1-
CaM complex in which the N-terminal portion of IF1 is in close
contact with the calmodulin C-terminal lobe.
DISCUSSION
The IF1-CaM complex was investigated in solution by a
combined strategy which integrates mass spectrometric metho-
dologies and cross-linking experiments. Crucial issues of the
structural characterization were the stoichiometry of the IF1-
CaM complex and the understanding of the contact region
between IF1 and calmodulin.
Mass spectral analysis of the IF1-CaM complex under native
conditions highlighted the 1:1 stoichiometry, indicating that a
single IF1moiety binds a single CaMmolecule.Most interestingly,
FIGURE 7: General analytical strategy for mapping the interaction
between IF1 and CaM by chemical cross-linking.
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the accuratemass value revealed that 4Ca2þ ions remain bound to
CaM, in accordance with the maintenance of a high Ca2þ affinity
in the complex (4). The ESI-MS did not reveal the presence of
higher order oligomers, as preliminarily suggested by gel filtration
chromatography. The 1:1 stoichiometry implies, therefore, that
CaM binds to monomeric IF1, although IF1 alone in solution at
acidic pH exists and is functional as a dimer, as already suggested
by several experimental data (3) and confirmed by mass spectral
analysis under native conditions in the present study.
The present results, togetherwith our previous data document-
ing the maintenance of a 1:1 molar ratio upon CaM fluorimetric
titration with IF1 up to 10 molar excess (2), are consistent with a
1:1 IF1-CaM complex stoichiometry in the micromolar con-
centration range, which correlates with the physiological con-
centration of CaM present in living cells (8.8 ( 2.2 μM) (33).
More details on the IF1-CaM interactionwere needed to asce-
rtain whether CaMmight interfere with the intersubunit contacts
of the IF1 dimer or bind the inhibitory activeN-terminal region of
the molecule. Cross-linking experiments identified residues at the
contact interface of the IF1-CaM complex. Glu123 in the CaM
molecule was shown to cross-link either the N-terminal amino
group of IF1 or the ε-amino group of IF1 Lys24.
A merely qualitative examination of the cross-linking data
suggested that a unique binding mode of IF1 in the IF1-CaM
complex is incompatible with the experimental results since the
same CaM residue (Glu123) was found cross-linked to two
different IF1 residues, suggesting the existence of at least two
types of IF1-CaM complexes, although the possibility of the
spatial proximity of the IF1 N-terminus and Lys 24 that can be
alternatively cross-linked toGlu123 cannot be ruled out. In order
to correctly interpret this result, it is also worth considering the
ability of CaM to recognize its targets in multiple modes, as
highlighted by similar experiments carried out on the well known
CaM-melittin complex (17) where multiple modes of binding
exist. Moreover, and mostly relevant in this case, the well docu-
mented (1) flexibility of the N-terminal region of IF1 is an
additional element that has to be taken into account to explain
the multiple binding modes observed in the IF1-CaM complex.
This N-terminal segment, extending from the central coiled-coil
of the molecule, appears to be essentially unstructured, as
demonstrated by the high accessibility to proteases exhibited by
the IF1 dimer up to Arg 37, with the most exposed segment being
the N-terminal portion spanning Glu31-Arg37. However, de-
spite the multiple binding mode observed, it is clear that it is the
N-terminal inhibitory region of IF1 that is involved in binding to
CaM, in agreement with the hypotheses that arose on the basis of
sequence analysis and with the previous data obtained with
synthetic peptides (2). The IF1 sequence 33-42 was previously
assessed as a putative target region for CaM on the basis of
fluorimetric binding studies using dansyl-CaM and native bovine
FIGURE 8: MS/MS spectra of the cross-linked peptides GSESGDNVR of IF1 and TNLGEKLTDEEMDEMof CaM. Tandemmass spectra of
the precursor ion [M þ 3H]3þ = 879.31. Fragments from the peptide GSESGDNVR are labeled with an R subscript and those from peptide
TNLGEKLTDEEMDEM with a β subscript. Most ion assignments are indicated on the peptide sequence in the figure.
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IF1 by comparing two synthetic peptides and two natural
mutants, namely, yeast inhibitor proteins IF1 and STF1 (2).
We can consider the contact interface at the 33-42 region to be
congruent with one of the multiple types of binding characterized
by the cross-linking of CaM Glu123 to IF1 Lys24.
Together, the findings that it is the N-terminal inhibitory
region of IF1 that is involved in the contact interface with CaM
and that the complex stoichiometry is 1:1 suggest that binding to
CaM promotes the dissociation of the active IF1 dimer without
directly interfering with the intersubunit contacts of the IF1
dimer.
The overall cross-linking data produced in this article clearly
indicate that only the C-terminal lobe of CaM is involved in
binding IF1. This definitively suggests that the IF1-CaM com-
plex deviates from the canonical or at least more frequent
representation of CaM complexes in which the protein adopts
a horseshoe-like structure with the N and C-terminal lobes, far
apart in the dumbbell native protein (34), coming in close contact
when the target peptide is bound, and originating an overall
globular shaped complex.
Novel structures of CaM complexed with large target frag-
ments, namely, the calcium-activated Kþ channel (23), and
anthrax adenylate cyclase exotoxin (24) have been solved reveal-
ing unexpected binding modes, and our data clearly put the IF1-
CaM complex among the noncanonical CaM interaction mode.
Moreover, a noncanonical binding mode might also explain the
unchanged CaM affinity for Ca2þ previously observed in the
complex (2). In themore common bindingmode, the dissociation
constants of Ca2þ from the EF hands of CaM in both C-terminal
and the N-terminal lobes decrease significantly as a consequence
of ternary complex formation (35-37).
Therefore, the IF1-CaM complex can be included in the
category of novel structures of CaM-target complexes. Inter-
estingly, Vetter and Leclerc reported that in the case of a Ca2þ
pump, the complex only involved the C-terminal lobe of CaM,
similar to what occurs in the IF1-CaM complex (20). In parti-
cular, NMR analysis of CaM complexed with the C20W peptide
of the Ca2þ pump, showed that the protein remained in an
extended conformation with a flexible central linker region bet-
ween Arg74 and Glu84, thus explaining the changes in fluores-
cence emission spectra of Lys75-dansylated CaM upon binding
to the C20W peptide (20). Similarly, the binding of Lys75-
dansylated CaM to IF1 showed changes in the fluorescence
emission suggesting that the linker region of CaM responded
with conformational changes to IF1 binding (2).
The involvement of only the C-terminal lobe of CaM suggests
that the N-terminal region of the protein might bind to a second
target more likely on the plasma membrane where IF1 and CaM
colocalize and where CaM is anchored to lipid rafts (25). More-
over, we can safely state that CaM and F1 can compete for the
binding of IF1 within the physiologic pH range. In fact, in vitro at
pH 6.7 CaM prevents IF1 from inhibiting both F1 (2, 4) and
FOF1ATPase (2) and that both IF1-F1 and IF1-CaM com-
plexes have Kd in the nanomolar range (2, 38). Noteworthy,
selective increase in IF1 expression on the cell surface that may
evoke some specific regulation has been observed to occur and
modulate cell surface-FOF1 activity in response to different
stimuli, i.e., TNFR in HUVEC cells and acute cholestasis in rat
liver (27, 39). Thus, we suggest that CaM on the cell surface may
sequester free IF1 even in the presence ofFOF1 andmaymodulate
the amount of the inhibitory IF1 in response to a proper
stimulus (25).
SUPPORTING INFORMATION AVAILABLE
Example of the limited proteolysis experiments, showing the
MALDI-MS analysis of the aliquots withdrawn following 0, 5,
and 20 min of digestion with Glu-C endoprotease; and the
SDS-PAGE analysis of the pull-down experiment carried out
with biotinylated IF1. This material is available free of charge via
the Internet at http://pubs.acs.org.
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Abstract: p63, a transcription factor related to the p53
tumor suppressor, plays a key role in epidermal dif-
ferentiation and limb development. The gene has two
distinct promoters that allow the formation of proteins
that either contain (TA) or lack (∆N) a transactivation
domain. ∆Np63R is the most widely expressed isoform,
at all stages of development and in adult tissues. It
supports the regenerative capacity of basal keratinocytes
and its upregulation is a hallmark of human squamous
carcinomas. To get insight into the complex biology of
∆Np63R, we set out to identify ∆Np63R interacting pro-
teins by co-immunoprecipitation in mammalian cells and
mass spectrometry analysis. A total of 49 potential
∆Np63R binding proteins, including several heteroge-
neous ribonucleoproteins (hnRNPs), were identified. In-
tegration of the proteomic data with a Human Coexpres-
sion Network highlighted 5 putative p63 protein interactors
whose expression is significantly comodulated with p63:
hnRNPA/B, hnRNPK, hnRNPQ, FUS/TLS and Keratin 5.
hnRNPA/B was already described as a p63 partner, but
the others were novel. Interaction of ∆Np63R with hnRN-
PQ, hnRNPK and FUS/TLS was confirmed by reciprocal
co-immunoprecipitations in human keratinocytes. The
finding that ∆Np63R exists in complexes with several
RNA-binding proteins lays the premises for the analysis
of the role of ∆Np63R in mRNAmetabolism and transport.
Keywords: Epithelial Differentiation • Mass Spectrometry •
p53 Gene Family • mRNA Metabolism • Protein Interaction
Introduction
The tumor suppressor p53 controls a powerful stress re-
sponse by integrating upstream signals from different types of
DNA damage and oncogenic stimuli. Activated p53 elicits cell
cycle arrest and apoptosis, thereby preventing the formation
of tumors.1 p53 is the founding member of a family of proteins
including p63 and p73.2 All three genes can regulate cell cycle
and apoptosis after DNA damage. However, mouse knockout
models revealed an unexpected functional diversity among
them. Indeed, p63 and p73 null mice exhibit severe develop-
mental abnormalities but no increased cancer susceptibility,
whereas this picture is reversed for p53 knockouts.3
The structure of the corresponding genes, named TP53, TP63
and TP73, is evolutionarily conserved. In particular, the most
conserved regions are those encoding the aminoterminal
transactivation domain (TA), the central DNA binding domain
(DBD), and the carboxyterminal oligomerization domain (OD).2,3
The TP63 gene has two distinct promoters allowing the
synthesis of proteins that either contain (TA) or lack (∆N) a
transactivation domain. In addition, alternative splicing at the
3′ end generates proteins with different C-termini, denoted R,
 and γ. Only the R-isoforms (TA and ∆N) contain a Sterile
Alpha Motif (SAM) domain,4 which is absent in p53. Distinct
p63 isoforms are expressed and differentially modulated during
epithelial differentiation.5 In particular, ∆Np63R is strongly
expressed in basal keratinocytes of stratified epithelia and
disappears in differentiating cells. Accordingly, human ∆Np63R
is known to support the regenerative capacity of basal kerati-
nocytes.4 Heterozygous germ line mutations of p63 cause rare
autosomal dominant developmental disorders associated with
ectodermal dysplasia and limb deformities.3 Accordingly, mice
lacking p63 are severely compromised in their ability to
generate limbs, and stratified epithelia such as skin.2
In stark contrast with the high mutation rate of p53 in a large
compendium of cancer types, p63 is not mutated in tumors.
Therefore, although p63 is able to activate p53 responsive genes
and induce apoptosis, it is debated whether it might act as a
tumor suppressor or an oncogene. Remarkably, ∆Np63R gene
is upregulated or amplified in a broad range of squamous cell
carcinomas, thus, suggesting that p63 might be required to
provide cancer cell population with a selective advantage.6
Studies from different groups showed that ∆Np63R overex-
pression contributes to cell dedifferentiation and induction of
metastasis.7,8 Conversely, it has recently been shown that
complete loss of p63 is associated with cancer metastasis and
poor prognosis, thus, implying that p63 can be a potential
marker for cancer progression and invasion.9
Despite its pleiotropic involvement in multiple facets of
epithelial cell biology, mechanistic explanation of how p63
accomplishes its functions remains to be defined. The study
of protein-protein interaction by mass spectrometry is an
increasingly important strategy to understand the role of
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multifunctional proteins. To shed light on the role of ∆Np63R
in epithelial biology, we set out to identify ∆Np63R binding
proteins by co-immunoprecipitation in H1299 cells followed
by mass spectrometry analysis. We identified 49 putative
∆Np63R molecular partners, including several hnRNPs. The
finding that ∆Np63R associates with multiple RNA-binding
proteins suggests that it may play a relevant role in RNA
metabolism processes.
Materials and Methods
Cell Culture and Transfections. H1299 cells derived from
human lung carcinoma were provided by ATCC (CRL-5803).
Cells were grown at 37 °C and 5% (v/v) CO2 in Dulbecco’s
modified Eagle medium supplemented with 10% fetal bovine
serum (Euroclone). HaCaT cells were maintained in RPMI
medium and 10% fetal calf serum. H1299 cells were seeded at
a density of about 70% confluence and transfected with 0.2 µg
of plasmid encoding myc∆Np63R using LipofectAMINE 2000
(Life Technologies, Inc.).
Immunoaffinity Purification of p63-Associated Proteins.
p63 complexes were affinity purified from 10 mg of total
extracts prepared from Myc∆Np63R transfected H1299 cells.
At 24 h after transfection, cells were washed with PBS and lysed
in 50 mM Tris/HCl, pH 7.5, 150 mM NaCl, 0.5% NP40, 5 mM
EDTA, 10% glycerol, and protease inhibitors (Sigma). Total
protein in cell extracts was quantified using the BioRad protein
assay and incubated with mouse anti-IgG agarose conjugated
beads (Sigma) overnight (o.n.) at 4 °C. Beads were pretreated
with 5% nonfat milk. After clarification, extracts were centri-
fuged at 3000 rpm for 5 min at 4 °C. Cell extracts were then
incubated o.n. with immobilized anti-Myc 9E10 antibody (Santa
Cruz). The beads were washed extensively with lysis buffer (150
mM NaCl, 10% glycerol, and 50 mM Tris/HCl, pH 7.5). Control
samples were prepared in parallel using untransfected cell
extracts. Protein samples were eluted with Myc competitor
peptide (200 µg/mL in BC100), TCA precipitated, resuspended
in 2× loading buffer (Sigma) and loaded on a 12.5% SDS
polyacrylamide gel. The gel was run for 1 h in Tris-Glycine
buffer at 25 mA and stained with colloidal Coomassie blue
(Pierce).
Western Blotting Analysis. Each step of the experimental
procedure was paralleled by Western blotting step that served
as control. Samples aliquots were resuspended in 2× loading
buffer (Sigma) and loaded in a SDS-10% polyacrylamide gel.
The gel was run in 10× Tris-Glycine buffer at 200 V, and
transferred to a PVDF membrane (Hybond-P, Amersham
Biosciences). The membrane was blocked with 4% nonfat milk
in TBS (25 mM Tris, pH 7.4, and 125 mM NaCl) for 1 h at room
temperature, washed 3 times with TBS and then incubated with
mouse anti-Myc horseradish peroxidase-conjugated secondary
antibodies (Alexis Biochemicals) Protein were revealed by
enhanced chemiluminescence (RPN2132; Amersham, Buck-
inghamshire, U.K.).
In Situ Digestion and MALDI Analysis. Trypsin, dithiothrei-
tol (DTT), iodoacetamide and R-cyano-4-hydroxycinnamic acid
were purchased from Sigma. NH4HCO3 was from Fluka. Trif-
luoroacetic acid (TFA)-HPLC grade was from Carlo Erba. All
other reagents and solvents were of the highest purity available
from Baker.
Slices containing protein bands were excised from the gel
and destained by repetitive washes with 0.1 M NH4HCO3, pH
7.5, and acetonitrile. Samples were reduced by incubation with
50 µL of 10 mM DTT in 0.1 M NH4HCO3 buffer, pH 7.5, and
carboxyamidomethylated with 50 µL of 55 mM iodoacetamide
in the same buffer. Enzymatic digestion was carried out with
trypsin (12.5 ng/µL) in 10 mM ammonium bicarbonate buffer,
pH 7.8. Gel pieces were incubated at 4 °C for 2 h. Trypsin
solution was then removed and a new aliquot of the same
solution was added; samples were incubated for 18 h at 37 °C.
A minimum reaction volume was used as to obtain the
complete rehydratation of the gel. Peptides were then extracted
by washing the gel particles with 10 mM ammonium bicarbon-
ate and 1% formic acid in 50% acetonitrile at room tempera-
ture. The resulting peptide mixtures were desalted using ZipTip
pipettes from Millipore, following the recommended purifica-
tion procedure.
MALDI-TOF mass spectra were recorded using an Applied
Biosystem Voyager STR instrument equipped with a nitrogen
laser (337 nm). One microliter of the analyte mixture was mixed
(1/1, v/v) with a 10 mg/mL solution of R-cyano-hydroxycin-
namic acid in acetonitrile/50 mM citrate buffer (2/3, v/v) and
was applied to the metallic sample plate and dried down at
room temperature. Acceleration and reflector voltage were set
up as follows: target voltage at 20 kV, grid at 66% of target
voltage, delayed extraction at 150 ns to obtain the best signal
to-noise ratios and the best possible isotopic resolution. Mass
calibration was performed using external peptide standards
purchased from Applied Biosystems. Raw data were analyzed
using the computer software provided by the manufacturer as
monoisotopic masses.
NanoHPLC-chip MS/MS Analysis. LC/MS/MS analyses were
performed on a LC/MSD Trap XCT Ultra (Agilent Technologies,
Palo Alto, CA) equipped with a 1100 HPLC system and a chip
cube (Agilent Technologies). After loading, the peptide mixture
was first concentrated and washed in 40 nL enrichment column
(Agilent Technologies chip), with 0.2% formic acid in 2%
acetonitrile as the eluent. The sample was then fractionated
on a C18 reverse-phase capillary column (Agilent Technologies
chip) at flow rate of 300 nL/min, with a linear gradient of eluent
B (0.2% formic acid in 95% acetonitrile) in A (0.2% formic acid
in 2% acetonitrile) from 7 to 60% in 50 min. Peptide analysis
was performed using data-dependent acquisition of one MS
scan (mass range from 300 to 1800 m/z) followed by MS/MS
scans of the three most abundant ions in each MS scan.
Dynamic exclusion was used to acquire a more complete survey
of the peptides by automatic recognition and temporary
exclusion (2 min) of ions from which definitive mass spectral
data was previously acquired. Nitrogen at a flow rate of 3 L/min
and heated to 325 °C was used as the dry gas for spray
desolvation. MS/MS spectra were measured automatically
when the MS signal surpassed the threshold of 50 000 counts.
Double charged ions were preferably isolated and fragmented
over single charged ions. The acquired MS/MS spectra were
transformed in Mascot generic file format and used for peptides
identification with a licensed version of MASCOT, in a local
database.
Protein Identification. Spectral data were analyzed using
Analyst software (version 1.4.1) and MSMS centroid peak lists
were generated using the MASCOT.dll script (version 1.6b9).
MSMS centroid peaks were threshold at 0.1% of the base peak.
MSMS spectra having less than 10 peaks were rejected. MSMS
spectra were searched against NCBInr database (2009/07/10
version, 211 309 entries) and then converted in Swiss-protein
code, using the licensed version of Mascot 2.1 (Matrix Science),
after converting the acquired MSMS spectra in mascot generic
file format. The Mascot search parameters were taxonomy
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human; “trypsin” as enzyme allowing up to 3 missed cleavages,
carbamidomethyl on as fixed modification, oxidation of M,
pyroGlu N-term Q, as variable modifications, 600 ppm MSMS
tolerance and 0.6 Da peptide tolerance and top 20 protein
entries. Spectra with a MASCOT score <25 having low quality
were rejected. The score used to evaluate quality of matches
for MSMS data was higher than 30.
Comparison with IntAct Data. Data frommass spectrometry
analysis were compared with those provided by IntAct database
(htpp://www.ebi.ac.uk/intact/search/do/search?searchString){0})
linked in the corresponding Swiss-Prot entries (htpp://www.expasy.
org/sprot/). Each protein candidate was submitted to the IntAct
databank obtaining a list of all proteins involved in interaction
with the query protein.
HierarchView (htpp://www.ebi.ac.uk/intact/hierarchView/
display.do) was used to construct a graphical representation
of the interaction network centered on each protein of interest
that had been used as bait in pull-down experiments. IntAct
database was also searched for selecting proteins belonging to
the functionally different complexes recruited by our bait to
obtain graph view of the interactions between these complexes.
Coexpression Analysis. The list of human genes whose
expression is comodulated with p63 was derived essentially as
described.10 Briefly, we collected 353 human normal tissue
Affymetrix microarray experiments, corresponding to 65 dif-
ferent tissues.11
We then calculated the Pearson correlation coefficients of
every probe set (r1) in the expression matrix with all other probe
sets (rx), and ranked the probe sets according to the values of
this index. A directed edge was established from r1 to rx if rx
fell within the top 1% rows in terms of correlation with r1.
These directed networks where then converted into undi-
rected networks by mapping the probe sets to the correspond-
ing Entrez Gene identifiers. The list of genes whose expression
is strictly comodulated with p63 is defined as the ensemble of
the first-level links of p63 in this network.
Co-Immunoprecipitation. HaCaT cells from subconfluent
100 mm plates were collected for preparation of whole-cell
extracts as previously described.12 Lysates containing 1 mg of
proteins were precleared with 30 µL of protein A-agarose (50%
slurry; Roche) and then incubated overnight at 4 °C with 3 µg
of anti-p63 monoclonal antibody (4A4; Santa Cruz), anti-
hnRNPK (H-300: sc-25373 Santa Cruz), anti-hnRNPQ (I8E4; sc-
56703 Santa Cruz), or anti-FUS (A300-302A Bethyl Laborato-
ries) antibodies. Anti-GFP antibodies (Roche) were used as
control of specificity. Anti-hnRNPA/B (H-200: sc-15385 Santa
Cruz) antibodies were used as control of positive interaction.
The immunocomplexes were collected by incubating with
protein A agarose at 4 °C for 4 h. Beads were washed vigorously
with 50 mM Tris-HCl, pH 7.5, 150 mN NaCl, 5 mM EDTA, 0.5%
NP40, and 10% glycerol, resuspended in 4× SDS-PAGE loading
buffer and loaded directly in an 8% SDS-polyacrylamide gel.
Results
Identification of Proteins Specifically Interacting with
the Bait. The proteins specifically interacting with p63 were
defined by functional proteomics using transfected Myc-tagged
∆Np63R protein as bait. Two biological replicates were per-
formed using different cellular extracts. Briefly, total protein
extract (10 mg) from ∆Np63R transfected H1299 cells was
precleared with underivatized agarose beads to minimize
nonspecific binding. The unbound material was immunopre-
cipitated with polyclonal anti-Myc IgG conjugated agarose
beads. The proteins bound to the affinity column were exten-
sively washed and eluted with two different concentration of
Myc peptide solution (Figure 1A, sample I and sample II).
Control experiments were carried out, in parallel, using extracts
from untransfected H1299 cells. Following each step of the
procedure, Western blotting was performed on a sample aliquot
using anti-Myc antibodies as a control (Figure 1A). The protein
mixture from the first myc elution was subjected to SDS-PAGE
and visualized with Coomassie Blue staining (Figure 1B).
Figure 1. Western blot analysis of ∆Np63R during the affinity
purification procedure. (A)Western blotting of extracts fromMyc-
∆Np63R transfected H1299 cells (sample). Untransfected H1299
cell extracts were used as control. Aliquots (40 µg) corresponding
to each step of the experimental procedure were subjected to
Western blotting and revealed with anti-Myc and peroxidase-
conjugated secondary antibodies. Whole cell extract (lane 1).
Unbound control (lane 6) and sample (lane 7) after precleaning
with underivatised agarose beads. Elution with myc-peptide
competitor, control (lanes 2 and 4), sample (lanes 3 and 5). (B)
SDS-PAGE fractionation of ∆Np63R protein complexes. ∆Np63R
protein complexes were isolated by immunoprecipitation experi-
ment. Following SDS-PAGE fractionation, Coomassie Blue stained
protein bands occurring in the sample (lane 5) and in the control
(lane 4) were submitted to mass spectral analyses. Correspond-
ing gel slices from the sample and control lanes (slices 1-25)
were submitted to the identification procedure. Common proteins
identified in both the sample and the control gel slices were
eliminated. Molecular weight markers are also shown (lane 1).
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Stained gel displayed a number of discrete bands both in the
control and sample lanes (lanes 4 and 5, respectively). Because
of the complexity of the gel patterns and the low resolution of
1D electrophoresis, several proteins can occur in the same gel
band. Therefore, protein bands specifically present in the
sample lane and absent in the control lane cannot be identified
by simply comparing the two gel profiles. Thus, the entire lanes
from the sample and the control were cut in 25 slices each and
the slices were destained and trypsin digested, in situ. The
resulting peptide mixtures were extracted from the gel, tested
by MALDI-MS, and analyzed by nanoLC/MS/MS analysis
generating sequence information on individual peptides.
This information, together with the peptide mass values, was
then used to search protein databases, leading to the identi-
fication of the protein components. All the gel bands from the
sample and control lanes were then compared on the basis of
the proteins effectively identified in each gel slice. Common
proteins identified both in the control and the sample slices
were discarded and only those proteins solely identified in the
sample slices and absent in the control were considered. As
further selection criteria, only the proteins, identified by
MASCOT search with at least 3 peptides, and found exclusively
in both biological replicates were selected, providing a full list
of putative ∆Np63R interactors.13 As an example, slice 11 from
the sample lanes, in Figure 1B, revealed the presence of 9
proteins identified with at least 3 peptides. However, six of
these putative interactors were also found in the corresponding
slices from the control lanes and were then discarded. The
remaining three proteins fulfilled the selection criteria and were
then considered as putative p63 interactors.
This strategy let us to obtain more confident identification
of truly ∆Np63R binding candidates minimizing the number
of false positives.14 It should be noted that some proteins
showed a higher electrophoretic mobility, with respect to their
corresponding molecular weight. This finding could be due to
some proteolytic processing. On the contrary, other protein
candidates exhibited a molecular mass lower than expected on
the basis of the electrophoretic mobility, likely due to the
occurrence of post-translational modifications. A total of 49
putative p63-interacting proteins were identified and listed in
Table 1 together with their corresponding genes and the
number of peptides used for their identification.
Database Analysis of Protein-Protein Interactions. To
assess whether the proteins identified by the proteomic screen-
ing were novel p63 interacting partners, we extensively searched
the literature and protein interaction databases for known
interactors. Interestingly, hnRNPA/B (ABBP1) was already
described as a p63 direct interactor.15
To define the functional relationships between the putative
p63 interactors, we classified them according to the Gene
Ontology annotation and analyzed if some of the GO keywords
were significantly enriched. Six distinct functional clusters were
represented: transcription, mRNA processing, mitosis and
protein folding factors, ribosomal and structural proteins
(Figure 2). Statistical analysis revealed that proteins involved
in RNA-binding and mRNA processing were significantly
enriched in our list of candidates (GO keywords: RNA binding,
1.8 × 10-13; mRNA processing, 1.9 × 10-5).
Integration of the Proteomic Screening with Coexpres-
sion Analysis. Integration of proteomic and transcriptomic data
can be of great help to identify functionally relevant protein-
protein interactions.16
To increase the likelihood of selecting the most functionally
significant interactors, among the p63-binders, we searched
microarray data for those genes having an expression profile
very similar to p63. To address this question, we extracted a
list of genes highly comodulated with p63 (Supporting Infor-
mation) from a recently described human coexpression net-
work obtained from a large meta analysis of normal tissues
microarray data.10 Although it is conceivable that the protein
expression profiles in cancer cells could be different from
normal cells, we reasoned that, in tumors, p63 should still retain
functionally relevant interactions with proteins that are nor-
mally coexpressed. Moreover, integration of proteomic data
from lung cancer cells with transcriptomics from normal tissues
should lead to the identification of interactors that may be of
interest to the p63 functions, far beyond the particular cell line
used for the proteomic screening.
Interestingly, five proteins included in our list of p63 putative
partners, Keratin 5, hnRNPA/B, hnRNPK, hnRNPQ (Syncrip)
and FUS/TLS, are also significantly comodulated with p63, in
human tissues. Keratin 5 is a structural protein; since it is highly
expressed in squamous cell lung carcinomas,,17,18 19 it might
likely represent a false positive.
FUS, hnRNPQ, hnRNPK, and hnRNPA/B (ABBP1) are all RNA
binding proteins involved in pre-mRNA processing, mRNA
export and turnover mechanisms.20 Since hnRNPA/B was
already validated as a p63 interactor,15 we decided to further
validate the interaction of p63 with hnRNPK, hnRNPQ and
FUS/TLS.
Confirmation of ∆Np63r Association with FUS/TLS,
hnRNPQ, and hnRNPK. To validate the interaction of ∆Np63R
with FUS/TLS, hnRNPK, or hnRNPQ, we performed co-immu-
noprecipitation assays in HaCaT human keratinocytes, a more
physiological environment. First, we verified that hnRNPK,
hnRNPQ, and FUS proteins are endogenously expressed in
HaCaT cells by Western blot (data not shown). Then, we
immunoprecipitated endogenous ∆Np63R, from HaCaT cells,
with the 4A4 antibody. Specific immunodetection showed that
FUS, hnRNPK, and hnRNPQ were present in p63 complexes
(Figure 3A,B and data not shown). Conversely, p63 was specif-
ically pulled down by antibodies against hnRNPQ, hnRNPK,
or FUS (Figure 3C and data not shown). Interestingly, the
amount of associated p63 was much higher for hnRNPK than
for FUS or hnRNPQ, indicating that the fraction of FUS or
hnRNPQ associated with p63 was a minor pool of the total FUS
and hnRNPQ proteins. Neither FUS nor hnRNP proteins were
immunoprecipitated using anti-GFP antibodies (Figure 3).
Immunoprecipitation with antibodies against ABBP1 was per-
formed as control of positive interaction (Figure 3D). These
results, together with the GO keyword overrepresentation
analysis, indicate that p63 might play a role in association with
components of ribonuclear protein complexes.
IntAct Data. Finally, we compared our proteomic results with
those provided by IntAct database (see Materials and Methods).
Each protein candidate was submitted to the IntAct databank
obtaining a list of all proteins involved in interaction with the
query protein. HierarchView (htpp://www.ebi.ac.uk/intact/
hierarchView/display.do) was used to construct a graphical
representation of the interaction network centered on each
protein of interest. IntAct database was also searched for
selecting proteins belonging to functionally different complexes
recruited by our bait. Total interaction graph view is reported
(Supporting Information), where the putative interactors iden-
tified by our MS approach are evidenced. Similar results were
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obtained performing the search with different programs such
as http://string.embl.de/ or http://www.thebiogrid.org/.
Discussion
∆Np63R plays a pivotal role in epithelial cell proliferation,
differentiation and transformation. However, the mechanistic
aspects of how p63 accomplishes its multiple functions remain
somewhat enigmatic and controversial. To address this point,
we have performed a comprehensive analysis of the interac-
tome of ∆Np63R in H1299 cells by mass spectrometry. We have
chosen these cells because they express neither p53 nor p73,
thus, making our analyses independent from the other mem-
bers of the p53 gene family.
To identify protein specifically interacting with ∆Np63R, we
performed co-immunoprecipitation and mass-spectrometry
analysis. We adopted the very stringent criterion of filtering
out those proteins that were not identified in two independent
biological replicates as well as those proteins that were seen
in the nonspecific elution sample. We identified a total of 49
proteins; 48 out of 49 were novel p63 putative partners. We
reasoned that ribosomal proteins, Keratin 5 and 6 could be
contaminants because of their abundance. Nevertheless, since
keratins are structural proteins highly expressed in lung
carcinomas and are induced by p63,17,1819 we cannot exclude
that they may actually interact with p63.
Data from the functional proteomics experiments were
integrated with transcriptomics from normal tissues. The
rationale of integrating proteomic data from lung cancer cells
with transcriptomics from normal tissues was that we wanted
to focus on the interactors that may be of interest to the p63
Table 1. Full List of ∆Np63R Putative Interactors Identified by Mass Spectrometry
slicea molecolar weight gene symbol accession number protein name
number of
peptides score
amino acid
coverage
2 273400 Da FAS P49327 FAS FAS [TNF receptor member 6] 17 633 10%
242984 Da CAD P27708 PYR1 Cad protein 4 51 3%
290959 Da FLNC Q14315 FLNC Filamin-C 3 50 2%
4 140958 Da DHX9 Q08211 DHX9 ATP-dependent RNA helicase A 7 124 6%
5 118315 Da SEC24C P53992 SC24C Protein transport protein Sec24C 3 44 2%
6 89322 Da VCP P55072 TERA Transitional endoplasmic reticulum ATPase 5 118 7%
521126 Da SACS Q9NZJ4 SACS Sacsin 8 47 3%
100200 Da PSMD2 Q13200 PSMD2 26S proteasome non-ATPase regulatory subunit 2 4 56 4%
7 70943 Da HNRNPR O43390 HNRPR Heterogeneous nuclear ribonucleoprotein R 3 81 5%
261140 Da GOLGA4 Q13439 GOGA4 Golgin subfamily A member 4 9 44 4%
8 72333 Da HSPA5 P11021 GRP78 78 kDa glucose-regulated protein [Precursor] 6 146 14%
53426 Da FUS P35637 FUS RNA-binding protein FUS 6 173 9%
10 163278 Da A2M P01023A2MG Alpha-2-macroglobulin [Precursor] 5 116 4%
69603 Da SYNCRIP O60506 HNRPQ Heterogeneous nuclear-ribonucleoprotein Q 7 93 18%
45923 Da ZNF676 Q8N7Q3 ZN676 Zinc finger protein 676 3 39 7%
11 76785 Da TP63 Q9H3D4 P63 Tumor protein 63 23 270 37%
59210 Da CPSF6 Q16630 CPSF6 Cleavage and polyadenylation specificity factor subunit 6 3 69 5%
70436 Da PLS3 P13797 PLST Plastin-3 3 56 7%
12 62378 Da KRT5 P13647 K2C5 Keratin, type II cytoskeletal 5 5 168 9%
63460 Da CARM1 Q86 × 55 CARM1 Histone-arginine methyltransferase CARM1 5 159 10%
60187 Da HNRNPL P14866 HNRPL Heterogeneous nuclear ribonucleoprotein L 7 139 19%
59621 Da CCT8 P50990 TCPQ T-complex protein 1 subunit theta 4 101 11%
54232 Da NONO Q15233 NONO Non-POU domain-containing octamer-binding protein 4 73 9%
50976 Da HNRNPK P61978 HNRPK Heterogeneous nuclear ribonucleoprotein K 7 50 19%
13 60025 Da KRT6C P48668 K2C6C Keratin, type II cytoskeletal 6C 13 797 25%
49895 Da TUBA1C Q9BQE3 TBA1C Tubulin alpha-1C chain 7 173 22%
59751 Da ATP5A1 P25705 ATPA ATP synthase subunit alpha, mitochondrial [Precursor] 3 86 7%
15 46109 Da RPL3 P39023 RL3 60S ribosomal protein L3 4 104 14%
50141 Da EEF1A1 P68104 EF1A1 Elongation factor R 1 4 90 9%
16 32854 Da RPSA P08865 RSSA 40S ribosomal protein SA 5 103 24%
105114 Da ZBTB4 Q9P1Z0 ZBTB4 Zinc finger and BTB domain-containing protein 4 3 42 4%
17 32142 Da HNRPCL1 O60812 HNRCL Heterogeneous nuclear ribonucleoprotein C-like 1 4 134 12%
39595 Da HNRPA3 P51991 ROA3 Heterogeneous nuclear ribonucleoprotein A3 3 125 11%
36225 Da HNRPAB Q99729 ROAA Heterogeneous nuclear ribonucleoprotein A/B 3 70 8%
306482 Da MAP1A P78559 MAP1A Microtubule-associated protein 1A 7 43 4%
19 34274 Da RPLP0 P05388 RLA0 60S acidic ribosomal protein P0 9 374 35%
22350 Da HIST1H1D P16402 H13 Histone H1.3 3 63 16%
162505 Da UACA Q9BZF9 UACA Uveal autoantigen with coiled-coil domains and ankyrin repeats 4 39 4%
20 31280 Da SNRPA P09012 SNRPA U1 small nuclear ribonucleoprotein A 6 165 24%
147810 Da UPF2 Q9HAU5 RENT2 Regulator of nonsense transcripts 2 4 35 5%
21 316415 Da CENPE Q02224 CENPE Centromeric protein E 7 44 2%
22 102642 Da SAFB Q15424 SAFB1 Scaffold attachment factor B1 4 42 8%
41775 Da EDG8 Q9H228 S1PR5 Sphingosine 1-phosphate receptor Edg-8 3 39 9%
24 17779 Da RPL24 P83731 RL24 60S ribosomal protein L24 3 90 15%
23577 Da RPL13A P40429 RL13A 60S ribosomal protein L13a 3 40 12%
25 17819 Da RPL12 P30050 RL12 60S ribosomal protein L12 4 91 18%
19794 Da MRLC2 P19105 MRLC3 Myosin regulatory light chain 2, nonsarcomeric 3 58 15%
26 83264 Da HSP90AB1 P08238 HS90B Heat shock protein HSP 90-beta 13 413 22%
a Gel slice numbers correspond to those reported in Figure 1B.
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functions, far beyond the particular cell line used for the
proteomic screening.
Among others, we identified ER stress response proteins
including TCPA, TCPQ, HSPA5, and HSP90B chaperones. Our
list also includes Sacsin (SACS) that participates to chaperone-
mediated protein folding20 and GRP78 that facilitates the
assembly of multimeric protein complexes inside the ER.21
Interestingly, GRP78 belongs to the family of HSP70, a gene
whose promoter is transactivated by ∆Np63R.22
Intriguingly, our list of ∆Np63R putative interactors includes
a remarkable number of heterogeneous ribonucleoproteins
(hnRNP). HnRNPs represent a wide gene family whose com-
ponents are involved in RNA metabolism processes and
transport.23,24 We identified hnRNPR, hnRNPQ, hnRNPL, hnRN-
PA3, hnRNPA/B, and hnRNPK as potential components of p63
protein complexes. The presence in our list of hnRNPA/B, also
known as ABBP1 (Apobec binding protein 1), already identified
as ∆Np63R partner, and hnRNPQ, which interacts with ABBP1,
represents a first strong validation of our approach. Remark-
ably, it was previously shown that the binding of ∆Np63R to
ABBP1 causes a shift of the FGFR-2 alternative splicing toward
its epithelial specific isoform.15 Furthermore, it was demon-
strated that ∆Np63R associates with the pre-mRNA splicing
factor SRA4 which mediates p63 association with the carboxy-
terminal domain of RNA polymerase II. Interestingly, AEC-
associated mutations of ∆Np63R affect the binding of p63 to
SRA4 causing aberrant splicing of ∆Np63R.25 The finding of a
physical association between hnRNPK and p63 was particularly
attractive since it has been described as a transcriptional
coactivator of p53 in response to DNA damage. HnRNPK is
implicated in chromatin remodelling, transcription and trans-
lation processes.26 Moreover, like p53, hnRNPK is ubiquitinated
by the MDM2 E3 ubiquitin ligase, a major regulator of p53
activity. Depletion of hnRNPK inhibits transcriptional induction
of p53 target genes and causes defects in DNA damage induced
cell cycle arrest.27
FUS/TLS is a RNA binding protein, and is a member of the
Ewing’s sarcoma family of RNA binding proteins. It often occurs
as a fusion protein with the transcription factor CHOP, which
is oncogenic. Apparently, FUS might function in nuclear-
cytoplasmic transport of mRNA. However, its specific functions
are still unknown.28
hnRNPQ, hnRNPK, and FUS/TSL were found in the list of
genes whose expression is consistently comodulated with p63
in normal human tissues. We verified their association with
∆Np63R using endogenous proteins in HaCaT keratinocytes,
a more physiological context. Interestingly, when co-immu-
noprecipitation was performed using the anti-FUS and the
Western blot was performed using the anti-p63, we could detect
a low amount of p63. In this case, we noticed that the level of
p63 bound to FUS was lower compared with the level of FUS
in total cell lysate suggesting that a large amount of FUS might
exist as a free form or engaged in distinct protein-protein
complexes. Interestingly, human keratinocytes express abun-
dant levels of FUS/TLS protein that localizes to the nuclei at
all levels of the epidermis.28 In conclusion, we have identified
a large set of new potential p63 protein partners that includes
a considerable number of hnRNPs. HnRNPs are component
of spliceosome, the large ribonucleoprotein complex that
catalyzes pre-mRNA splicing. Our data indicate that p63 might
be involved in mRNA metabolism processes, an aspect of the
p63 biology that is still under-investigated.
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Figure 2. Functional clusters of ∆Np63R interacting partners.
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Figure 3. ∆Np63R interacts with hnRNPK, hnRNPQ, and FUS/TLS.
(A) Untransfected HaCaT cell lysates were immunoprecipitated
with anti hnRNPK, anti-p63, or anti-GFP antibodies. Immuno-
complexes were blotted and probed with anti-hnRNPK and anti-
p63 antibodies. The expression level of endogenous hnRNPK and
p63 are shown in lane 1 (input). (B) Untransfected HaCaT cell
lysates were immunoprecipitated with anti FUS or anti-p63
antibodies, as indicated. The immunocomplexes were blotted
and probed with anti-FUS and anti-p63 antibodies. The expres-
sion level of endogenous FUS and p63 are shown in lane 1
(input). (C) Cell lysates from untransfected HaCaT cells were
immunoprecipitated with anti-hnRNPQ or anti-GFP antibodies.
Immunocomplexes were blotted and probed with antibodies
against hnRNPQ or p63. The expression level of endogenous
hnRNPQ and p63 are shown in the input lane. (D) Immunocom-
plexes from untransfected HaCaT cell lysates obtained with anti-
p63 or anti-GFP antibodies were analyzed by SDS-PAGE and
probed with anti-p63 and anti-ABBP1 antibodies. The expression
levels of p63 and ABBP1 are shown in lane 1 (input).
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Abstract The identification of proteinaceous components
in paintings remains a challenging task for several reasons.
In addition to the minute amount of sample available,
complex and variable chemical composition of the paints
themselves, possible simultaneous presence of several
binders and contaminants, and degradation of the original
materials due to aging and pollution are complicating
factors. We proposed proteomic strategies for the identifi-
cation of proteins in binders of paintings that can be
adapted to overcome the requirements and difficulties
presented by specific samples. In particular, we worked
on (1) the development of a minimally invasive method
based on the direct tryptic cleavage of the sample without
protein extraction; (2) the use of microwave to enhance the
enzymatic digestion yield, followed by the analysis of the
peptide mixtures by nanoLC-MS/MS with electrospray
ionization (ESI). Moreover, as an additional tool to tackle
the problem of contaminating proteins, we exploited the
possibility of generating an exclusion list of the mass
signals that in a first run had been fragmented and that the
mass spectrometer had to ignore for fragmentation in a
subsequent run. The methods, tested on model samples,
allowed the identification of milk proteins in a sample from
paintings attributed to Cimabue and Giotto, thirteenth-
century Italian masters, decorating the vaults of the upper
church in the Basilica of St. Francis in Assisi, Italy.
Keywords Proteinaceous binders . Enzymatic digestion .
LC-ESI-MS/MS . Paintings . Paraloid B72
Introduction
Science can interact with art in many ways. One way, and
the most important one currently, is providing tools to
safeguard our cultural heritage for future generations.
Art paintings have traveled through the ages and the
artistic techniques and materials employed were directly
associated with the geographical, social, and time frames in
which the artists lived and created.
The characterization of painting materials using analyt-
ical methods contributes not only to our knowledge of the
artists’ techniques, but also to our understanding of the
evolution of painting styles. Furthermore, it is useful for
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dating artworks as well as in authenticating of historic
paintings. Determination of chemical composition of
painting materials is an essential step that restorers require
to choose the best preservation procedure. In fact, because
aging can cause irreversible damage to ancient master-
pieces, curators will not understand the sources of deteri-
oration of artworks and cannot arrest degradative processes
without a prior knowledge of the painting composition.
From a technical point of view, paintings are complex
materials characterized by intrinsic heterogeneity on a
microscale. They usually consist of multiple layers of 10–
200 μm thickness made of organic (lakes) and/or inorganic
pigments dispersed in an organic matrix (binder), applied
on a preparation substrate, and coated with a varnish
protective layer. This complexity makes the approach to
their scientific investigation quite challenging, particularly
when considering that analytical studies in the science of
cultural heritage often involve invaluable works of art, for
which destructive sampling techniques should be avoided
or severely limited wherever possible. Consequently,
scientists have made great efforts to put forward either
non-destructive or micro-destructive analytical approaches
to characterize painting materials and their alteration
products [1]. This goal is especially true for the wide class
of natural organic substances historically used in art (oils,
resins, gums, wax, and proteinaceous material), due to their
variable composition and their propensity to undergo
chemical and biological degradation processes [2].
Of the many proteinaceous substances found in nature,
animal glue, egg (both yolk and albumen), and casein from
milk have long been used for preparation of binders,
coatings, and adhesives, used alone, mixed together, or in
combination with oils and other organic materials. Different
methods have been proposed in literature to characterize
proteinaceous components in paintings, and, so far, identi-
fication of the specific proteins occurring in binders has
been essentially performed using high-performance liquid
chromatography (HPLC), gas chromatography (GC)-mass
spectrometry (MS), and pyrolysis (Py)-GC-MS [3, 4].
GC-MS and HPLC methods are based on the quantita-
tive determination of the amino acids profile following
protein hydrolysis. In Py-GC-MS analysis, recognition of
proteins is achieved by observing specific markers formed
during the pyrolytic step. However, a number of drawbacks
can affect these methods, i.e., presence of contaminants,
similar amino acid composition of proteinaceous binders
from different biological sources (i.e., collagen from bovine
or rabbit), and, particularly, alteration of amino acid ratios
during sample preparation procedures or modification of
the residues due to natural reactions as the artwork ages [3].
In the last few years, several new methods for reliable
differentiation of proteinaceous materials have been devel-
oped, including ELISA, immunofluorescence and chemilu-
minescence, but they still need further refinement for
routine laboratory applications [5–8].
More recently, protein mass spectrometry was success-
fully used for painting analysis, providing promising results
[9–11]. As in a classical proteomic procedure, the protein-
aceous binders were enzymatically digested with specific
proteases, typically trypsin, which selectively cleaves the
peptide bond following basic amino acids (namely lysine
and arginine). From each individual protein occurring in the
binders, a specific set of peptides is released following the
enzymatic digestion that constitutes a molecular “finger-
print” of that particular protein. This peptide fingerprint is
by far more specific than amino acids profile in identifying
proteins. The peptide mixture originated by enzyme
digestion can be analyzed by different mass spectrometry
procedures leading to the unambiguous identification of
proteins. The highly sensitive MALDI-TOF analysis gen-
erates a mass spectrum characterized by the accurate mass
values of the peptides that often enables a reliable
identification by comparison with reference samples in
databases without further analysis [11, 12]. With samples
containing several proteins in mixture, where the above
procedure can fail to provide confident results, conversely,
nanoliquid chromatography coupled to tandem mass spec-
trometry analysis (LC-MS/MS) provides sequence infor-
mation on some peptides in the mixture, thus allowing
unambiguous identification of the proteins in artworks [10].
However, application of mass spectrometry to conservation
science still deserves specific considerations arising from the
intrinsic nature of the samples themselves, These include a
minute quantity of available sample, the need for minimally
invasive analysis, the complex and quite variable chemical
composition of the paints themselves, because of the possible
simultaneous presence of several binders and contaminants,
and degradation of the original materials affected by aging and
pollution. Thus, the field of art restoration demands analytical
methods that offer high sensitivity and are unaffected by
endogenous as well as exogenous interferences.
Our attention focused on protein identification by an
analytical approach exploiting the potentials of proteomic
techniques. In particular, we developed a minimally
invasive method based on the direct enzymatic digestion
without protein extraction, and the use of microwaves to
enhance the hydrolysis reaction, followed by the analysis of
the obtained peptide mixture by nanoLC-MS/MS with
electrospray ionization (ESI). Moreover, as additional tool
to tackle the problem of contaminating proteins, we
proposed a strategy based on creating an exclusion list of
mass signals and running replicates of the sample where the
precursor ions detected in the initial run(s) are excluded for
MS/MS in the subsequent run.
We investigated the possible use of proteinaceous bind-
ers in the stunning ensemble of the thirteenth-century
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paintings attributed to Cimabue and Giotto decorating the
vaults of the upper church in the Basilica of St. Francis in
Assisi. Following the earthquake that damaged the church
on September 26, 1997, the two transept vaults showing St.
Matthew the Evangelist and St. Hieronymus collapsed,
crashing the masterpieces into tens of thousands pieces.
During the restoration campaign, some tiny fragments of
the collapsed paintings became available for diagnostic
purposes. Unfortunately, the lack of a systematic analytical
campaign, combined with the uncertain localization of the
painting fragments, and tiny amount of analyzed material,
not representative of the whole painting surface, will hinder
any art history conclusions based on our results.
Before analyzing the samples from the vaults, we tested
and optimized the procedures for a reliable and efficient
identification of proteinaceous materials on several painting
models. Furthermore, to evaluate possible analytical inter-
ferences of the acrylic resin used to consolidate the
fragments, laboratory models treated with the fixative
Paraloid B72 were also considered during experimentation.
Materials and methods
Reagents
Ammonium hydrogen carbonate (AMBIC), ethylenediami-
netetraacetic acid (EDTA) and iodoacetamide were pur-
chased from Fluka; Tri(hydroxymethyl)aminomethane
(Tris), urea, dithiothreitol (DTT), Proteomics sequencing
grade trypsin were from Sigma; formic acid from Baker and
acetonitrile (ACN) were purchased from Romil. Deionized
water was obtained from Millipore cartridge equipment.
Painting samples
Pictorial models were prepared using carbonated plaster as
support to simulate mural paintings. The plaster was
obtained by carbonation of a mixture of lime and sand
with a weight ratio of about 1:3 and the painting layers
were applied directly onto the dried surface (from hours to
days to get dried). Either malachite (CuCO3·Cu(OH)2) or
hematite (Fe2O3) were used as pigments while egg,
skimmed milk, and animal glue were used as binders with
a pigment to binder ratio of 3:1. Additional standards
homologous of those containing malachite were also
prepared and treated with a solution of Paraloid B-72
(CTS s.r.l., Vicenza, Italy) in acetone. A sample of
carbonated plaster of the support without painting layers
was used as laboratory blank and processed in the same
way of the pictorial models.
The analysis of historic painting materials from the
Basilica of St. Francis in Assisi concerned four micro-
samples (labeled GA01, GA07, CA14, and CA17) obtained
from the painting fragments recovered from the collapsed
vaults. The fragments were characterized by white and
yellow (GA01) and red pigments (GA07, CA14, CA17)
and were subjected to surface elemental analyses by non-
invasive X-ray fluorescence spectroscopy (see ref. [13] for
instrumental details), preliminarily to LC-MS/MS inves-
tigations. Elemental profiles showed the major presence of
Ca from the substrate and Fe in all the samples, while Pb
was found only in CA14 and CA17.
All samples of painting layers were available as few
milligrams fragments (1–3 mg).
Sample treatment Samples and blank reference sample
were subjected to different treatments depending on the
following analytical procedures.
Alkaline extraction Micro-samples scraped off the painting
models were subjected to protein extraction by adding
500 µl of 2.5 M NH3 aqueous solution in an ultrasonic bath
for 45 min. The extraction cycle was repeated three times.
The extraction solutions were collected and dried to remove
NH3. The dried residue was resuspended in a denaturant
buffer (guanidine 6 M, Tris 0.3 M, EDTA 10 mM, pH 8.0),
and incubated with 40 mM dithiothreitol (final concentra-
tion) at 37 °C for 2 h to reduce disulfide bonds. The
alkylation reaction was carried out with iodoacetamide at
845 mM final concentration at room temperature in the
dark for 30 min. The samples were desalted with a PD10
column in ammonium bicarbonate 10 mM following
absorbance at 280 nm to single out protein-containing
fractions. The collected fractions were subjected to enzy-
matic hydrolysis.
Enzymatic digestion Samples were digested by sequencing-
grade trypsin. In solution, digestion was carried out in
ammonium bicarbonate 10 mM by addition of 1 μg of
trypsin at 37 °C for 16 h. The reaction was stopped by
lowering pH to ~1 with formic acid and the peptide
mixtures were concentrated and purified using a reverse-
phase C18 Zip Tip pipette tips (Millipore). The peptides
were eluted with 20 μl of a solution made of 50%
acetonitrile, 0.1% formic acid in MilliQ water.
The digestion in heterogeneous phase was carried out
incubating for 16 h, approximately 1–3 mg of solid sample, in
ammonium bicarbonate 10 mM pH 7.5, containing trypsin
0.16 µM. The supernatant was then recovered by centrifuga-
tion and the peptide mixture analyzed by LC-MS/MS.
Microwave-assisted digestion [14] was carried out in
heterogeneous phase on samples prepared as above for
standard heterogeneous phase digestion in solution. The
sample tube was then placed in an ice bath at the center of a
domestic microwave oven (700 W), with the cap open, and
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irradiated for 15 min at the highest power. The supernatant
was then recovered by centrifugation and the peptide
mixture analyzed by LC-MS/MS.
LC-MS/MS analysis
The peptide mixtures were analyzed using a CHIP MS Ion
Trap XCT Ultra equipped with a capillary 1100 HPLC
system and a chip cube (Agilent Technologies, Palo Alto,
CA). After loading, the peptide mixture (8 µl in 0.2%
formic acid) was first concentrated and washed at 4 µl/min
in 40 nl enrichment column (Agilent Technologies chip),
with 0.2% formic acid in 2% acetonitrile as eluent. The
sample was then fractionated on a C18 reverse-phase
capillary column (75 µm×43 mm in the Agilent Technol-
ogies chip) at flow rate of 300 nl/min, with a linear gradient
of eluent B (0.2% formic acid in 95% acetonitrile) in A
(0.2% formic acid in 2% acetonitrile) from 7% to 60% in
50 min.
Peptide analysis was performed using data-dependent
acquisition of one MS scan (mass range from 400 to
2000 m/z) followed by MS/MS scans of the three most
abundant ions in each MS scan.
Alternatively, the peptide mixtures were analyzed using
a 4000 QTrap mass spectrometer (Applied Biosystem)
interfaced with a nano HPLC 1100 system (Agilent
Technologies). A volume of 8 μl of each sample was
loaded at 10 μl/min with 0.1% formic acid on an Agilent
reverse-phase pre-column cartridge (Zorbax 300 SB-C18,
5×0.3 mm, 5 μm) to desalt and concentrate the mixture.
The peptides were separated on an Agilent reverse-phase
column (Zorbax 300 SB-C18, 150 mm×75 μm, 3.5 μm)
and the elution was performed at 0.3 μl/min using a linear
gradient of solvent A (0.1% formic acid, 2% ACN in water)
and solvent B (0.1% formic acid, 2% water in ACN) with
an increase of solvent B from 5% to 65% in 60 min.
Spectra were acquired on a m/z 400–1400 range and the
MS/MS spectra were acquired on the five most abundant
ions in each MS scan, using the best collision energy
calculated on the bases of m/z values and charge state
(rolling collision energy).
Raw data from nanoLC-MS/MS analyses were
employed to query non-redundant protein databases (NCBI,
either on all entries or with the appropriate taxonomy
restriction) using in-house MASCOT software (Matrix
Science, Boston, USA).
Results
In developing of our approach to define a general route
leading to the identification of proteinaceous binders in
paintings we took into account several aspects of the
analytical procedure: (1) protein extraction; (2) protein
hydrolysis, (3) peptide MS analysis; (4) interference from
other components or contaminating background; and (5)
database search.
Methodological development
First, we adopted the most widely used sample pretreatment
for chromatographic analysis, i.e. protein alkaline extrac-
tion [15, 16], to verify the applicability of our proteomic
analyses and to test the interference of other components,
such as pigments or contaminant proteins. As second step,
we developed the strategy to reduce the invasiveness of the
analysis and to be ready to afford artistic samples.
Pigment interference An overview of the literature on the
study and characterization of proteinaceous material in
paintings indicates that analysis is often hindered by the co-
presence in the samples of mineral pigments whose
chemical nature could strongly affect the analytical results
because of formation of complexes between amino acids
and metals [15, 17]. We first tested whether our proteomic
approach was also affected by metals contained in the
pigments. We therefore analyzed painting models prepared
with proteinaceous binders (egg, milk, or animal glue) and
either hematite (a quite commonly used pigment), or
malachite (a copper-containing pigment reported to be
among the most interfering ones). Proteins were extracted
from the painting models with ammonia, as in several
experiments reported in the literature to address for metal
interference [15–17]. Ammonia extraction is not a proce-
dure for suppression of interference when copper is present.
The dried extracted proteins were submitted to reduction
and alkylation steps, enzymatic hydrolysis with trypsin,
followed by LC-MS/MS analysis, as in a routine proteo-
mics experiment and applied to artistic samples by Tokarski
et al. [10]. In this integrated strategy, the peptides generated
in the enzymatic hydrolysis were separated by capillary
chromatography in function of their hydrophobicity, and
then analyzed on-line by tandem mass spectrometry,
revealing information on the aminoacidic sequence beside
the peptide molecular mass.
The spectra obtained were then submitted to MS/MS Ion
Search in the MASCOT software, that allows protein
identification based on raw MS/MS data from one or more
peptides. As an example, in the painting model containing
egg and malachite, five chicken proteins with more than
two peptides each were identified.
As shown in Table 1, the proteinaceous binders were
successfully identified in all the cases, regardless of the
pigment used except for the sample with egg in presence of
hematite, where only keratins could be assigned with a
reasonable score (see below).
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Table 1 Identification of proteins in painting models
Sample Identified protein (accession number) Total scorea Matched sequence
Egg + haematite / / /
Egg + malachite Apovitellenin-1(P02659) 276 LAEQLMEK
LAEQLMEK+M(OX)
NFLINETAR
AGQFLLDVSQTTVVSGIR
DWLVIPDAAAAYIYEAVNK
RDWLVIPDAAAAYIYEAVNK
DWLVIPDAAAAYIYEAVNKVSPR
RDWLVIPDAAAAYIYEAVNKVSPR
Vitellogenin-1(P87498) 193 LALIEVQK
NVNFDGEILK
LTELLNSNVR
QKLALIEVQK
NVPLYNAIGEHALR
VADPIEVGIAAEGLQEMFVR
VADPIEVGIAAEGLQEMFVR+M(OX)
KLSDWKALPRDKPFASGYLK
ALKLMHLLRAANEENYESVWK+M(OX)
Vitellogenin-2(P02845) 167 YVIQEDR
MVVALTSPR
MVVALTSPR+M(OX)
LPLSLPVGPR
MTPPLTGDFR
VGATGEIFVVNSPR
SPQVEEYNGVWPR
EALQPIHDLADEAISR
NAHKAVAYVKWGWDCR
NPVLQQVACLGYSSVVNR
Milk + haematite Alpha-S1-casein (P02662) 28 FFVAPFPEVFGK
YLGYLEQLLRLKK
Milk + malachite Beta-lactoglobulin (P02754) 180 ALPMHIR
TKIPAVFK
TPEVDDEALEK
TPEVDDEALEKFDK
VYVEELKPTPEGDLEILLQK
Alpha-S1-casein (P02662) 130 YLGYLEQLLR
HIQKEDVPSER
FFVAPFPEVFGK
HQGLPQEVLNENLLR
Beta-casein (P02666) 39 AVPYPQR
HKEMPFPK
KVLILACLVALALAR
DMPIQAFLLYQEPVLGPVR
Animal glue + haematite Collagen alpha-1 (I) bovine (P02453) 110 GLPGTAGLPGMK
GANGAPGIAGAPGFPGAR
SGDRGETGPAGPAGPIGPVGAR
GPPGSAGSPGKDGLNGLPGPIGPPGPR
Collagen alpha-2 (I) bovine (P02465) 100 IGQPGAVGPAGIR
GEAGPAGPAGPAGPR
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Contaminant proteins interference In the case of the
sample prepared with egg and hematite, MASCOT identi-
fied many signals arising from the digestion of contami-
nating keratins. The problem of protein contamination is
also very critical in ordinary proteomic analysis, but it is
usually overcome by operating all the chemical manipu-
lations in controlled conditions, thus preventing the sample
from contacting any possible source of contamination from
sampling to sample loading onto the mass spectrometer, as
well as preparing appropriate blank control samples.
Samples coming from artwork have, instead, an intrinsic
contamination problem that originates from environmental
exposure, restoration interventions, or the artist’s tools,
such as the bristle brushes. Moreover, field control samples
are generally not available for samples from artworks.
To circumvent contaminations, we adopted an exclusion
list of the peptides that, in a first LC-MS/MS run allowed
for identification of keratins or other protein contaminants
and that in a further subsequent run have to be ignored by
the mass spectrometer for fragmentation. In classical
proteomic analysis, this expedient avoids “waste” of the
mass spectrometer’s time in fragmenting peptides derived
from trypsin autodigestion or common protein contami-
nants and to mitigate undersampling problems [18]. Our
list was created ad hoc when identification of the binder
was unsuccessful in the first run because of the presence of
other protein contaminants and included all signals that
have been identified as peptides from contaminating
sources, i.e., keratins. In our case, the list contained
64 m/z values, but, in principle, many more signals could
be included.
We therefore repeated the analysis of the standard
sample containing egg and hematite, following the same
LC-MS/MS protocol, but for the addition of the exclusion
list. Databases were interrogated with the new set of data
obtained, and Apovitellenin-1 was identified with a 62
MASCOT score (Table 2), by means of two peptides,
respectively the 63–70 (LAEQLMEK) and the 51–59
(NFLINETAR), thus successfully assigning egg as binder.
Good quality of the fragmentation spectra was obtained in
these conditions (see Fig. 1, which shows the spectrum
originating from the fragmentation of the doubly charged
ion at m/z of 539.30, corresponding to peptides 51–59 of
apovitellin-1). To fully test the strategy, the same procedure
was also successfully carried out on the sample containing
animal glue and hematite that had already provided a
satisfactory identification with the standard LC-MS/MS
analysis, but where some keratins had also been detected.
As result, a general increase of the identification score has
been observed for the proteins already identified in the run
without the ad hoc exclusion list (Table 2), and, moreover,
one more protein was identified (Collagen alpha-2 (XI)
bovine, acc. n. Q32S24) confirming the effectiveness of
such a strategy.
Sample treatment Several different extraction methods
have been proposed in literature, ranging from water to
acidic or alkaline extraction, microwave- or ultrasonic-
assisted [3, 10, 19, 20], which, in most cases provided
similar results. We also tested several protocols, without
observing any remarkable difference among the different
extraction procedures (data not shown). The extraction of
Table 1 (continued)
Sample Identified protein (accession number) Total scorea Matched sequence
GEPGAPGENGTPGQTGAR
GLPGVAGSVGEPGPLGIAGPPGAR
GENGPVGPTGPVGAAGPSGPNGPPGPAGSR
Collagen alpha-1 (III) bovine (P04258) 35 DGASGHPGPIGPPGPR
SGDRGETGPAGPSGAPGPAGSR
Animal glue + malachite Collagen alpha-1 (I) bovine (P02453) 42 GQAGVMGFPGPK+M(OX)
GFPGLPGPSGEPGK
SGDRGETGPAGPAGPIGPVGAR
GARGEPGPAGLPGPPGER
GAPGADGPAGAPGTPGPQGIAGQR
GAPGPAGPKGSPGEAGRPGEAGLPGAK
Different models were tested containing combinations of either malachite or hematite with the most common natural binders, i.e. egg, milk, or
bovine glue. Proteins were alkaline extracted, trypsin digested and analyzed by capillary LC-MS/MS. Proteins were identified searching NCBI
database, with Chordata as taxonomy restriction, with MS/MS ion search MASCOT software (Matrix Science). Only proteins identified with at
least two peptides were considered
a Ions score is −10×Log(P), where P is the probability that the observed match is a random event. Individual ions scores >38 indicate identity or
extensive homology. Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. http://www.matrixscience.
com/help/interpretation_help.html
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proteins can be difficult because of the low solubility of
some of them. Taking advantage of the intrinsic ability of
the proteomic approach to identify proteins from individual
peptides without the need to extract the intact protein
molecule, we also comparatively tested the results obtained
digesting the proteinaceous binder directly on the sample
without any pretreatment. This approach was extremely
interesting, because it can be considered a minimally invasive
one, since the protease in aqueous solution, at neutral pH, can
be deposited on the surface of the sample and then gently
removed without significantly affecting the sample itself.
Moreover, by this approach, even when the protein is
embedded in the painting layer, few peptides protruding from
it can be digested and released by the protease in solution, and
it provides enough material for a reliable identification.
Another set of solid micro-samples from the pictorial
models prepared as reported in the materials and methods
section, with malachite dispersed in the three considered
binders was analyzed without any protein extraction or sample
pretreatment but gently washing the samples with few
microliters of distilled water (about 50 μl per 1–3 mg of paint
fragments), followed by overnight incubation of the solid
sample in heterogeneous phase, at 37 °C in a solution of
ammonium bicarbonate 10 mM, pH 7.5, containing trypsin
0.16 µM. As shown in Table 3, the results obtained with this
minimally invasive procedure are extremely promising as
egg and milk binders were unambiguously identified in two
of three samples. In one sample, 12 proteins from chicken
egg were identified by means of a sequence determination of
98 peptides in total. While in the other sample, the sequence
information of 17 peptides allowed the identification of six
proteins from bovine milk.
The same micro-samples containing malachite were
subjected to microwave-assisted digestion, always in
heterogeneous phase and without any sample pretreatment
other than gentle washing with distilled water. Microwave
irradiation was recognized in the mid-1980s to be an
efficient heating source for chemical application, where
reactions that require several hours under conventional
conditions can often be completed in a few minutes with
very high yields and reaction selectivity [21]. In recent
years, several groups have applied the microwave technique
to protein digestion and shortened the digestion process to
several minutes [14, 22, 23].
Table 3 reports in parallel the results obtained on the
same samples treated with trypsin either with conventional
incubation in water bath overnight at 37 °C or with the
assistance of the exposure to microwave irradiation. The
results obtained were similar but not completely superim-
posable. An increase in the identification score was
observed in most cases when hydrolysis was microwave-
assisted. Most importantly, the sample prepared with rabbit
glue, for which the overnight digestion had not provided
any consistent result, was successfully recognized when the
digestion was performed in the microwave, with two
proteins identified from seven peptides sequences. Possibly,
the increase in thermal motion correlated with microwave
irradiation, as well as the increase in temperature in the
sample itself, improved accessibility of the substrate protein
to the enzyme in the heterogeneous phase.
Finally, both conventional and microwave-assisted tryp-
sin digestion provided satisfactory results also for the
proteomic analysis of samples treated with Paraloid B72
(Table 3). Paraloid B72 is an ethyl methacrylate co-polymer
often used by restorers as paintings fixative due to its
properties of being durable, reversible, and non-yellowing.
The deposition of Paraloid on the painting surface created a
thin, transparent film that could, in principle, impair any
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Fig. 1 MS/MS spectrum of the
doubly charged ion at m/z
539.30, from the hydrolyzed
extract of the egg-based
painting model, presenting
the y and b fragments of
the apovitellenin-1 (P02659)
peptide (NFLINETAR)
2276 G. Leo et al.
Table 3 Identification of the proteins in the binder of painting models by trypsin digestion in heterogeneous phase and with microwave irradiation
Sample Identified protein (accession number) Sample treatment
o/n trypsin digestion Microwave-assisted trypsin
digestion
Total
scorea
Number of
identified peptides
Total
scorea
Number of
identified peptides
Egg + malachite vitellogenin 2 precursor (P02845) 1166 25 1573 40
apolipoprotein B (P11682) 839 19 406 9
Vitellogenin-1 precursor (P87498) 633 14 669 14
Ovalbumin (P01012) 579 8 814 16
ovotransferrin BB type (Q4ADJ7) 428 7 421 8
Apovitellenin-1 precursor (P02659) 323 5 425 7
Lysozyme (P00698) 276 5 260 4
Ovalbumin-related protein Y (P01014) 227 5 179 4
Vitellogenin-2 (P02845) 177 3 / /
Ovoglycoprotein (Q8JIG5) 156 2 / /
TENP protein(O42273) 111 3 / /
Unnamed protein product [Gallus gallus]
(NCBI code: 63524)
80 2 165 3
clusterin (Q9YGP0) / / 53 2
Milk + malachite casein alpha-S1 (P02662) 211 7 213 5
Serum albumin precursor (P02769) 166 3 / /
Beta-casein precursor (P02666) 112 3 96 4
casein alpha-S2 (P02663) 96 2 103 2
kappa-casein precursor (P02668) 92 1 221 5
beta-lactoglobulin (P02754) 67 1 303 7
Alpha-2-HS-glycoprotein (P12763) / / 123 3
Rabbit glue + malachite Chain A, The Structure Of Collagen Type
I (P02453)
/ / 211 5
Collagen alpha-2 (I) chainI (P02466) / / 110 2
Egg + malachite + Paraloid
B-72
Ovalbumin (P01012) / / 784 16
Vitellogenin-2 (P02845) 264 7 755 19
Lysozyme (P00698) 65 2 237 3
Vitellogenin-1 precursor (P87498) 62 1 204 5
apolipoprotein B (P11682) 57 1 375 9
Apovitellenin-1 precursor (P02659) / / 240 4
Ovotransferrin (P02789) / / 182 4
Unnamed protein product [Gallus gallus]
(NCBI code: 63524)
/ / 179 4
Milk + malachite + Paraloid
B-72
casein alphaS1 (P02662) 265 5 229 7
beta-casein (P02666) 199 5 325 9
beta-lactoglobulin (P02754) 132 3 280 7
kappa-casein precursor (P02668) 124 2 204 3
alpha s2 casein (P02663) 86 1 163 3
Rabbit glue + malachite +
Paraloid B-72
Collagen alpha-1 (I) (P02454) 233 5 282 6
Collagen alpha-2 (I) chainI (P02466) 152 3
Proteins were identified searching NCBI database, with Chordata as taxonomy restriction, with MS/MS Ion search MASCOT software (Matrix
Science). Only proteins identified with at least two peptides were considered as significant. An extended version of the table, with the sequence of
the identified peptides, is reported in the Supplementary material
a Ions score is −10×Log(P), where P is the probability that the observed match is a random event. Individual ions scores >38 indicate identity or
extensive homology. Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits http://www.matrixscience.
com/help/interpretation_help.html
Identification of proteinaceous binders in paintings 2277
subsequent analysis unless specific treatment was used to
remove it. In all experiments, the proteinaceous binders
could be successfully and unequivocally identified as egg,
milk, and rabbit glue without removing the protective film
of the acrylic polymer. The observation that the model
sample containing iron and animal glue was not character-
ized while that containing also Paraloid B72 was success-
fully characterized (Table 3), is , however, indicative of the
fact that the unquestionable potentiality of proteomics (with
sensibility in the femtomolar range) is always subjected to
the alea of sampling: the accessibility of the binder within
the sample is a variable that can effectively affect the results
obtained. In the former case, the use of microwave has been
instrumental in producing positive results, possibly because
heating and vibration have made the binder accessible to
the protease. Conversely, the surface created by Paraloid
B72 might not be homogenous enough to prevent the
access of the enzyme to the substrate in the sample.
Application to artistic samples
The experience on laboratory pictorial models prompted us
to propose a general workflow to operate with artistic
samples, where the conventional digestion overnight with
trypsin at 37 °C is the first choice, as the mildest one and
that could be eventually considered as a minimally invasive
treatment of the sample.
The four micro-samples obtained from the fragments
recovered by the collapsed vaults of the Basilica of St.
Francis in Assisi were carefully washed with MilliQ H2O
and incubated overnight with 200 ng of trypsin in
ammonium bicarbonate 10 mM, pH 7.5. The supernatants
were recovered by centrifugation and loaded for the
nanoLC-MS/MS analysis. In the GA07 sample, three milk
proteins could be identified with reasonable score from the
sequence of 11 peptides (Table 4). An example of the
fragmentation spectra that allowed milk binder identifica-
tion is given in Fig. 2. On the contrary, in the other samples,
no significant identification could be obtained.
The latter samples were then subjected to microwave-
assisted trypsin digestion in heterogeneous phase in
ammonium bicarbonate 10 mM, pH 7.5 with 200 ng of
trypsin. The supernatants were recovered by centrifugation
and loaded for the nanoLC-MS/MS analysis. Not even in
this case was significant identification obtained, but for the
GA04 sample, that returned the sequence of a peptide with
a reasonable score spanning from Ala67 to Arg74 of
Apovitellenin-1 precursor. One protein from the sequence
of one peptide. Was that enough to unequivocally identify
the binder? Probably not. According to the still-open
discussion about the guidelines for peptide and protein
identification data, a reliable identification of a protein
requires at least two peptides with a reasonable score [24].
Any further treatment of the samples (exclusion lists,
alkaline or acidic extraction) did not produce any additional
successful identification.
Discussion
With the work presented in this paper, we propose
proteomic strategies for the identification of proteins in
binders of paintings that can be helpful to overcome
requirements and difficulties presented by specific samples.
Table 4 Protein identification in the binder of fragments recovered by the collapsed vaults of the Basilica of St. Francis in Assisi
SAMPLE Identified protein (Accession number) Total scorea Matched sequence
GA07 casein alphaS1 (P02662) 113 FFVAPFPEVFGK
VPQLEIVPNSAEER
HQGLPQEVLNENLLR
kappa-casein C (P02668) 91 YIPIQYVLSR
SPAQILQWQVLSNTVPAK
SPAQILQWQVLSNTVPAK + Deamidation (NQ)
Beta-casein precursor (P02666) 81 DMPIQAFLLYQEPVLGPVR
DMPIQAFLLYQEPVLGPVR + Oxidation (M)
GA04 Apovitellenin-1 precursor (P02659) 78 AGQFLLDVSQTTVVSGIR
CA14 No identification / /
CA17 No identification / /
Proteins were identified searching NCBI database, with Chordata as taxonomy restriction, with MS/MS Ion search MASCOT software (Matrix
Science). Only proteins identified with at least two peptides were considered as significant
a Ions score is −10×Log(P), where P is the probability that the observed match is a random event. Individual ions scores >38 indicate identity or
extensive homology. Protein scores are derived from ions scores as a non-probabilistic basis for ranking protein hits. http://www.matrixscience.
com/help/interpretation_help.html
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Until recently, the most common and reliable approach to
the specific identification of protein media in old paintings
was generally based on acid hydrolysis, followed by
derivatization and quantitative determination of the relevant
amino acids either by GC-MS or liquid chromatography [3].
Proteinaceous binders are, then, identified on the basis of the
relative abundance of the quantified amino acids. With the
amino acid distribution susceptible to significant changes
owing to several effects (i.e., pigment interference, degrada-
tion process, and contamination), this approach may lead to
erroneous results [3, 15].
The proteomic approach to properly identify a protein
requires that the sequence of a few peptides is determined
irrespective of the integrity of the full protein, and it does not
suffer from the problems derived from quantitative determi-
nation of the aminoacidic profile. Indeed, since peptide
sequences and not simple amino acid composition are
determined, they are a much more specific fingerprint of a
protein. Moreover, even few peptides could be enough to
reliably identify a protein [24].
Most importantly, the proteomic approach can overcome
the intrinsic complexity of the protein mixture in a sample.
Conversely, binder identification gains reliability from the
identification of more than a single protein from the same
source (Tables 1, 2, and 3). What artists used were not
single proteins, but natural material, such as egg, milk, or
animal glue, which are composed by multiple proteins in
mixture. The possibility of discriminating and identifying
them constitute an added value of the proteomic approach
for the proper identification of complex mixture of
proteinaceous binders.
The standard proteomic approach had already been proven
successful for the unambiguous and rapid identification of
proteins in binding media [10]. However, samples from
artistic masterpieces pose challenges, requiring specific
strategies to be adopted to be successfully investigated.
Because of the preciousness of the material, ideally, non-
destructive treatment of the sample is mandatory. The
proteomic analysis herein proposed cannot be considered as
fully non-invasive as a spectroscopic one, but the heteroge-
neous enzymatic digestion in aqueous buffer was the softest
treatment that could be proposed, akin to a simple cleaning
procedure. Another advantage of the proteomic approach is
that the integrity of the protein molecule is not required for
reliable results. Just a few peptides protruding from the
material can be recognized by the used enzyme and released
in solution, and their aminoacidic sequences are sufficient to
correctly identify the protein. We therefore suggest as first
choice, especially for surface/top paint layer analysis, the
heterogeneous enzymatic hydrolysis of the sample. The
extension of this strategy to multilayer works is more
complicated, and deserves further attention. The possibility
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from the analysis of the
microwave-assisted trypsin di-
gestion in the heterogeneous
phase of the sample GA07 from
the Vault of Basilica di Assisi,
presenting the y and b fragments
of the casein alphaS1 (P02662)
peptide (FFVAPFPEVFGK)
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of an imaging mass spectrometry [25] of artworks is
extremely attractive and should be considered in the future.
In recent years, several groups have applied the microwave
technique to protein digestion to improve the digestion process
and to shorten it to several minutes [14, 22, 23]. We observed
a general increase of the number of peptides useful to the
identification when the enzymatic digestion was microwave-
assisted (see Table 3), and, most importantly, one artistic
sample provided satisfactory identification of the binders
when hydrolysis was carried out in the microwave oven.
We therefore suggest, as a general practice, to treat
samples from artworks with heterogeneous hydrolysis at
37 °C at neutral pH. When not successful, the same sample
can be subsequently submitted to more invasive procedure,
such as microwave-assisted proteolysis.
It is worth mentioning that, to verify whether the
negative results obtained even with microwave-assisted
proteolysis were due to the procedure adopted or to the
sample itself, unsuccessful samples were also submitted to
the most traditional extraction methods for proteins (i.e.,
alkaline or acidic treatment) prior to classical enzymatic
digestion and LC-MS/MS analysis. However, positive
identification of the binders was never produced.
Another source of complication for this kind of sample
arises from environmental contaminations. We propose a
strategy of general applicability to circumvent the problem,
by elaborating an exclusion list of the contaminating
peptides that, in a first run have been fragmented and that
the mass spectrometer had to ignore for fragmentation in a
further subsequent run. Such a strategy can constitute an
additional tool, to be used in difficult cases where abundant
contaminant proteins have been detected.
However, although definitively successful with 90% of
the model samples we tested, negative results were also
obtained with artistic samples, possibly because of sam-
pling (i.e., in a piece of the painting where the searched
binder was less abundant or even absent, or where more
contaminants were present). Samples from masterpieces
like those we worked on, which could not be provided in
several replicas, have experienced different and severe
contaminations, and aging of the organic material thus
dramatically increasing the complexity of the sample and
complicating the identification of the components.
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